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CHAPTER 1
GENERAL INTRODUCTION AND 
THESIS OUTLINE
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Chapter 1
INTRODUCTION TO THUMB BASE OSTEOARTHRITIS
The thumb base joint (CMC-1) is a saddle joint, connecting the trapezium and 
first metacarpal bone into a highly mobile joint. Located at the base of the thumb, 
the CMC-1 allows positioning the thumb relative to the fingers, enabling func-
tional grasps and dexterity.
While allowing a large Range Of Motion (ROM), the CMC-1 is relatively unstable 
by nature due to limited ligamentary support and the CMC-1 suffers from high 
joint loading.1-6
Osteoarthritis (OA) of the CMC-1 arises due to multiple factors, such as biological 
factors, genetic associations and several factors related to characteristics 
of the joint, such as CMC-1 instability.1-3,7-11 CMC-1 OA can be classified by the 
Eaton classification, which runs from stage I (no degeneration) to IV (extensive 
degeneration of both the CMC-1 and scaphotrapeziotrapezoid joint (STT))11, but 
radiographically-diagnosed CMC-1 OA is only modestly associated with clinical 
symptoms.12,13
WHAT IS THE IMPACT ON PATIENTS AND SOCIETY?
CMC-1 OA is a common condition in the elderly, with a symptomatic prevalence 
of 7% and 2% amongst females and males aged ≥50 years; the radiographic 
prevalence is even higher.7,12,14 These prevalence numbers are likely to increase 
due to the aging population15,16 and the associated direct treatment costs and 
societal costs are substantial.17
Patients with CMC-1 OA often experience thumb pain and limitations in hand 
function and activities of daily life (ADL).12,13 Furthermore, as ligamentous laxity 
increases, dorsoradial subluxation may occur in the CMC-1 joint, followed by 
metacarpophalangeal (MCP-1) hyperextension, interphalangeal (IP-1) hyper-
flexion, and limited first web space: a typical z-deformity.1-3,6 Additionally, patients 
with CMC-OA often present clinical features such as thenar muscle wasting, 
nodes and joint synovitis.3,6,7,12,13
11
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HOW TO TREAT PATIENTS WITH CMC-1 INSTABILITY OR OA?
Present treatment for CMC-1 instability or subsequent OA aims to reduce pain 
intensity and improve hand function and ADL. Current guidelines and systematic 
reviews advise starting with non-surgical treatment, which may include anal-
gesics, intra-articular injections, orthotics and exercise programs.18-20 While 
these interventions are used widely, evidence supporting these non-surgical 
treatments, especially exercise programs, is limited.6,18-25 Nonetheless, while 
analgesics, intra-articular injections, and orthotics provide short-term results18-
21,23, exercise programs aim to provide a long-term solution by improving lifestyle, 
joint mechanics and function.6,22,24,25 Theoretically, improving joint mechanics 
might be very beneficial, both for patients with CMC-1 instability as patients 
with CMC-1 OA, since improving joint mechanics might reduce subluxation and 
synovitis, thereby preventing further joint degeneration in later life.1-3,9-11Most 
exercise programs aim to improve active stability and positioning of the CMC-1 
into a more stable position of extension/abduction, since the CMC-1 becomes 
unstable during flexion and adduction.1-3,9,22,24,25 Additionally, exercises focus on 
maintaining the first web space and pinch strength.3,6,23-25 Usually, this includes 
coordination and strengthening exercises of the intrinsic thenar muscles 
(except the adductor pollicis), extensor pollicis brevis and the first dorsal inter-
osseous.3,6,24 Exercises are often complemented by orthotics, to reduce sublux-
ation and inflammation, but orthotics are also prescribed as a stand-alone 
treatment.3,23 Despite this clear treatment rationale, the effectiveness of non-sur-
gical treatment, or exercises in particular, remains unclear since non-surgical 
treatment is only studied to a limited extent.
When non-surgical treatment fails to alleviate symptoms, conversion to surgery 
may be considered. In the past years, a variety of surgical techniques are 
described, which may include a trapeziectomy, with or without Ligament Recon-
struction and/or Tendon Interposition (LRTI).19,26,27 CMC-1 arthrodeses and 
implants are also used, but these techniques are associated with a higher risk 
of complications (e.g., non-union or dislocation).19,26,27 Surgical treatment comes 
with prolonged recovery, discomfort, and limitations for the patient and high 
costs for society.19,28,29 Furthermore, it has been reported that for a trapeziectomy 
both with or without LRTI, 11-33% of the patients would not consider the same 
treatment again under the same circumstances.28,30-33 Some studies emphasize 
the importance of postoperative rehabilitation for patients who underwent CMC-1 
arthroplasty to reduce pain and improve hand function and ADL.19,26 However, the 
1
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lack of consensus on the content of postoperative rehabilitation for patients who 
underwent CMC-1 arthroplasty is acknowledged as well and optimal immobili-
zation period and time points for the initiation of ROM or strengthening exercises 
are unclear.19,26 It is, for example, unclear if concepts such as early active rehabil-
itation are equally safe and effective in CMC-1 resection arthroplasty as in other 
surgical treatments, such as hip replacement34, tendon repair in the hand35,36 or 
open reduction and internal fixation for distal radius fracture.37
WHAT FACTORS PREDICT OUTCOMES AND TREATMENT 
CHOICES?
It is unclear which factors predict outcomes of treatment for CMC-1 OA, such 
as conversion to surgical treatment following non-surgical treatment or acute 
postoperative pain following surgical treatment. Over the last decade, multiple 
studies demonstrated that psychological characteristics, such as depression, 
anxiety, negative illness perception and pain catastrophizing are highly prevalent 
in patients with several types of OA.38-47 However, little is known about (differ-
ences in) psychological characteristics and treatment expectations in patients 
with CMC-1 OA scheduled for non-surgical or surgical treatment. Furthermore, 
previous studies indicate that pain catastrophizing48-53, female sex48,49,51, preoper-
ative pain48-50,52,53, expected pain53, higher age48-50,52,53, previous chronic pain48,50, 
higher anxiety48-50,52,53, surgical fear53, and less optimism48,49 results in higher 
acute postoperative pain after hip, knee or other elective surgery. However, it is 
unknown if these factors also predict acute postoperative pain in patients surgi-
cally treated for CMC-1 OA.
HOW TO MEASURE OUTCOMES PATIENTS WITH HAND AND 
WRIST CONDITIONS?
In the past years, the value-based healthcare (VBHC) framework by Porter and 
Teisberg54,55 has been recognized as a model to improve the quality of healthcare 
against affordable costs. Within this framework, value is defined as the outcomes 
achieved divided by the costs.54,55 Measuring outcome is therefore a key aspect 
of VBHC, preferably by using a condition-based standard set of outcome tools 
at predetermined time points independent of treatment type or healthcare 
profession.54,55 To implement VBHC, government organizations endorse the 
standard sets developed by the International Consortium for Health Outcome 
Measurement (ICHOM).56,57 Although some efforts on standardizing outcome 
13
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measurement exist in hand and wrist care58,59, such an internationally adopted 
standard set for measuring outcomes of hand and wrist care is currently 
unavailable. The lack of such a standard set makes it very difficult to make valid 
comparisons, both in daily clinical practice and research, e.g., following different 
treatments for patients with CMC-1 OA. Furthermore, the creation of a standard 
set will allow benchmarking and comparing different treatment centers, facil-
itate shared decision making and improve quality of healthcare.54,55 Therefore, 
an international, minimum standard set of outcome measures that matter most 
to patients with hand and wrist conditions is needed. In addition, innovative 
approaches for measuring outcome in routine daily hand and wrist care are 
needed.
GENERAL AIMS AND OUTLINE
The outcomes of non-operative and postoperative treatment, predictors for 
treatment choices and predictors for treatment outcome are insufficiently 
studied in patients with CMC-1 OA. Further, standardization of and innovative 
approaches for outcome measurement in hand and wrist conditions are needed. 
Simple rules of thumb are not sufficient or applicable for treating patients with 
CMC-1 OA, but in contrast, evidence-based, patient-, and treatment-specific 
guidelines are needed.
Therefore, in Part 1 of this thesis, the outcomes following non-surgical treatment 
for CMC-1 OA and CMC-1 instability are presented in Chapter 2 and 4, respec-
tively. Additionally, Part 1 investigates the added value of exercise therapy 
in addition to an orthosis in patients with CMC-1 OA in Chapter 3, and Part 1 
investigates predictors for the outcomes of non-surgical treatment in Chapter 
5. Subsequently, in Chapter 6, patients scheduled for CMC-1 resection arthro-
plasty are compared with their non-surgical counterparts in terms of sociodemo-
graphics, clinical, and psychological factors.
In Part 2 of this thesis, a systematic review on the postoperative rehabilitation 
following CMC-1 resection arthroplasty is performed in Chapter 7 and the 
outcomes following shorter and longer immobilization after CMC-1 resection 
arthroplasty are compared in Chapter 8. Additionally, Part 2 investigates 
predictors for acute postoperative pain following CMC-1 resection arthroplasty 
in Chapter 9.
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Part 3 presents the development, design, and implementation of the hand and 
wrist study cohort in Chapter 10. Moreover, Part 3 describes the process of 
international standardization of outcome measurement in hand and wrist care by 
developing the ICHOM standard set for hand and wrist conditions in Chapter 11.
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Chapter 2
ABSTRACT
Introduction: Initial treatment for symptomatic carpometacarpal (CMC) osteoar-
thritis (OA) of the thumb is usually non-surgical. However, evidence on the effect 
of a hand orthosis and hand therapy for mid and long-term results is limited, 
and it is unknown how many patients undergo additional surgical treatment. 
Therefore, the aim of this study is to describe the outcome of a hand orthosis and 
hand therapy for CMC OA in a large cohort study, and to evaluate the conversion 
rate to surgical treatment.
Methods: In this multicenter, prospective cohort study, patients treated with a 
hand orthosis and hand therapy for primary CMC OA between 2011 and 2014 
were included. Pain (visual analog scale) and function (Michigan Hand Question-
naire) were measured at baseline, 6 weeks, 3 months, and at 12 months after the 
start of treatment. All patients converted to surgery were recorded between 2012 
and 2016. Outcome was compared with baseline, and post hoc comparisons 
were made between patients who were not converted to surgery and patients 
who were converted to surgery after initially receiving a hand orthosis and hand 
therapy. Lastly, subgroup analysis was performed based on baseline pain levels.
Results: After a mean follow-up of 2.2 ± 0.9 years, 15% of all patients were surgi-
cally treated. In the group that was not converted to surgery, pain (visual analog 
scale) significantly improved from 49 ± 20 at baseline to 36 ± 24 at 12 months. The 
Michigan Hand Questionnaire score was essentially unchanged from 65 ± 15 at 
baseline to 69 ± 10 at 12 months. Post hoc testing showed that improvement in 
pain was only significant between baseline and 6weeks, and thereafter stabilized 
until 1 year after the start of treatment. The group that eventually converted to 
surgery did not show any improvement in pain and function during conservative 
treatment.
Conclusions: In this cohort of patients with thumb CMC OA who underwent 
hand therapy including an orthosis, 15% of the patients underwent additional 
surgical treatment. The patients (85%) who did not undergo surgery improved in 
pain and function, although only improvements in pain were significant and clin-
ically relevant. Most improvement was seen in the first 6 weeks and stabilized till 
1 year after the start of treatment.
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INTRODUCTION
Treatment guidelines for carpometacarpal (CMC) osteoarthritis (OA) of the thumb 
usually advise a period of non-surgical treatment before considering surgical 
treatment for all patients with primary CMC OA.1-4 Non-surgical treatment for 
CMC OA can consist of orthosis immobilization, intra-articular steroid injections, 
hand therapy, or a combination of modalities.5-7 When non-surgical treatment fails 
to provide enough pain relief or functional improvement in daily life, a decision 
may be made to proceed to surgical treatment.
However, the existing evidence on the effectiveness of non-surgical treatment 
is of poor quality, primarily due to small sample sizes, non-generalizable study 
samples, or short follow-up time. In addition, most of these studies are limited 
to only comparing different types of orthoses and not the effect of combination 
therapy, that is, an orthosis with hand therapy.8-10 For example, a systematic 
review by Egan and Brousseau8 showed that hand orthoses may help to relieve 
pain, but sample sizes of the included studies were very small (N=  10-37) and 
follow-up times relatively short (1 wk to 6 mo). In addition, hand function was not 
measured. Another systematic review on comparative studies of hand orthoses 
or hand therapy of CMC OA9 concluded that a hand orthosis or hand therapy 
may provide pain reduction, but all studies had a short follow-up time (2 wk to 3 
mo) and study samples comprising only older individuals (70-90 y). In addition, 
none of the studies evaluated outcome after a combination of a hand orthosis 
and hand therapy.1,2,4,11
A recent meta-analysis of Aebischer et al.10 based on studies on hand orthoses, 
hand therapy, and nonpharmaceutical treatment for CMC OA concluded that 
combination therapy is more effective for pain than single interventions. Because 
of the paucity of available evidence, it is unknown how many patients respond 
favorably, and how many patients who initially received a hand orthosis and hand 
therapy are eventually converted to surgical treatment. In addition, the timing of 
surgical intervention, in relation to receiving a hand orthosis and hand therapy 
(e.g., how long should surgery be delayed if patients do not respond to a hand 
orthosis and hand therapy), is unknown as well.
Therefore, the aim of this study was to describe the one-year outcome of 
providing a hand orthosis and hand therapy for thumb CMC OA, and to identify 
when and how many patients need additional surgical treatment.
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METHODS
Study population
This study was conducted as an observational, prospective cohort study, 
performed in a private hand surgery clinic (Xpert Clinic, the Netherlands), 
consisting of 11 locations, with 13 European board-certified hand surgeons 
delivering care. Hand therapy was given by more than 50 hand therapists at 
specialized hand therapy clinics, located in or near an Xpert clinic (Handtherapie 
Nederland, the Netherlands).
All patients evaluated at the outpatient clinic between January 2011 and 
November 2014, clinically diagnosed with CMC OA and treated with a hand 
orthosis and hand therapy, were asked to participate in this study. All patients 
received an x-ray of their hand to confirm the clinical diagnosis and to grade the 
severity of CMC OA. However, because the grading of the osteoarthritis was 
done in a nonsystematic way, we did not further analyze the CMC OA severity 
based on the x-ray images. The study was approved by the local institutional 
review board, and all patients signed an informed consent. Exclusion criteria 
were previous CMC surgery, post-traumatic OA, isolated scaphotrapeziotrap-
ezoid OA on the x-ray, or a history of prior intra-articular corticosteroid injections 
in the thumb CMC joint. Furthermore, patients with active trigger finger, carpal 
tunnel syndrome, OA of the interphalangeal joints, or de Quervain tendonitis 
were excluded when they received simultaneous treatment for these conditions 
at the start of treatment.
Intervention
Treatment was based on the Dutch treatment guideline.1 In general, treatment 
consisted of prescribing a custom-made or prefabricated orthosis (based on the 
preference of the surgeon, hand therapists, and insurance of the patient) and 
2 sessions of hand therapy per week of an average duration of 25 minutes per 
session. The hand therapists all received the same internal training on how to 
treat CMC OA with hand therapy. However, this was a pragmatic study in the 
sense that the hand therapy was not strictly protocolled and controlled, but eval-
uated, based on clinical practice. Therapy sessions were planned by judgment 
of the therapist and ability and availability of the patient. In some cases, patients 
received only a hand orthosis without further treatment, for example because of 
their insurance or schedules.
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The treatment was divided into 2 phases: phase I (week 0-6) included instruc-
tions to wear the hand orthosis almost 24 hours per day and consisted of hand 
therapy for optimizing thumb position (training pinch and grasping movements 
without hyperextension in the metacarpophalangeal thumb joint and without 
CMC adduction) and using a full thumb range of motion (where the specific coor-
dination of the intrinsic and extrinsic muscles of the thumb is trained); in phase 
II (week 7-12), the hand orthosis was slowly phased out: the patient was advised 
to use the hand orthosis only during heavy activities, depending on pain level 
and the patient’s ability to perform activities with a stable thumb position. The 
hand therapy during this phase focused on maintaining the pain reduction, intro-
ducing the learned stability during daily activities and improving thenar muscle 
strength. In this phase, fewer hand therapy sessions were scheduled and 
patients performed more home exercises, up to 4-6 times a day. The number 
of prescribed home exercises ranged between 3 and 6 exercises per day, with 
10-15 repetitions each, depending on the individual patient and the level of pain.
After this period of supervised therapy, patients were encouraged to keep 
doing the exercises, and patients were allowed to use the hand orthosis when 
necessary. No corticosteroid injections were given for their CMC OA during or 
after hand therapy, and no anti-inflammatory medication was prescribed by the 
surgeon.
Measures
Baseline demographics of all patients, including duration of complaints, comor-
bidity, and hand medical history, were collected before the start of treatment. 
Outcome measures were recorded before the start of the treatment, at 6 weeks, 
at 3 months, and at 12 months through our web-based outcome registration. 
All patients had a follow-up appointment with their hand surgeon after approx-
imately 3 months, during which progress was evaluated.
Pain and function
Pain was measured with a visual analog scale (VAS) during 2 situations: pain 
during activities and pain experienced during the last week. To measure patient-
rated hand function, the Michigan Hand Questionnaire was used (MHQ, Dutch 
Language Version; 0 = poorest function, 100 = ideal function).12-14 The MHQ is a 
self-reported questionnaire with 6 domains and 37 items. The Minimal Clinically 
Important Difference ranges between 9 and 13 points for total MHQ and between 
11 and 14 points for the subdomain pain, for nontraumatic hand conditions.15
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Surgery
All patients had a follow-up appointment with their hand surgeon after approxi-
mately 3 months; further follow-up was only scheduled when indicated. Surgical 
intervention was discussed when patients did not respond well to the hand 
orthosis and hand therapy and had functional impairments and/or residual pain. 
Together with the surgeon, the decision to operate was made based on the 
symptoms of the patient. All surgeries performed between January 2012 and 
February 2016, together with time until surgery, were retrieved from the clinical 
records, independent of whether patients responded to the questionnaires. 
These results were separately analyzed and not combined with the results of 
the questionnaires, which made it possible to report conversion to surgery on all 
patients eligible for inclusion (Figure 1).
Statistical analysis
We performed a sample size calculation to determine the number of patients 
required to detect a conventional effect size of 0.15 for pain (VAS) after receiving 
a hand orthosis and hand therapy. The required sample was 90 participants.16
Baseline demographics were available in more than 98% of the patients. 
Because data were collected during daily clinical practice, we had a substantial 
proportion of nonresponse during follow-up (Figure 1). In addition, the data that 
were missing at 12 months consisted of both patients who did not fill in the ques-
tionnaires and patients who had already converted to surgery. Because of this, a 
thorough non-responder analysis on the whole group was performed using χ2 
statistics or t-tests for all variables measured at baseline based on the response 
at 1 year. No significant differences were found at baseline between patients who 
filled in the questionnaires at follow-up and patients who did not fill the ques-
tionnaires at follow-up. In addition, Little’s MCAR test17 for all separate outcome 
variables showed that more than 95% of the outcome variables were missing at 
random. We therefore performed all main analysis with patients who responded 
at all follow-up measurements (complete case analysis). As a secondary analysis, 
we performed multiple imputations to compare the outcome for consistency 
with the complete case analysis. We performed multiple imputation by chained 
equations by fully conditional specification and used all patients. We imputed 10 
times and compared the imputed data with the complete case data using t-tests 
(Appendix A). Here again, no significant differences were found between the 
imputed analysis and the complete case analysis.
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Hereafter, analysis of variance tests with repeated measures were performed to 
compare baseline and follow-up measurements, combined with Tukey’s post-hoc 
tests, to determine between which follow-up points the significant difference 
existed. In addition, we compared patients who eventually received surgery 
with patients who did not convert to surgery using independent samples t-tests. 
Because the decision to operate was made from 3 months onward, patients 
who eventually received surgery filled in the questionnaires only until 3 months. 
This allowed us to compare the group that was not operated with the group that 
converted to surgery up to 3 months without having to impute any data.
To study the influence of different baseline pain levels on outcome after 
treatment, we divided patients into 4 subgroups based on baseline pain level 
(VAS), correcting for regression to the mean, which can occur if a variable is 
extreme on its first measurement; in that case, it will tend to be closer to the 
average on its second measurement.18 Corrections were made based on a test-
retest reliability of 0.85 for VAS pain.19 For all tests, we considered a P-value 
smaller than .05 as statistically significant.
Table 1. Baseline characteristics
Baseline Characteristics Total
(n=122)
Variables N % or mean ± SD
Age (years) 126 60 ± 8
Duration symptoms (weeks) 126 40 ± 72
Sex Female 91 72
Treated hand Right 63 50
Workload
No work 67 53
Light physical work 22 18
Moderate physical work 30 24
Heavy physical work 7 6
Dominance
Left 14 11
Right 107 85
Both 5 4
Abbreviations: SD = Standard deviation
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RESULTS
Study population
Between January 2012 and November 2014, 1,033 patients with complaints of 
CMC OA visited Xpert Clinic, of whom 809 were eligible for inclusion. Of those 
patients eligible for inclusion, 122 completed all follow-up measurements without 
undergoing surgery and were used to analyze the primary outcomes: pain and 
function. In addition, 28 patients who underwent surgery completed all follow-up 
measurements until 3 months. Figure 1 shows the flowchart and Table 1 shows 
the baseline characteristics.
Figure 1. Flowchart of the study. CTS, carpal tunnel syndrome; DIP, distal interphalangeal joint; PIP, 
proximal interphalangeal joint.
To study conversion to surgery, we included all 809 patients, because the 
recording of conversion to surgery was independent of the response of the 
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patients to the questionnaires. Patients were followed for a minimum of 1.5 
years to verify whether they had undergone surgical intervention. After a mean 
follow-up of 2.2 ± 0.9 (±standard deviation) years, 124 patients (15%) were surgi-
cally treated (Figure 2). The majority of the surgically treated patients (n  =  93; 
75%) were operated on within the first year after the start of hand therapy and the 
median number of days until surgery was 160 (interquartile range, 40-280) days.
Figure 2. Survival analysis. Chart shows the duration of time until receiving surgery. On the y axis 
the proportion of patients not operated is shown, and on the x axis the number of days since the start 
of a hand orthosis and hand therapy. A total of 15.3% converted to surgery with a median number of 
days until surgery of 5 months.
Pain
The patients who did not convert to surgery showed a significant decrease 
in pain during the last week, VAS from 49 ± 20 (mean ± standard deviation) at 
baseline to 36 ± 24 at 12 months after the start of treatment (P < .05), and showed 
a significant decrease in pain during activities (VAS) from 60 ± 21 to 44 ± 27 after 
12 months (P < .05) (Figure 3A).
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Figure 3. Outcome in pain (VAS) and function (MHQ). In the group that was not operated, there was 
a significant improvement in pain between baseline and 12 months. Furthermore, most improvement 
was seen in the first 6 week. In the group that was eventually operated, there was no significant im-
provement between baseline and 3 months after receiving a hand orthosis and hand therapy. Error 
bars indicate standard errors.
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Post hoc tests showed that improvements were only significant between 
baseline and 6 weeks: 14.5 points improvement (95% confidence interval [CI], 7.2 
- 21.8; P < .05) for pain during the last week and 17.6 points improvement (95% 
CI, 9.8-25.4; P < .05) for pain during activities. Between 6 weeks and 12 months, 
no significant change occurred: 1.8 points mean difference (95% CI, -9.1 to 5.5; 
P =  .922) for pain during the last week and 1.7 points mean difference (95% CI, 
-9.5 to 6.1; P = .945) for pain during activities.
The patients who chose to convert to surgery after 3 months had at baseline (at 
the start of receiving a hand orthosis and hand therapy) a mean score of pain 
experienced during the last week of 62 ± 17, and a mean score of pain during 
activities of 67 ± 25. At follow-up, no significant change was seen between 
baseline and 3 months in pain experienced during the last week (1.6 points mean 
difference, 95% CI, -6.1 to 9.2; P = .677) or pain during activities (1.5 points mean 
difference, 95% CI, -11.0 to 8.0; P = .749).
When comparing patients who were converted to surgery with the patients who 
were not converted, we observed that the converted patients had at baseline 
13.0 (95% CI, 5.0-21.0; P < .05) points higher pain experienced during the last 
week and 6.6 (95% CI, -2.3 to 15.5; P =  .143) points higher pain during activities 
compared with the patients who were not converted. At 3 months the differences 
increased, with patients who were converted having 22.4 (95% CI, 12.9-32.0; P < 
.05) points higher pain experienced during the last week and 25.6 (95% CI, 15.9-
35.4; P < .05) points higher pain during activities compared with the patients who 
were not converted.
Function
The patients who did not convert to surgery showed a significant change in 
function (total MHQ score) from 65 ± 15 at baseline to 69 ± 10 after 12 months 
(P < .05) (Figure 3B). Post hoc tests showed that for function, improvement was 
significant between baseline and 6 weeks: 6.2 (95% CI, 1.2-11.2; P < .05) points 
improvement, but the improvement in function was no longer significant at 1 year 
after the start of treatment (mean difference + 3.7 points; 95% CI, -0.95 to 11.2; 
P = .172) (Figure 3B).
The patients who chose to convert to surgery after 3 months had at baseline a 
mean function score of 58 ± 18. At follow-up, no significant improvement was 
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seen between baseline and 3 months in function (0.2 points mean difference; 
95% CI, -4.4 to 4.1; P = .939).
When comparing patients who were converted with the patients who were not 
converted, we observed that the converted patients had at baseline 7.0 (95% 
CI, 0.2-13.7; P = .044) points less function compared with the patients who were 
not converted. At 3 months the differences increased, with patients who were 
converted having 15.0 (95% CI, 8.5-21.4; P < .05) points less function compared 
with the patients who were not converted.
Figure 4. Subgroup analysis of Visual Analogue Scales (VAS) for pain during last week (A) and pain 
during activities (B) based on baseline pain levels. The figure shows the outcome of treatment on 
subgroups. Patients with high baseline pain improved in outcome, whereas patients with low baseline 
pain deteriorated in outcome. Error bars indicate standard errors.
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Subgroup analysis
When grouping patients who were not converted to surgery based on the severity 
of baseline pain (Figure 4), pain only improved significantly in groups where pain 
at baseline was higher than 50 on average (VAS); the higher the average pain 
level at baseline, the higher the reduction in pain. In contrast, patients with a 
baseline level of 25 or lower (VAS) showed a significant increase in pain after a 
hand orthosis and hand therapy.
DISCUSSION
In this prospective cohort study using data collected as part of routine clinical 
care, we found that after a mean follow-up of 2.2 years, 15% of the patients 
treated with a hand orthosis and hand therapy underwent surgical treatment, 
after a median duration of 5 months from receiving a hand orthosis and hand 
therapy. When we divided patients who eventually did or did not convert to 
surgery, we found that the group that was not converted to surgery showed 
significant improvement in pain within 1 year after being treated with a hand 
orthosis and hand therapy for CMC OA. Most of this improvement was gained 
in the first 6 weeks of treatment, where after improvements were maintained. In 
addition, we saw that both pain and functional outcome were worse in the group 
that eventually received surgery, both at baseline and at the follow-up measure-
ments. In the group that was converted to surgery, no improvement in pain and 
function was seen at follow-up measurements. Subgroup analysis, based on 
baseline pain levels, showed that patients with mean baseline pain levels of 50 
or higher had a significant reduction in the amount of pain experienced, whereas 
patients with mean baseline pain levels of 25 or lower had a significant increase 
in pain.
The improvements on a group level in pain and function after a hand orthosis 
and hand therapy are in line with the limited available evidence. For example, 
Villafañe et al.20 randomized 60 patients with CMC OA to manual therapy or a 
placebo intervention and found that the manual therapy group had a significant 
pain reduction after 1 month, whereas the placebo intervention did not reduce 
pain. Between 1 and 2 months after the start of manual therapy, pain did not 
change in this study, which is in line with our finding that pain reduced mostly 
within the first 6 weeks, although manual therapy in their study had a very 
different treatment protocol compared with our study, including passive nerve 
mobilization and joint mobilization. Similarly, the small retrospective study of 
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O’Brien and Giveans21 described that, within 90 days, hand therapy significantly 
reduced pain from 3.3 to 2.7 on a 1-5 Likert scale.
It should be noted that not all significant improvements in this study were clin-
ically relevant. In our study, we found a clinically relevant improvement of 12 
on the MHQ subdomain pain.15 However, the improvement on the total MHQ 
score of 4 points did not exceed the Minimal Clinically Important Difference of 
9-13 points15, indicating that the improvement in function may not be clinically 
relevant. Because Frouzakis et al.22 found that pain reduction is the primary 
reason for patients to seek treatment, the clinically relevant pain reduction in this 
study supports the implementation of a hand orthosis and hand therapy in these 
patients.
Although we found that only approximately 15% of our patients received addi-
tional surgical treatment, we are not aware of any other studies reporting this 
outcome after a hand orthosis and hand therapy. Wajon et al.23 concluded 
in a Cochrane review that they could not provide any information on the right 
time to convert to surgical treatment. Berggren et al.24 reported that 23 of 33 
patients (70%) waiting for operation could be treated successfully with hand 
therapy within 7 months before surgery, and within 7 years, only 2 more patients 
underwent additional surgical treatment. However, because patients in this study 
were already planned for surgery, we cannot compare this rate with our study.
This study has a number of specific strengths and limitations. An important 
strength of this study is the large sample size of 122 patients. Another strength is 
the pragmatic nature of this study, recording how hand therapy is performed in 
actual clinical practice, outside of the more controlled and potentially less natural 
setting of a randomized controlled trial. At the same time, the natural setting 
is also a limitation of the study because treatment was not completely stan-
dardized. Therapists adjusted treatment to the specific condition of the patient, 
severity of the complaints, time schedule, and type of insurance of the patient. 
Treatment in the form of purely an orthosis is very different compared with an 
orthosis and hand therapy. In addition, compliance with the treatment protocol 
by the participants was not recorded. The natural setting also resulted in the 
proportion of missing data, another limitation of our study. An important reason 
for missing data is that patients who had residual pain or functional complaints 
after being treated with hand therapy and an orthosis received surgical treatment 
and therefore were “missing” after 12 months. Another possible reason for our 
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missing data is that patients may have gone elsewhere to receive treatment. 
However, because these patients visited this center seeking treatment and, as a 
part of protocol, first received hand therapy and orthosis, our experience is that 
only a very small portion of patients elect to undergo surgery elsewhere when 
hand therapy leads to insufficient relief of symptoms.
Another limitation of this study is that it focuses only on the combination of an 
orthosis and hand therapy, but cannot conclude anything on the outcome of 
other treatment strategies, such as topical or oral anti-inflammatory medication or 
intra-articular corticosteroid injections. We did not perform radiological staging, 
because the Dutch guideline1 for the treatment of CMC OA indicates that x-rays 
can support the diagnosis of CMC OA but that radiological staging according to 
Eaton and Glickel does not have added value, due to only fair interobserver reli-
ability and only fair correlation with symptoms. Inherent to the cohort nature of 
this study is that a control group is lacking. Therefore, this study does not provide 
information on what the relative effectiveness is compared with, for example, no 
treatment or direct surgical treatment. Finally, the relatively short follow-up is a 
limitation, because decisions regarding surgical treatment in patients with OA 
usually develop over years, and are influenced by various other factors.
Our results support clinical guidelines stating that treatment for CMC OA should 
first be non-surgical, because, at a group level, outcome significantly improved 
up to 1 year after treatment and the majority of patients did not undergo addi-
tional surgical treatment within the first 2 years. Subgroup analysis indicates that 
initial non-surgical treatment with an orthosis and hand therapy is also relevant, 
particularly for patients with higher baseline pain levels, because this subgroup 
showed the largest improvement in pain. The implication of our findings for 
patients with relatively low baseline pain levels is less clear. In this group, pain 
significantly increased at follow-up. However, they had a relatively low conversion 
to surgery rate. A possible explanation may be that these patients had only minor 
impairments before treatment, and became more aware of the pain in their thumb 
and the impairments in daily living during their treatment, which could contribute 
to the increased pain at 12 months after receiving an orthosis and hand therapy.
Although we found that the median duration to surgery was 5 months, this 
finding was subject to multiple local factors, and therefore, may be less general-
izable. For example, as a rule, decision making on additional surgical treatment 
was scheduled at the outpatient clinic after 3 months, when treatment was 
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completed. In addition, factors such as waiting lists, personal factors, holidays, 
or financial reasons and insurance policies influenced the timing of surgery. To 
answer the question about the best timing to convert to surgery, a different study 
design would be preferred, using more frequent measurements.
For future research, it would be interesting to study the effect of patient 
adherence to therapy on treatment outcome. Future studies should also focus on 
identifying prognostic factors to predict which patients will have a good outcome 
after a hand orthosis and hand therapy and which can benefit more from early 
surgery. In addition, future research should focus on the optimal timing of this 
decision. Moreover, other possible predictors that can influence treatment 
outcome should be evaluated, such as coping mechanisms, catastrophizing, 
quality of life, emotional, and mental health.
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Supplementary Table 1. When applying Bonferroni correction to account for multiple testing, a 
P-value of <.003 was required to find a significant difference. No significant differences were found 
for all variables. 
Variable Mean complete cases ± SD
Mean imputed 
data ± SD P-value
VAS Pain during activities baseline 57.4 ± 22 61.0 ± 22 0.154
VAS Pain during activities 6 weeks 45.3 ± 22 48.8 + 23 0.205
VAS Pain during activities 3 months 44.4 ± 23 47.2 ± 23 0.288
VAS Pain during activities 12 months 42.7 ± 26 45.7 ± 22 0.330
VAS Pain in the last week baseline 48.1 ± 19 49.6 ± 20 0.537
VAS Pain in the last week 6 weeks 35.2 ± 19 39.7 ± 21 0.060
VAS Pain in the last week 3 months 38.3 ± 22 40.4 ± 21 0.396
VAS Pain in the last week 12 months 35.1 ± 25 39.8 ± 19 0.099
MHQ Total baseline 64.3 ± 15 63.9 ± 14 0.820
MHQ Total 6 weeks 70.0 ± 9 68.7 ± 9 0.428
MHQ Total 3 months 70.8 ± 15 70.3 ± 11 0.791
MHQ Total 12 months 73.1 ± 15 71.9 ± 9.8 0.502
MHQ Pain baseline 57.7 ± 24 62.0 ± 26 0.151
MHQ Pain 6 weeks 43.8 ± 20 49.7 ± 20 0.011
MHQ Pain 3 months 41.2 ± 21 46.3 ± 21 0.040
MHQ Pain 12 months 39.1 ± 25 40.8 ± 20 0.557
Abbreviations: MHQ = Michigan Hand Questionnaire; SD =Standard Deviation; VAS = Visual Analog 
Scale
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ABSTRACT
Objective: To compare the effect of exercises and orthotics with orthotics 
alone on pain and hand function in patients with thumb base (CMC-1) osteoar-
thritis (OA) and to predict outcomes on pain and hand function of exercises and 
orthotics.
Design: Prospective cohort study with propensity score matching
Setting: Data collection took place in thirteen outpatient clinics for hand surgery 
and hand therapy in the Netherlands.
Participants: A consecutive, population-based sample of 173 patients with 
CMC-1 OA was included in this study of which 84 were matched on baseline 
demographics and baseline primary outcomes.
Interventions: Exercises and orthotics versus orthotics alone.
Main Outcome Measure(s): Primary outcomes included pain and hand 
function at three months, measured using Visual Analogue Scales (0-100, VAS) 
and the Michigan Hand outcomes Questionnaire (0-100, MHQ).
Results: A larger decrease in VAS pain at rest (11.1 points difference, 95% 
Confidence interval(CI): 1.9, 20.3, p=0.002) and during physical load (22.7 points 
difference, 95% CI: 13.6, 31.0, p<0.001,) was found in the exercise + orthotic group 
compared to the orthotic group. Additionally, larger improvement was found for 
the MHQ subscales pain, work performance, aesthetics and satisfaction in the 
exercise + orthotic group. No differences were found on other outcomes. Baseline 
scores of metacarpophalangeal flexion, presence of scapho-trapezio-trapezoid 
OA, VAS pain at rest, heavy physical labor and MHQ total predicted primary 
outcomes for the total exercise + orthotic group (N=131).
Conclusions: Conservative treatment for patients with CMC-1 OA should 
include exercises, since there is a relatively large treatment effect compared to 
using an orthosis alone. Future research should study exercises and predictors 
in a more standardized setting to confirm this finding.
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INTRODUCTION
Osteoarthritis (OA) of the thumb base joint (CMC-1) is a common disorder, with 
a radiologically diagnosed prevalence amongst females aged ≥50 years of 
33-40%.1-3 Patients with CMC-1 OA often experience thumb pain, limitations in 
activities of daily life (ADL) and present clinical features such as thenar muscle 
wasting or thumb deformity.1,4
Guidelines and reviews advise to start with non-surgical treatment, including 
analgesics, intra-articular injections, orthotics and exercise programs.5-7 While 
these interventions are widely used, evidence that supports these non-sur-
gical treatments, especially exercise programs, is limited.5-13 Nonetheless, while 
analgesics, intra-articular injections or orthotics provide short-term results, 
exercise programs may provide a long-term solution by improving lifestyle, joint 
mechanics and function.12
Most exercise programs intend to improve active stability and positioning of the 
CMC-1 into a more stable position of extension/abduction, since the CMC-1 
becomes less stable during flexion/adduction.9,12-17 Additionally, exercises focus 
on maintaining the first web space and pinch strength.10-14 Orthotics often 
complements exercises, to reduce subluxation and inflammation, but are also 
prescribed as a stand-alone treatment.11,14
If non-surgical treatment fails to alleviate symptoms, conversion to surgical 
treatment may be considered. However, disadvantages of surgical treatment are 
its long recovery, prolonged patient discomfort & limitations and high costs.6,18,19 
Furthermore, it has been reported that for a trapeziectomy with/without ligament 
reconstruction and tendon interposition, 11-33% of the patients would not 
consider the same treatment again under the same circumstances.19-23 Hence, 
because of the potential advantages compared to surgical treatment, more 
research on the added value of exercises in addition to orthotics is needed, 
since few studies are conducted and those available are of low methodological 
quality.5,7,8,11 Furthermore, it is unclear if there are predictors for outcome of exer-
cises.12 It is, for example, unclear if exercises are equally effective in patients with 
scapho-trapezio-trapezoid (STT) OA (Eaton stage >III24) compared to isolated 
CMC-1 OA (Eaton stages I-III).12 This prospective cohort study compares the 
effect of a combination therapy consisting of range of motion, coordination and 
strengthening exercises and orthotics versus orthotics alone on pain and hand 
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function in patients with CMC-1 OA. Furthermore, predictors of outcome for the 
combination therapy are studied to optimize treatment selection for patients with 
CMC-1 OA.
METHODS
Study design
This is a prospective cohort study with propensity score matching (PSM) using 
a consecutive, population-based sample, reported following the STROBE 
statement.25
Setting
This study was performed at thirteen outpatient clinics for hand therapy and 
hand surgery in The Netherlands. Data collection took place between October 
2015 and February 2017 and the local Medical Research Ethical Committee 
approved this study. Data collection was part of routine outcome measurement 
using GemsTracker electronic data capture tools.26 GemsTracker (GEneric 
Medical Survey Tracker) is a secure web-based application for distribution of 
questionnaires and forms during clinical research and quality registrations.27,28
A certified hand surgeon diagnosed patients with CMC-1 OA by physical exam-
ination and radiographic evaluation to determine Eaton stage.6,24 Subsequently, 
patients were referred for hand therapy and follow-up with the hand surgeon 
took place after three months to decide if further treatment was needed.
Participants
Participants were eligible for inclusion when they were adult and diagnosed 
with stage I-IV24 CMC-1 OA. Exclusion criteria were: 1) secondary CMC-1 OA 
(i.e. due Bennett’s fracture); 2) comorbidity interfering with treatment/outcome 
(i.e. Quervain’s tenosynovitis); 3) patient history includes surgery interfering with 
treatment/outcome; or 4) steroid injection <6 weeks in hand/wrist.
Treatment
Due the observational design, treatment was not completely standardized as in 
randomized controlled trials. However, the hand therapists were trained to use 
and carry out treatment following a strict guideline.29 The guideline prescribes 
the use of both orthotics and exercises. However, the exercises are not applied 
for every patient, depending on considerations made by the hand therapist and 
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patient (i.e. influenced by therapy costs/traveling distance). Therefore, the hand 
therapists completed surveys at baseline, six weeks and three months on the 
treatment content and potential deviations to ensure guideline usage.29
Participants with more than two hand therapy sessions were classified into the 
exercise + orthotic group, received exercises and a static orthosis to reduce 
synovitis and instability.11,30 The orthosis was thermoplastic, custom-made and 
immobilized the CMC-1 in extension/abduction and the first metacarpopha-
langeal joint (MCP-1) in flexion. The exercise program included hand therapy 
sessions and exercises performed at home by the patient, aiming to improve 
active stability of the CMC-1 during pinch in extension/abduction as instability 
and degeneration occurs in flexion/adduction.10,12,14-17 In the first treatment phase 
(week 0-6), coordination of the intrinsic thenar muscles (except the adductor 
pollicis), extensor pollicis brevis and the first dorsal interosseous was exer-
cised.10,12,14 Participants were instructed to use the orthosis 24h/day in this phase, 
except during exercises. In the second phase (week 6-3 months), orthosis usage 
was reduced, guided by the hand therapist and strengthening exercises for the 
thenar muscles (except adductor pollicis) were initiated (details in Appendix 1).10,12 
Participants in the orthotic group were provided with the same orthosis, usage 
instructions and wearing time, but only two or less hand therapy sessions were 
scheduled in which general advice and information on CMC-1 OA was provided 
and no structured exercises were performed.
Variables, data sources/measurement
Primary & secondary outcomes
Primary outcomes were pain and hand function. Pain at rest and during physical 
load (i.e. activities needing pinch force, such as opening a jar or turning a key) 
was measured at baseline, six weeks and three months using a Visual Analogue 
Scale (VAS, 0-100, higher scores indicate more pain). The VAS is a reliable and 
valid instrument to measure pain intensity in patients with rheumatic diseases 
and has a minimal clinical important difference (MCID) of eleven.31 Hand 
function was measured at baseline and three months using the Michigan Hand 
Outcomes Questionnaire (MHQ).32 The MHQ total score was used as primary 
outcome while the subscales were secondary outcomes (0-100, higher scores 
indicate better performance except for the subscale pain).32 The MHQ has a high 
internal consistency, high internal validity, acceptable reliability and is particu-
larly applicable for patients with hand OA.32 The MCID for the MHQ is 8-13 (3-23 
3
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for the subscales).33,34 Additionally, patient satisfaction was assessed at three 
months using a self-designed questionnaire on treatment effect and willingness 
to undergo treatment again. Conversion to surgery within 12 months was derived 
from patient charts.
Additional measurements
Stage of CMC-1 OA6,24, age, gender, type of work, therapy frequency, symptom 
duration and dominant side treated was derived from patient charts and surveys 
completed by the hand therapists. The hand therapists performed and registered 
measurements using standardized forms and were trained to conduct stan-
dardized measurements.35 Additional baseline characteristics included MCP-1 
flexion/hyperextension and inter metacarpal distance (IMD). MCP-1 flexion/
hyperextension was measured using the American Society of Hand Therapists 
recommendations.35 Presence of hyperextension at MCP-1 was dichotomized 
while MCP-1 flexion was used as continuous variable. IMD was measured 
using a caliper, because its reliability is superior to goniometric measurements 
of abduction.36,37 Measurements of IMD were dichotomized, where 3.3mm 
difference between the unaffected and affected side was defined as limited 
IMD, since 3.3mm is the smallest detectable difference for IMD.37 In bilateral 
involvement, the hand with the worst baseline MHQ score was used.
Initially, our study protocol included pinch & grip strength measurements. 
However, due to substantial missing data we considered the available data as 
potentially biased, hence we chose not to include these measurements.
Study size
No recommendations on power analysis for PSM were found in literature. A 
study on Dupuytren’s disease by Zhou et al.28 used PSM, where 60% of the total 
sample was matched. Therefore, we estimated that at least 60% of the total 
sample would be matched, resulting in an estimated sample of 124 before PSM 
and 74 after PSM for a F-test, a conventional medium effect size of .15 (defined 
by Cohen38) and a power of 0.80. Since group ratio between the orthotic and 
exercise + orthotic group was unclear prior to analysis, we enlarged the sample 
to >200.
Statistical methods
At baseline, 91.7% of the demographic characteristics and primary outcomes 
were available. When data was missing, we checked whether it could be retrieved 
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from patient charts. Missing value analysis on demographics and outcomes at 
three months showed a non-significant Little’s test (p=0.495 and p=0.341 respec-
tively), which confirmed that missing values were missing completely at random 
(MCAR).39-41 To further evaluate missing data at three months, significant testing 
was performed on demographic characteristics and baseline primary outcomes 
to compare participants with the presence of a primary outcome at three months 
with participants without the presence of a primary outcome at three months. 
No significant differences between were found (Appendix 2). Since data were 
MCAR and no differences were found between participants with and without the 
presence of a primary outcome at three months, multiple imputation was used 
to obtain missing data for continuous variables with <75% missing, resulting in 
excluding the patient satisfaction questionnaire from multiple imputation.39,42,43
Since comparing groups in observational studies is usually difficult due to differ-
ences between groups in covariates, we used PSM.44 PSM involves a propensity 
score, which is the probability for an individual to be assigned to a particular 
treatment given observed covariates.45,46 PSM allows comparing matched indi-
viduals, the only difference being whether they are treated with the intervention 
of interest or not.45
Propensity scores were estimated using logistic regression, where treatment 
status was regressed on baseline characteristics,45-47 using: VAS pain at rest and 
during physical load, MHQ total score, MCP-1 hyperextension, MCP-1 flexion, 
limited IMD, presence of STT OA (Eaton >III24), age, gender, type of work, symptom 
duration and dominant side treated. The propensity scores were subsequently 
used to match participants on a one-to-one basis using a nearest-neighbor algo-
rithm with a matching tolerance width of 0.2 SD of the logit of the propensity 
score.45,47 Between-group differences in demographic characteristics were 
analyzed before and after matching using standardized mean differences.47-49
Continuous outcomes were analyzed using univariate linear mixed model 
analysis and paired sample t-tests. The threshold for significance is lowered to 
0.0125 from a conventional 0.05 to correct for multiple testing. The patient satis-
faction questionnaire was analyzed on item level using Wilcoxon signed rank and 
McNemar tests.
To predict primary outcomes at three months, multivariate backward regression 
analysis was used on the complete exercise + orthotic group (including 
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unmatched participants). The same characteristics as in PSM were used, 
with therapy frequency added. Data were checked for multicollinearity using 
correlation coefficients and variance inflation factor (VIF). A VIF >10 was 
considered an indication for multicollinearity.50
Figure 1. Flow chart of this study, demonstrating that 42 participants per group were matched using 
propensity score matching
 
RESULTS
Initially, 209 participants were included (Figure 1). Twenty-seven participants 
were excluded due to comorbidity and nine participants were excluded because 
of corticosteroid injection(s). Hence, 173 participants were finally included. The 
orthotic group contained 42 participants while the exercise + orthotic group 
contained 131 participants. After matching, both groups contained 42 partic-
ipants. Small38 between-group differences remained after matching (Table 1). 
The mean number of therapy sessions was 6.7 (SD=1.9) in the exercise + orthotic 
group.
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Primary & secondary outcomes
VAS pain at rest decreased 11.1 points more in the exercise + orthotic group 
compared to the orthotic group at three months (95% Confidence interval (CI): 1.9, 
20.3, p=0.002, Figure 2). Furthermore, VAS pain during physical load decreased 
22.7 points more in the exercise + orthotic group compared to the orthotic group 
(95% CI: 13.6, 31.0, p<0.001, Figure 3).
No significant between-group differences were found on the MHQ total score 
(Table 2, p=0.273), but the subscales pain, work performance, aesthetics and 
satisfaction improved more in the exercise + orthotic group compared to the 
orthotic group with 8, 10.1, 5 and 12.9 points difference respectively (Figures 
4-5, Table 2, p<0.001-0.008). No significant differences were found on other 
MHQ subscales or the patient satisfaction questionnaire (Table 2). Conversion 
to surgery was 7% (N=3) in the exercise + orthotic group and 10% (N=4) for the 
orthotic group (p=0.693).
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Figure 2. Pain at rest as measured with a Visual Analogue Scale (VAS) for the orthotic group (blue 
line) and the exercise + orthotic group (green line). Group means and standard errors are plotted. 
Linear mixed model analysis demonstrates a significant difference between the groups (p=0.002).
Figure 3. Pain during physical load as measured with a Visual Analogue Scale (VAS) for the orthotic 
group (blue line) and the exercise + orthotic group (green line). Group means and standard errors 
are plotted. Linear mixed model analysis demonstrates a significant difference between the groups 
(p<0.001).
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Figure 4. Work performance as measured with the Michigan Hand outcomes Questionnaire 
(MHQ) for the orthotic group (blue line) and the exercise + orthotic group (green line). Group means 
and standard errors are plotted. Paired samples T-tests demonstrate a significant difference be-
tween the groups (p=0.008).
Figure 5. Satisfaction as measured with Michigan Hand outcomes Questionnaire (MHQ) for the 
orthotic group (blue line) and the exercise + orthotic group (green line). Group means and standard 
errors are plotted. Paired samples T-tests demonstrate a significant difference between the groups 
(p<0.001).
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Prediction of outcome
Multiple regression identified several predictors in the total exercise + orthotic 
group (N=131), with a relatively small explained variance of 16% (VAS pain at rest), 
19% (VAS pain during physical load) and 26% (MHQ total score, Table 3). Higher 
baseline score for VAS pain at rest predicted a higher score at three months. 
Furthermore, lower MCP-1 flexion, higher VAS pain at rest baseline score and 
presence of STT OA predicted a higher VAS pain score during physical load at 
three months. However, when comparing participants with (N=17) and without 
(N=114) STT OA within the total exercise + orthotic group, pain during physical 
load significantly decreased at three months in both subgroups, by 29.5 and 36.4 
points respectively (p<0.001). Type of work with heavy physical labor (i.e. working 
in construction) predicted a lower MHQ total score at three months while a 
higher MHQ total baseline score predicted a higher score at three months.
Table 3. Predictors for outcomes in the total exercise + orthotic group (N=131) on Visual Analogue 
Scale (VAS) pain during physical load and at rest and the Michigan Hand outcomes Questionnaire 
(MHQ) total score. MCP-1 = first metacarpophalangeal joint, STT = scaphotrapeziotrapezoid joint, 
OA = osteoarthritis
Predictor Beta coefficient Adjusted R square p-value
VAS pain rest at 3 months
- VAS rest baseline score 0.286
0.161
<0.001
VAS pain physical load at 3 months
- MCP-1 flexion
- Presence of STT OA
- VAS rest baseline score
-0.424
11.976
0.424
0.190
0.011
0.063
<0.001
MHQ total score at 3 months
- Type of work: heavy  physical 
labor
- MHQ total baseline score
-13.782
0.522
0.255
0.034
<0.001
 
DISCUSSION
This study found superior and clinically relevant results for the exercise + orthotic 
group compared to the orthotic group on VAS pain (at rest and during physical 
load) and the MHQ subscales pain, work performance, aesthetics and satis-
faction. No significant differences were found on MHQ total score, its subscales 
and the patient satisfaction questionnaire. Furthermore, predictors for outcomes 
of a combination of exercises and orthotics were baseline MCP-1 flexion, 
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presence of STT OA, VAS pain at rest, type of work with a heavy physical labor 
and MHQ total.
Our findings on treatment effect are not completely in line with literature. Several 
studies 7,9,11,13 found positive outcomes on pain and hand function for exercises, 
while other studies5,8 found insufficient or low evidence for the use of exercises. 
This contradiction may be related to the fact that systematic reviews reported 
that most studies on exercises for patients with CMC-1 OA are of low method-
ological quality.5,7,8,11 Additionally, some studies9,13 used similar exercises as in this 
study, while some studies included in the systematic reviews for example applied 
manual mobilizations to the CMC-1 or mainly applied exercises for general hand 
OA instead of CMC-1 OA specifically.5,7,8 Hence, more high-quality studies on 
exercises for patients with CMC-1 OA are needed.
We found that within the exercise + orthotic group, baseline MCP-1 flexion, 
presence of STT OA, VAS pain at rest, type of work with a heavy physical labor 
and MHQ total were predictors of the primary outcomes at three months, 
although the explained variance was only 16-26%. STT OA was a predictor for 
worse outcomes on VAS pain during physical load, but despite this, pain during 
physical load significantly decreased on average still 29.5 points in the exercise 
+ orthotic group. This suggests that exercises are also feasible and effective for 
patients with Eaton stage IV24, but future research should investigate if exercises 
need to be adapted for patients with STT OA since the STT is presumably also 
influenced by wrist motion.51
The findings on MCP-1 flexion suggest that the exercises positively influenced 
biomechanics during pinch, since prevention of MCP-1 hyperextension and 
applying MCP-1 flexion might prevent further subluxation and degeneration 
of the CMC-1.12,14-17 However, future studies should investigate the influence of 
MCP-1 flexion on the disease course of CMC-1 OA.
Additionally, heavy physical labor predicted a lower MHQ total score, possibly 
because it is more difficult for patients with heavy physical labor to adapt in ADL.
Study Limitations
The significant and clinically relevant benefits of exercises may be a result of 
improved thumb positioning and the strengthening exercises improving pinch 
strength. However, a limitation is that insufficient data was available to report 
3
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outcomes on strength. Additionally, the use of multiple imputation on other 
outcomes may have introduced bias, despite missing value analyses and the 
non-significant Little’s test. Furthermore, substantial statistical power was lost 
in the variables where no multiple imputation was used. For example, outcomes 
on patient satisfaction demonstrated superior but non-significant results in the 
exercise + orthotic group. Hence, it is recommended that future research on this 
topic is employed with emphasis on prevention of missing data.
While a limitation of this study is its observational character, a strength is that 
the results are collected in daily practice and are therefore representative for 
actual daily care. However, despite that the hand therapists received training in 
guideline usage, complete standardization of treatment could not be ensured 
as in randomized controlled trials. Additionally, blinding was not possible in the 
present design and i.e. analgesics usage is not controlled. Furthermore, indi-
cation bias may have occurred in treatment allocation if unidentified covariates 
were present. Further exploration on (predictors for) outcomes of exercises is 
needed in a standardized, randomized controlled trial. However, the small differ-
ences38 in baseline characteristics (with a highest SMD of 0.33), largely already 
present prior to PSM gives us confidence that the results of a randomized 
controlled trial would be similar.
Additionally, a limitation is that large variation on MCID’s of the MHQ is reported 
in literature. Hence, the significant differences in MHQ subscales should be inter-
preted with caution.33,34
Another limitation is that contextual or placebo effects may be present, since 
the exercise + orthotic group received more attention from the hand therapists 
compared to the orthotic group. Hence, studies investigating contextual effects 
of exercises are needed.
Lastly, a limitation of the exercise program may be the costs compared to an 
orthosis only. Potential cost saving could be achieved if exercise programs 
reduce the conversion to surgery compared to no exercises. In the present 
study, conversion to surgery within 12 months was not significantly different 
between the exercise + orthotic group (7%) and the orthotic group (10%), but 
this may be due to the low number of events does not allowing to detect signif-
icant differences. Therefore, it is recommended that future studies investigate 
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the cost-effectiveness of exercise programs (including conversion to surgery) in 
addition to an orthosis in a larger, standardized randomized controlled trial.
CONCLUSIONS
In conclusion, positive effects of exercises were found on pain in patients with 
CMC-1 OA. Therefore, exercise programs are recommended in the treatment for 
patients with CMC-1 OA, particularly because of the relatively large treatment 
effects compared to an orthosis alone. Furthermore, baseline MCP-1 flexion, 
presence of STT OA, VAS pain at rest, type of work with a heavy physical labor 
and MHQ total predict outcomes for exercises combined with orthotics. Future 
research should study exercises in randomized controlled trials. 3
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APPENDIX 1
First phase of treatment (week 0-6)
Examples of the exercises, performed 4-6 times a day, 10-15 repetitions.12,23
The exercises aim to improve the specific function of the intrinsic thenar muscles 
(except the adductor pollicis), the extensor pollicis brevis and the first dorsal 
interosseous.
1 – Abductor pollicis brevis / longus coordination exercise
A.  B. 
2 – Extensor pollicis brevis coordination exercise
A.  B. 
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3 – Flexor pollicis brevis coordination exercise
A.  B. 
Second phase of treatment (week 6 – 3 months)
Examples of the exercises, performed 2-3 times a day. Force is applied for 2-3 
seconds and build up until 50-100 repetitions. 12,23
 
      5 – Applying manual resistance at the radial, 
4 – Pulling a rubber band in closed  ulnar and dorsal aspect of the proximal 
and correct key pinch   phalanx in closed and correct key pinch
               
     
     7 – Applying manual resistance at the radial,  
     ulnar and dorsal aspect of the proximal   
6 – Pulling a rubber band in open chain  phalanx in open chain
              
3
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APPENDIX 2
Supplementary Table 1. Non-responder analysis, where participants with the presence of a prima-
ry outcome at three months were compared with participants without a primary outcome at three 
months using independent samples t-tests, Chi square tests and Fisher’s exact tests. SD = standard 
deviation, OA = Osteoarthritis, MCP-1 = first metacarpophalangeal joint, IMD = inter metacarpal dis-
tance. VAS = Visual Analogue Scale, MHQ = Michigan Hand outcomes Questionnaire
Non-responder analysis
Primary outcome 
at three months 
present
Primary outcome 
at three months 
absent
p-value
Participants, N 127 (73,4%) 46 (26,6%)
Age in years, mean 
(SD) 60.2 (8.6) 60.9 (8.6) 0.662
Females, N (%) 96 (75.6%) 34 (73.9%) 0.844
Dominant side treated, N (%) 57 (44.9%) 15 (32.6%) 0.166
Type of work, N (%)
Unemployed 53 (41.7%) 19 (41.3%) 0.983
Light physical 
labor 27 (21.3%) 11 (23.9%) 0.983
Moderate physi-
cal labor 32 (25.2%) 11 (23.9%) 0.983
Heavy physical 
labor 15 (11.8%) 5 (10.9%) 0.983
Duration of symp-
toms in months, 
mean (SD)
29.1 (28.7 24.9 (32.7) 0.443
Eaton Stage OA, 
N (%)
I-III 113 (89%) 38 (82.6%) 0.304
IV 14 (11%) 8 (17.4%) 0.304
MCP-1 Hyperex-
tension, N (%) 94 (80.3%) 32 (78%) 0.822
MCP-1 flexion in 
degrees, mean 
(SD)
51.0 (12.1) 52.9 (12.4) 0.394
IMD limited, N (%) 32 (32.3%) 12 (33.3%) 1.000
VAS, 0-100 (SD)
At rest 26.9 (24.4) 30.3 (21.2) 0.416
During physical 
load 67.1 (16.4) 69.8(15.9) 0.353
MHQ total, 0-100 
(SD) 57.8 (16.4) 57.1 (14.4) 0.916
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ABSTRACT
Objective: To describe outcomes of non-surgical treatment for symptomatic 
thumb carpometacarpal (CMC-1) instability. Secondary, to evaluate the 
conversion rate to surgical treatment.
Design: Prospective cohort study
Setting: 20 outpatient clinics for hand surgery and hand therapy in the 
Netherlands.
Participants: A consecutive sample of 431 patients with symptomatic CMC-1 
instability
Intervention: non-surgical treatment including exercise therapy and an orthosis
Main Outcome Measure(s): Pain (Visual Analog Scale, VAS, 0-100) and hand 
function (Michigan Hand Questionnaire, MHQ 0-100) at baseline, 6 weeks and 
3 months. Conversion to surgery was recorded for all patients with a median 
follow-up of 2.8 years (range 0.8-6.7y).
Results: VAS scores for pain during the last week, at rest and during physical 
load improved with a mean difference at 3 months of 17 [97.5% Confidence 
interval: 9:25], 13 [9:18] and 19 [12:27] respectively (p<0.001). No difference was 
present at 3 months for MHQ total score, but the subscales ADL, work, pain and 
satisfaction improved by 7 [1:14], 10 [4:16], 5 [2:9] and 12 [2:22] points respectively 
(p<0.001-0.007). After median follow-up of 2.8y, only 59 (14%) participants were 
surgically treated. Both in the subgroups that did and did not convert to surgery, 
VAS pain scores decreased at 3 months compared to baseline (p<0.001-0.010), 
whereas MHQ total score did not improve in both subgroups. However, VAS and 
MHQ scores remained worse for patients that eventually converted to surgery 
(p<0.001).
Conclusions: In this large sample of patients with symptomatic CMC-1 insta-
bility, non-surgical treatment demonstrated clinically relevant improvements 
in pain and aspects of hand function. Furthermore, after 2.8 years, only 14% of 
all patients were surgically treated, indicating that non-surgical treatment is a 
successful treatment of choice.
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INTRODUCTION
Symptomatic thumb carpometacarpal (CMC-1) instability can arise from multiple 
causes, such as generalized hypermobility, congenital disorders, or trauma and 
may cause pain and limitations in activities of daily living (ADL).1-4 Furthermore, it 
has been suggested in literature that CMC-1 instability may predispose CMC-1 
osteoarthritis (OA) later in life.5-10
Whereas multiple studies have investigated non-surgical treatment for CMC-1 
OA11-15, to our knowledge, there are no studies describing outcome of non-sur-
gical treatment for symptomatic CMC-1 instability. Similar to patients with 
CMC-1 OA, orthotics and exercise programs may provide a long-term solution 
by improving lifestyle, joint mechanics and function, but evidence for their effec-
tiveness in symptomatic CMC-1 instability is lacking.11-15
Exercise therapy for CMC-1 instability intends to improve active stability and 
positioning of the CMC-1 into a more stable position of extension/abduction, 
since the CMC-1 is less stable during flexion/adduction.6,8-10,16-18 Additionally, 
exercise therapy aims to maintain the first web space and improve thumb pinch 
strength.3,6,12,17,18 Furthermore, (temporary use of) orthotics often complement 
exercise therapy to reduce subluxation and inflammation.6,12 Theoretically, 
improving joint mechanics in patients with CMC-1 instability might be very bene-
ficial since CMC-1 instability may precede CMC-1 osteoarthritis (OA) later in 
life.5-10
In cases of symptomatic CMC-1 instability where insufficient improvement 
occurs following non-surgical treatment, surgical stabilization of the CMC-1 joint 
can be considered.2,19,20 However, the outcome of these procedures are not very 
predictable and it has been reported that results of these surgical procedures 
are unsatisfactory in 12-55%2,19. In addition, surgical treatment comes with long 
recovery, prolonged patient discomfort & limitations and high costs.21-23. Hence, 
since non-surgical treatment potentially has many advantages compared to 
surgical treatment and since no studies are available on this topic, more research 
on non-surgical treatment for CMC-1 instability is needed. Therefore, the aim of 
this study is to describe the outcomes of non-surgical treatment, exercise therapy 
and an orthosis, for symptomatic CMC-1 instability. Secondary, the objective was 
to evaluate the conversion rate to surgical treatment.
4
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METHODS
Study design
This is a prospective cohort study using a consecutive, population-based sample, 
reported following the STROBE statement.24
Setting
Data were collected at Xpert Clinic and Handtherapie Nederland, comprising 
20 outpatient clinics for hand surgery and therapy in The Netherlands, and 
took place between January 2012 and September 2018 after approval by the 
local Medical Research Ethical Committee. Data collection was part of routine 
outcome measurement using GemsTracker electronic data capture tools.25 
GemsTracker (GEneric Medical Survey Tracker) is a secure web-based appli-
cation for distribution of questionnaires and forms during clinical research and 
quality registrations, details have been published earlier.11,15,26
Participants
All patients were initially diagnosed with CMC-1 instability by one of the certified 
hand surgeons by physical examination. Radiographic evaluation of the CMC-1 
joint was not systematically performed but radiographs were obtained if CMC-1 
OA was suspected. Subsequently, patients were referred for hand therapy. 
Follow-up with the hand surgeon took place after three months to decide if addi-
tional treatment was needed. For this study, we excluded patients that: 1) were 
diagnosed with CMC-1 OA (including radiographic confirmation); 2) had comor-
bidity interfering with treatment/outcome (i.e. de Quervain’s tenosynovitis); 3) 
had a patient history includes surgery interfering with treatment/outcome; or 4) 
received a steroid injection <6 weeks in hand or wrist.
Treatment
The treatment in this study was not completely standardized as in randomized 
controlled trials, since data collection was part of usual care. However, treatment 
by the hand therapists was carried out using a strict guideline,27 which prescribes 
the use of both exercises and orthotics when needed. The exercises and 
orthotics were not applied in every patient, since the treatment was tailored to 
the patient’s needs and based on a shared-decision making process (e.g., influ-
enced by patient preferences, therapy costs and traveling distance).
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If an orthosis was provided, this included a static orthosis to reduce synovitis 
and instability.12,28 The orthosis was custom-made, thermoplastic and immobi-
lized the CMC-1 in extension/abduction and the first metacarpophalangeal joint 
(MCP-1) in slight flexion. The exercise program included hand therapy sessions 
and exercises performed by the patient at home. These exercises aimed to 
improve the active stability of the thumb during pinch in extension/abduction, 
since flexion/adduction causes instability, and eventually degeneration.3,6,8-10,18 In 
the first six weeks, the exercises aimed to improve coordination of the intrinsic 
thenar muscles (except the adductor pollicis), extensor pollicis brevis and the 
first dorsal interosseous.3,6,11,18 Due to the observational design of this study, no 
strict prescriptions regarding orthotic usage were provided, but in general, if an 
orthosis was applied, participants were instructed to use it during heavy and 
provocative activities. Guided by the hand therapist, orthosis usage was reduced 
in the subsequent six weeks.  Furthermore, strengthening exercises for the 
thenar muscles (except adductor pollicis) were initiated in this phase in addition 
to the coordination exercises.3,6,11,18
Variables, data sources/measurement
Primary & secondary outcomes
Primary outcomes in this study were pain and hand function at three months. 
Mean pain in the last week, pain at rest and pain during physical load were 
measured at baseline, six weeks and three months using a Visual Analogue Scale 
(VAS, 0-100, higher scores indicate more pain). The VAS is a widely used, reliable 
and valid tool for measuring pain intensity and has a minimal clinical important 
difference (MCID) of eleven points.29 Hand function at baseline and three months 
was evaluated using the Michigan Hand outcomes Questionnaire (MHQ).30 We 
used the MHQ total score as primary outcome while its six subscales were 
secondary outcomes (0-100, higher scores indicate better performance except 
for the subscale pain).30 The MHQ is a widely used tool for measuring hand 
function and has a high internal consistency, high internal validity, acceptable 
reliability.30 The MHQ has a MCID of 8-13 points (3-23 for the subscales).31,32 Addi-
tional measurements included patient satisfaction at six weeks, three months 
and 12 months, assessed using a self-designed questionnaire on the perceived 
treatment effect and the patients’ willingness to undergo the treatment again. 
Conversion to surgery within a median follow-up of 2.8 years (range 0.8 - 6.7 
years) was derived from patient charts and additional questionnaires distributed 
one year after start of non-surgical treatment. If a patient converted to surgery, 
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we measured the time in months between the start of the non-surgical treatment 
and the decision to proceed to surgical treatment. Additional variables that were 
routinely collected in our database at baseline included age, sex, type of work, 
symptom duration, treatment side and dominance (Table 1).
Table 1. Demographic characteristics
Variable Demographic characteristics (N = 431)
Age, mean ± SD 38.2 ± 13
Female sex, % 80%
Symptom duration in months, mean ±SD 16.4 ± 24.9
Treatment Side, %
- Left
- Right
40%
60%
Dominance, %
- Left
- Right
- Both
6%
91%
3%
Type of work, %
- Unemployed
- Light physical labor
- Moderate physical labor
- Heavy physical labor
18%
32%
36%
14%
Second opinion, % 9%
Study size
Power analysis for a repeated measures design with two primary outcomes using 
a conventional medium effect size of 0.15 (defined by Cohen33), a = 0.025 and a 
power of 0.80 showed that a total sample of 87 participants was needed, which 
was well below the sample of 435 participants that we were able to include.
Statistical methods
At baseline, 62-72% of the primary outcomes were available. If there was missing 
data, we checked whether it could be retrieved from patient charts. Missing value 
analysis for outcomes at three months demonstrated a non-significant Little’s 
test (p=0.771), which suggested that missing values were missing completely at 
random.34-36 To further evaluate missing data at three months, significance testing 
on demographic characteristics and baseline primary outcomes was performed 
to compare participants with the presence of a primary outcome at three months 
with participants without the presence of a primary outcome at three months. No 
significant differences between participants with and without the presence of a 
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primary outcome at three months were found (Supplementary Table 1). Because 
the data were missing completely at random and no differences between partici-
pants with and without the presence of a primary outcome at three months were 
present, we used multiple imputation to obtain missing data for continuous vari-
ables with <75% missing.34,37,38
Treatment outcomes were analyzed using univariate linear mixed model 
analyses, using the outcome of interest as a dependent variable and timepoint as 
a fixed factor. Assumptions were checked using residual plots and normal proba-
bility plots. The threshold for significance is lowered to 0.025 from a conventional 
0.05 to correct for multiple testing.
In addition to the overall treatment effect in the entire sample, we performed 
subgroup analysis for the patients that eventually converted to surgery, again 
using linear mixed model analyses.
Figure 1. Flowchart of the study
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RESULTS
Pain, hand function and satisfaction with treatment result
A total of 462 participants was screened for eligibility and 431 participants were 
included after applying the eligibility criteria. From the excluded participants, 26 
participants received an injection, 1 had comorbidity (de Quervain’s tenosyno-
vitis) and 4 had recurrent CMC-1 instability following previous surgery (Figure 1). 
VAS scores for pain during the last week, pain at rest and pain during physical 
load improved with mean differences at 3 months of 17 [97.5% Confidence 
interval: 9:25], 13 [9:18] and 19 [12:27] points respectively (p<0.001, Figure 2).
Figure 2. Visual Analogue Scale (VAS, 0-100, higher scores represent more pain) scores for pain 
physical load, mean pain last week and pain at rest at baseline, 6 weeks and 3 months. Linear mixed 
model analysis demonstrated that pain during physical load, mean pain last week and pain at rest 
decreased at 3 months compared to baseline (p<0.001). Group means and standard errors are plotted.
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Figure 3. Overall distribution of the entire sample for Visual Analogue Scale (VAS, 0-100, higher scores 
represent more pain) at baseline and 3 months after non-surgical treatment, displaying the number 
of patients per 10-point intervals in VAS score.
Figure 3 demonstrates the distribution of VAS pain during physical load at 
baseline and 3 months, indicating large variability in pain levels both prior to 
and after treatment. However, Figure 4 shows the course of VAS pain during 
physical load over time for four quartiles of baseline pain levels, indicating that 
higher baseline pain during physical load not necessarily leads to more pain at 
follow-up.
Figure 4. Course over time for Visual Analogue Scale (VAS, 0-100, higher scores represent more 
pain), categorized by quartiles for baseline pain during physical load, indicating that patients with 
higher baseline pain demonstrate the largest improvement and patients with lower baseline pain 
demonstrate little improvement.
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For the MHQ total score, no significant difference was present at 3 months, but 
the MHQ subscales ADL, work performance, pain and satisfaction with hand 
function improved compared to baseline (p<0.001-0.007, Table 2). No significant 
changes were found in the MHQ subscales overall hand function and aesthetics. 
At 3 months, 83% of the participants would consider to undergo the non-surgical 
treatment again under similar circumstances (Table 2).
Table 2. Outcomes for Michigan Hand outcomes Questionnaire (MHQ, score range 0-100, higher 
scores indicate better performance except for the pain subscale) at baseline and 3 months and pa-
tient satisfaction at three months following non-surgical treatment. Significance testing for mean 
differences in MHQ at 3 months was performed using linear mixed model analysis.
Variable Baseline 3 months Mean difference
baseline - 3 months 
[97.5% CI]
p-value
Total MHQ, mean (SD)
MHQ Subscales:
- Overall hand function
- ADL
- Work performance
- Pain (higher scores indicate   
  more pain)
- Aesthetics
- Satisfaction with hand 
  function
60.7 (14.1)
57.6 (17.7)
62.3 (23)
53.3 (26)
36.9 (24.2)
81.9 (19.2)
43.3 (20.5)
64.8 (18.9)
60.2 (25.6)
69.7 (26.7)
63.1 (23.8)
31.6 (14.5)
72 (28.9)
55.7 (34.3)
4.2 [-2:11]
2.6 [-2:8]
7.4 [1:14]
9.8 [4:16]
5.2 [2:9]
9.9 [-5:25]
12.4 [2:22]
0.036
0.154
<0.001
<0.001
0.007
0.096
<0.001
Satisfaction with treatment result, %
- Excellent
- Good
- Fair
- Moderate
- Poor
10%
38%
23%
21%
8%
Participants that would undergo 
treatment again, % 83%
Conversion to surgery
Figure 5 shows the survival curve for conversion to surgery, indicating that after 
a median follow-up of 2.8 years, 59 (14%) participants converted to surgical 
treatment. For the participants that converted to surgical treatment, median time 
to make the decision to convert to surgery was 3.4 months (range: 1-37 months) 
after the start of the non-surgical treatment.
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Figure 5. Survival curve displaying the number of patients that converted to surgery over time. The 
y-axis represents the percentage of patients not converting to surgery and the x-axis the time in 
months after start of treatment. After a median time of 3.4 months after the start of the non-surgical 
treatment (range of conversion: 1-37 months), 14% decided to convert to surgery.
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Figure 6A-B: Visual Analogue Scale (VAS 0-100, higher scores represent more pain, Figure 6A) 
score for pain during physical load and Michigan Hand outcome Questionnaire (MHQ, 0-100, 
higher scores represent better function, Figure 6B) separately for participants that converted to 
surgery (n=59, 14%) and participants that did not convert to surgery (n=372, 86%). Linear mixed 
model analysis demonstrated that pain during physical load decreased in both participants that 
did (p=0.010) or did not convert to surgery at 3 months compared to baseline (p<0.001). For MHQ 
total score, no significant improvement was achieved in both subgroups (p=0.046-0.152). However, 
both pain and hand function levels were worse for patients that eventually converted to surgery 
(p<0.001). Moreover, there was an interaction between subgroup and change in pain or hand func-
tion scores over time (p<0.001). VAS scores during rest and VAS last week demonstrated the same 
pattern as VAS during physical load. Group means and standard errors are plotted.
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DISCUSSION
We found a clinically relevant decrease in pain for patients treated non-surgically 
for symptomatic CMC-1 instability. Furthermore, only 14% of the patients were 
surgically treated after a median follow-up of 2.8 years. In addition, improvements 
were found in secondary outcomes for ADL, work performance and satisfaction 
with hand function. Additionally, our subgroup analysis indicated that for patients 
who eventually converted to surgery, there still was a clinically relevant decrease 
in pain scores despite the decision to proceed to surgical treatment. However, 
both pain and hand function scores remained worse over time in the subgroup 
that converted to surgery compared to those who did not convert to surgery.
To our knowledge, this is the first study reporting outcomes for non-surgical 
treatment for symptomatic CMC-1 instability, hence we cannot compare our 
results with previous studies. Since our study indicates clinically relevant 
improvement in patient reported outcome measures and surgical treatment 
may lead to unsatisfactory results,2,19 it is highly recommended that non-sur-
gical treatment for symptomatic CMC-1 instability is considered as a primary 
treatment of choice in patients with CMC-1 instability. This is especially the 
case since non-surgical treatment for CMC-1 instability is aiming to improve life-
style, joint mechanics and function and might therefore prevent or at least delay 
the development of CMC-1 OA in later life, since CMC-OA might be a result of 
CMC-1 instability.5-10 However, since we did not evaluate the disease course 
over a longer period of time in this study, future studies should investigate if 
non-surgical treatment for CMC-1 instability has a preventive effect in CMC-1 OA 
development.
When analyzing the subgroup of patients with CMC-1 instability that eventually 
converted to surgery, we found a clinically relevant decrease in pain scores at 
three months compared to baseline scores. This decrease in pain levels over 
time is in contrast to findings by Tsehaie et al.15, who found that in patients with 
CMC-1 OA that eventually converted to surgery, pain levels did not change 
over time. In another study39, Tsehaie et al. found that the decision to undergo 
surgical treatment strongly depends on a change in pain levels during non-sur-
gical treatment. Our findings suggest that in patients with CMC-1 instability this 
is not the case, and the decision to undergo surgery might depend on higher 
residual pain levels and not on change in pain score over time. This is supported 
by our finding that while pain levels decreased in the subgroup that converted 
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to surgery, pain levels and hand function scores remained worse compared to 
those of the subgroup of patients that did not convert to surgery. However, future 
studies using prediction models in patients with CMC-1 instability are needed to 
validate this hypothesis.
Another remarkable finding is that, in general in our sample, we found a rela-
tively large variability in outcomes. For example, we found that while 83% of the 
patients would undergo the same treatment again, 17% would not. Further, we 
found large variation in pain levels both prior to treatment and 3 months after 
treatment. However, whereas some studies report that higher baseline pain 
predict higher residual pain in patients with CMC-1 OA11,14, our study also indi-
cates that this pattern might be otherwise in patients with CMC-1 instability. 
These findings indicate that while the majority of patients responds well to this 
non-surgical treatment, some patients do not. Hence, future studies need to 
investigate factors that contribute to this variability in outcome.
Study limitations
A strength of this study is that this is, to our knowledge, the first study reporting 
outcomes of non-surgical treatment for CMC-1 instability. Furthermore, we were 
able to evaluate a large group of 431 using standardized patient reported outcome 
measures. However, there are also a number of limitations. First, a limitation of 
this study is its observational character. Despite standardization of treatment 
using strict protocols and standardized procedures for data collection, inherent 
to observational studies, the actual provided treatment might have deviated from 
the treatment protocols. For example, the exercises and orthotics might not have 
been applied in every patient. However, in contrast to a randomized controlled 
trial setting, an advantage of our observational study design is that the results are 
highly representative for actual daily practice.
An additional limitation of this study is that the present study does not allow 
evaluation of separate treatment effects of exercise therapy or the usage of 
orthoses in CMC-1 instability. While the exercise therapy aims to improve joint 
mechanics, active stability and strength and the orthosis aims to reduce sublux-
ation and inflammation, it is unknown if combining this treatment with orthoses 
is useful. Hence, future studies should investigate the long-term outcomes for 
these different non-surgical treatments for CMC-1 instability separately in a more 
standardized setting.
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Another limitation of this study is the amount of missing data and the need for 
multiple imputation. However, our non-responder analyses and the non-sig-
nificant Little’s test give us confidence that our outcomes represent the target 
population.
Furthermore, a limitation of this study is that the percentage of conversion 
to surgery that we report might be an underestimation, since, despite our 
efforts to follow our patients over time, a patient might have been surgically 
treated elsewhere. Hence, this percentage of patients converting to surgery 
following non-surgical treatment for CMC-1 instability needs validation in future 
prospective research.
In conclusion, patients treated non-surgically for symptomatic CMC-1 instability 
showed a clinically relevant decrease in pain and improvement in secondary 
outcomes such as ADL, work performance and satisfaction with hand function. 
Furthermore, only 14% of all 431 patients converted to surgery after a median 
follow-up of 2.8 years, indicating this non-surgical treatment is a successful 
treatment of choice, although we found large variation in pain levels. Future 
studies should investigate predictive factors that contribute to this variability in 
outcome following non-surgical treatment for CMC-1 instability.
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Supplementary Table 1. Non-responder analysis, where participants with the presence of a prima-
ry outcome at three months were compared with participants without a primary outcome at three 
months using independent samples t-tests and Chi square tests. SD = standard deviation, VAS = Visual 
Analogue Scale, MHQ = Michigan Hand outcomes Questionnaire
Variable Primary outcome at 
three months present
Primary outcome at 
three months absent
p-value
Participants, N (%) 153 (36%) 278 (64%) -
Age, mean ±SD 37.2 ± 12.8 38.8 ± 13.1 0.232
Female sex, % 80% 79% 0.757
Symptom duration in months, mean 
±SD 18.4 ± 29.1 15.3 ± 22.3 0.218
Treatment Side, %
- Left
- Right
40%
60%
40%
60%
0.932
Dominance, %
- Left
- Right
- Both
7%
90%
3%
5%
91%
4%
0.595
Type of work, %
- Unemployed
- Light physical labor
- Moderate physical labor
- Heavy physical labor
14%
31%
42%
13%
20%
33%
32%
15%
0.182
Second opinion, % 12% 7% 0.080
VAS pain rest, mean (SD) 38.6 ± 24.3 39.4 ± 24.5 0.785
VAS pain physical load, mean (SD) 64.9 ± 20.1 63.2 ± 23.6 0.503
MHQ total, mean (SD) 60.8 ± 14.8 60.3 ± 14.2 0.764
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ABSTRACT
Objective: 1) to identify predictive factors for outcome after splinting and hand 
therapy for CMC OA and to identify predictive factors for conversion to surgical 
treatment, and 2) to determine how many patients that have not improved in 
outcome within six weeks after start of treatment will eventually improve after 
three months.
Methods: In this observational prospective multi-center cohort study, 809 
patients with CMC OA received splinting and weekly hand therapy for three 
months between 2011 and 2014. Main outcome measures were pain and satis-
faction measured with a visual analog scale, and function measured with the 
Michigan Hand Questionnaire at baseline, six weeks and three months post-
treatment. Using regression analysis, patient demographics and pretreatment 
baseline scores were considered as predictors for the outcome of conservative 
treatment after three months and for conversion to surgery.
Results: Multivariable regression model explained 34-42% of the variance in 
outcome (p<0.001) with baseline satisfaction, pain and function as significant 
predictors. Cox regression analysis showed that baseline pain and function were 
significant predictors for conversion to surgery. Of patients with no clinically-rel-
evant improvement in pain and function after six weeks, 73-83% also had no clin-
ically-relevant improvement after three months.
Conclusion: This study showed that patients with either high pain or low function 
may benefit most from conservative treatment. We therefore recommend to 
always start with conservative treatment, regardless of symptom severity of 
functional loss at start of treatment. Furthermore, it seems valuable to consider 
changing the content of conservative treatment or to discuss surgery with 
patients after six weeks of therapy, when levels of improvement are still mainly 
unsatisfactory.
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INTRODUCTION
Primary osteoarthritis (OA) of the carpometacarpal (CMC) joint is common 
among the elderly.1 Multiple options are available to treat CMC OA2-4 and various 
guidelines recommend to start with conservative treatment that can include: 
hand therapy, topical or oral non-steroidal anti-inflammatory drugs, intra-articular 
steroid injection, and splinting.5-7
 Studies on outcome after non-operative treatment are mainly based on group 
level analysis and large variation is reported between individual patients, e.g. 
some were highly satisfied and almost/fully free of pain, while others were 
unsatisfied and/or had residual pain.8-10 However, the quality of most of these 
studies was only weak to moderate. For example, although one systematic 
review showed that hand orthosis may help relieve pain, the sample size of the 
included studies ranged from only 10 to 37 patients and follow-up ranged from 
only 1 week to 6 months. 8 Another systematic review on comparative studies 
of hand orthosis or hand therapy for CMC OA, concluded that hand orthosis 
or hand therapy may provide some reduction in pain; however, the follow-up of 
these latter studies ranged from 2 weeks to 3 months and the study samples 
comprised only older individuals (aged 70-90 years).9
Whereas for various surgical techniques for CMC OA predictive factors for 
outcome have been described11,12, no predictors are reported for the outcome 
of conservative treatment; thus, it remains unclear which patients might benefit 
from conservative treatment.
Therefore, this study aims to: 1) identify predictive factors for outcome after 
splinting/hand therapy for CMC OA and for conversion to surgical treatment, 
and 2) determine how many patients with no improvement in outcome within six 
weeks after start of treatment will improve after three months.
METHODS
This observational, prospective multi-center cohort study was conducted using 
data collected between January 2011and November 2014. All patients with 
symptomatic, clinically-diagnosed CMC OA were asked to participate and were 
included at Xpert Clinic in the Netherlands. This clinic comprises 15 locations in 
the Netherlands, with 16 European Board certified (FESSH) hand surgeons and 
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over 50 hand therapists. No remuneration was provided to any of the patients. 
The study was approved by the local institutional review board (MEC-2015-691) 
and written informed consent was obtained from all patients.
For the present study, patients diagnosed with primary, non-traumatic CMC OA 
by a hand surgeon were eligible for inclusion; patients were selected that were 
not previously surgically treated for CMC OA and did not have simultaneous 
treatment for any other hand condition(s). Excluded were patients who received 
intra-articular corticosteroid injection as part of their treatment, since this 
treatment may interact with the effectiveness of splinting and/or hand therapy.
Treatment
Treatment was based on the current treatment guideline in the Netherlands.7 In 
general, treatment consisted of prescribing a custom-made or pre-fabricated 
orthosis (based on the preference of the surgeon, hand therapists, and medical 
insurance of the patient). The orthotic device was a butterfly thumb orthosis in 
which the CMC joint of the thumb was fixed in extension/abduction, and the 
metacarpophalangeal joint (MCP-1) of the thumb was fixed in mild flexion.
In addition, patients received two sessions of hand therapy per week of (on 
average) 25 min per session. All hand therapists received the same internal 
training on how to treat CMC OA with hand therapy. However, this was a prag-
matic study in that the hand therapy was not strictly protocolled and controlled 
but was evaluated based on clinical practice. Therapy sessions were planned 
based on the judgment of the therapist, and the ability and availability of the 
patient. In a small minority of the cases, patients did not visit a hand therapist and 
only received a hand orthosis; however, the number of patients receiving only an 
orthosis was negligible.
The treatment was divided into two phases; phase one (weeks 0-6) included 
instructions to wear the splint (almost) 24 h/day, and consisted of hand therapy 
for optimizing thumb position (training pinch and grasping movements without 
hyperextension in the metacarpophalangeal thumb joint and without CMC 
adduction) and using a full thumb range of motion (i.e. training specific coordi-
nation of the intrinsic/extrinsic muscles of the thumb). The rationale for advising 
patients to wear the orthotic device 24 h/day was to give the thumb rest, reduce 
inflammation, and improve stability in the joint.13,14 Another goal of the first 
phase of the study was to re-learn correct positioning of the thumb; to achieve 
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this patients should preferably be without pain. In phase two (weeks 7-12), the 
splint was slowly phased out: the patients were advised to use the splint only 
during heavy activities, depending on the pain level and the patient’s ability to 
perform activities with a stable thumb position. During this phase, hand therapy 
focused on maintaining pain reduction, introducing the stability learned during 
daily activities, and improving thenar muscle strength. In addition, fewer hand 
therapy sessions were scheduled and patients performed more home exercises 
(up to 4-6 times a day). The number of prescribed home exercises ranged from 
3-6 exercises per day, with 10-15 repetitions each, depending on the individual 
patient and the level of pain.
After this period of supervised therapy, patients were encouraged to continue 
doing the exercises and were allowed to use the splint when necessary. No corti-
costeroid injections were given for CMC OA during or after hand therapy, and no 
anti-inflammatory medication was prescribed by the surgeon.
Measures
At the start of treatment, baseline data of all patients were collected, including 
duration of complaints, hand dominance, sex, age, comorbidity and occupation. 
Outcome measures were recorded via our web-based conservative outcome 
registration at i) start of treatment (baseline), and at ii) six weeks and iii) three 
months after start of treatment.
Conservative treatment was evaluated at the follow-up appointment at three 
months. Surgical intervention was discussed when patients did not respond 
well to the splinting and hand therapy and had functional impairments and/or 
residual pain. All surgeries performed between January 2012 and February 2016, 
together with the time until surgery, were retrieved from the clinical records; this 
information was collected irrespective of whether or not patients responded to 
the study questionnaires.
Pain, function and satisfaction
Pain was measured using a Visual Analogue Scale (VAS, where 0=no pain and 
100=the worst possible pain) during two situations: i) pain during physical load, 
and ii) pain intensity during the week prior to the follow-up measurement. The 
minimal clinically important difference (MCID) for VAS pain is 9.7.15 In the present 
study, for convenience, the MCID for VAS pain was considered to be 10. Hand 
function was measured with the Michigan Hand Questionnaire (MHQ; Dutch 
5
94
Chapter 5
Language Version) where 0=poorest function and 100=ideal function).16-18 The 
MHQ measures patient-rated, self-reported hand function based on 37 items, 
covering six domains (pain, esthetics, hand function, performance of activities of 
daily living, work performance, and satisfaction). For non-traumatic hand condi-
tions, the MCID for the total MHQ ranges from 9-13 points.19 In the present study, 
for convenience, the MCID for the total MHQ score was considered to be 10. 
Lastly, we asked patients to score overall satisfaction with their hand on a VAS 
where 0=completely dissatisfied and 100=completely satisfied.
Statistical analysis
Since data were collected during daily clinical practice, there was a substantial 
proportion of non-response during follow-up (Supplementary Table 1). Therefore, 
we performed an extensive responder/non-responder analysis (Supplementary 
Table 2) and missing data analysis and concluded that the outcome variables 
were missing at random. Therefore, we performed multiple imputation by 
chained equations (MICE) by fully conditional specification. Multiple imputation 
is an appropriate method to handle large amounts of missing data (up to 80%).20
To identify predictors for outcome, patient demographics and baseline measures 
of pain, function and satisfaction were examined. Outcome was defined as pain, 
function and self-reported satisfaction with the hand at six weeks and at three 
months after start of treatment, and conversion to surgery. First, the correlation 
between a possible predictor and each outcome parameter was studied using 
Pearson’s correlation. Univariate Cox regression analysis was used to examine 
predictors at the time of conversion to surgery. All variables with a univariate 
association with a significance level of <0.10 were used for backward entered 
multivariable linear regression analysis, and backward entered conditional Cox 
regression. For all tests, a p-value ≤ 0.05 was considered statistically significant.
Secondly, in the absence of a clinically relevant improvement at six weeks, 
we examined how often there was a clinically-relevant improvement in pain 
and function at three months after start of treatment. This allowed to evaluate 
whether further conservative treatment after six weeks was beneficial. A clinical-
ly-relevant improvement was defined as an improvement of more than the MCID 
of 10 for pain and of 10 for the MHQ (as described above). The diagnostic value of 
the six-week outcome for the outcome at three months was further tested with a 
receiver operating characteristic (ROC) curve.
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Based on the ROC curve the following were calculated: i) the sensitivity (i.e. the 
proportion of patients with no clinically-relevant improvement at 0-3 months 
that also had no clinically-relevant improvement at 0-6 weeks), ii) the speci-
ficity (i.e. the proportion of patients with a clinically-relevant improvement at 
0-3 months that also had a clinically-relevant improvement at 0-6 weeks), iii) 
the positive predictive value (i.e. the proportion of patients with a clinically-rel-
evant improvement at 0-3 months that had no clinically-relevant improvement 
at 0-6 weeks), and iv) the false-positive rate (i.e. the proportion of patients with 
no clinically-relevant improvement at 0-3 months that had a clinically-relevant 
improvement at 0-6 weeks).
Figure 1. Flowchart of the study
RESULTS
Study population and outcome of conservative treatment
The study included 809 patients who were treated for complaints due to CMC 
OA between January 2011 and November 2014: Figure 1 presents an overview 
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of the study population. Table 1 lists the baseline characteristics of the patients, 
and outcome at six weeks and three months after start of treatment. There was 
a significant improvement in satisfaction (from 41± 22 at baseline to 56 ± 23 at 
three months), a significant decrease in pain (from 49 ± 20 at baseline to 40 ± 21 
at three months) and a significant improvement in hand function (from 66 ± 14 at 
baseline to 72 ± 11 at three months). After a mean follow-up of 2.2 years, 15% of 
the patients underwent surgery.
Table 1. Baseline characteristics and outcome of treatment with splinting and hand therapy at 6 
weeks and at 3 months.
Variables Baseline
(% or mean ±SD)
6 weeks
(mean ± SD)
3 months
(mean ± SD)
Sex Female 76
Treated hand Right 50
Workload No work 43
Light physical work 23
Moderate physical 
work 23
Heavy physical work 11
Dominance Left 9
Right 87
Both 4
Age (years) 60 ± 9
Duration of symptoms (months) 34 ± 62
Pain during activities (VAS 0-100)* 61 ± 22 49 ± 23 48 ± 23
Pain intensity during the week prior to 
follow-up (VAS 0-100)* 49 ± 20 40 ± 21 40 ± 21
MHQ (0-100) Total¥ 66 ± 14 70 ± 9 72 ± 11
Daily Activities¥ 77 ± 22 82 ± 15 80 ± 18
Function¥ 66 ± 16 67 ± 14 68 ± 15
Esthetics¥ 85 ± 17 86 ± 15 86 ± 17
Satisfaction¥ 61 ± 26 70 ± 19 71 ± 21
Pain* 54 ± 25 46 ± 19 42 ± 21
Work performance¥ 61 ± 23 63 ± 20 68 ± 20
Hand satisfaction (VAS 0-100)¥ 41 ± 22 54 ± 24 56 ± 23
*: High scores indicate worse outcome
¥: High scores indicate good outcome
Abbreviations: MHQ, Michigan Hand Questionnaire; VAS, Visual analog scale; SD, Standard 
Deviation
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Predictive factors
Univariate analysis showed that pre-treatment baseline scores, sex, age, 
workload and treated hand side correlated with the outcome measures (Table 2). 
Results of the multivariable regression analysis are given in Table 3. For change 
in pain after three months (VAS), the multivariable regression model explained 
34% of the variance in outcome (p<0.001), with one significant predictor i.e. 
pain intensity during the week prior to the baseline measurement. For change 
in patient satisfaction (VAS) after three months, the multivariable regression 
analysis model explained 38% of the variance in outcome (p<0.001), with baseline 
patient satisfaction with their hand as significant predictor. For change in function 
(MHQ) after three months, the multivariable regression analysis model explained 
42% of the variance in outcome (p<0.001), with baseline function and baseline 
patient satisfaction with their hand as significant predictors.
Table 2. Results of univariate analysis. Correlation coefficients are displayed.
Baseline Variables Outcome at 6 weeks Outcome at 3 months Conversion 
to surgery
Δ in 
overall 
pain‡ 
(VAS)
Δ in hand 
satisfaction
(VAS)
Δ in hand 
function
(total 
MHQ)
Δ in 
overall 
pain‡ 
(VAS)
Δ in hand 
satisfaction
(VAS)
Δ in hand 
function
(total MHQ)
hazard ratio 
B per 10
Sex 0.129* 0.070*
Age 0.109*
Dominance -0.07**
Treated hand 0.073** 0.302* 0.209*
Duration of com-
plaints
Workload -0.064**
Hand function (MHQ 
Total) 0.170* -0.134* -0.796* 0.156* -0.169* -0.648* 0.72*
Hand Satisfaction 
(VAS) 0.179* -0.558* -0.188* 0.206* -0.616* -0.122* 0.82*
Pain during activities 
(VAS) -0.419* 0.195* 0.233* -0.440* 0.244* 0.245* 1.23*
Pain intensity during 
the week prior to 
follow-up (VAS)
-0.581* 0.213* 0.216* -0.581* 0.235* 0.220* 1.32*
‡ Pain refers to pain intensity during the week prior to follow-up
*Association significant at p-value <0.05.
** Association significant at p-value <0.10.
Empty cells indicate a non-significant correlation at p-value >0.10
Abbreviations: MHQ, Michigan Hand outcomes Questionnaire; VAS, Visual Analogue Scale
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For the probability of converting to surgery, Cox regression analysis resulted in 
two significant predictors: function (MHQ) at baseline and pain intensity during 
the week prior to the baseline measurement. For every 10 points of improvement 
in MHQ at baseline, the probability of a patient undergoing surgery decreased by 
19%. For every 10 points of improvement in pain intensity during the week prior 
to the baseline measurement, the probability of a patient undergoing surgery 
decreased by 26%.
Table 3. Multivariable regression analysis: beta-coefficients related to different outcome measures.
Baseline variables Outcome at 6 weeks Outcome at 3 months Conver-
sion to 
surgery
Δ in 
overall 
pain‡ 
(VAS)
Δ in hand 
satisfaction
(VAS)
Δ in hand 
function
(total 
MHQ)
Δ in 
overall 
pain‡ 
(VAS)
Δ in hand 
satisfaction
(VAS)
Δ in hand 
function
(total 
MHQ)
Δ in overall 
pain‡ (VAS)
R2 (% explained 
variance) 35% 31% 63% 34% 38% 42%
Hand function 
(MHQ Total) -0.780* -0.648 0.81*
Hand satisfaction 
(VAS) -0.126* -0.697* -0.808* 0.039
Pain intensity 
during the week 
prior to follow-up 
(VAS)
-0.770* -0.741* 1.26*
‡ Pain refers to pain intensity during the week prior to follow-up
*Association significant at p-value <0.05
Empty cells indicate a nonsignificant correlation at p-value >0.05
Abbreviations: MHQ, Michigan Hand outcomes Questionnaire; VAS, Visual Analogue Scale
 
Sensitivity analysis
After three months of conservative treatment, 380 patients showed a clinical-
ly-relevant improvement on pain scores (VAS). Using the ROC curve, we calcu-
lated a sensitivity of 0.765 (95% CI 0.721-0.803) and a specificity of 0.676 (95% CI 
0.626-0.722). This resulted in a positive predicted value of 73% (95% CI 68-77%) 
(Table 4), indicating that 73% of the patients that had no clinically-relevant 
improvement in pain after six weeks also had no clinically-relevant improvement 
in pain after three months.
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After three months, 259 patients showed a clinically-relevant improvement in 
function (MHQ). Again, using the ROC curve, we calculated a sensitivity of 0.896 
(95% CI 0.867-0.920) and a specificity of 0.618 (95% CI 0.555-0.677). This resulted 
in a positive predicted value of 83% (95% CI 80-86%) (Table 4), indicating that 
83% of the patients who had no clinically-relevant improvement in function after 
six weeks also had no clinically-relevant improvement in function after three 
months of conservative treatment. We redid the sensitivity analysis using the 
dataset with only complete cases and observed very similar outcome (Supple-
mentary Table 3).
Table 4. Positive predictive values for pain and function at six weeks, i.e. the percentage of patients 
that did not show a clinically-relevant improvement at three months and did not show a clinically-rel-
evant improvement at six weeks.
Pain (VAS)
Clinically-relevant 
improvement at 0 to 3 
monthsÞ
Yes No Total
Positive predictive 
value (95% CI)
Negative likeli-
hood ratio (95% 
CI)
Clinically-relevant 
improvement 0 to 6 
weeks‡
No† 123 328 451 0.73 (0.67-0.79) 0.35 (0.29-0.41)
Yes 257 101 358
Total 380 429 809
Hand function (MHQ)
Clinically-relevant 
improvement at 0 to 3 
months‡
Yes No Total
Positive predictive 
value (95% CI)
Negative likeli-
hood ratio (95% 
CI)
Clinically-relevant 
improvement at 0 to 6 
weeks‡
No† 99 492 592 0.83 (0.80-0.86) 0.17 (0.13-0.22)
Yes 160 57 217
Total 259 550 809
Þ Clinically-relevant improvement defined as an improvement of 10 or more on the 0-100 VAS 
scale15
‡ Clinically-relevant improvement defined as an improvement of 10 or more on the 0-100 MHQ 
scale16-18
Abbreviations: MHQ, Michigan Hand outcomes Questionnaire; VAS, Visual Analogue Scale
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DISCUSSION
This study had two main aims. The first was to identify predictive factors for 
outcome of conservative treatment and predictive factors for conversion to 
surgical treatment. The multivariable regression model explained 34-42% of 
the variance in satisfaction, pain and function (MHQ) after three months, with 
baseline satisfaction with the hand, baseline pain and baseline function (MHQ) 
as predictive factors. In addition, every 10 points of improvement in baseline pain 
led to a 26% decrease in the risk of conversion to surgery of 26% and every 10 
points of improvement in baseline MHQ score led to a 19% decrease in the risk of 
conversion to surgery.
The second aim was to determine how many patients that showed no 
improvement in pain within six weeks after start of conservative treatment also 
showed no improvement after three months of treatment. A negative predictive 
value of 73% was found for pain and 83% for function (MHQ). This indicates that, 
in the absence of a clinically-relevant improvement after six weeks, 73% of the 
patients show no clinically-relevant improvement on the VAS pain score after 
three months, and 83% of the patients show no clinically-relevant improvement 
on the MHQ score after three months.
To our knowledge, the present study is the first to identify baseline predictive 
factors for conservative treatment of CMC OA. For surgery, a study on predictive 
factors for outcome showed that patients with CMC OA with hyperextension of 
the MCP joint or a restricted thumb web had a worse outcome after surgery; 
however, that study did not report the percentage of explained variance.11 In 
daily practice, patients with considerable pain often undergo surgical treatment 
without first receiving hand therapy. The present study shows that patients 
with the most pain and the lowest level of function may benefit most from hand 
orthosis and hand therapy. Therefore, we recommend to always start with 
conservative treatment, irrespective of symptom severity or functional loss at 
start of treatment.
Since the present study found only moderate levels of explained variances, we 
can only partially predict which patients will have a greater chance of bene-
fitting from conservative treatment. The predictors for conversion to surgery 
indicate which patients are more likely to undergo surgery and which will not. 
For example: in our patients with a baseline pain score of >75, 31% will undergo 
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surgery, whereas in patients with a baseline pain score of <25, only 5% will 
undergo surgery. Overall, at baseline we could not identify subgroups of patients 
with such a high probability of undergoing surgery after conservative treatment 
that this warranted selection for immediate surgery, without prior conservative 
treatment.
Although the baseline factors we found have only moderate predictive value, 
we did establish that a lack of clinical improvement in outcome after six weeks 
is a good indicator for a lack of clinical improvement in pain and function after 
three months. Only 17-27% of our patients that showed no clinically-relevant 
improvement in pain and function after six weeks showed a clinically-relevant 
improvement in these parameters after three months. In daily practice, surgeons 
tend to prescribe hand therapy for an arbitrary number of weeks/months, 
without knowing exactly when to evaluate treatment. Our findings indicate that, 
when the outcome is still unsatisfactory at six weeks, it may be worthwhile to 
evaluate treatment, potentially adjust the content of hand therapy or to discuss 
surgery with patients at that time. Future studies will hopefully elucidate whether 
changing the content of hand therapy or early termination of unsuccessful 
conservative treatment and conversion to surgery will lead to more efficient and 
cost-effective healthcare.
Study limitations
This study has both strengths and limitations. The main strength is the large 
sample size and another is the study’s observational design, i.e. recording how 
conservative treatment is performed in actual clinical practice, rather than within 
the stricter and potentially less-natural setting of a randomized controlled trial. 
However, this was also a limitation since the measurements took place in multiple 
locations with the risk of large variation in treatment; this precluded the possibility 
of completely standardizing the treatment protocol. Also, unfortunately, from our 
database we were unable to retrieve the total number of therapy sessions for 
each patient and adjust outcomes based on these sessions. Future research 
could investigate to what extent the number of therapy sessions received might 
influence outcome.
One limitation is the lack of a control group. Therefore, the predictors found for 
outcome after three months of conservative treatment provide no information 
on the effectiveness of conservative treatment compared to no treatment, or 
compared to direct surgical treatment.
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Secondly, there was a substantial amount of missing data. Since a small number 
of patients had failed conservative treatment before three months and received 
surgical treatment, their outcome measurements at three months were missing. 
However, the data missing for patients at three months were missing completely 
at random and no underlying mechanisms could be identified.
Another limitation is that, after being treated conservatively in our clinic, patients 
may have been treated surgically elsewhere, which may lead to underreporting 
of the rate of surgery. However, since our clinic specializes in treating hand and 
wrist conditions, we assume that the number of patients treated elsewhere is 
negligible.
Future research
Since we found only moderate baseline predictors for outcome after conser-
vative treatment, future studies could focus on other predictive factors, e.g. 
psychosocial factors. For example, a recent systematic review2121 found that 
depression and anxiety were highly prevalent in patients with osteoarthritis and 
that patients with these symptoms experienced more pain and had less optimal 
outcomes. Another study found that patients seeking care for CMC OA had more 
catastrophic thinking and higher rates of depression compared to patients that 
did not seek treatment for CMC OA.22 Moreover, according to a report describing 
predictors for outcome after surgical treatment for osteoarthritis12, future 
research could also focus on other objective measures, such as range of motion 
(hyperextension of MCP and narrow first web) and strength of thumb.
CONCLUSIONS
In these patients with CMC OA, the present study found that: 1) satisfaction, pain 
and function measured at baseline explained 32-42% of the outcome of these 
parameters after three months of conservative treatment and the probability of 
undergoing surgery, and 2) a lack of improvement after six weeks resulted in a 
73-83% negative predictive value for a lack of improvement in pain and function 
after three months. Therefore, for all patients with CMC OA, we recommend to 
start with hand orthosis and hand therapy irrespective of symptom severity. In 
addition, it may be beneficial to evaluate treatment after a relatively short period 
of conservative treatment (e.g. six weeks) when there has been no demonstrable 
clinically-relevant improvement during that period.
103
CMC-1 OA Treated Non-operatively: Predicting Outcome
REFERENCES
1. Marshall M, van der Windt D, Nicholls E, Myers H, Dziedzic K. Radiographic 
thumb osteoarthritis: frequency, patterns and associations with pain and clinical 
assessment findings in a community-dwelling population. Rheumatology. 
2011;50(4):735-739.
2. Stamm TA, Machold KP, Smolen JS, Fischer S, Redlich K, Graninger W, Ebner W, 
Erlacher L. Joint protection and home hand exercises improve hand function in 
patients with hand osteoarthritis: a randomized controlled trial. Arthritis Rheum. 
2002;47(1):44-49.
3. Joshi R. Intraarticular corticosteroid injection for first carpometacarpal osteoar-
thritis. J Rheumatol. 2005;32(7):1305-1306.
4. Colditz JC. The biomechanics of a thumb carpometacarpal immobilization splint: 
Design and fitting. J Hand Ther. 2000;13(3):228-235.
5. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, 
Welch V, Wells G, Tugwell P. American College of Rheumatology 2012 recommen-
dations for the use of nonpharmacologic and pharmacologic therapies in osteoar-
thritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465-474.
6. Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, Dinçer F, 
Dziedzic K, Häuselmann HJ, Herrero-Beaumont G, Kaklamanis P, Lohmander 
S, Maheu E, Martín-Mola E, Pavelka K, Punzi L, Reiter S, Sautner J, Smolen J, 
Verbruggen G, Zimmermann-Górska I. EULAR evidence based recommendations 
for the management of hand osteoarthritis: Report of a Task Force of the EULAR 
Standing Committee for International Clinical Studies Including Therapeutics 
(ESCISIT). Ann Rheum Dis. 2007;66(3):377-388.
7. NVPC, NVvH. Dutch Plastic (NVPC) and Hand (NVvH) Surgery Societies: Guideline 
for conservative and surgical treatment for primary osteoarthritis of the thumb base 
joint (Richtlijn Conservatieve en Chirurgische Behandeling van Primaire Artrose 
van de Duimbasis). Amsterdam, N-Holland, The Netherlands: NVvH; 2014.
8. Egan MY, Brousseau L. Splinting for osteoarthritis of the carpometacarpal joint: a 
review of the evidence. Am J Occup Ther. 2007;61(1):70-78.
9. Spaans AJ, van Minnen LP, Kon M, Schuurman AH, Schreuders AR, Vermeulen 
GM. Conservative treatment of thumb base osteoarthritis: a systematic review. 
2015(1531-6564 (Electronic)).
10. Aebischer B, Elsig S, Taeymans J. Effectiveness of physical and occupational therapy 
on pain, function and quality of life in patients with trapeziometacarpal osteoar-
thritis– A systematic review and meta-analysis. Hand Therapy. 2016;21(1):5-15.
11. Degreef I, De Smet L. Predictors of outcome in surgical treatment for basal joint 
osteoarthritis of the thumb. Clin Rheumatol. 2006;25(2):140-142.
12. Moineau G, Richou J, Liot M, Le Nen D. Prognostic factors for the recovery of hand 
function following trapeziectomy with ligamentoplasty stabilisation. Orthop Trau-
matol Surg Res. 2009;95(5):352-358.
5
104
Chapter 5
13. Kjeken I, Smedslund G, Moe RH, Slatkowsky-Christensen B, Uhlig T, Hagen KB. 
Systematic review of design and effects of splints and exercise programs in hand 
osteoarthritis. Arthritis Care Res. 2011;63(6):834-848.
14. Neumann DBT. The carpometacarpal joint of the thumb: stability, deformity, and 
therapeutic intervention. The Journal of orthopaedic and sports physical therapy. 
2003;33(7):386-399.
15. Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N. 
Minimal perceptible clinical improvement with the Western Ontario and McMaster 
Universities osteoarthritis index questionnaire and global assessments in patients 
with osteoarthritis. J Rheumatol. 2000;27(11):2635-2641.
16. van der Giesen FJ, Nelissen RG, Arendzen JH, de Jong Z, Wolterbeek R, Vliet Vlieland 
TP. Responsiveness of the Michigan Hand Outcomes Questionnaire--Dutch 
language version in patients with rheumatoid arthritis. Arch Phys Med Rehabil. 
2008;89(6):1121-1126.
17. Chung KC, Pillsbury MS, Walters MR, Hayward RA. Reliability and validity testing of 
the Michigan Hand Outcomes Questionnaire. J Hand Surg Am. 1998;23(4):575-587.
18. Marks M, Audige L, Herren DB, Schindele S, Nelissen RG, Vliet Vlieland TP. 
Measurement properties of the German Michigan Hand Outcomes Questionnaire 
in patients with trapeziometacarpal osteoarthritis. Arthritis Care Res (Hoboken). 
2014;66(2):245-252.
19. London DA, Stepan JG, Calfee RP. Determining the Michigan Hand Outcomes 
Questionnaire minimal clinically important difference by means of three methods. 
Plast Reconstr Surg. 2014;133(3):616-625.
20. Lee JH, Huber Jr J. Multiple imputation with large proportions of missing data: 
How much is too much? Paper presented at: United Kingdom Stata Users’ Group 
Meetings 20112011.
21. Sharma A, Kudesia P, Shi Q, Gandhi R. Anxiety and depression in patients with 
osteoarthritis: impact and management challenges. Open access rheumatology : 
research and reviews. 2016;8:103-113.
105
CMC-1 OA Treated Non-operatively: Predicting Outcome
Supplementary Table 1. Number of complete cases per variable
Variable Number of cases
Sex 809 (100%)
Treated hand 809 (100%)
Workload 806 (100%)
Dominance 806 (100%)
Age (years) 809 (100%)
Duration of symptoms (months) 806 (100%)
Pain during activities at baseline 746 (92%)
Pain during previous week at baseline 746 (92%)
Satisfaction with hand at baseline 746 (92%)
Pain during activities at 6 weeks 515 (64%)
Pain during previous week at 6 weeks 515 (64%)
Satisfaction with hand at 6 weeks 515 (64%)
Pain during activities at 3 months 391 (48%)
Pain during previous week at 3 months 391 (48%)
Satisfaction with hand at 3 months 391 (48%)
MHQ at baseline 610 (75%)
MHQ at 6 weeks 290 (36%)
MHQ at 3 months 380 (47%)
Abbreviations: MHQ, Michigan Hand outcomes Questionnaire
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Supplementary Table 2. Baseline characteristics and responder/non-responder analysis.
Baseline characteristics
Total
(n=809)
% or mean ± SD
Responders at 3 
months (n=391)
% or mean ± SD
Non-responders at 
3 months (n=418)% 
or mean ± SD
p-value†
Sex Female 76 75 77 0.735
Treated hand Right 50 48 51 0.445
Workload
No work 45 47 44
0.141
Light physical 
work 23 19 24
Moderate 
physical work 23 27 22
Heavy physical 
work 9 6 10
Dominance
Left 9 11 8
0.359Right 87 83 88
Both 4 5 4
Age (years) 60 ± 9 60 ± 8 60 ± 9 0.630
Duration of symptoms (weeks) 34 ± 62 45 ± 92 32 ± 50 0.070
Pain during activities 
(VAS 0-100)* 61 ± 22 61 ± 21 61 ± 23 0.985
Pain intensity during the week 
prior to follow-up (VAS 0-100)* 49 ± 21 50 ± 20 49 ± 21 0.856
MHQ (0-100)
Total¥ 64 ± 15 63 ± 16 64 ± 15 0.443
Daily Activities¥ 77 ± 23 76 ± 24 78 ± 23 0.408
Function¥ 66 ± 18 67 ± 17 66 ± 18 0.640
Esthetics¥ 85 ± 18 85 ± 19 85 ± 18 0.753
Satisfaction¥ 60 ± 28 58 ± 27 60 ± 29 0.539
Pain* 63 ± 27 62 ± 25 63 ± 28 0.589
Work perfor-
mance¥ 61 ± 25 57 ± 23 62 ± 25 0.016
Hand satisfaction (VAS 0-100) ¥ 41 ± 22 42 ± 21 40 ± 23 0.387
† Significance of comparison between baseline characteristics of the responders and non-re-
sponders at 3-month measurement.
* High scores indicate worse outcome
¥ High scores indicate good outcome
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Supplementary Table 3. Positive predictive values for pain and function at six weeks, i.e. the per-
centage of patients that did not show a clinically-relevant improvement at three months and did not 
show a clinically-relevant improvement at six weeks using the dataset with only complete cases. No 
differences in outcome between the imputed dataset (Table 4) and the dataset with only complete 
cases were seen.
Pain (VAS)
Clinically-relevant 
improvement at 0 to 3 
monthsÞ
Yes No Total Positive predictive value (95% CI)
Negative likelihood 
ratio (95% CI)
Clinically-relevant 
improvement 0 to 6 
weeks‡
No† 39 119 158 0.75 (0.68-0.82) 0.35 (0.27-0.45)
Yes 122 43 165
Total 161 162 323
Hand function (MHQ)
Clinically-relevant 
improvement at 0 to 3 
months‡
Yes No Total Positive predictive value (95% CI)
Negative likelihood 
ratio (95% CI)
Clinically-relevant 
improvement at 0 to 
6 weeks‡
No† 28 87 115 0.76 (0.67-0.83) 0.17 (0.09-0.33)
Yes 34 9 43
Total 62 96 158
Þ Clinically-relevant improvement defined as an improvement of 10 or more on the 0-100 VAS 
scale15,16
‡ Clinically-relevant improvement defined as an improvement of 10 or more on the 0-100 MHQ 
scale10
Abbreviations: MHQ, Michigan Hand outcomes Questionnaire; VAS, Visual Analogue Scale.
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ABSTRACT
Background: Psychological characteristics, such as depression, anxiety or 
negative illness perception are highly prevalent in patients with several types of 
OA. It is unclear whether there are differences in the clinical and psychological 
characteristics of patients with thumb carpometacarpal (CMC-1) osteoarthritis 
(OA) scheduled for non-surgical treatment and those with surgical treatment.
Questions/purposes: (1) What are the differences in baseline sociodemo-
graphic characteristics and clinical characteristics (including pain, hand function, 
and health-related quality of life) between patients with thumb CMC-1 OA 
scheduled for surgery and those treated non-operatively? (2) What are the differ-
ences in psychological characteristics between patients scheduled for surgery 
and those treated non-surgically, for treatment credibility, expectations, illness 
perception, pain catastrophizing, and anxiety and depression? (3) What is the 
relative contribution of baseline sociodemographic, clinical, and psychological 
characteristics to the probability of being scheduled for surgery?
Methods: This was a cross-sectional study using observational data. Patients 
with CMC-1 OA completed outcome measures before undergoing either 
non-surgical or surgical treatment. Between September 2017 and June 2018, 
1273 patients were screened for eligibility. In total, 584 participants were 
included: 208 in the surgery group and 376 in the nonsurgery group. Baseline 
sociodemographic, clinical, and psychological characteristics were compared 
between groups, and a hierarchical logistic regression analysis was used to 
investigate the relative contribution of psychological characteristics to being 
scheduled for surgery, over and above clinical and sociodemographic variables. 
Baseline measures included pain, hand function, satisfaction with the patient’s 
hand, health-related quality of life, treatment credibility and expectations, illness 
perception, pain catastrophizing, and anxiety and depression.
Results: Patients in the surgery group had longer symptom duration, more often 
a second opinion, higher pain, treatment credibility and expectations and worse 
hand function, satisfaction, HRQoL, illness perception and pain catastrophizing 
compared with the non-surgery group (effect sizes ranged from 0.20 to 1.20; 
p values ranged from < 0.001 to 0.044). After adjusting for sociodemographic, 
clinical, and psychological factors, we found that the following increased the prob-
ability of being scheduled for surgery: longer symptom duration (standardized 
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odds ratio [SOR], 1.86; p  =  0.004), second-opinion visit (SOR, 3.81; p  =  0.027), 
lower satisfaction with the hand (SOR, 0.65; p = 0.004), higher treatment expec-
tations (SOR, 5.04; p < 0.001), shorter perceived timeline (SOR, 0.70; p = 0.011), 
worse personal control (SOR, 0.57; p < 0.001) and emotional response (SOR, 
1.40; p = 0.040). The hierarchical logistic regression analysis including sociode-
mographic, clinical, and psychological factors provided the highest area under 
the curve (sociodemographics alone: 0.663 [95% confidence interval 0.618 to 
0.709]; sociodemographics and clinical: 0.750 [95% CI 0.708 to 0.791]; sociode-
mographics, clinical and psychological: 0.900 [95% CI 0.875 to 0.925]).
Conclusions: Patients scheduled to undergo surgery for CMC-1 OA have a 
worse psychological profile than those scheduled for non-surgical treatment. 
Our findings suggest that psychological characteristics should be considered 
during shared decision-making, and they might indicate if psychological inter-
ventions, training in coping strategies, and patient education are needed. Future 
studies should prospectively investigate the influence of psychological charac-
teristics on the outcomes of patients with CMC-1 OA.
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INTRODUCTION
Thumb carpometacarpal (CMC-1) osteoarthritis (OA) is common, with a symp-
tomatic prevalence of 7% and 2% among women and men aged at least 50 
years, respectively 1-3. Patients with CMC-1 OA often have thumb pain and limita-
tions to activities of daily life and present with clinical features such as thenar 
muscle wasting or a thumb deformity 1,4. Usually, initial treatment is non-surgical 
(for example, hand therapy), including exercises, orthotics, or both 5-12. Increasing 
evidence shows that non-operative treatment decreases pain and improves hand 
function and patient satisfaction 5,7,8,10,13,14. When non-surgical treatment does not 
alleviate symptoms, surgery may be considered 15,16. Tsehaie et al. 14 reported that 
after non-surgical treatment, 15% of the patients eventually underwent surgical 
treatment after a mean period of 2.2 years, indicating that most patients with 
CMC-1 OA respond well to non-surgical treatment. In another study, Tsehaie et 
al. 17 found that baseline sociodemographic and clinical variables (such as pain 
intensity or hand function) account for 31% to 42% of the variance in outcome 
when predicting the results of non-surgical treatment and subsequent surgery, 
indicating that not all relevant covariates were covered.
During the past decade, studies have demonstrated that psychological charac-
teristics such as depression, anxiety, negative illness perception, and pain cata-
strophizing are highly prevalent in patients with several types of OA 18-27. However, 
little is known about differences in psychological characteristics and treatment 
expectations between patients with CMC-1 OA who have non-surgical treatment 
and those with surgical treatment. Hypothetically, when a non-surgical treatment 
fails (perhaps repeatedly), this suggests that a different psychological profile may 
be present at the start of surgical treatment. Only one study, by Lozano-Calderon 
et al. 28, evaluated differences between patients electing to undergo surgical 
and those choosing to undergo non-surgical treatment, using a relatively small 
sample of 72 participants and evaluating DASH scores, pain anxiety, catastroph-
izing, and depression. However, important domains such as illness perception, 
treatment credibility and expectations, and health-related quality of life were not 
studied, and the study might have been underpowered to determine between-
group differences or predictors of whether a patient would elect to undergo 
surgery. More insight into the psychological profiles and treatment expectations 
of patients with CMC-1 OA treated non-surgically and those treated surgically is 
needed. This would provide clinicians and patients with valuable information for 
shared decision-making; decrease the number of surgeries performed; improve 
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the outcomes of surgery; or indicate if psychological interventions, training in 
coping strategies, and patient education are needed.
Therefore, we formulated the following research questions: (1) What are the 
differences in baseline sociodemographic characteristics and clinical character-
istics (including pain, hand function, and health-related quality of life) between 
patients with thumb CMC-1 OA scheduled for surgery and those treated non-op-
eratively? (2) What are the differences in psychological characteristics between 
patients scheduled for surgery and those treated non-surgically, for treatment 
credibility, expectations, illness perception, pain catastrophizing, and anxiety and 
depression? (3) What is the relative contribution of baseline sociodemographic, 
clinical, and psychological characteristics to the probability of being scheduled 
for surgery?
PATIENTS AND METHODS
Study Design
This was a cross-sectional study using baseline data collected before non-sur-
gical or surgical treatment in a large observational cohort, following the STROBE 
statement 29.
Setting
Data were collected as part of routine outcome measurements using 
GemsTracker electronic data capture tools (Erasmus MC and Equipe Zorgbed-
rijven, Rotterdam/Eindhoven, The Netherlands) 30. GemsTracker is a secure 
web-based application for distributing questionnaires and documents during 
clinical research and quality registration 31,32. Data were collected at 18 outpatient 
hand surgery and therapy clinics in the Netherlands between September 2017 
and June 2018. The study was approved by the local medical research ethical 
committee. Following the Dutch treatment guideline 33, all patients with CMC-1 
OA diagnosed by a certified hand surgeon were initially referred for hand therapy 
and non-surgical treatment. Follow-up with the hand surgeon occurred after 
approximately 3 months, after which the decision to proceed to further (surgical) 
treatment could be made, based on persistent symptoms and patient preference. 
We classified patients who started with the non-surgical, hand therapy treatment 
as the nonsurgery group, and patients who proceeded to surgical treatment 
were classified as the surgery group.
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Participants
Participants were eligible for inclusion if they were adults with CMC-1 OA 
diagnosed by a Federation of European Societies for Surgery of the Hand 
(FESSH)-certified hand surgeon and if they were scheduled for either non-sur-
gical or surgical treatment. Non-surgical treatment included an orthosis 
combined with exercise therapy, which consisted hand therapy sessions (guided 
by an physical/occupational hand therapist, nationally certified in most cases) 
and exercises performed at home by the patient to improve active stability of 
the CMC-1 9,11,13,14,34. Surgical procedures included ligament reconstruction 
and tendon interposition as described by Burton and Pellegrini 35 and Weilby 36 
(using either the flexor carpi radialis or abductor pollicis longus tendon) 36, simple 
trapeziectomy, and arthrodesis. Participants were excluded from this study if 
they had a comorbidity (such as de Quervain’s tenosynovitis) that interfered with 
the treatment or outcome, prior surgery of the CMC-1 in the same hand, steroid 
injection in the affected hand or wrist within 6 weeks, surgery that targeted 
multiple pathologies (for example, an additional carpal tunnel release in the same 
session), or missing data for any measure being studied. Additionally, 13 patients 
were excluded because they completed the same measures both before their 
non-surgical and their subsequent surgical treatment. After applying the eligi-
bility criteria, 584 participants were included: 208 in the surgery group and 376 in 
the nonsurgery group (Fig. 1).
Variables, Data Sources, and Measurement
Similar to other studies 37-39, we classified variables into three categories: socio-
demographic, clinical, and psychological. All data represented baseline values 
before non-surgical or surgical treatment. Sociodemographic characteristics 
included age, sex, symptom duration, treatment side, dominance, type of work, 
whether the patient was seen for a second opinion, and type of surgery (for the 
surgery group).
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Figure 1. This flowchart illustrates the exclusions criteria for this study.
Clinical characteristics included pain, hand function, satisfaction, and health-re-
lated quality of life. We used the VAS 40 to measure pain (VAS score ranges from 0 
to 100; higher scores indicate more pain) and the patients’ satisfaction with their 
hand (exact question: “How satisfied are you with your hand at this moment?”; 
higher scores indicate better satisfaction). To assess hand function, we used the 
Michigan Hand outcomes Questionnaire (MHQ, range 0 to 100; higher scores 
indicate better performance, except for the subscale of pain), which is particu-
larly applicable to patients with OA of the hand 41. Health-related quality of life 
was measured using the EuroQol-5D-5L (EQ-5D-5L) 42.
Psychological characteristics included treatment credibility, treatment expec-
tations, illness perception, pain catastrophizing, and anxiety and depression. 
Treatment credibility and expectations were measured using the Credibility/
Expectancy Questionnaire (CEQ), consisting of a credibility and expectancy 
subscale (score range is 3 to 27; higher scores indicate higher credibility 
or expectations) 43. Illness perception was measured using the brief Illness 
Perception Questionnaire ([IPQ]; item scores range from 0 to 10; higher scores 
indicate worse illness perception) 44. Pain catastrophizing was measured with the 
Pain Catastrophizing Scale ([PCS]; score range is 0 to 52; higher scores indicate 
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more catastrophizing) 45. Furthermore, anxiety and depression were measured 
with the Patient Health Questionnaire for anxiety and depression ([PHQ-4]; 
score range: 0 to 6 for the subscales of anxiety and depression; higher scores 
indicate more anxiety and depression), which is a tool for detecting depressive 
disorders 46. Scores of 3 or higher for the subscales indicate a potential anxiety or 
depression disorder 46.
Study Size
A power analysis using an independent sample t-test (the primary analysis) with 
a conventional effect size 47 of 0.25 and power of 0.80 (a = 0.05) and an allocation 
ratio of 0.57 showed that 546 participants were needed, which was well below 
the sample of 584 participants we were able to include.
Statistical Methods
We compared baseline sociodemographic, clinical, and psychological char-
acteristics between patients with CMC-1 OA scheduled for non-surgical 
treatment and those with surgical treatment, using independent sample t-tests 
and chi-square tests. Additionally, to more specifically investigate the relative 
contribution of sociodemographic, clinical, and psychological characteristics to 
the probability of being scheduled for surgery, we used a hierarchical logistic 
regression analysis with the treatment group as a dependent variable. Using this 
method, the relative contribution of psychological characteristics can be studied 
in more detail after adjusting for sociodemographic characteristics (for example, 
symptom duration) and clinical characteristics (such as VAS pain levels). Vari-
ables were added to this hierarchical model in separate steps. To illustrate the 
fit of the different models, we determined the area under the curve, Nagelkerke’s 
r2, and receiver operating characteristic curves for these different models. In this 
analysis, we carefully selected each variable for inclusion in every step based 
on the construct it measures. This means that not all variables from the primary 
analysis were used in the hierarchical model; we excluded variables for which 
there was overlap in the measured construct (for example, the EQ-5D-5L anxiety/
depression index and PHQ-4). All available variables are reported in the primary 
analyses to provide an overview of both groups that was as clear as possible.
In the first step of the hierarchical model, only sociodemographic character-
istics including age, sex, symptom duration, treatment side, dominance, type 
of work, and second-opinion visit were added. In the second step, we added 
clinical characteristics, including VAS scores for pain at rest and during physical 
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loading; VAS satisfaction; MHQ subscales of hand function, activities of daily 
life, work, and aesthetics; and the EQ-5D-5L index score. In the third step, we 
added psychological characteristics, including the CEQ subscales of credibility 
and expectancy; IPQ items of consequences, timeline, personal control, identity, 
concern, coherence, and emotional response; the PCS; and the PHQ anxiety and 
depression subscales.
We evaluated multicollinearity using correlation coefficients and the variance 
inflation factor. A variance inflation factor greater than 10 was considered an indi-
cation of multicollinearity 48.
Table 1. Final model following hierarchical logistic regression analyses (n = 584) using sociodemo-
graphic, clinical and psychological characteristics explaining the relative contribution of being in the 
surgery group. Unstandardized and standardized odds ratios (SOR), 95% confidence intervals for the 
unstandardized ORs are displayed, along with the area under the curve (AUC) and Nagelkerke R2 for 
the model. *Significant at < 0.05 level. MHQ = Michigan Hand outcomes Questionnaire, CEQ = Cred-
ibility and Expectancy Questionnaire, IPQ = brief Illness Perception Questionnaire, PCS = Pain Cata-
strophizing Scale, PHQ = Patient Health Questionnaire.
Variables
Final model
Unstandardized OR
(95% CI) Standardized OR
Step 1: Sociodemographic character-
istics
Treatment side 0.84 (0.54 to 1.30) 0.84
Dominance 1.01 (0.50 to 2.05) 1.01
Gender 0.77 (0.42 to 1.43) 0.77
Age onset 1.01 (0.97 to 1.05) 1.05
Symptom duration 1.01* (1.00 to 1.02) 1.86
Second opinion 3.81* (1.17 to 12.4) 3.81
Type of work category
Type of work category (1) 1.07 (0.54 to 2.14) 1.07
Type of work category (2) 0.73 (0.37 to 1.42) 0.73
Type of work category (3) 1.31 (0.55 to 3.13) 1.31
Step 2: Clinical characteristics
VAS pain at rest 1.00 (0.99 to 1.01) 1.01
VAS pain during physical load 1.01 (1.00 to 1.03) 1.34
VAS satisfaction with the patient’s hand 0.98* (0.97 to 0.99) 0.65
MHQ hand function 1.00 (0.99 to 1.02) 1.01
MHQ activities of daily living 1.00 (0.99 to 1.01) 0.87
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Table 1. Continued
Variables
Final model
Unstandardized OR
(95% CI) Standardized OR
MHQ work 0.99 (0.98 to 1.01) 0.86
MHQ aesthetics 0.99 (0.98 to 1.01) 0.86
EQ-5D-5L index score 0.40 (0.05 to 3.58) 0.87
Step 3: Psychological characteristics
CEQ credibility 1.04 (0.94 to 1.15) 1.18
CEQ expectancy 1.42* (1.29 to 1.56) 5.04
IPQ consequences 1.04 (0.88 to 1.23) 1.09
IPQ timeline 0.86* (0.77 to 0.97) 0.70
IPQ personal control 0.78* (0.70 to 0.87) 0.57
IPQ symptoms due to illness 1.00 (0.89 to 1.13) 1.01
IPQ concern 1.00 (0.88 to 1.14) 1.00
IPQ understanding 1.02 (0.90 to 1.16) 1.03
IPQ emotional response 1.12* (1.01 to 1.25) 1.40
PCS 1.01 (0.97 to 1.04) 1.05
PHQ anxiety subscale 0.92 (0.71 to 1.19) 0.89
PHQ depression subscale 0.89 (0.65 to 1.22) 0.87
AUC (95% CI; p value) 0.900 (0.875 to 0.925; p < 0.001)
Nagelkerke R2 0.56
RESULTS
After adjusting for sociodemographic, clinical, and psychological factors, we found 
that longer symptom duration (standardized odds ratio [SOR], 1.86; p  =  0.004), 
second-opinion visit (SOR, 3.81; p = 0.027), lower satisfaction with the hand (SOR, 
0.65; p  =  0.004), higher treatment expectations (SOR, 5.04; p < 0.001), shorter 
perceived timeline (SOR, 0.70; p  =  0.011), worse personal control (SOR, 0.57; p < 
0.001) and emotional response (SOR, 1.40; p  =  0.040) increased the probability of 
being scheduled for surgery to an area under the curve (AUC) of 0.900 (Table 1).
In an examination of sociodemographics alone, we found that patients in the surgery 
group reported a longer symptom duration (36 months) than did those in the 
nonsurgery group (23 months; p = 0.001) and visited our center more often for a 
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second opinion (7% versus 2%; p = 0.001). There were no other between-group 
differences in sociodemographic characteristics (Table 2).
Table 2. Sociodemographic characteristics for the surgery group (N=208) and the non-surgery group 
(N=376). 
Variable
Surgery group
(N=208)
Non-surgery group 
(N=376) p-value
Age, mean ±SD 60.7 ± 7.9 60.3 ± 7.6 0.532
Female gender, % 78.8% 77.7% 0.740
Symptom duration in months, mean ±SD 36.3 ± 36.5 22.7 ± 57.1 0.001
Treatment Side*, %
- Left
- Right
- Both
*statistics are used to test left/right only, 
since bilateral surgical treatment is not 
employed
48.6%
51.4%
-
46%
47.6%
6.4%
0.893
Dominance, %
- Left
- Right
- Both
7.2%
89.4%
3.4%
6.6%
90.7%
2.7%
0.854
Type of surgery, %:
- LRTI (Burton-Pellegrini)
- LRTI (Weilby-FCR)
- LRTI (Weilby-APL)
- Simple trapeziectomy
- Arthrodesis
23.1%
57.7%
7.7%
10.1%
1.4%
-
-
-
-
-
NA
Type of work, %
- Unemployed
- Light physical labor
- Moderate physical labor
- Heavy physical labor
45.7%
16.8%
23.1%
14.4%
41.2%
22.9%
26.6%
9.3%
0.079
Second opinion, % 7.2% 1.9% 0.001
Abbreviations: LRTI = Ligament Reconstruction and Tendon Interposition, FCR = Flexor Carpi Ra-
dialis, APL = Abductor Pollicis Longus
Considering clinical characteristics, patients in the surgical treatment group reported 
worse symptom severity scores for the VAS and MHQ (except for the subscale of 
aesthetics) than did those in the non-surgical treatment group (p < 0.001 to 0.006; 
absolute effect sizes ranging from 0.24 to 0.67) (Table 3). Additionally, patients in the 
surgery group reported worse scores for the EQ-5D-5L domains of self-care, daily 
activities, pain and discomfort indexes, and total index score (p < 0.001 to 0.016; 
absolute effect sizes ranging from 0.22 to 0.46) (Table 3).
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Table 3. Baseline mean ±SD values for clinical characteristics and symptom severity for the Visual 
Analogue Scales (VAS, score range: 0–100), the Michigan Hand outcomes Questionnaire (MHQ, 
score range: 0–100) and EQ-5D-5L (score range: 0–100 for self-rated health, 1–5 for subscales and 
-0.33–1.0 for the index score).
Variable
Surgery group
(N=208)
Non-surgery 
group (N=376)
Effect size
(Cohen’s d) p-value
VAS past week 67.2 ± 17.3 54.6 ± 21.5 0.65 <0.001
VAS rest 51.4 ± 22.7 40.2 ± 25.9 0.46 <0.001
VAS physical load 75.6 ± 17.4 63.3 ± 22.4 0.61 <0.001
VAS satisfaction with 
the patient’s hand 
(“How satisfied are 
you with your hand at 
this moment?”)
25.3 ± 20.4 37.2 ± 22.1 -0.56 <0.001
MHQ hand function 52.1 ± 17.9 57.9 ± 17.9 -0.32 <0.001
MHQ Activities of 
daily living 57.2 ± 27 69.1 ± 24.4 -0.46 <0.001
MHQ Work 49.1 ± 26.8 60.5 ± 25.8 -0.43 <0.001
MHQ Pain 64.5 ± 14.8 53.8 ± 17.1 0.67 <0.001
MHQ Aesthetics 78.9 ± 19.6 81.5 ± 19.6 -0.13 0.124
MHQ Satisfaction 42.2 ± 27.6 48.5 ± 24.9 -0.24 0.006
MHQ Total 50.1 ± 14.3 58.4 ± 14.7 -0.58 <0.001
EQ-5D-5L Self-rated 
health 75.6 ± 18.3 75.8 ± 18.4 0.00 0.859
EQ-5D-5L Mobility 1.36 ± 0.69 1.48 ± 0.82 -0.16 0.054
EQ-5D-5L Self care 1.44 ± 0.68 1.30 ± 0.61 0.22 0.016
EQ-5D-5L Daily 
activities 2.56 ± 0.97 2.30 ± 0.91 0.28 0.002
EQ-5D-5L Pain and 
discomfort 3.18 ± 0.72 2.85 ± 0.73 0.46 <0.001
EQ-5D-5L Anxiety 1.38 ± 0.73 1.32 ± 0.67 0.09 0.360
EQ-5D-5L index value 0.68 ± 0.16 0.73 ± 0.15 -0.31 0.001
When we compared the groups in terms of psychological characteristics, patients in the surgery 
group reported higher credibility and expectancy of their treatment than did those in the nonsur-
gery group (p < 0.001), with effect sizes of 0.81 and 1.20, respectively (Table 4). For the IPQ, patients 
in the surgery group reported having worse consequences, identity, concern, and emotional 
response because of their illness and a shorter expected timeline of their illness than did those in 
the nonsurgery group (p < 0.001 to 0.018; absolute effect sizes ranging from 0.20 to 0.47). Addition-
ally, patients in the surgery group reported less personal control but more treatment control than 
did those in the nonsurgery group, suggesting a more external locus of control (p < 0.001; absolute 
effect sizes 0.46 and 0.90, respectively). Furthermore, patients in the surgery group reported more 
pain catastrophizing on the PCS (p < 0.001; effect size = 0.31) than did those in the non-surgical 
treatment group. No differences were found in PHQ scores (Table 4).
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Table 4. Baseline mean ± SD scores on psychological questionnaires for treatment expectations, 
illness perception, pain catastrophizing and anxiety and depression. CEQ = Credibility and Expectancy 
Questionnaire (score range: 3–27), IPQ = brief Illness Perception Questionnaire (score range 0–10), 
PCS = Pain Catastrophizing Scale (score range: 0–52) PHQ = Patient Health Questionnaire-4 (PHQ, 
score range: 0-6 for the subscales)
Variable
Surgery group 
(n = 208)
Nonsurgery 
group (n = 376)
Effect size
(Cohen’s d) p value
CEQ credibility 23.5 ± 2.8 20.8 ± 3.8 0.81 <0.001
CEQ expectancy 22.3 ± 3.1 17.6 ± 4.6 1.20 <0.001
IPQ consequences: How much does 
your illness affect your life? (10 = severe-
ly affects my life)
7.4 ± 1.8 6.4 ± 2.3 0.47 <0.001
IPQ timeline: How long do you think your 
illness will continue? (10 = forever) 6.7 ± 2.5 7.7 ± 2.3 -0.42 <0.001
IPQ personal control: How much control 
do you feel you have over your illness? 
(0 = absolutely no control)
4.3 ± 2.5 5.3 ± 2.1 -0.46 <0.001
IPQ treatment control: How much do 
you think your treatment can help your 
illness? (10 = extremely helpful)
8.3 ± 1.4 6.8 ± 1.8 0.90 <0.001
IPQ identity: How much do you 
experience symptoms from your illness? 
(10 = many severe symptoms)
6.9 ± 2.4 6 ± 2.5 0.38 <0.001
IPQ concern: How concerned are you 
about your illness? (10 = extremely 
concerned)
6.5 ± 2.5 5.9 ± 2.7 0.20 0.018
IPQ coherence: How well do you feel 
you understand your illness? (10 = un-
derstand very clearly)
8.4 ± 2 8.4 ± 1.8 0.00 0.974
IPQ emotional response: How much 
does your illness affect you emotionally? 
(for example, does it make you angry, 
scared, upset or depressed? (10 = ex-
tremely affected emotionally)
5.2 ± 3 4.2 ± 2.9 0.37 <0.001
PCS 14.4 ± 10.3 11.4 ± 9.1 0.31 <0.001
PHQ subscale anxiety 0.80 ± 1.35 0.77 ± 1.31 0.02 0.765
PHQ subscale depression 0.67 ± 1.28 0.55 ± 1.09 0.10 0.252
PHQ anxiety cutoff (score 3 or higher), 
n (%) 25 (12%) 32 (8.5%) NA 0.171
PHQ depression cutoff (score 3 or 
higher), n (%) 17 (8.2%) 20 (5.3%) NA 0.175
PHQ total 1.47 ± 2.44 1.32 ± 2.22 0.06 0.437
When analyzing the different models resulting from our hierarchical regression, 
the model including sociodemographic, clinical, and psychological factors 
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provided the highest areas under the curve (sociodemographics alone: 0.663 
[95% CI 0.618 to 0.709]; sociodemographics and clinical: 0.750 [95% CI 0.708 to 
0.791]; sociodemographics, clinical and psychological: 0.900 [95% CI 0.875 to 
0.925], Supplementary Table 1). The ROC curve indicates that the probability of 
being scheduled for surgery is for the largest part explained by the last model, 
including sociodemographic, clinical, and psychological characteristics (Fig. 2).
Figure 2. Receiver operating characteristic curve for the hierarchical models, with AUCs of 0.663, 
0.750, and 0.900 for sociodemographic, plus clinical and plus psychological characteristics, respec-
tively, indicating that the probability of being in the surgery group is for the largest part of explained 
by the model with sociodemographic, clinical and psychological characteristics. ROC = receiver op-
erating characteristic; AUC = area under the curve.
 
DISCUSSION
Psychological characteristics, such as depression, anxiety or negative illness 
perception are highly prevalent in patients with OA. Before our study, it was 
unclear whether there are differences in the clinical and psychological char-
acteristics of patients with CMC-1 OA scheduled for non-surgical or surgical 
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treatment. More insight in psychological profile of these patients would provide 
clinicians and patients with valuable information for shared decision-making and 
indicate if psychological interventions, training in coping strategies, and patient 
education are needed. We found that patients with CMC-1 OA scheduled for 
surgery have a worse psychological profile than do those undergoing non-sur-
gical treatment. Additionally, the probability of being scheduled for surgery is 
best explained by our model, including sociodemographic, clinical, and psycho-
logical characteristics.
Limitations
The results of these between-group comparisons should be interpreted with 
caution because patients undergoing surgical treatment usually receive non-sur-
gical treatment first but do not improve. In the present study, we do not know 
whether between-group differences occurred because of deterioration in clinical 
and psychological characteristics over time after initiating non-surgical treatment 
or if these differences were predetermined and predictors of conversion to 
surgery. Furthermore, the amount of missing data that lead to our final sample 
(n  =  584 patients) and surgeon’s preferences may have resulted in selection 
bias. Hence, our sample may be a different representation compared with the 
target population of patients with CMC-1 OA. Another limitation is that although 
we reported effect sizes, which allow comparisons across populations and 
measurement instruments, the between-group differences in this study should 
be interpreted in light of minimal clinical important difference values established 
in other disease populations, such as for the VAS and the MHQ 40,49,50.
Differences in Baseline Characteristics between Patients Treated 
Surgically and Those Treated Non-operatively
We found that patients scheduled for surgical treatment had longer symptom 
duration, more often sought a second opinion, had higher pain, treatment cred-
ibility and expectations and worse hand function, satisfaction, HRQoL, illness 
perception, and pain catastrophizing compared with those scheduled for 
non-surgical treatment. We did not find between-group differences in anxiety or 
depression.
Although several studies investigated the psychological profiles of patients with 
OA 18-27, only one other study 28 specifically compared the psychological profiles 
of patients with CMC-1 OA scheduled for surgical or non-surgical treatment. 
However, the study by Lozano-Calderon et al. 28 had a sample that was too 
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small to find any between-group differences, and many different measurement 
tools were used compared with our study (that is, the DASH versus the MHQ 
for evaluating hand function), making it difficult to compare findings. Our study 
confirms prior reports 18-27, which showed that psychological characteristics are 
of major importance in patients with chronic musculoskeletal diseases such 
as OA, and these characteristics influence clinical decision-making, although 
perhaps unconsciously 18,20-27. Because the underlying pathology of OA of the 
CMC-1 is chronic, our study results might be generalizable to patients scheduled 
to undergo surgical or non-surgical treatment of other chronic diseases or body 
regions; for example, hip or knee OA. Therefore, future research should address 
other chronic diseases or body regions.
In the present study, we did not find between-group differences in anxiety or 
depression. However, Becker et al. 22 found differences in depression between 
patients visiting a clinician for CMC-1 OA and patients with coincidentally diag-
nosed CMC-1 OA. Becker et al. 22 used the nine-item version of the PHQ, which 
is a more extensive screening tool than the four-item tool used in the present 
study. However, a score of 5 or higher on the nine-item version of the PHQ indi-
cates mild depression 51, and in the study by Becker et al. 22, a mean score of 4.5 
was found in the group visiting a clinician for CMC-1 OA. This indicates that on 
average, no depression was present, which is comparable to our results.
Factors Contributing to the Probability of Being Scheduled for Surgery
Our findings suggest that patients with CMC-1 OA scheduled for surgical 
treatment have a worse psychological profile compared with patients scheduled 
for non-surgical treatment. The decision to undergo surgery might be influ-
enced by potentially modifiable psychological characteristics, and addressing 
these factors may decrease the number of surgeries performed or improve 
the outcomes of surgery. Psychological interventions, training in coping strat-
egies, and more extensive patient education may be indicated before surgical 
treatment is performed. However, although the correlation of psychological char-
acteristics with the outcome of non-surgical or surgical treatment of CMC-1 OA 
is currently unknown, this correlation is known in patients who undergo surgery 
for carpal tunnel syndrome or trigger finger 52. Future longitudinal studies should 
address the correlation of psychological characteristics with the outcomes of 
both non-surgical and surgical treatment of CMC-1 OA.
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We found that patients in the nonsurgery group expected to have a longer illness 
duration and had more personal control, less treatment control (IPQ scores), 
and lower treatment expectations (CEQ scores) than did those in the surgical 
group. Patients scheduled for non-surgical treatment may cope with chronic 
disease differently than those with surgical treatment, implying that they are 
more willing to accept aging processes and adapt to daily life than patients who 
undergo surgery. Furthermore, the participants in the surgery group reported 
having higher treatment credibility and expectations but worse clinical and other 
psychological characteristics, suggesting that more research on how to manage 
treatment credibility and expectations is needed, especially in this population.
In the final model, we found a relatively large OR for whether a second opinion 
contributed to the probability of surgery. This finding may be explained by the 
theory that patients seeking a second opinion already had a relatively long 
clinical course, and they may have postponed surgery for a longer time period. 
However, this hypothesis cannot be confirmed with the present cross-sectional 
study design and should be investigated in a longitudinal setting.
CONCLUSIONS
In conclusion, we found worse clinical and psychological characteristics in 
patients scheduled for surgical treatment of CMC-1 OA than in patients at the initi-
ation of non-surgical treatment. Furthermore, the probability of being scheduled 
for surgery was mostly explained by the model including sociodemographic, 
clinical, and psychological characteristics. A more thorough psychological eval-
uation might be considered before surgery is performed, especially in patients 
with high expectations, worse illness perception, and pain catastrophizing. 
Additionally, addressing these factors might decrease the number of surgeries 
performed, improve the outcomes of surgery or indicate if psychological inter-
ventions, training in coping strategies, and patient education might be indicated 
before converting to surgery. Future studies should investigate the influence of 
psychological characteristics on the outcomes of patients with CMC-1 OA.
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ABSTRACT
Objective: When conservative treatment fails to alleviate symptoms in patients 
with thumb base (CMC-1) osteoarthritis (OA), CMC-1 arthroplasty is indicated. 
However, there is no consensus regarding the components of postoperative 
rehabilitation for patients who underwent CMC-1 arthroplasty. This systematic 
review provides an overview of rehabilitation for patients who underwent CMC-1 
arthroplasty, with emphasis on early active mobilization.
Data sources/study selection: PubMed/MEDLINE, Embase, CINAHL and 
Cochrane were searched for articles written in English that described postoper-
ative regime (including immobilization period/method and/or description of exer-
cises/physical therapy, follow-up ≥six weeks) on CMC-1 arthroplasty.
Data extraction: The PRISMA statement was used as guidance in this review 
and methodological quality was assessed using the Effective Public Health 
Practice Project quality assessment tool. Randomized studies were additionally 
scored using the Physiotherapy Evidence Database scale.
Data synthesis: Twenty-seven studies were included, concerning 1015 partic-
ipants in whom 1118 surgical procedures were performed. A summary on the 
components of postoperative rehabilitation used in the included studies on 
CMC-1 OA is presented for different surgical interventions. We found that early 
active recovery (including short immobilization, early initiation of ROM and 
strength exercises) provides positive outcomes on pain, limitations in ADL and 
grip & pinch strength, but comparative studies are lacking. Furthermore, three 
postoperative exercises/therapy phases were identified in the literature: the 
‘acute phase’, the ‘unloaded phase’ and the ‘functional phase’, but again compar-
ative studies are lacking.
Conclusions: Early active recovery is used more often in the literature and does 
not lead to worse outcomes or more complications. This systematic review 
provides guidance for clinicians in the content of postoperative rehabilitation on 
CMC-1 arthroplasty. The review also clearly identifies the almost complete lack 
of high quality, comparative studies on postoperative rehabilitation after CMC-1 
arthroplasty.
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INTRODUCTION
Osteoarthritis (OA) of the thumb base joint (CMC-1) is a common disorder in the 
elderly.1 The prevalence of radiologically diagnosed CMC-1 OA amongst females 
aged ≥50 years is 33-36%.2,3 The number of patients with CMC-1 OA is expected 
to increase because of the ageing population.4 Patients with CMC-1 OA often 
experience pain, have reduced pinch- and/or grip strength and report limitations 
in activities of daily life (ADL).5
When conservative treatment fails to reduce pain and limitations in ADL, 
CMC-1 arthroplasty may be indicated.6 In the past decades, a variety of surgical 
techniques are described.7,8 When CMC-1 OA is treated surgically, usually a 
trapeziectomy is performed, with or without ligament reconstruction and/or 
tendon interposition.6-8 CMC-1 arthrodesis and implants are also used, but the 
usage of these techniques has been associated with a higher risk of complica-
tions (i.e. non-union or dislocation).6-8
Some studies emphasize the importance of postoperative rehabilitation for 
patients who underwent CMC-1 arthroplasty in order to improve pain intensity, 
limitations in ADL and improve range of motion (ROM) and grip & pinch 
strength.6,8 However, the lack of consensus on the content of postoperative reha-
bilitation for patients who underwent CMC-1 arthroplasty is mentioned as well.6,8
A systematic review by Wolfe et al. in 2014 on postoperative rehabilitation 
following CMC-1 arthroplasty concluded that no recommendations on postop-
erative rehabilitation could be made, due to a large reported variation regarding 
type and duration of postoperative immobilization, postoperative exercises, and 
duration before patients returned to full activities.9 Furthermore, no overview of 
postoperative rehabilitation and variations as used in literature (i.e. differences 
in immobilization period) is presented for different types of surgery. Additionally, 
their search in 2013 was limited to PubMed and Cochrane and limited infor-
mation on the search strings and the inclusion and exclusion criteria is provided.9 
Therefore, an overview of the postoperative rehabilitation as used in the liter-
ature on CMC-1 arthroplasty remains desirable.
Aims and research questions
The aim of this systematic review is to describe and to create an overview on the 
different components and phases of postoperative rehabilitation protocols for 
7
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patients who underwent CMC-1 arthroplasty and to quantify how often these are 
used. Furthermore, we investigated several specific components or variations in 
postoperative rehabilitation protocols that are presently discussed. Since tensile 
strength of scar tissue is at 80% of normal tissue at 6 weeks and at 50% at 4 
weeks, we specifically studied these time frames.10 We formulated the following 
research questions:
1. What type of postoperative rehabilitation (including immobilization period 
and initiation of ROM & strengthening exercises) is used in literature for 
different types of surgery, categorized by used tendon plasty?
2. What are the outcomes of short immobilization (4-6 weeks or ≤4 weeks) 
with regard to pain intensity, limitations in ADL, grip & pinch strength and 
complications?
3. What are the outcomes of ROM and strengthening exercises in an early 
phase (≤4 weeks) with regard to pain intensity, limitations in ADL and grip & 
pinch strength and complications?
METHODS
Design
This systematic review was conducted using the PRISMA statement as 
guidance.11
The inclusion of eligible articles was conducted by 2 reviewers (RW & BD), 
disagreements were resolved in a consensus meeting between the two raters.
Search strategy
The electronic databases MEDLINE (PubMed, from 1950), Embase (Elsevier, 
from 1974), CINAHL (EBSCO, from 1961) and the Cochrane Library (time limit 
unknown) were searched for eligible articles (search date: June 15th 2017). The 
references of the included articles were scanned for eligibility after primary and 
secondary screening.
The following MeSH terms and keywords (and their synonyms) were employed: 
‘carpometacarpal joint’, ‘thumb’, ‘arthroplasty’, ‘trapeziectomy’, ‘ligament recon-
struction and tendon interposition’, ‘rehabilitation’ and ‘hand therapy’. The 
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complete search strategy can be found in Appendix 1. We considered each 
tendon plasty as ligament reconstruction and tendon interposition (LRTI), except 
if authors specifically stated that only ligament reconstruction or tendon interpo-
sition was used.
Eligibility criteria
Articles were eligible for inclusion if they (1) concern patients who underwent 
CMC-1 arthroplasty due to symptomatic CMC-1 OA; (2) concern human males/
females aged ≥18 years; (3) describe an intervention with a follow-up of ≥six 
weeks postoperatively; (4) Provide an adequate description of postoperative 
regime, including immobilization period, immobilization method or description 
of exercises/physical therapy treatment; (5) provide a description of the type of 
surgery performed; (6) describe a comparison of results over time (i.e. preoper-
ative vs. postoperative); (7) included pain intensity and/or limitations in ADL and/
or grip & pinch strength as outcome measures and (8) were written in English.
Articles were excluded when they (1) provide an abstract only, clinical 
commentary, research letter, editorial note, review presented at meetings, 
preliminary study, case reports with complications/exceptions or when full-texts 
was unavailable; (2) concern revision arthroplasty, external fixation, implant/
prosthesis, arthrodesis, osteotomy, structural involvement of the first metacar-
pophalangeal (MCP-1) joint (i.e. volar capsulodesis) or other procedures; (3) are 
(systematic) reviews or (4) are long-term follow-up studies with already included 
study populations.
Study selection
Initially, articles were screened for eligibility on title and abstract. When titles and 
abstracts implied that an article was potentially eligible for inclusion, a full-text 
copy of the report was obtained. Additionally, reference tracking was performed 
in all included articles (see Figure 1: Flow chart).
Data extraction
Two reviewers (RW and JT) extracted data using a standard extraction form, 
disagreements were resolved in a consensus meeting between the two. Data 
extracted from the included articles were: (1) authors, publication year, and 
study location; (2) study design; (3) study population; (4) surgical intervention; 
(5) immobilization period; (6) therapy/exercises (7) outcome measurements; and 
(8) outcomes. If data were missing or further information was required, serious 
7
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attempts were made to contact the first two authors to request the required 
information. The rehabilitation protocol of the included studies was identified 
and summarized.
Assessment of methodological quality (risk of bias)
Two reviewers (RW and JT) independently assessed the methodological validity 
of the included articles. The methodological quality (risk of bias) was scored using 
the Effective Public Health Practice Project quality assessment tool (EPHPP),12 
randomized studies were scored using the Physiotherapy Evidence Database 
(PEDro) scale as well.13 Disagreements were resolved in a consensus meeting 
between the two raters. The strength of inter-rater agreement was measured by 
Cohen`s κ coefficient.14
Figure 1. Flowchart of the search process (derived from PRISMA11)
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Synthesis of results and data analysis
Effect sizes were calculated for comparative studies included in this review when 
means and standard deviations for pre and posttest outcomes were provided. 
If data were missing or further information was required, we contacted the first 
two authors to request the required information. When standard deviations 
were obtained, the pretest standard deviations were pooled to calculate effect 
sizes.15,16 Cohen16 defined conventional values for effect sizes, where a value of 
0.20 reflects a small, 0.50 a medium and 0.80 reflects a large effect size. Results 
of individual studies were not statistically pooled due to a limited number of 
comparative studies per research question and large heterogeneity.
RESULTS
Study selection and study characteristics
The initial search identified 1397 articles. After applying the inclusion and 
exclusion criteria, 27 studies were included in this systematic review (see Figure 
1).
An overview of the included studies, their characteristics, measurements and 
outcomes are shown in Table 1. In the 27 selected studies, a total of 1015 partici-
pants were included in which 1118 procedures were performed. Twelve different 
surgical procedures were performed in the 27 included studies (Table 2). In 
eight studies, eleven surgical co-interventions were performed (Supplementary 
Table 1, Appendix 2). Six studies17-22 described that no other co-interventions 
were performed and it is unclear if other co-interventions were performed in the 
thirteen remaining studies.23-35
On methodological quality (risk of bias), a Kappa score of 0.84 and 0.82 was 
found between the reviewers (RW & JT) with regard to the EPHPP and the PEDro 
scale respectively; both scores representing very good agreement.14 Supple-
mentary Table 2 (Appendix 2) gives an overview of the methodological quality of 
the included studies.
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical 
intervention
Co-
interventions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Abbas et 
al.23 2012
Case series N = 10
F/M = 10/0
Age = 50-60 (N=4), 61-70 
(N=3), 71-80 (N=2), 81-90) 
N=1) Dominance: 7
Modified LRTI 
using PL for 
interposition 
and FCR for 
ligament re-
construction
Unknown/not 
described
0-6 weeks: short 
arm thumb spica 
cast, K-wire excision 
after six weeks
6 weeks: Range of motion ex-
ercises were begun with grad-
ual progression to resistive 
pinch and grip strengthening 
by 12 weeks postoperatively
Limitations in ADL (Quick 
DASH).
Measures at: T0 (pre-oper-
ative), T1 (3 months), T2 (6 
months)
Quick DASH Score at T0: 58.8, T1: 40.5, T2: 31.3 
(p=0.005)
Ataker et 
al.36 2012
Retrospective 
Cohort
N = 23 consecutive 
patients, 27 thumbs
F/M = 21/2
Age = 63.5 years (range: 
30-83 years)
Dominance: 13/27
Modified LRTI 
according to 
Burton-Pel-
legrini using 
FCR
CTR (n=3), 
trigger release 
(n=3), de 
Quervain 
tenosynovitis 
surgery (n=2), 
and extensor 
pollicis brevis 
tenodesis for 
MCP-1 joint 
reconstruction 
(n=1).
0-2 weeks: spica 
plaster cast (wrist 
in 20° extension, 
thumb in midway 
between extension 
and abduction, and 
the IP joint of the 
thumb is free)
2-6 weeks: CMC 
butterfly (24h/day),
6-8 weeks: CMC 
butterfly (only at 
night)
Mean of 16.8 therapy sessions
0-4 weeks: ROM exercises for 
the unaffected fingers, IP 1, 
elbow, and shoulder; and flexor 
and extensor tendon gliding 
exercises as a home-based 
program. The home exercise 
program includes 1. Fist/
extension, 2. Finger abduction 
and adduction exercises (dig 
2-5). 4x day 10 reps.
4-6 weeks: AROM exercis-
es for CMC-1 and MCP1 
supervised by a PT, no CMC-1 
flexion/adduction, opposition. 
Scar management.
Pain intensity (VAS 0-10), 
Limitations in ADL (DASH), 
ROM, Grip & pinch 
strength, joint imaging 
(SMD)
Measures at: T0 (pre-op-
erative): T1 (12 weeks): and 
T2 (31.5 months, range: 
12-57 months)
VAS at T0: 8, T1: 3, T2: 3 (p<0.001).
DASH at T0: 56, T1: 29, T2: 24 (p<0.001).
Increase in palmar and radial abduction, 
Kapandji score (p<0.001).
Grip strength (kg) at T0: 12, T1: 18 (p<0.001), T2: 
13, Lateral pinch at T0: 3, T1: 5, T2: 4 (p<0.001).
Joint imaging at T0: 11 mm, T1: 5 mm, T2: 3 mm
6-8 weeks: progressive ROM 
and strengthening: isometric 
abduction, extension, and 
adduction. If patient can per-
form opposition to Kapandji 6 
with no pain, complete flexion 
can be attempted gradually. 
AROM IP, MP, CMC1, and 
thumb opposition added to the 
home exercise program 4xday 
10 reps.
8-10 weeks: Isotonic strength, 
gentle pinch, grip using 
putties, and power webs; and 
the resistance is increased 
gradually.
10-12 weeks: Strengthen-
ing exercises with putty + 
discharge.
12+ weeks: no restrictions
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical 
intervention
Co-
interventions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Abbas et 
al.23 2012
Case series N = 10
F/M = 10/0
Age = 50-60 (N=4), 61-70 
(N=3), 71-80 (N=2), 81-90) 
N=1) Dominance: 7
Modified LRTI 
using PL for 
interposition 
and FCR for 
ligament re-
construction
Unknown/not 
described
0-6 weeks: short 
arm thumb spica 
cast, K-wire excision 
after six weeks
6 weeks: Range of motion ex-
ercises were begun with grad-
ual progression to resistive 
pinch and grip strengthening 
by 12 weeks postoperatively
Limitations in ADL (Quick 
DASH).
Measures at: T0 (pre-oper-
ative), T1 (3 months), T2 (6 
months)
Quick DASH Score at T0: 58.8, T1: 40.5, T2: 31.3 
(p=0.005)
Ataker et 
al.36 2012
Retrospective 
Cohort
N = 23 consecutive 
patients, 27 thumbs
F/M = 21/2
Age = 63.5 years (range: 
30-83 years)
Dominance: 13/27
Modified LRTI 
according to 
Burton-Pel-
legrini using 
FCR
CTR (n=3), 
trigger release 
(n=3), de 
Quervain 
tenosynovitis 
surgery (n=2), 
and extensor 
pollicis brevis 
tenodesis for 
MCP-1 joint 
reconstruction 
(n=1).
0-2 weeks: spica 
plaster cast (wrist 
in 20° extension, 
thumb in midway 
between extension 
and abduction, and 
the IP joint of the 
thumb is free)
2-6 weeks: CMC 
butterfly (24h/day),
6-8 weeks: CMC 
butterfly (only at 
night)
Mean of 16.8 therapy sessions
0-4 weeks: ROM exercises for 
the unaffected fingers, IP 1, 
elbow, and shoulder; and flexor 
and extensor tendon gliding 
exercises as a home-based 
program. The home exercise 
program includes 1. Fist/
extension, 2. Finger abduction 
and adduction exercises (dig 
2-5). 4x day 10 reps.
4-6 weeks: AROM exercis-
es for CMC-1 and MCP1 
supervised by a PT, no CMC-1 
flexion/adduction, opposition. 
Scar management.
Pain intensity (VAS 0-10), 
Limitations in ADL (DASH), 
ROM, Grip & pinch 
strength, joint imaging 
(SMD)
Measures at: T0 (pre-op-
erative): T1 (12 weeks): and 
T2 (31.5 months, range: 
12-57 months)
VAS at T0: 8, T1: 3, T2: 3 (p<0.001).
DASH at T0: 56, T1: 29, T2: 24 (p<0.001).
Increase in palmar and radial abduction, 
Kapandji score (p<0.001).
Grip strength (kg) at T0: 12, T1: 18 (p<0.001), T2: 
13, Lateral pinch at T0: 3, T1: 5, T2: 4 (p<0.001).
Joint imaging at T0: 11 mm, T1: 5 mm, T2: 3 mm
6-8 weeks: progressive ROM 
and strengthening: isometric 
abduction, extension, and 
adduction. If patient can per-
form opposition to Kapandji 6 
with no pain, complete flexion 
can be attempted gradually. 
AROM IP, MP, CMC1, and 
thumb opposition added to the 
home exercise program 4xday 
10 reps.
8-10 weeks: Isotonic strength, 
gentle pinch, grip using 
putties, and power webs; and 
the resistance is increased 
gradually.
10-12 weeks: Strengthen-
ing exercises with putty + 
discharge.
12+ weeks: no restrictions
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Başar et 
al.22 2012
Retrospective 
Cohort
N =19
F/M = 18/1
Age = 55 (±5,7 years)
Dominance: 18/19
Modified LRTI 
using full-thick-
ness FCR
None 0-4 weeks: thumb 
spica
4-8 weeks: remov-
able splint
8 weeks: splint 
removed
4-8 weeks: MCP & IP joint 
exercises and isometric 
thenar abduction amplification 
exercises
8 weeks - 3 months: CMC-1 
joint mobilization allowed. 
Easy grasping exercises and 
progressive thenar abduction 
amplification exercises against 
resistance were started.
+ 3 months: resistive grasping 
and gripping exercises were 
started and increased progres-
sively
Pain intensity (VAS 0-10 
+ other), ROM (Buck-
Gramcko score, Kapandji), 
grip & pinch (tip pinch & 
lateral pinch) strength, joint 
imaging (SMD)
Measures at: T0 (pre-op-
erative) and T1 (60 months 
± 15)
Pain intensity T0: 7(±0.9), T1: 0.9 (±1.4) ROM: 
Grip & pinch strength: Grip T0: 13.15, T1: 19.28, 
tip pinch T0: 2.78, T1: 4.45, lateral pinch T0: 
4.13, T1: 5.60, all strength measures significant 
(p<0.0001)
At T1, 0.2 mm height, not significant.
Burton et 
al.24 1986
Retrospective 
Cohort
N = 24 patients, 25 
thumbs (4 revisions, 1 
bilateral),
F/M = 21/3,
Age = 55.4. Domi-
nance = 3/24
Partial (6 
cases) or 
complete 
trapeziectomy 
(19 cases) with 
LRTI using 
FCR, all with 
K-wire
Unknown/not 
described
0-4 weeks: thumb 
spica cast immobi-
lization followed by 
pin removal
4-6 weeks: isoprene 
thumb Spica splint 
support, worn con-
stantly except for 
hand exercises and 
washing. Splinting 
is stopped when full 
ROM is attained and 
thenar strength is 
improved to a func-
tional level, usually 
8 to 12 weeks after 
surgery
4-6 weeks: 1). AROM CMC-1 
abduction and extension while 
avoiding flexion adduction po-
sition, 2) AROM flexion of the 
MCP and IP joints with MC1 
supported in abduction by the 
patient’s opposite hand.
6 weeks, continued to 4-6 
months: Thenar strengthening 
is emphasized.
8 weeks: grip and pinch 
strengthening is begun
Grip & pinch strength, 
Pain relief (self designed), 
joint imaging (method not 
described)
Measures at: T0 (pre-op-
erative) and T1 (postoper-
ative follow-up at 2 years, 
range 1-4,5 years). Pain 
relief only measured at T1
Pain relief: 92% of patients enjoyed excellent 
pain relief and were satisfied with the thumb.
T1 showed an overall improvement in grip and 
pinch strength of 19% compared with T0 values 
(no significance mentioned). Average loss of 
11% of the initial postoperative arthroplasty 
space
Davis et 
al.37 2004
Randomized 
controlled trial 
investigating 
different 
surgical 
procedures
N = 162 patients, 183 
thumbs
(Trapeziectomy group: 
62, PL group: 59, FCR 
group: 62)
F/M = 162/0
Age = Trapeziectomy 
group: 58 (range: 44-82), 
PL group: 60 (range: 41-
74), LRTI group: 59 (range: 
40-75) (3 groups) Dom-
inance: Trapeziectomy 
group: 34/58, PL group: 
38/60, LRTI group: 36/59
Trapeziectomy, 
trapeziecto-
my with PL 
interposition, 
trapeziectomy 
with LRTI with 
50% FCR.
Total group: 
CTR (n=42), 
MCP K-wire 
(n=9), MCP 
capsulodesis 
(n=9), MCP 
arthrodesis 
(n=4), Quervain 
release (n=4), 
trigger thumb 
release (n=5), 
Trigger finger 
release (n=2)
0-6 weeks: plaster 
of Paris splint, wrist 
neutral & thumb 
abduction
4 weeks: K-wire exci-
sion if applicable
6 weeks: Physiotherapy was 
not arranged routinely but 
when the thumb plaster was 
discarded each patient was 
shown a series of exercises to 
mobilize and strengthen her 
thumb.
Pain intensity, stiffness, 
weakness and restriction 
of ADL (measured at once 
in categorical scores, 
self-designed), grip & 
pinch strength, ROM.
Measures at: T0 (pre-oper-
ative), T1 (3 months), T2 (12 
months)
Pain intensity, stiffness, weakness and 
restriction of ADL improved ‘markedly’ at T1 
and further at T2 (no significance described). 
There was no significant difference between the 
different types of surgery
ROM improved at T2 compared to T0 (no sig-
nificance mentioned), there was no significant 
difference between different types of surgery.
Thumb key and tip-pinch and grip strength in 
the whole study group at T1 were not different 
from T0. However, thumb key- and tip- pinch 
and grip strength in the whole group at the T2 
were all significantly stronger compared to T0 
(p<0.001 for all 3 types of surgery)
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Başar et 
al.22 2012
Retrospective 
Cohort
N =19
F/M = 18/1
Age = 55 (±5,7 years)
Dominance: 18/19
Modified LRTI 
using full-thick-
ness FCR
None 0-4 weeks: thumb 
spica
4-8 weeks: remov-
able splint
8 weeks: splint 
removed
4-8 weeks: MCP & IP joint 
exercises and isometric 
thenar abduction amplification 
exercises
8 weeks - 3 months: CMC-1 
joint mobilization allowed. 
Easy grasping exercises and 
progressive thenar abduction 
amplification exercises against 
resistance were started.
+ 3 months: resistive grasping 
and gripping exercises were 
started and increased progres-
sively
Pain intensity (VAS 0-10 
+ other), ROM (Buck-
Gramcko score, Kapandji), 
grip & pinch (tip pinch & 
lateral pinch) strength, joint 
imaging (SMD)
Measures at: T0 (pre-op-
erative) and T1 (60 months 
± 15)
Pain intensity T0: 7(±0.9), T1: 0.9 (±1.4) ROM: 
Grip & pinch strength: Grip T0: 13.15, T1: 19.28, 
tip pinch T0: 2.78, T1: 4.45, lateral pinch T0: 
4.13, T1: 5.60, all strength measures significant 
(p<0.0001)
At T1, 0.2 mm height, not significant.
Burton et 
al.24 1986
Retrospective 
Cohort
N = 24 patients, 25 
thumbs (4 revisions, 1 
bilateral),
F/M = 21/3,
Age = 55.4. Domi-
nance = 3/24
Partial (6 
cases) or 
complete 
trapeziectomy 
(19 cases) with 
LRTI using 
FCR, all with 
K-wire
Unknown/not 
described
0-4 weeks: thumb 
spica cast immobi-
lization followed by 
pin removal
4-6 weeks: isoprene 
thumb Spica splint 
support, worn con-
stantly except for 
hand exercises and 
washing. Splinting 
is stopped when full 
ROM is attained and 
thenar strength is 
improved to a func-
tional level, usually 
8 to 12 weeks after 
surgery
4-6 weeks: 1). AROM CMC-1 
abduction and extension while 
avoiding flexion adduction po-
sition, 2) AROM flexion of the 
MCP and IP joints with MC1 
supported in abduction by the 
patient’s opposite hand.
6 weeks, continued to 4-6 
months: Thenar strengthening 
is emphasized.
8 weeks: grip and pinch 
strengthening is begun
Grip & pinch strength, 
Pain relief (self designed), 
joint imaging (method not 
described)
Measures at: T0 (pre-op-
erative) and T1 (postoper-
ative follow-up at 2 years, 
range 1-4,5 years). Pain 
relief only measured at T1
Pain relief: 92% of patients enjoyed excellent 
pain relief and were satisfied with the thumb.
T1 showed an overall improvement in grip and 
pinch strength of 19% compared with T0 values 
(no significance mentioned). Average loss of 
11% of the initial postoperative arthroplasty 
space
Davis et 
al.37 2004
Randomized 
controlled trial 
investigating 
different 
surgical 
procedures
N = 162 patients, 183 
thumbs
(Trapeziectomy group: 
62, PL group: 59, FCR 
group: 62)
F/M = 162/0
Age = Trapeziectomy 
group: 58 (range: 44-82), 
PL group: 60 (range: 41-
74), LRTI group: 59 (range: 
40-75) (3 groups) Dom-
inance: Trapeziectomy 
group: 34/58, PL group: 
38/60, LRTI group: 36/59
Trapeziectomy, 
trapeziecto-
my with PL 
interposition, 
trapeziectomy 
with LRTI with 
50% FCR.
Total group: 
CTR (n=42), 
MCP K-wire 
(n=9), MCP 
capsulodesis 
(n=9), MCP 
arthrodesis 
(n=4), Quervain 
release (n=4), 
trigger thumb 
release (n=5), 
Trigger finger 
release (n=2)
0-6 weeks: plaster 
of Paris splint, wrist 
neutral & thumb 
abduction
4 weeks: K-wire exci-
sion if applicable
6 weeks: Physiotherapy was 
not arranged routinely but 
when the thumb plaster was 
discarded each patient was 
shown a series of exercises to 
mobilize and strengthen her 
thumb.
Pain intensity, stiffness, 
weakness and restriction 
of ADL (measured at once 
in categorical scores, 
self-designed), grip & 
pinch strength, ROM.
Measures at: T0 (pre-oper-
ative), T1 (3 months), T2 (12 
months)
Pain intensity, stiffness, weakness and 
restriction of ADL improved ‘markedly’ at T1 
and further at T2 (no significance described). 
There was no significant difference between the 
different types of surgery
ROM improved at T2 compared to T0 (no sig-
nificance mentioned), there was no significant 
difference between different types of surgery.
Thumb key and tip-pinch and grip strength in 
the whole study group at T1 were not different 
from T0. However, thumb key- and tip- pinch 
and grip strength in the whole group at the T2 
were all significantly stronger compared to T0 
(p<0.001 for all 3 types of surgery)
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Eaton et 
al.38 1985
Retrospective 
cohort
N = 21 patients, 25 
thumbs (4 bilateral)
F/M = 14/7 men. 
Age = 57.3 years (range: 
31-72). Dominance of the 
17 patients with unilateral 
involvement = 12/17
Partial 
trapeziectomy 
with LRTI using 
FCR.
Stabilization 
of the MP 
joint for MP 
hyperexten-
sion >30° (n=5). 
Advancement 
or plication of 
a somewhat 
lax APL tendon 
(n=6).
0-4 weeks: plaster 
shell immobilizing 
CMC-1 and MCP1, 
along with K-wire.
4 weeks: K-wire 
excision
4-6 weeks: extension and cir-
cumduction of the CMC joint 
emphasized.
6-8 weeks: thumb is progres-
sively opposed beginning with 
kapandji 3 gradually extended 
to kapandji 10. Pinch strength-
ening is emphasized once full 
ROM has been achieved.
Pinch strength, clinical 
results were graded as 
excellent, good, fair or 
failure
Measures at: T0 (pre-op-
erative) and T1 (follow-up 
37,5 months, range 14-60 
months).
Pinch strength at T0: 5.5 kg, T1: 6.1 kg (no signif-
icance reported)
All patients had ‘relief of pain’ at T1. 55% report-
ed no pain whatsoever, and 44% described ‘an 
occasional twinge or rare mild ache’. No patient 
had postoperative pain, even those whose clini-
cal results were graded as fair. According to the 
grading system, 41.7% of the cases were graded 
as excellent, 50% were good, and 8.3% were fair
Horlock et 
al.25 2002
Randomized 
controlled trial 
investigating 
short vs. long 
immobiliza-
tion
N = 39 patients, 40 
thumbs (Early group: 20, 
Late group: 20)
F/M = 30/10 (Early group: 
14/6, Late group: 16/4)
Age = Early group: 58 ± 7 
years, Late group: 59 ± 9 
years Dominance: 20/40
Trapeziectomy Unknown/not 
described
Early group:
0-1 week: Scotch-
cast application
1-6 weeks: Custom 
made Spica only 
during physical load 
and night
Late group:
0-2 week: Scotch-
cast application
2-4 weeks: Custom 
made Spica 24/7
4-6 weeks: gentle 
motion aloud out of 
splint
Early group:
1+ week: Light use allowed 
of the hand and were taught 
active exercises for the thumb
Late group:
4-6 weeks: Gentle use and mo-
bilization were then allowed 
out of the splint
Pain intensity, hand func-
tion, opinion about rehabili-
tation regimen, satisfaction 
with operation (VAS 0-100), 
ROM, grip & pinch strength 
and joint imaging (SMD & 
TMD).
Measures at: T0 (preopera-
tive), T1 (6-8 months)
No significant difference in pain intensity de-
crease. The early group experienced more con-
venience compared to the late group (p<0.05).
Significant decrease in MCP-1 ROM was found 
in the late mobilization group but not in de early 
group (within group p<0.02).
No significant difference in grip & pinch 
strength, although the early group performed 
slightly better when pooling effect sizes of grip, 
pulp pinch and key pinch strength.
Complications were observed in 15% of the par-
ticipants in the early group compared to 5% in 
the late group. No differences between groups 
in median SDM, 2 mm larger decrease in TM 
within the early group, but not significant
Kriegs-Au 
et al.21 
2004
Randomized 
controlled trial 
investigating 
different 
surgical 
procedures
N = 43 patients, 52 
thumbs. Finally 31 par-
ticipants/thumbs were 
followed-up (LR group: 15, 
LRTI group: 16)
 F/M = 25/6 (LR group: 
13/2, LRTI group: 12/4)
Age = LR group: 58.4 
/ LRTI group: 59 years 
range/±SD: unknown 
Dominance: 20/31 (LR 
group: 9/15, LRTI group: 
11/16)
Trapeziecto-
my with LR 
with FCR vs. 
Trapeziectomy 
with LRTI with 
FCR
None Both groups:
0-3 week: Spica cast 
immobilization
3-6 weeks: Individ-
ually fitted thumb 
spica splint that was 
worn constantly, 
except during 
bathing
Both groups:
6 weeks: Active and active-as-
sisted range-of- motion and 
thenar muscle-strengthening 
exercises were performed
Grip & pinch strength, 
Buck-Gramcko score, 
ROM, self-administered 
questionnaire (pain, 
strength, daily function, 
dexterity, cosmetic 
appearance, willingness 
to undergo surgery again, 
overall satisfaction with 
result), current and past 
employment status and 
activity levels, joint imaging 
(SMD).
Measures at: T0 (preop-
erative), T1 (48.2 months, 
range 32-64 months)
All outcomes: Significant improvements, 
although no differences for different types of 
surgery mentioned. Proximal migration of the 
first metacarpal was 37-42%.
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Eaton et 
al.38 1985
Retrospective 
cohort
N = 21 patients, 25 
thumbs (4 bilateral)
F/M = 14/7 men. 
Age = 57.3 years (range: 
31-72). Dominance of the 
17 patients with unilateral 
involvement = 12/17
Partial 
trapeziectomy 
with LRTI using 
FCR.
Stabilization 
of the MP 
joint for MP 
hyperexten-
sion >30° (n=5). 
Advancement 
or plication of 
a somewhat 
lax APL tendon 
(n=6).
0-4 weeks: plaster 
shell immobilizing 
CMC-1 and MCP1, 
along with K-wire.
4 weeks: K-wire 
excision
4-6 weeks: extension and cir-
cumduction of the CMC joint 
emphasized.
6-8 weeks: thumb is progres-
sively opposed beginning with 
kapandji 3 gradually extended 
to kapandji 10. Pinch strength-
ening is emphasized once full 
ROM has been achieved.
Pinch strength, clinical 
results were graded as 
excellent, good, fair or 
failure
Measures at: T0 (pre-op-
erative) and T1 (follow-up 
37,5 months, range 14-60 
months).
Pinch strength at T0: 5.5 kg, T1: 6.1 kg (no signif-
icance reported)
All patients had ‘relief of pain’ at T1. 55% report-
ed no pain whatsoever, and 44% described ‘an 
occasional twinge or rare mild ache’. No patient 
had postoperative pain, even those whose clini-
cal results were graded as fair. According to the 
grading system, 41.7% of the cases were graded 
as excellent, 50% were good, and 8.3% were fair
Horlock et 
al.25 2002
Randomized 
controlled trial 
investigating 
short vs. long 
immobiliza-
tion
N = 39 patients, 40 
thumbs (Early group: 20, 
Late group: 20)
F/M = 30/10 (Early group: 
14/6, Late group: 16/4)
Age = Early group: 58 ± 7 
years, Late group: 59 ± 9 
years Dominance: 20/40
Trapeziectomy Unknown/not 
described
Early group:
0-1 week: Scotch-
cast application
1-6 weeks: Custom 
made Spica only 
during physical load 
and night
Late group:
0-2 week: Scotch-
cast application
2-4 weeks: Custom 
made Spica 24/7
4-6 weeks: gentle 
motion aloud out of 
splint
Early group:
1+ week: Light use allowed 
of the hand and were taught 
active exercises for the thumb
Late group:
4-6 weeks: Gentle use and mo-
bilization were then allowed 
out of the splint
Pain intensity, hand func-
tion, opinion about rehabili-
tation regimen, satisfaction 
with operation (VAS 0-100), 
ROM, grip & pinch strength 
and joint imaging (SMD & 
TMD).
Measures at: T0 (preopera-
tive), T1 (6-8 months)
No significant difference in pain intensity de-
crease. The early group experienced more con-
venience compared to the late group (p<0.05).
Significant decrease in MCP-1 ROM was found 
in the late mobilization group but not in de early 
group (within group p<0.02).
No significant difference in grip & pinch 
strength, although the early group performed 
slightly better when pooling effect sizes of grip, 
pulp pinch and key pinch strength.
Complications were observed in 15% of the par-
ticipants in the early group compared to 5% in 
the late group. No differences between groups 
in median SDM, 2 mm larger decrease in TM 
within the early group, but not significant
Kriegs-Au 
et al.21 
2004
Randomized 
controlled trial 
investigating 
different 
surgical 
procedures
N = 43 patients, 52 
thumbs. Finally 31 par-
ticipants/thumbs were 
followed-up (LR group: 15, 
LRTI group: 16)
 F/M = 25/6 (LR group: 
13/2, LRTI group: 12/4)
Age = LR group: 58.4 
/ LRTI group: 59 years 
range/±SD: unknown 
Dominance: 20/31 (LR 
group: 9/15, LRTI group: 
11/16)
Trapeziecto-
my with LR 
with FCR vs. 
Trapeziectomy 
with LRTI with 
FCR
None Both groups:
0-3 week: Spica cast 
immobilization
3-6 weeks: Individ-
ually fitted thumb 
spica splint that was 
worn constantly, 
except during 
bathing
Both groups:
6 weeks: Active and active-as-
sisted range-of- motion and 
thenar muscle-strengthening 
exercises were performed
Grip & pinch strength, 
Buck-Gramcko score, 
ROM, self-administered 
questionnaire (pain, 
strength, daily function, 
dexterity, cosmetic 
appearance, willingness 
to undergo surgery again, 
overall satisfaction with 
result), current and past 
employment status and 
activity levels, joint imaging 
(SMD).
Measures at: T0 (preop-
erative), T1 (48.2 months, 
range 32-64 months)
All outcomes: Significant improvements, 
although no differences for different types of 
surgery mentioned. Proximal migration of the 
first metacarpal was 37-42%.
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Kuhns et 
al.39 2003
Prospective, 
Single-Sur-
geon Study
N = 26
F/M = 19/7
Age = 65 years range: 
52-82 years Dominance: 
unknown
Trapeziectomy 
with k-wire 
immobilization
MCP-1 volar 
plate capsulod-
esis to correct 
hyperexten-
sion (n=7), CTR 
(n=4), trigger 
digit release 
(n=4 digits in 2 
patients), gan-
glion excision 
(n=1), lipoma 
excision (n=1).
0-10 days: short-arm 
thumb spica splint
10 days - 5-6 weeks: 
thumb spica cast
5-6 weeks: K-wire 
removal
+5-6 weeks: elastic 
roller bandage then 
was used to protect 
the thumb from 
extreme movements 
(each patient was 
encouraged to wean 
their use of the elas-
tic bandage during 
the first week after 
K-wire removal)
5 weeks: warm water soaks 
with range-of-motion exercis-
es were initiated.
7 weeks: those who were not 
adducting their thumb fully 
into the plane of the palm 
and opposing it to the fifth 
metacarpal head (N=8) were 
referred for hand therapy for 
recovery of motion, instructed 
not to initiate strengthening 
exercises
Jebsen subtests II and III 
dexterity tests, AIMS2, pain 
relief, ROM opposition, 
Grip & pinch strength, joint 
imaging (SMD)
Measures at: T0 (preoper-
ative), T1 (6 months), T2 (24 
months)
At final follow-up, 92% was pain free.
Significant improvements in 3 subscales of the 
AIMS 2
At T1, 92% adducted fully into the plane of the 
palm and 96% opposed to the fifth metacarpal 
head
Significant improvements in grip (+47%), key 
pinch (+33%), and tip pinch (+23%) strength at 
T2. SMD decreased with 51% at T1 compared to 
T0, no correlation between proximal migration 
and functional outcomes.
Lee et al.26 
2015
Retrospective 
Cohort
N = 19
F/M = 13/6
Age = 62 years range 
43-82 years Dominance: 
11/19
Trapeziectomy 
with APL sling
Unknown/not 
described
0-4 week: thumb 
spica cast in ab-
duction
4 weeks +: activity of the 
thumb was encouraged
Pain intensity (VAS 0-10), 
limitations in ADL (DASH) 
patient satisfaction (self 
designed), returning to 
work (self designed), ROM, 
grip & pinch strength, joint 
imaging (SMD)
Measures at: T0 (preopera-
tive), T1 (36 months, range 
19 to 73.7 months)
VAS at T0: 7.2, T1: 1.7 (p<0.05)
DASH at T0: 41, T1: 18, (p<0.05)
Significant improvements in al ROM measure-
ments at T1. Of the working participants, 77% 
returned to their work or activities without 
any difficulty or occupation modification, in 
23% modifications were required. “All patients 
expressed their satisfaction for improved post-
operative appearance of the hand.”
Increase of 1.1 kg in power pinch (p<0.05) at T1, 
no difference in tip pinch and grip strength at T1. 
SMD decreased 34.3% (p<0.05)
Lins et al.40 
1996
Retrospective 
Cohort
N = 27 patients, 30 
thumbs
F/M = 25/2
Age = 64 years range 
43-77 years Dominance: 
19/30
LRTI with 
(partial N=20/
whole N=10) 
FCR and 
k-wire.
CTR (n=4), IP-1 
joint arthrode-
sis (n=1)
0-4 weeks: Thumb 
spica cast followed 
by Kirschner pin 
removal. Removable 
thumb spica splint 
at 4 weeks until 12 
weeks
4 weeks: gentle ROM exer-
cises
12 weeks: unrestricted thumb 
movement allowed
Pain intensity (self de-
signed), functional status / 
satisfaction (self designed), 
grip & pinch strength, web 
space, joint imaging (SMD).
Measures at: T0 (preoper-
ative), T1 (42-43 months, 
range 14-88 months)
At T1, 85% patients considered the frequency 
of pain ‘improved a lot or resolved complete-
ly’ compared to T0 and 89% considered the 
duration and severity as ‘improved a lot or 
completely’ at T1, compared to T0.
At T1, 89% of the patients were satisfied with the 
‘relief of pain’
Web space increased with 1.09 cm (p<0.02)
Grip strength increased with 5.9 kg (p<0.001) 
and pinch strength increased with 1.4 kg 
(p<0.01)
SMD decreased with 30% (p<0.05)
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Kuhns et 
al.39 2003
Prospective, 
Single-Sur-
geon Study
N = 26
F/M = 19/7
Age = 65 years range: 
52-82 years Dominance: 
unknown
Trapeziectomy 
with k-wire 
immobilization
MCP-1 volar 
plate capsulod-
esis to correct 
hyperexten-
sion (n=7), CTR 
(n=4), trigger 
digit release 
(n=4 digits in 2 
patients), gan-
glion excision 
(n=1), lipoma 
excision (n=1).
0-10 days: short-arm 
thumb spica splint
10 days - 5-6 weeks: 
thumb spica cast
5-6 weeks: K-wire 
removal
+5-6 weeks: elastic 
roller bandage then 
was used to protect 
the thumb from 
extreme movements 
(each patient was 
encouraged to wean 
their use of the elas-
tic bandage during 
the first week after 
K-wire removal)
5 weeks: warm water soaks 
with range-of-motion exercis-
es were initiated.
7 weeks: those who were not 
adducting their thumb fully 
into the plane of the palm 
and opposing it to the fifth 
metacarpal head (N=8) were 
referred for hand therapy for 
recovery of motion, instructed 
not to initiate strengthening 
exercises
Jebsen subtests II and III 
dexterity tests, AIMS2, pain 
relief, ROM opposition, 
Grip & pinch strength, joint 
imaging (SMD)
Measures at: T0 (preoper-
ative), T1 (6 months), T2 (24 
months)
At final follow-up, 92% was pain free.
Significant improvements in 3 subscales of the 
AIMS 2
At T1, 92% adducted fully into the plane of the 
palm and 96% opposed to the fifth metacarpal 
head
Significant improvements in grip (+47%), key 
pinch (+33%), and tip pinch (+23%) strength at 
T2. SMD decreased with 51% at T1 compared to 
T0, no correlation between proximal migration 
and functional outcomes.
Lee et al.26 
2015
Retrospective 
Cohort
N = 19
F/M = 13/6
Age = 62 years range 
43-82 years Dominance: 
11/19
Trapeziectomy 
with APL sling
Unknown/not 
described
0-4 week: thumb 
spica cast in ab-
duction
4 weeks +: activity of the 
thumb was encouraged
Pain intensity (VAS 0-10), 
limitations in ADL (DASH) 
patient satisfaction (self 
designed), returning to 
work (self designed), ROM, 
grip & pinch strength, joint 
imaging (SMD)
Measures at: T0 (preopera-
tive), T1 (36 months, range 
19 to 73.7 months)
VAS at T0: 7.2, T1: 1.7 (p<0.05)
DASH at T0: 41, T1: 18, (p<0.05)
Significant improvements in al ROM measure-
ments at T1. Of the working participants, 77% 
returned to their work or activities without 
any difficulty or occupation modification, in 
23% modifications were required. “All patients 
expressed their satisfaction for improved post-
operative appearance of the hand.”
Increase of 1.1 kg in power pinch (p<0.05) at T1, 
no difference in tip pinch and grip strength at T1. 
SMD decreased 34.3% (p<0.05)
Lins et al.40 
1996
Retrospective 
Cohort
N = 27 patients, 30 
thumbs
F/M = 25/2
Age = 64 years range 
43-77 years Dominance: 
19/30
LRTI with 
(partial N=20/
whole N=10) 
FCR and 
k-wire.
CTR (n=4), IP-1 
joint arthrode-
sis (n=1)
0-4 weeks: Thumb 
spica cast followed 
by Kirschner pin 
removal. Removable 
thumb spica splint 
at 4 weeks until 12 
weeks
4 weeks: gentle ROM exer-
cises
12 weeks: unrestricted thumb 
movement allowed
Pain intensity (self de-
signed), functional status / 
satisfaction (self designed), 
grip & pinch strength, web 
space, joint imaging (SMD).
Measures at: T0 (preoper-
ative), T1 (42-43 months, 
range 14-88 months)
At T1, 85% patients considered the frequency 
of pain ‘improved a lot or resolved complete-
ly’ compared to T0 and 89% considered the 
duration and severity as ‘improved a lot or 
completely’ at T1, compared to T0.
At T1, 89% of the patients were satisfied with the 
‘relief of pain’
Web space increased with 1.09 cm (p<0.02)
Grip strength increased with 5.9 kg (p<0.001) 
and pinch strength increased with 1.4 kg 
(p<0.01)
SMD decreased with 30% (p<0.05)
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Mo et al.27 
2004
Case series N = 14 patients, 14 thumbs
F/M = 11/3
Age = 59.6 years range 
31-79 years Dominance: 
5/11
LRTI with FCR 
(sometimes 
scaphotra-
peziotrapezoid 
joint excision) 
& K-wire
Unknown/not 
described
0-4 weeks: thumb 
spica cast followed 
by pin removal at 4 
weeks
4-8 weeks: remov-
able spica
4 weeks: exercises with 
emphasis on extension/
abduction, on maintaining 
MCP joint flexion and avoiding 
hyperextension
8 weeks: strengthening 
exercises
Limitations in ADL 
(DASH), ROM, grip & pinch 
strength. Joint imaging 
(SMD)
Measures at: T0 (preopera-
tive), T1 (20 months, range 
12-44 months)
DASH outcomes associated with strength, no 
results over time reported
The distance from thumb tip to the base of the 
small finger during maximum flexion decreased 
with 0.4 cm (p=0.02)
Grip strength improved with 26% at T1 com-
pared to T0 (p=0.01), pinch strength improved 
11% (p=0.11).
SMD improved with 2.5%, no correlation 
between proximal migration and functional 
outcomes.
Nylen et 
al.41 1993
Prospective 
cohort
N = 93 patients, 102 
thumbs
F/M = 89/11
Age = 59 years range 
40-78 Dominance: 56%
LRTI with FCR 
without K-wire
MCP arthrod-
esis (n=6) 
MCP-1 tem-
porary pinned 
(n=13). 4 other 
procedures 
were per-
formed in the 
similar hand 
(procedure 
unknown)
0-5 weeks: plaster 
spica with thumb 
in RAB/PAB. An 
abduction splint was 
sometimes used in-
termittently for a few 
weeks thereafter.
5 weeks: physiotherapy was 
started (therapy content 
unknown)
Pain intensity (self de-
signed), limitations in ADL 
(self designed) Adduction 
contracture (self designed: 
severe, moderate, slight, 
none), ROM, grip & pinch 
strength, satisfaction. 
Return to work, joint imag-
ing (SMD)
Measures at: T0 (preopera-
tive), T1 (36 months, range 
24-54 months)
At T1, 49% was ‘pain free’ and 51% had ‘some 
pain’
Of the patients with limitations in ADL preopera-
tively, 73% reported no limitations at T1.
Adduction contracture ‘diminished’ in 57% of 
the patients, decrease was not significant
Significant improvements in pinch strength, no 
significant difference in grip strength.
At T1, 88% was satisfied. Average SMD at T1 
was 4 mm.
Poole et 
al.28 2011
Randomized 
controlled trial 
investigating 
the added 
value of 
postoperative 
exercises/
therapy
N = 9 participants (splint/
HT group: 4, splint/HP 
group: 5)
F/M = 8/1 (splint/HT 
group: 3/1, splint/HP 
group: 5/0)
Age = 58.0 (splint/HT 
group: 59.3 (range 49–68) 
splint/HP group: 58.4 
(range 52–64)) Domi-
nance: 4/9
Partial 
trapeziectomy 
with LRTI 
using PL and 
The joint was 
pinned in 1 cm 
of distraction 
with K-wires
Unknown/
not described 
(first stated 
excluded, later 
included)
0-4 weeks: bulky 
dressing and a splint 
was applied
3-4 weeks: K-wire 
removal.
Both groups: 4 
weeks: thumb spica 
or c-bar splint, 
no description of 
discontinuation
The splint/HP group:
4 weeks postoperatively: 1 
consult, which included thumb 
spica or c-bar splint, and home 
program (included information 
regarding splint wear, methods 
to control edema, AROM 
exercises, and massage of the 
hand). The splint/HT group:
4 weeks postoperatively: 
receive a thumb spica or c-bar 
splint followed by outpatient 
occupational therapy 1 hour, 
one time a week for approxi-
mately 4 weeks. Therapy in-
cluded: application of a thumb 
spica or c-bar splint, reduction 
of edema, instructions in 
range of motion and strength 
exercises, and ADL
Pain intensity (Boston 
Questionnaire), Limitations 
in ADL (JHFT, AHFT), Grip 
& pinch strength, Quality of 
life (AIMS 2)
Measures at: T0 (pre-op) 
and T1 (6 months postop-
eratively).
Improvements in pain intensity in both groups, 
although no significant within group differ-
ences due to small sample size. No significant 
differences between groups, although a larger 
decrease in symptom severity was found in the 
hand therapy group (ES = 0.53)
Higher improvements in limitations in ADL in the 
hand therapy group for both the JHFT (ES = 0.52) 
as the AHFT (ES = 0.33), although not significant 
due to sample size.
Improvements in grip (+13%) & 3-point pinch 
strength (+27%) were only found in the hand 
therapy group, while grip (-8%) & 3-point pinch 
strength (-6%) decreased in the home program 
group (ES grip strength = 0.77, ES 3-point 
pinch = 0.95).
Significant improvements in several subscales 
of the Arthritis Impact Measurement Scales 2 
for both groups, no between group differences.
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Mo et al.27 
2004
Case series N = 14 patients, 14 thumbs
F/M = 11/3
Age = 59.6 years range 
31-79 years Dominance: 
5/11
LRTI with FCR 
(sometimes 
scaphotra-
peziotrapezoid 
joint excision) 
& K-wire
Unknown/not 
described
0-4 weeks: thumb 
spica cast followed 
by pin removal at 4 
weeks
4-8 weeks: remov-
able spica
4 weeks: exercises with 
emphasis on extension/
abduction, on maintaining 
MCP joint flexion and avoiding 
hyperextension
8 weeks: strengthening 
exercises
Limitations in ADL 
(DASH), ROM, grip & pinch 
strength. Joint imaging 
(SMD)
Measures at: T0 (preopera-
tive), T1 (20 months, range 
12-44 months)
DASH outcomes associated with strength, no 
results over time reported
The distance from thumb tip to the base of the 
small finger during maximum flexion decreased 
with 0.4 cm (p=0.02)
Grip strength improved with 26% at T1 com-
pared to T0 (p=0.01), pinch strength improved 
11% (p=0.11).
SMD improved with 2.5%, no correlation 
between proximal migration and functional 
outcomes.
Nylen et 
al.41 1993
Prospective 
cohort
N = 93 patients, 102 
thumbs
F/M = 89/11
Age = 59 years range 
40-78 Dominance: 56%
LRTI with FCR 
without K-wire
MCP arthrod-
esis (n=6) 
MCP-1 tem-
porary pinned 
(n=13). 4 other 
procedures 
were per-
formed in the 
similar hand 
(procedure 
unknown)
0-5 weeks: plaster 
spica with thumb 
in RAB/PAB. An 
abduction splint was 
sometimes used in-
termittently for a few 
weeks thereafter.
5 weeks: physiotherapy was 
started (therapy content 
unknown)
Pain intensity (self de-
signed), limitations in ADL 
(self designed) Adduction 
contracture (self designed: 
severe, moderate, slight, 
none), ROM, grip & pinch 
strength, satisfaction. 
Return to work, joint imag-
ing (SMD)
Measures at: T0 (preopera-
tive), T1 (36 months, range 
24-54 months)
At T1, 49% was ‘pain free’ and 51% had ‘some 
pain’
Of the patients with limitations in ADL preopera-
tively, 73% reported no limitations at T1.
Adduction contracture ‘diminished’ in 57% of 
the patients, decrease was not significant
Significant improvements in pinch strength, no 
significant difference in grip strength.
At T1, 88% was satisfied. Average SMD at T1 
was 4 mm.
Poole et 
al.28 2011
Randomized 
controlled trial 
investigating 
the added 
value of 
postoperative 
exercises/
therapy
N = 9 participants (splint/
HT group: 4, splint/HP 
group: 5)
F/M = 8/1 (splint/HT 
group: 3/1, splint/HP 
group: 5/0)
Age = 58.0 (splint/HT 
group: 59.3 (range 49–68) 
splint/HP group: 58.4 
(range 52–64)) Domi-
nance: 4/9
Partial 
trapeziectomy 
with LRTI 
using PL and 
The joint was 
pinned in 1 cm 
of distraction 
with K-wires
Unknown/
not described 
(first stated 
excluded, later 
included)
0-4 weeks: bulky 
dressing and a splint 
was applied
3-4 weeks: K-wire 
removal.
Both groups: 4 
weeks: thumb spica 
or c-bar splint, 
no description of 
discontinuation
The splint/HP group:
4 weeks postoperatively: 1 
consult, which included thumb 
spica or c-bar splint, and home 
program (included information 
regarding splint wear, methods 
to control edema, AROM 
exercises, and massage of the 
hand). The splint/HT group:
4 weeks postoperatively: 
receive a thumb spica or c-bar 
splint followed by outpatient 
occupational therapy 1 hour, 
one time a week for approxi-
mately 4 weeks. Therapy in-
cluded: application of a thumb 
spica or c-bar splint, reduction 
of edema, instructions in 
range of motion and strength 
exercises, and ADL
Pain intensity (Boston 
Questionnaire), Limitations 
in ADL (JHFT, AHFT), Grip 
& pinch strength, Quality of 
life (AIMS 2)
Measures at: T0 (pre-op) 
and T1 (6 months postop-
eratively).
Improvements in pain intensity in both groups, 
although no significant within group differ-
ences due to small sample size. No significant 
differences between groups, although a larger 
decrease in symptom severity was found in the 
hand therapy group (ES = 0.53)
Higher improvements in limitations in ADL in the 
hand therapy group for both the JHFT (ES = 0.52) 
as the AHFT (ES = 0.33), although not significant 
due to sample size.
Improvements in grip (+13%) & 3-point pinch 
strength (+27%) were only found in the hand 
therapy group, while grip (-8%) & 3-point pinch 
strength (-6%) decreased in the home program 
group (ES grip strength = 0.77, ES 3-point 
pinch = 0.95).
Significant improvements in several subscales 
of the Arthritis Impact Measurement Scales 2 
for both groups, no between group differences.
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Prosser et 
al.29 2014
Randomized 
Controlled 
Trial investi-
gating partial 
vs. complete 
immobiliza-
tion
N=56 (3 lost to follow-up, 
Rigid: 28, Semi-rigid: 28).
F/M = 45/11 (Rigid: 23/28, 
Semi-rigid: 22/28)
Age = 67.8 ±8.0 (Rigid 66.9 
±8.5, Semi-rigid 69.6 ±7.8)
Dominance = 27/56 (Rigid: 
14/28, Semi-rigid: 13/28)
Trapeziectomy 
& LRTI using 
FCR (N= 53), or 
trapeziectomy 
alone (N=3, 
(rigid N=1, 
semi-rigid 
N=2))
Unknown/not 
described
Both groups:
0-2 weeks: dorsal 
plaster back slab im-
mobilizing wrist and 
thumb. Thereafter: 
randomization.
Semi-rigid group:
2-6 weeks: custom 
made neoprene 
with a bonded 
thermoplastic piece 
from IP 1 to distal 
2/3 of the forearm, 
with thermoplastic 
piece on radial 
aspect of thumb 
extending from mid 
proximal phalanx to 
just below the wrist 
and was bonded to 
the neoprene with 
thumb in maximal 
comfortable PAB.
Rigid-group:
2-6 weeks: 
thermoplastic 
custom-made wrist-
thumb splint
Both rigid/semi-rigid:
0-2 weeks: composite 
extension/flexion advised by 
surgeon
Week 2-3: thumb IP flexion/
extension, wrist flexion/exten-
sion 4x day 10 reps
Week 3-4: isolated AROM MCP 
flexion/extension to neutral 
only (0) out of orthosis. Empha-
sis placed on flexion.
4-6 weeks: TMC AROM PAB, 
no opposition.
6 weeks: Wean splint, passive 
exercises, graded strengthen-
ing grip and pinch, scar man-
agement. Light activity at 6 
weeks upgraded to moderate 
to heavy activity at 12 weeks.
0-4 weeks: scheduled for 
weekly visits, 4-10 weeks: 
fortnightly
Pain intensity and lim-
itations in ADL (PRWHE, 
MHQ), and pinch strength.
Measures at: T0 (pre-op-
erative), T1 (6 weeks), T2 (3 
months) and T3 (1 year)
No significant differences in pain intensity and 
limitations in ADL.
No significant differences in pinch strength
Complications were observed in 14% of the 
participants in the rigid group compared to 7% 
in the semi-rigid group.
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Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Prosser et 
al.29 2014
Randomized 
Controlled 
Trial investi-
gating partial 
vs. complete 
immobiliza-
tion
N=56 (3 lost to follow-up, 
Rigid: 28, Semi-rigid: 28).
F/M = 45/11 (Rigid: 23/28, 
Semi-rigid: 22/28)
Age = 67.8 ±8.0 (Rigid 66.9 
±8.5, Semi-rigid 69.6 ±7.8)
Dominance = 27/56 (Rigid: 
14/28, Semi-rigid: 13/28)
Trapeziectomy 
& LRTI using 
FCR (N= 53), or 
trapeziectomy 
alone (N=3, 
(rigid N=1, 
semi-rigid 
N=2))
Unknown/not 
described
Both groups:
0-2 weeks: dorsal 
plaster back slab im-
mobilizing wrist and 
thumb. Thereafter: 
randomization.
Semi-rigid group:
2-6 weeks: custom 
made neoprene 
with a bonded 
thermoplastic piece 
from IP 1 to distal 
2/3 of the forearm, 
with thermoplastic 
piece on radial 
aspect of thumb 
extending from mid 
proximal phalanx to 
just below the wrist 
and was bonded to 
the neoprene with 
thumb in maximal 
comfortable PAB.
Rigid-group:
2-6 weeks: 
thermoplastic 
custom-made wrist-
thumb splint
Both rigid/semi-rigid:
0-2 weeks: composite 
extension/flexion advised by 
surgeon
Week 2-3: thumb IP flexion/
extension, wrist flexion/exten-
sion 4x day 10 reps
Week 3-4: isolated AROM MCP 
flexion/extension to neutral 
only (0) out of orthosis. Empha-
sis placed on flexion.
4-6 weeks: TMC AROM PAB, 
no opposition.
6 weeks: Wean splint, passive 
exercises, graded strengthen-
ing grip and pinch, scar man-
agement. Light activity at 6 
weeks upgraded to moderate 
to heavy activity at 12 weeks.
0-4 weeks: scheduled for 
weekly visits, 4-10 weeks: 
fortnightly
Pain intensity and lim-
itations in ADL (PRWHE, 
MHQ), and pinch strength.
Measures at: T0 (pre-op-
erative), T1 (6 weeks), T2 (3 
months) and T3 (1 year)
No significant differences in pain intensity and 
limitations in ADL.
No significant differences in pinch strength
Complications were observed in 14% of the 
participants in the rigid group compared to 7% 
in the semi-rigid group.
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Roberts et 
al.30 2001
Retrospective 
Cohort
N = 23, 25 thumbs 
F/M = unknown
Age = median 60 (Q1 = 53, 
Q3 =65), Dominance = un-
known
Trapeziecto-
my with LRTI 
using FCR 
(N =7) or partial 
trapeziectomy 
with LRTI using 
FCR (N=18)
Unknown/not 
described
0-10 days: bivalve 
radial plaster thumb 
spica splint, and 
ulnar plaster gutter 
splint. Wrist in 
approximately 15° 
DF, thumb midway 
abduction & exten-
sion, and thumb IP 
free. 10 days: new 
radial gutter splint 
was fabricated
3 weeks: splint 
discontinued
3 weeks: AROM wrist and 
thumb 3-4 times a day scar 
management initiated, Swell-
ing and pain modalities (i.e. 
paraffin, Coban, gloves).
6 weeks: strengthening exer-
cises begun for patients “who 
complained of weakness with 
pinch and grip.” exercises con-
sisted of isometrics and active 
motion against resistance. 
Education in joint protection, 
modification of pinch, and the 
use of adaptive equipment was 
provided
Pain intensity (VAS 0-10), 
limitations in ADL (self 
designed: 15-item daily 
living checklist). Preop-
erative pain intensity and 
limitations in ADL were 
measured retrospectively, 
Grip & pinch strength.
Measures at: T0 (pre-oper-
ative), T1 (postop, median 1 
year and 11 months, range 
3 months-11 years, Q1 1 
year, Q3 3 years 4 months).
Hemi-trapezium resections:
VAS median improvement: 7.0 cm (p=0.001, 
N=12)
ADL median improvement: 33% (p=0.001, N=13).
Grip & pinch strength median improvements 
between T0-T1: grip 10.2 kg (p=0.01, N=12), 
lateral pinch 2.3 kg (p=0.01, N=13), tripod pinch 
2.6 kg (p=0.01, N=8), and tip-to-tip pinch 1.6 kg 
(p=0.03, N=7)
Full-trapezium resections:
VAS median improvement: 8.0 cm (p = 0.04, 
N=5)
ADL median improvement: 60% (p=0.4, N=5)
Grip & pinch strength median improvements 
between T0-T1: grip
13.4 kg (p = 0.07, N=4), lateral pinch 0.9 kg 
(p=0.29, N=4), tripod pinch -0.4 kg (p = 1.0, N=3), 
and tip-to-tip pinch -0.4 kg (p =1.0, N=3)
Rocchi et 
al.31 2011
Retrospective 
Cohort
N=50, 8 lost to follow-up
F/M = 34/8
Age = 60 ±9, range 49 - 79)
Dominance = 31/50
Trapeziectomy 
with LRTI using 
APL
Unknown/not 
described
Week 0-1: plaster 
splint with wrist 
encompassed, MC1 
in slight abduction. 
Week 1-4: thermo-
plastic splint with 
thumb in increment-
ed abduction and 
opposition.
Week 4-6: Splinting 
only at night
0-4 weeks: IP1 movements 
prescribed. 4+ weeks: exer-
cises to regain full ability; i.e. 
opposition exercises which 
gradually progressed from 
aiming at the tip of the fifth 
finger, then towards reaching 
its base. Only for 8/42 patients 
a rehabilitation program was 
deemed necessary and exer-
cises of passive, active-assist-
ed and active range-of-motion 
were started.
Pain intensity (VAS 
mentioned, but results 
expressed as no pain and 
restriction, mild pain with 
use and some restriction, 
pain at rest and some 
restriction and pain at rest 
and severe restriction), 
satisfaction (VAS), limita-
tions in ADL (DASH), Grip 
& key pinch strength, joint 
imaging (SMD). Measures 
at: T0 (pre-operative), T1 (3 
months), T2 (6 months) and 
T3 (12 months)
N=42, 8 lost to follow-up
At T3, zero patients had any pain at rest, only 
1 occasional mild pain. No significance men-
tioned.
Satisfaction 9.6, time point unknown.
DASH at T0: 43.3, T1: 25.5, T2: 19.1 T3: 14.5, no 
significance mentioned.
Grip strength at T0: 16.0 kg, at T3: 19.2 kg, key 
pinch at T0: 3.7 kg and at T3: 5.6 kg, no signifi-
cance mentioned. At T3, SMD averaged 6.4 mm
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Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Roberts et 
al.30 2001
Retrospective 
Cohort
N = 23, 25 thumbs 
F/M = unknown
Age = median 60 (Q1 = 53, 
Q3 =65), Dominance = un-
known
Trapeziecto-
my with LRTI 
using FCR 
(N =7) or partial 
trapeziectomy 
with LRTI using 
FCR (N=18)
Unknown/not 
described
0-10 days: bivalve 
radial plaster thumb 
spica splint, and 
ulnar plaster gutter 
splint. Wrist in 
approximately 15° 
DF, thumb midway 
abduction & exten-
sion, and thumb IP 
free. 10 days: new 
radial gutter splint 
was fabricated
3 weeks: splint 
discontinued
3 weeks: AROM wrist and 
thumb 3-4 times a day scar 
management initiated, Swell-
ing and pain modalities (i.e. 
paraffin, Coban, gloves).
6 weeks: strengthening exer-
cises begun for patients “who 
complained of weakness with 
pinch and grip.” exercises con-
sisted of isometrics and active 
motion against resistance. 
Education in joint protection, 
modification of pinch, and the 
use of adaptive equipment was 
provided
Pain intensity (VAS 0-10), 
limitations in ADL (self 
designed: 15-item daily 
living checklist). Preop-
erative pain intensity and 
limitations in ADL were 
measured retrospectively, 
Grip & pinch strength.
Measures at: T0 (pre-oper-
ative), T1 (postop, median 1 
year and 11 months, range 
3 months-11 years, Q1 1 
year, Q3 3 years 4 months).
Hemi-trapezium resections:
VAS median improvement: 7.0 cm (p=0.001, 
N=12)
ADL median improvement: 33% (p=0.001, N=13).
Grip & pinch strength median improvements 
between T0-T1: grip 10.2 kg (p=0.01, N=12), 
lateral pinch 2.3 kg (p=0.01, N=13), tripod pinch 
2.6 kg (p=0.01, N=8), and tip-to-tip pinch 1.6 kg 
(p=0.03, N=7)
Full-trapezium resections:
VAS median improvement: 8.0 cm (p = 0.04, 
N=5)
ADL median improvement: 60% (p=0.4, N=5)
Grip & pinch strength median improvements 
between T0-T1: grip
13.4 kg (p = 0.07, N=4), lateral pinch 0.9 kg 
(p=0.29, N=4), tripod pinch -0.4 kg (p = 1.0, N=3), 
and tip-to-tip pinch -0.4 kg (p =1.0, N=3)
Rocchi et 
al.31 2011
Retrospective 
Cohort
N=50, 8 lost to follow-up
F/M = 34/8
Age = 60 ±9, range 49 - 79)
Dominance = 31/50
Trapeziectomy 
with LRTI using 
APL
Unknown/not 
described
Week 0-1: plaster 
splint with wrist 
encompassed, MC1 
in slight abduction. 
Week 1-4: thermo-
plastic splint with 
thumb in increment-
ed abduction and 
opposition.
Week 4-6: Splinting 
only at night
0-4 weeks: IP1 movements 
prescribed. 4+ weeks: exer-
cises to regain full ability; i.e. 
opposition exercises which 
gradually progressed from 
aiming at the tip of the fifth 
finger, then towards reaching 
its base. Only for 8/42 patients 
a rehabilitation program was 
deemed necessary and exer-
cises of passive, active-assist-
ed and active range-of-motion 
were started.
Pain intensity (VAS 
mentioned, but results 
expressed as no pain and 
restriction, mild pain with 
use and some restriction, 
pain at rest and some 
restriction and pain at rest 
and severe restriction), 
satisfaction (VAS), limita-
tions in ADL (DASH), Grip 
& key pinch strength, joint 
imaging (SMD). Measures 
at: T0 (pre-operative), T1 (3 
months), T2 (6 months) and 
T3 (12 months)
N=42, 8 lost to follow-up
At T3, zero patients had any pain at rest, only 
1 occasional mild pain. No significance men-
tioned.
Satisfaction 9.6, time point unknown.
DASH at T0: 43.3, T1: 25.5, T2: 19.1 T3: 14.5, no 
significance mentioned.
Grip strength at T0: 16.0 kg, at T3: 19.2 kg, key 
pinch at T0: 3.7 kg and at T3: 5.6 kg, no signifi-
cance mentioned. At T3, SMD averaged 6.4 mm
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Saehle et 
al.32 2002
Retrospective 
Cohort
N = 47, 55 thumbs 
F/M = 44/3
Age = 58 years, range: 
44-73 years Dominance: 
unknown
Trapeziectomy 
with LRTI using 
APL
Unknown/not 
described
0-4/5 weeks: Plaster 
of Paris
Unknown Pain intensity (VAS 0-100, 
only at T1), Limitations in 
ADL (self-designed at T0 
and T1 & DASH, only at T1), 
ROM (only at T1), Grip & 
pinch strength (compared 
with other hand, only at 
T1), Cosmetics (VAS 0-100, 
only at T1), joint imaging 
(SMD)
Measures at: T0 (preopera-
tive), T1 (41 months, range 
16-60 months)
Median VAS pain intensity at T1: 11
ADL function measured with self-designed 
questionnaire improved in 51% of the patients 
at T1 compared to T0. Median DASH scores for 
the disability/symptom and work scales were 
both 28.
The distal phalanx of the 5th finger could be 
reached by 52 of the 55 operated hands
Average key pinch and grip strengths of the op-
erated hands were reduced with 11% and 22% 
respectively compared to unaffected side.
Median VAS score for the cosmetic result at T1: 
5. SMD decreased with 55% at T1 compared to 
T0, no correlation between proximal migration 
and clinical results.
Sirotakova 
et al.42 
2007
Case series N = 74, 104 thumbs 
F/M = 59/15
Age = 59 years range 
40-82 years Dominance: 
unknown
Trapeziectomy 
with APL sling 
(around FCR/
ECRL)
CTR (n=19 
hands in 15 
(20%) patients)
0-2 weeks: plaster of 
Paris splint.
2-4 weeks: thermo-
plastic splint.
4+ weeks: Most 
remove the splint 
and only wear it at 
night. Sometimes 
during day
The patient is seen weekly by 
the therapists
0-2 weeks: IP-1 joint flexion 
and extension exercises, 
which are performed
5 times on 3 occasions each 
day
2-6 weeks: opposition exer-
cises.
Pain intensity, stiffness, 
weakness of the hand, 
functional disability (self 
designed), ROM, grip & 
pinch strength, joint imag-
ing (SMD)
Measures at: T0 (preoper-
ative), T1 (6 months), T2 (12 
months)
‘Excellent’ results in terms of pain relief were 
achieved in 91%
Improvements in all ROM measures at T2 (not 
statistically tested)
Grip & pinch strength improved in all measures 
at T2 (not statistically tested), SMD decreased 
with 29% at T2
Soejima et 
al.33 2006
Prospective 
cohort
N = 18, 21 thumbs 
F/M = 16/2
Age = 63 years range: 
52-77 years Dominance: 
unknown
Trapeziectomy 
with LRTI using 
APL
Unknown/not 
described
0-2 weeks: short 
arm spica splint.
2 weeks: range-of-motion and 
grip-strengthening exercises 
were initiated.
Pain intensity (self 
designed), ROM, and grip 
& pinch strength, joint 
imaging (SMD)
Measures at: T0 (preopera-
tive), T1 (33 months, range 
12-71 months)
At T1, 61% had no pain, 24% had mild pain with 
strenuous activities and 14% had mild pain with 
light work
ROM radial and palmar abduction increased 
with 14° (p=0.09) and 8° (p=0.07) degrees 
respectively
Grip and the pinch strength increased with 2 kg 
(p=0.18) and from 1.3 kg (p=0.23), respectively
SMD decreased with 15% (p<0.05)
Varitimidis 
et al.43 
2000
Retrospective 
Cohort
N = 58, 62 thumbs 
F/M = 48/10
Age = 58.4 years range: 
28-80 years Dominance: 
31/58
Trapeziectomy 
with LRTI using 
entire FCR, 
partial tra-
peziodectomy 
in 32 cases
MCP-1 arthrod-
esis (n=3), CTR 
(n=4), trigger 
finger release 
(n=3), IP-1 
arthrodesis 
(n=2).
0-4 weeks: Radial 
thumb spica splint.
4 weeks: Removable 
splint is applied.
6 weeks: weaning 
from splint begins.
3 months: free from 
immobilization
4 weeks: Physical therapy is 
started if significant stiffness 
exists.
3 months: more intense 
strengthening exercises are 
started if necessary. Physical 
therapy usually is continued 
until the end of the fourth 
month, when satisfactory 
pinch and grip strength have 
been achieved
Pain intensity (self de-
signed), ROM, grip & pinch 
strength, joint imaging 
(SMD)
Measures at: T0 (preop-
erative), T1 (42.5 months, 
range 21-86 months)
T1: 95% had no pain, compared to 0% at T0. 
Increase of pain in 0% of participants
8% improvement in palmar abduction and a 
10% improvement in radial abduction at T1 
compared to T0
Significant improvement in strength at T1 in all 
measurements. SMD decreased with 10%
157
Postoperative Rehabilitation: a Systematic Review
Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Saehle et 
al.32 2002
Retrospective 
Cohort
N = 47, 55 thumbs 
F/M = 44/3
Age = 58 years, range: 
44-73 years Dominance: 
unknown
Trapeziectomy 
with LRTI using 
APL
Unknown/not 
described
0-4/5 weeks: Plaster 
of Paris
Unknown Pain intensity (VAS 0-100, 
only at T1), Limitations in 
ADL (self-designed at T0 
and T1 & DASH, only at T1), 
ROM (only at T1), Grip & 
pinch strength (compared 
with other hand, only at 
T1), Cosmetics (VAS 0-100, 
only at T1), joint imaging 
(SMD)
Measures at: T0 (preopera-
tive), T1 (41 months, range 
16-60 months)
Median VAS pain intensity at T1: 11
ADL function measured with self-designed 
questionnaire improved in 51% of the patients 
at T1 compared to T0. Median DASH scores for 
the disability/symptom and work scales were 
both 28.
The distal phalanx of the 5th finger could be 
reached by 52 of the 55 operated hands
Average key pinch and grip strengths of the op-
erated hands were reduced with 11% and 22% 
respectively compared to unaffected side.
Median VAS score for the cosmetic result at T1: 
5. SMD decreased with 55% at T1 compared to 
T0, no correlation between proximal migration 
and clinical results.
Sirotakova 
et al.42 
2007
Case series N = 74, 104 thumbs 
F/M = 59/15
Age = 59 years range 
40-82 years Dominance: 
unknown
Trapeziectomy 
with APL sling 
(around FCR/
ECRL)
CTR (n=19 
hands in 15 
(20%) patients)
0-2 weeks: plaster of 
Paris splint.
2-4 weeks: thermo-
plastic splint.
4+ weeks: Most 
remove the splint 
and only wear it at 
night. Sometimes 
during day
The patient is seen weekly by 
the therapists
0-2 weeks: IP-1 joint flexion 
and extension exercises, 
which are performed
5 times on 3 occasions each 
day
2-6 weeks: opposition exer-
cises.
Pain intensity, stiffness, 
weakness of the hand, 
functional disability (self 
designed), ROM, grip & 
pinch strength, joint imag-
ing (SMD)
Measures at: T0 (preoper-
ative), T1 (6 months), T2 (12 
months)
‘Excellent’ results in terms of pain relief were 
achieved in 91%
Improvements in all ROM measures at T2 (not 
statistically tested)
Grip & pinch strength improved in all measures 
at T2 (not statistically tested), SMD decreased 
with 29% at T2
Soejima et 
al.33 2006
Prospective 
cohort
N = 18, 21 thumbs 
F/M = 16/2
Age = 63 years range: 
52-77 years Dominance: 
unknown
Trapeziectomy 
with LRTI using 
APL
Unknown/not 
described
0-2 weeks: short 
arm spica splint.
2 weeks: range-of-motion and 
grip-strengthening exercises 
were initiated.
Pain intensity (self 
designed), ROM, and grip 
& pinch strength, joint 
imaging (SMD)
Measures at: T0 (preopera-
tive), T1 (33 months, range 
12-71 months)
At T1, 61% had no pain, 24% had mild pain with 
strenuous activities and 14% had mild pain with 
light work
ROM radial and palmar abduction increased 
with 14° (p=0.09) and 8° (p=0.07) degrees 
respectively
Grip and the pinch strength increased with 2 kg 
(p=0.18) and from 1.3 kg (p=0.23), respectively
SMD decreased with 15% (p<0.05)
Varitimidis 
et al.43 
2000
Retrospective 
Cohort
N = 58, 62 thumbs 
F/M = 48/10
Age = 58.4 years range: 
28-80 years Dominance: 
31/58
Trapeziectomy 
with LRTI using 
entire FCR, 
partial tra-
peziodectomy 
in 32 cases
MCP-1 arthrod-
esis (n=3), CTR 
(n=4), trigger 
finger release 
(n=3), IP-1 
arthrodesis 
(n=2).
0-4 weeks: Radial 
thumb spica splint.
4 weeks: Removable 
splint is applied.
6 weeks: weaning 
from splint begins.
3 months: free from 
immobilization
4 weeks: Physical therapy is 
started if significant stiffness 
exists.
3 months: more intense 
strengthening exercises are 
started if necessary. Physical 
therapy usually is continued 
until the end of the fourth 
month, when satisfactory 
pinch and grip strength have 
been achieved
Pain intensity (self de-
signed), ROM, grip & pinch 
strength, joint imaging 
(SMD)
Measures at: T0 (preop-
erative), T1 (42.5 months, 
range 21-86 months)
T1: 95% had no pain, compared to 0% at T0. 
Increase of pain in 0% of participants
8% improvement in palmar abduction and a 
10% improvement in radial abduction at T1 
compared to T0
Significant improvement in strength at T1 in all 
measurements. SMD decreased with 10%
7
158
Chapter 7
Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Vermeulen 
et al.19 
2009
Prospective 
cohort
N = 19, 20 thumbs 
F/M = 17/2
Age = 58 years range: 
51-80 years Dominance: 
unknown
Trapeziecto-
my with LRTI 
(Weilby) using 
FCR
None 0-4 weeks: spica 
cast.
4 weeks: removable 
protective orthosis
4 weeks: physiotherapy was 
started by a hand therapist 
(therapy content unknown)
Limitations in ADL (DASH, 
Specific Personal Ques-
tionnaire), grip & pinch 
strength, ROM.
Measures at: T0 (preoper-
ative), T1 (0 months), T2 (3 
months), T3 (6 months), T4 
(12 months)
DASH score: at T0: 51, T2: 36, T3: 30.5, T4: 30 
(p<.001)
Significant improvements in inter metacarpal 
distance, Kapandji score
Significant improvements in 3-point pinch 
strength, and overall grip strength at final 
follow-up.
Vermeulen 
et al.20 
2014
Randomized 
controlled trial 
investigating 
different 
surgical 
procedures
N = 72
(BP group: 36, Weilby 
group: 36)
F/M = 72/0
Age = BP Group: 64.7 ± 
9.1, Weilby group: 63.5 ± 
8.5 years
Dominance: 36/72
(BP group: 18/36, Weilby 
group: 18/36)
Trapeziectomy 
with LRTI using 
FCR (BP) vs. 
Trapeziectomy 
with Weilby 
sling
None 0-4 weeks: spica 
cast.
4 weeks: removable 
protective orthosis
4 weeks: a hand therapist 
started standardized hand 
therapy focused on reducing 
edema and regaining func-
tionality by increasing mobility, 
stability, and strength of the 
thumb
Pain intensity and lim-
itations in ADL (PRWHE, 
DASH), ROM, Grip & pinch 
strength, complications, 
joint imaging (SMD)
Measures at: T0 (preoper-
ative), T1 (3 months), T2 (12 
months)
Pain intensity (PRWHE) decreased significantly 
for both types of surgery at T2 (Weilby: -17 
points vs. Burton-Pellegrini: -18 points (score 
range 0-50)). DASH: significant improvements 
for both types of surgery (Weilby: -16 points 
vs. Burton-Pellegrini: -20 points (score range 
0-100)).
No differences between different types of 
surgery, except in CMC-1 extension (decrease 
in Burton-Pellegrini group)
Increase in grip strength for both types of 
surgery (Weilby: +3 kg vs. Burton-Pellegrini: +4 
kg). Key pinch decreased 0.1 kg for both types 
of surgery, Tip-pinch increased 0.4 kg for both 
types of surgery and 3-point pinch increased 
for both types of surgery (Weilby: +0.3 kg vs. 
Burton-Pellegrini: +0.5 kg). Statistical testing for 
group differences was not reported
In total, complications were observed in 27,8% 
of the participants (Weilby: 23,1% vs. Burton-Pel-
legrini: 32,5%, difference not significant). SMD 
at T2 during rest in Weilby group decreased 
with 33%, in Burton-Pellegrini group with 48%, 
during pinch in Weilby group: 66%, Burton-Pel-
legrini group: 57%
Werthel et 
al.34 2016
Prospective 
cohort
N = 43, 49 thumbs, 4 were 
lost to follow-up.
F/M = unknown
Age = 67 years range 
53-85 years Dominance: 
18/39
Trapeziectomy 
with LRTI using 
FCR
Unknown/not 
described
0-5 weeks: thumb 
and wrist immobi-
lized in a cast
Physiotherapy was not 
required on a systematic basis 
postoperatively
Pain intensity (VAS), limita-
tions in ADL (DASH) grip & 
pinch strength, ROM.
Measures at: T0 (preopera-
tive), T1 (37 months, range 
29–72 months)
VAS during rest at T0: 2.3, at T1: 0.3 (p<0.05), 
VAS during key pinch at T0: 5.4, at T1: 1.3 
(p<0.05)
Quick DASH at T0: 49.4, at T1: 22.1 (p<0.05)
Significant improvements in all ROM measures, 
except MCP-1 hyperextension.
Pinch strength at T0: 3.3, T1: 5.1 (p<0.05), no 
change in grip strength.
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Vermeulen 
et al.19 
2009
Prospective 
cohort
N = 19, 20 thumbs 
F/M = 17/2
Age = 58 years range: 
51-80 years Dominance: 
unknown
Trapeziecto-
my with LRTI 
(Weilby) using 
FCR
None 0-4 weeks: spica 
cast.
4 weeks: removable 
protective orthosis
4 weeks: physiotherapy was 
started by a hand therapist 
(therapy content unknown)
Limitations in ADL (DASH, 
Specific Personal Ques-
tionnaire), grip & pinch 
strength, ROM.
Measures at: T0 (preoper-
ative), T1 (0 months), T2 (3 
months), T3 (6 months), T4 
(12 months)
DASH score: at T0: 51, T2: 36, T3: 30.5, T4: 30 
(p<.001)
Significant improvements in inter metacarpal 
distance, Kapandji score
Significant improvements in 3-point pinch 
strength, and overall grip strength at final 
follow-up.
Vermeulen 
et al.20 
2014
Randomized 
controlled trial 
investigating 
different 
surgical 
procedures
N = 72
(BP group: 36, Weilby 
group: 36)
F/M = 72/0
Age = BP Group: 64.7 ± 
9.1, Weilby group: 63.5 ± 
8.5 years
Dominance: 36/72
(BP group: 18/36, Weilby 
group: 18/36)
Trapeziectomy 
with LRTI using 
FCR (BP) vs. 
Trapeziectomy 
with Weilby 
sling
None 0-4 weeks: spica 
cast.
4 weeks: removable 
protective orthosis
4 weeks: a hand therapist 
started standardized hand 
therapy focused on reducing 
edema and regaining func-
tionality by increasing mobility, 
stability, and strength of the 
thumb
Pain intensity and lim-
itations in ADL (PRWHE, 
DASH), ROM, Grip & pinch 
strength, complications, 
joint imaging (SMD)
Measures at: T0 (preoper-
ative), T1 (3 months), T2 (12 
months)
Pain intensity (PRWHE) decreased significantly 
for both types of surgery at T2 (Weilby: -17 
points vs. Burton-Pellegrini: -18 points (score 
range 0-50)). DASH: significant improvements 
for both types of surgery (Weilby: -16 points 
vs. Burton-Pellegrini: -20 points (score range 
0-100)).
No differences between different types of 
surgery, except in CMC-1 extension (decrease 
in Burton-Pellegrini group)
Increase in grip strength for both types of 
surgery (Weilby: +3 kg vs. Burton-Pellegrini: +4 
kg). Key pinch decreased 0.1 kg for both types 
of surgery, Tip-pinch increased 0.4 kg for both 
types of surgery and 3-point pinch increased 
for both types of surgery (Weilby: +0.3 kg vs. 
Burton-Pellegrini: +0.5 kg). Statistical testing for 
group differences was not reported
In total, complications were observed in 27,8% 
of the participants (Weilby: 23,1% vs. Burton-Pel-
legrini: 32,5%, difference not significant). SMD 
at T2 during rest in Weilby group decreased 
with 33%, in Burton-Pellegrini group with 48%, 
during pinch in Weilby group: 66%, Burton-Pel-
legrini group: 57%
Werthel et 
al.34 2016
Prospective 
cohort
N = 43, 49 thumbs, 4 were 
lost to follow-up.
F/M = unknown
Age = 67 years range 
53-85 years Dominance: 
18/39
Trapeziectomy 
with LRTI using 
FCR
Unknown/not 
described
0-5 weeks: thumb 
and wrist immobi-
lized in a cast
Physiotherapy was not 
required on a systematic basis 
postoperatively
Pain intensity (VAS), limita-
tions in ADL (DASH) grip & 
pinch strength, ROM.
Measures at: T0 (preopera-
tive), T1 (37 months, range 
29–72 months)
VAS during rest at T0: 2.3, at T1: 0.3 (p<0.05), 
VAS during key pinch at T0: 5.4, at T1: 1.3 
(p<0.05)
Quick DASH at T0: 49.4, at T1: 22.1 (p<0.05)
Significant improvements in all ROM measures, 
except MCP-1 hyperextension.
Pinch strength at T0: 3.3, T1: 5.1 (p<0.05), no 
change in grip strength.
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Wong et 
al.18 2009
Retrospective 
Cohort
N = 22 patients, 22 
thumbs
F/M = 16/6
Age = 50 years range: 
43-75 years Dominance: 
13/22
Trapeziectomy 
with LRTI using 
FCR & PL
None 0-6 weeks: thermo-
plastic removable 
thumb spica splint
6 weeks: Gentle thumb and 
wrist mobilization exercise 
and control of the swelling 
immediately after removal of 
the splint.
8 weeks: Active thumb and 
wrist joint mobilization exer-
cise (i.e. putty exercise and 
sandbag).
12 weeks: Passive thumb and 
wrist joint mobilization exer-
cise together with vigorous 
strengthening exercise such 
as Dexter training, Theraband 
exercise were started
Pain intensity (self 
designed), grip & pinch 
strength, ROM, joint imag-
ing (SMD)
Measures at: T0 (preop-
erative) T1 (2 weeks) T2 (4 
weeks), T3 (8 weeks), T4 
(12 weeks), T5 (24 weeks) 
and T6 (52 weeks), T7 
(final follow-up: average 
48 months, range 12-72 
months)
At final follow-up, 82% was ‘pain free’
Kapandji score increased from 4 at T0 to 6 at T7 
(p=0.04)
When comparing T0 with T7, differences were 
found in grip strength (+4 kg, p=0.03), tip pinch 
(+0.7 kg, p=0.04) and key pinch (+1.0 kg, p=0.03), 
at T7 SMD space ratio decreased with 9% and 
SMD in mm decreased with 13%
Yang et 
al.19,20,28,35,39-
41,43 2014
Retrospective 
Cohort
N = 19, 21 thumbs 
F/M = 18/1
Age = 60 years range 
52-75 years Dominance: 
unknown
Trapeziectomy 
with modified 
LRTI using FCR
Unknown/not 
described
0-2 weeks: volar 
plaster splint.
2-6 weeks: thumb 
spica cast with 
which the thumb is 
placed in an abduct-
ed position.
6-12 weeks: patient 
wears brace inter-
mittently
6 weeks: range of motion and 
strengthening exercises are 
started
Pain intensity (VAS 
0-10) ROM, grip & pinch 
strength, joint imaging 
(SMD)
Measures at: T0 (preop-
erative), further examined 
at 2 weeks, 6 weeks and 3 
months after surgery, then 
every 3 months for the first 
year, and every 6 months 
thereafter. Final follow-up 
analyzed: T1 (13.9 months, 
range 9-28 months))
VAS pain at T0: 6.6, T1: 0.5 (p<0.05),
Improvement in ROM at T1 compared to T0 
(p<0.05) Grip strength at T0: 18.6, T1: 20.5 
(p>0.05), Tip pinch strength at T0: 4.4, T1: 4.5 
(p>0.05). At T1 SMD space ratio decreased with 
56% and SMD in mm decreased with 55%
J. Yao et 
al.17 2014
Case study N = 1,
F/M= 1/0
Age = 63
Dominance: unknown
Trapeziectomy 
with tightrope 
suspension
None 0-10 days: plaster 
thumb spica 
orthosis. 10-18 days: 
custom fabrication 
spica orthosis.
18 days-10 weeks: 
butterfly splint if 
needed, discontin-
ued after 10 weeks
10-18 days: AROM exercises 
(unspecified).
18 days - 2 months +18 days: 
edema control, scar massage, 
isometric exercises lateral 
pinch strength, guidance 
regarding ADL
Limitations in ADL (DASH).
Measures at: T0 (pre-oper-
ative), T1 (11 months)
DASH at T0: 63, at T1: 10
Note: N = number of participants, F/M = Females/Males, LRTI = Ligament Reconstruction and 
Tendon Interposition, FCR = Flexor carpi radialis, CMC-1 = thumb base joint, IP-1 = thumb interpha-
langeal joint, MCP-1 = thumb metacarpophalangeal joint, ROM = range of motion, AROM = active 
range of motion, VAS = Visual Analogue Scale, DASH = Disabilities of the Arm, Shoulder and 
Hand, APL = Abductor pollicis longus, PL = Palmaris longus, HT = Hand therapy, HP = Home 
program, ADL = Activities of daily life, PAB = Palmar abduction, CTR = carpal tunnel release, Dom-
inance = number of treatments of dominant side, BP = Burton-Pellegrini, SMD = distance between 
base of first metacarpal and distal end of scaphoid, TMD = distance between base of first metacar-
pal and radial border of trapezoid
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Table 1. Overview of the characteristics, measurements and outcomes of the included studies.
Author, 
year
Study design Study population 
(N, F/M, age (mean, 
range/±SD), right/left, 
dominance)
Surgical inter-
vention
Co-interven-
tions
Postoperative 
rehabilitation - 
immobilization 
period
Postoperative rehabilitation 
- Exercises
Measurements (instru-
ments, follow-up)
Outcomes
Wong et 
al.18 2009
Retrospective 
Cohort
N = 22 patients, 22 
thumbs
F/M = 16/6
Age = 50 years range: 
43-75 years Dominance: 
13/22
Trapeziectomy 
with LRTI using 
FCR & PL
None 0-6 weeks: thermo-
plastic removable 
thumb spica splint
6 weeks: Gentle thumb and 
wrist mobilization exercise 
and control of the swelling 
immediately after removal of 
the splint.
8 weeks: Active thumb and 
wrist joint mobilization exer-
cise (i.e. putty exercise and 
sandbag).
12 weeks: Passive thumb and 
wrist joint mobilization exer-
cise together with vigorous 
strengthening exercise such 
as Dexter training, Theraband 
exercise were started
Pain intensity (self 
designed), grip & pinch 
strength, ROM, joint imag-
ing (SMD)
Measures at: T0 (preop-
erative) T1 (2 weeks) T2 (4 
weeks), T3 (8 weeks), T4 
(12 weeks), T5 (24 weeks) 
and T6 (52 weeks), T7 
(final follow-up: average 
48 months, range 12-72 
months)
At final follow-up, 82% was ‘pain free’
Kapandji score increased from 4 at T0 to 6 at T7 
(p=0.04)
When comparing T0 with T7, differences were 
found in grip strength (+4 kg, p=0.03), tip pinch 
(+0.7 kg, p=0.04) and key pinch (+1.0 kg, p=0.03), 
at T7 SMD space ratio decreased with 9% and 
SMD in mm decreased with 13%
Yang et 
al.19,20,28,35,39-
41,43 2014
Retrospective 
Cohort
N = 19, 21 thumbs 
F/M = 18/1
Age = 60 years range 
52-75 years Dominance: 
unknown
Trapeziectomy 
with modified 
LRTI using FCR
Unknown/not 
described
0-2 weeks: volar 
plaster splint.
2-6 weeks: thumb 
spica cast with 
which the thumb is 
placed in an abduct-
ed position.
6-12 weeks: patient 
wears brace inter-
mittently
6 weeks: range of motion and 
strengthening exercises are 
started
Pain intensity (VAS 
0-10) ROM, grip & pinch 
strength, joint imaging 
(SMD)
Measures at: T0 (preop-
erative), further examined 
at 2 weeks, 6 weeks and 3 
months after surgery, then 
every 3 months for the first 
year, and every 6 months 
thereafter. Final follow-up 
analyzed: T1 (13.9 months, 
range 9-28 months))
VAS pain at T0: 6.6, T1: 0.5 (p<0.05),
Improvement in ROM at T1 compared to T0 
(p<0.05) Grip strength at T0: 18.6, T1: 20.5 
(p>0.05), Tip pinch strength at T0: 4.4, T1: 4.5 
(p>0.05). At T1 SMD space ratio decreased with 
56% and SMD in mm decreased with 55%
J. Yao et 
al.17 2014
Case study N = 1,
F/M= 1/0
Age = 63
Dominance: unknown
Trapeziectomy 
with tightrope 
suspension
None 0-10 days: plaster 
thumb spica 
orthosis. 10-18 days: 
custom fabrication 
spica orthosis.
18 days-10 weeks: 
butterfly splint if 
needed, discontin-
ued after 10 weeks
10-18 days: AROM exercises 
(unspecified).
18 days - 2 months +18 days: 
edema control, scar massage, 
isometric exercises lateral 
pinch strength, guidance 
regarding ADL
Limitations in ADL (DASH).
Measures at: T0 (pre-oper-
ative), T1 (11 months)
DASH at T0: 63, at T1: 10
Note: N = number of participants, F/M = Females/Males, LRTI = Ligament Reconstruction and 
Tendon Interposition, FCR = Flexor carpi radialis, CMC-1 = thumb base joint, IP-1 = thumb interpha-
langeal joint, MCP-1 = thumb metacarpophalangeal joint, ROM = range of motion, AROM = active 
range of motion, VAS = Visual Analogue Scale, DASH = Disabilities of the Arm, Shoulder and 
Hand, APL = Abductor pollicis longus, PL = Palmaris longus, HT = Hand therapy, HP = Home 
program, ADL = Activities of daily life, PAB = Palmar abduction, CTR = carpal tunnel release, Dom-
inance = number of treatments of dominant side, BP = Burton-Pellegrini, SMD = distance between 
base of first metacarpal and distal end of scaphoid, TMD = distance between base of first metacar-
pal and radial border of trapezoid
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Table 2. Types of surgical interventions performed in included studies
Surgical intervention N Reference(s)
Trapeziectomy with LRTI using the FCR 448 19-22,29,30,34-36,41,43
Trapeziectomy with LRTI using the APL 249 26,31-33,42
Trapeziectomy with LRTI using the FCR and PL 32 18,23
Trapeziectomy with LRTI using the FCR and Kirschner-wire fixation 125 24,27,37,40
Trapeziectomy with tendon interposition using the PL and Kirschner-
wire fixation 59
37
Trapeziectomy with ligament reconstruction using the FCR 15 21
Partial trapeziectomy with LRTI using the FCR 18 30
Partial trapeziectomy with LRTI using the FCR and Kirschner-wire 
fixation 31
24,38
Partial trapeziectomy with LRTI using the PL and Kirschner-wire fixation 9 28
Trapeziectomy 43 25,29
Trapeziectomy with Kirschner-wire fixation 88 37,39
Trapeziectomy with tightrope suspension 1 17
Total 1118
NOTE: No distinction was made between half or complete tendon use or the presence or absence 
of a bone tunnel in this classification.
Abbreviations: APL, abductor pollicis longus; FCR, flexor carpi radialis; LRTI, ligament reconstruc-
tion and tendon interposition; N, number of interventions per hand (multiple interventions were 
performed in several cases because of bilateral disease); PL, palmaris longus.
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Results of individual studies and synthesis of results
Six comparative studies were included, of which three investigated the research 
questions of the present study (the other three studies compared different 
surgical procedures). Given the low amount of comparative studies on the 
research questions, no statistical pooling was performed. A summary of the 
rehabilitation protocols as used in the included studies (including total immobi-
lization period, initiation of ROM and strengthening exercises) is displayed per 
surgical intervention (categorized by used tendon plasty) in Figure 2. Figure 2 
shows that the most progressive postoperative rehabilitation (including short 
immobilization and early initiation of ROM and strength exercises) is used in the 
literature for simple trapeziectomy or for LRTI with either a slip, a strip of or the 
entire Abductor Pollicis Longus (APL) tendon.
Figure 2. A summary of the rehabilitation protocols used in the included studies regarding total 
immobilization period and initiation of ROM and strengthening exercises is displayed per surgical 
intervention (categorized by the tendon used). The displayed time frames indicate the range (minimum 
to maximum period) of the used period in the literature. Abbreviations: APL, abductor pollicis longus; 
FCR, flexor carpi radialis; LRTI, ligament reconstruction and tendon interposition; PL, palmaris longus.
Postoperative immobilization
An overview of the immobilization periods and methods per study, sorted by year 
of publication in Table 3, shows that the total immobilization varied substantially, 
from 2 to 12 weeks. In most studies, emphasis was placed on immobilization in 
palmar abduction and extension of the CMC-1. Type of immobilization consisted 
of plaster cast immobilization only18,23,26,32-34,37,38, plaster cast immobilization 
7
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followed by a removable splint which is gradually reduced17,24,29,31,35,36,39,40,42,43 or 
completely discontinued at a certain moment.21,22,25,27,30 Splint usage gradually 
reduced over time consisted of only night usage31,36,42, the use of a butterfly 
splint if needed17 or the splint is stopped when full ROM is attained and thenar 
strength is improved to a functional level.24 The discontinuation criterion was not 
described clearly in eight studies.19,20,28,35,39-41,43
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Two comparative studies25,29 on postoperative immobilization were found (Table 4). 
In these studies, partial immobilization until 6 weeks was compared with complete 
immobilization until 6 weeks. The authors did not find more complications or worse 
outcomes at six to twelve months postoperatively when partial immobilization was 
used; on the contrary, the same or better outcomes were found in the groups that 
used partial immobilization compared to complete immobilization. Insufficient data 
was provided by Prosser et al29 to calculate effect sizes. In the study by Horlock et 
al. effect sizes on pain intensity, satisfaction, ROM and grip & pinch strength range 
from -0.66 to 0.66, where positive values indicate superior results for partial immo-
bilization (Table 4).
Table 4 also provides the outcomes for studies using a total immobilization period 
4-6 weeks or ≤4 weeks respectively. Fourteen studies18-21,23,25,28,29,31,34,37,39,41,42 used 
a total immobilization period of 4-6 weeks and five studies26,30,32,33,38 used a total 
immobilization period ≤4 weeks. We found similar complications and outcomes in 
studies using a total immobilization period of 4-6 or ≤4 weeks compared to studies 
that used an immobilization period ≥6 weeks.
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Table 4. Overview of studies comparing different types of immobilization and of studies using a total 
immobilization period of 4-6 weeks or ≤4 weeks. Immobilization methods and outcomes per study 
are displayed.
Studies compar-
ing immobilization
Immobilization methods Measures at Measurements &
instruments
Outcomes
Horlock et al.25 2002 Late vs. early mobilization:
Cast immobilization for two 
weeks followed by ther-
moplastic splint 24h/day 
until six weeks vs. cast im-
mobilization for one week 
followed by thermoplastic 
splint only during physical 
load until six weeks.
T0 (preoperative)
T1 (6-8 months)
1) Pain intensity, Hand 
function, Opinion about 
rehabilitation regimen, 
Satisfaction with operation 
(VAS 0-100)
2) ROM
3) Grip & pinch strength.
4) Complications
5) Joint imaging (SMD & 
TMD)
1) No significant difference in pain intensity decrease, although ES = -0.66 due to preoperative 
group differences, but VAS score at T1: Late group = 30, Early group = 28. The early group 
experienced more convenience compared to the late group (ES = 0.66, p<0.05).
2) Significant decrease in MCP-1 ROM was found in the late mobilization group but not in de 
early group (ES = 0.19, within group p<0.02).
3) No significant difference in grip & pinch strength, although the early group performed slightly 
better when pooling effect sizes of grip, pulp pinch and key pinch strength (ES = 0.05).
4) Complications were observed in 15% of the participants in the early group compared to 5% in 
the late group.
5) No differences between groups in median SDM, 2 mm larger decrease in TM within the early 
group, but not significant
Prosser et al.29 2014 Rigid vs. semi-rigid immobi-
lization:
Thermoplastic splint until 6 
weeks with full immobiliza-
tion of the thumb and wrist 
vs. combined thermoplas-
tic and neoprene splint 
until 6 weeks allowing 
thumb and wrist motion
T0 (preoperative)
T1 (6 weeks)
T2 (3 months)
T3 (1 year)
1) Pain intensity and 
limitations in ADL (PRWHE, 
MHQ)
2) Pinch strength
3) Complications
1) No significant differences in pain intensity and limitations in ADL. Insufficient data was provid-
ed to calculate ES.
2) No significant differences in pinch strength. Insufficient data was provided to calculate ES.
3) Complications were observed in 14% of the participants in the rigid group compared to 7% in 
the semi-rigid group.
Abbas et al.23 2012 Only plaster cast immobi-
lization
T0 (preoperative)
T1 (3 months)
T2 (6 months)
1) Limitations in ADL (Quick 
DASH)
1) Quick DASH Score at T0: 58.8, T1: 40.5, T2: 31.3 (p=0.005)
Davis et al.37 2004 Only plaster cast immobi-
lization
T0 (preoperative)
T1 (3 months)
T2 (12 months)
1) Pain intensity, stiffness, 
weakness and restriction of 
ADL (measured at once in 
categorical scores, self-de-
signed)
2) ROM
3) Grip & pinch strength
1) Pain intensity, stiffness, weakness and restriction of ADL improved ‘markedly’ at T1 and further 
at T2 (no significance described). There was no significant difference between the different types 
of surgery
2) ROM improved at T2 compared to T0 (no significance mentioned), there was no significant 
difference between different types of surgery.
3) Thumb key- and tip-pinch and grip strength in the whole study group at T1 were not different 
from T0. However, thumb key- and tip- pinch and grip strength in the whole group at the T2 were 
all significantly stronger compared to T0 (p<0.001 for all 3 types of surgery)
Horlock et al.25 2002 Late vs. early mobilization:
Cast immobilization for two 
weeks followed by ther-
moplastic splint 24h/day 
until six weeks vs. cast im-
mobilization for one week 
followed by thermoplastic 
splint only during physical 
load until six weeks.
T0 (preoperative)
T1 (6-8 months)
1) Pain intensity, Hand 
function, Opinion about 
rehabilitation regimen, 
Satisfaction with operation 
(VAS 0-100)
2) ROM
3) Grip & pinch strength.
4) Complications
5) Joint imaging (SMD & 
TMD)
1) No significant difference in pain intensity decrease, although ES = -0.66 due to preoperative 
group differences, but VAS score at T1: Late group = 30, Early group = 28. The early group 
experienced more convenience compared to the late group (ES = 0.66, p<0.05).
2) Significant decrease in MCP-1 ROM was found in the late mobilization group but not in de 
early group (ES = 0.19, within group p<0.02).
3) No significant difference in grip & pinch strength, although the early group performed slightly 
better when pooling effect sizes of grip, pulp pinch and key pinch strength (ES = 0.05).
4) Complications were observed in 15% of the participants in the early group compared to 5% in 
the late group.
5) No differences between groups in median SDM, 2 mm larger decrease in TM within the early 
group, but not significant
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Table 4. Overview of studies comparing different types of immobilization and of studies using a total 
immobilization period of 4-6 weeks or ≤4 weeks. Immobilization methods and outcomes per study 
are displayed.
Studies compar-
ing immobilization
Immobilization methods Measures at Measurements &
instruments
Outcomes
Horlock et al.25 2002 Late vs. early mobilization:
Cast immobilization for two 
weeks followed by ther-
moplastic splint 24h/day 
until six weeks vs. cast im-
mobilization for one week 
followed by thermoplastic 
splint only during physical 
load until six weeks.
T0 (preoperative)
T1 (6-8 months)
1) Pain intensity, Hand 
function, Opinion about 
rehabilitation regimen, 
Satisfaction with operation 
(VAS 0-100)
2) ROM
3) Grip & pinch strength.
4) Complications
5) Joint imaging (SMD & 
TMD)
1) No significant difference in pain intensity decrease, although ES = -0.66 due to preoperative 
group differences, but VAS score at T1: Late group = 30, Early group = 28. The early group 
experienced more convenience compared to the late group (ES = 0.66, p<0.05).
2) Significant decrease in MCP-1 ROM was found in the late mobilization group but not in de 
early group (ES = 0.19, within group p<0.02).
3) No significant difference in grip & pinch strength, although the early group performed slightly 
better when pooling effect sizes of grip, pulp pinch and key pinch strength (ES = 0.05).
4) Complications were observed in 15% of the participants in the early group compared to 5% in 
the late group.
5) No differences between groups in median SDM, 2 mm larger decrease in TM within the early 
group, but not significant
Prosser et al.29 2014 Rigid vs. semi-rigid immobi-
lization:
Thermoplastic splint until 6 
weeks with full immobiliza-
tion of the thumb and wrist 
vs. combined thermoplas-
tic and neoprene splint 
until 6 weeks allowing 
thumb and wrist motion
T0 (preoperative)
T1 (6 weeks)
T2 (3 months)
T3 (1 year)
1) Pain intensity and 
limitations in ADL (PRWHE, 
MHQ)
2) Pinch strength
3) Complications
1) No significant differences in pain intensity and limitations in ADL. Insufficient data was provid-
ed to calculate ES.
2) No significant differences in pinch strength. Insufficient data was provided to calculate ES.
3) Complications were observed in 14% of the participants in the rigid group compared to 7% in 
the semi-rigid group.
Abbas et al.23 2012 Only plaster cast immobi-
lization
T0 (preoperative)
T1 (3 months)
T2 (6 months)
1) Limitations in ADL (Quick 
DASH)
1) Quick DASH Score at T0: 58.8, T1: 40.5, T2: 31.3 (p=0.005)
Davis et al.37 2004 Only plaster cast immobi-
lization
T0 (preoperative)
T1 (3 months)
T2 (12 months)
1) Pain intensity, stiffness, 
weakness and restriction of 
ADL (measured at once in 
categorical scores, self-de-
signed)
2) ROM
3) Grip & pinch strength
1) Pain intensity, stiffness, weakness and restriction of ADL improved ‘markedly’ at T1 and further 
at T2 (no significance described). There was no significant difference between the different types 
of surgery
2) ROM improved at T2 compared to T0 (no significance mentioned), there was no significant 
difference between different types of surgery.
3) Thumb key- and tip-pinch and grip strength in the whole study group at T1 were not different 
from T0. However, thumb key- and tip- pinch and grip strength in the whole group at the T2 were 
all significantly stronger compared to T0 (p<0.001 for all 3 types of surgery)
Horlock et al.25 2002 Late vs. early mobilization:
Cast immobilization for two 
weeks followed by ther-
moplastic splint 24h/day 
until six weeks vs. cast im-
mobilization for one week 
followed by thermoplastic 
splint only during physical 
load until six weeks.
T0 (preoperative)
T1 (6-8 months)
1) Pain intensity, Hand 
function, Opinion about 
rehabilitation regimen, 
Satisfaction with operation 
(VAS 0-100)
2) ROM
3) Grip & pinch strength.
4) Complications
5) Joint imaging (SMD & 
TMD)
1) No significant difference in pain intensity decrease, although ES = -0.66 due to preoperative 
group differences, but VAS score at T1: Late group = 30, Early group = 28. The early group 
experienced more convenience compared to the late group (ES = 0.66, p<0.05).
2) Significant decrease in MCP-1 ROM was found in the late mobilization group but not in de 
early group (ES = 0.19, within group p<0.02).
3) No significant difference in grip & pinch strength, although the early group performed slightly 
better when pooling effect sizes of grip, pulp pinch and key pinch strength (ES = 0.05).
4) Complications were observed in 15% of the participants in the early group compared to 5% in 
the late group.
5) No differences between groups in median SDM, 2 mm larger decrease in TM within the early 
group, but not significant
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Table 4. Overview of studies comparing different types of immobilization and of studies using a total immobilization period of 4-6 weeks or ≤4 weeks. Immobilization methods and outcomes per study are displayed.
Studies with a 
total immobiliza-
tion period 
4-6 weeks
Immobilization methods Measures at Measurements &
instruments
Outcomes
Kriegs-Au et al.21 
2004
Plaster cast immobilization 
+ removable splint
T0 (preopera-
tive), T1 (48.2 
months, range 
32-64 months)
1) ROM
2) Grip & pinch strength
3) Buck-Gramcko score
4) Self-designed ques-
tionnaires: pain, strength, 
daily function, dexterity, 
cosmetic appearance, will-
ingness to undergo surgery 
again, overall satisfaction 
with result, current and past 
employment status and 
activity levels.
5) Joint imaging (SMD)
All outcomes: Significant improvements, although no differences for different types of surgery 
mentioned. Proximal migration of the first metacarpal was 37-42%.
Kuhns et al.39 2003 Plaster cast immobilization 
+ removable splint gradual-
ly reduced
T0 (preoper-
ative), T1 (6 
months), T2 (24 
months)
1) Pain relief (measurement 
instrument unclear)
2) Limitations in ADL 
(Jebsen subtests II and III 
dexterity tests, AIMS2)
3) ROM (descriptive only)
4) Grip & pinch strength.
5) Joint imaging
1) At final follow-up, 92% was pain free.
2) Significant improvements in 3 subscales of the AIMS 2
3) At T1, 92% adducted fully into the plane of the palm and 96% opposed to the fifth metacarpal 
head
4) Significant improvements in grip (+47%), key pinch (+33%), and tip pinch (+23%) strength at T2
5) SMD decreased with 51% at T1 compared to T0, no correlation between proximal migration 
and functional outcomes.
Nylen et al.41 1993 Plaster cast immobilization 
+ removable splint
T0 (preoper-
ative), T1 (36 
months, range 
24-54 months)
1) Pain intensity (self de-
signed)
2) Limitations in ADL (self 
designed)
3) ROM: Adduction contrac-
ture (self designed: severe, 
moderate, slight, none)
4) Grip & pinch strength
5) Satisfaction, return to 
work (self-designed)
6) Joint imaging (SMD)
1) At T1, 49% was ‘pain free’ and 51% had ‘some pain’
2) Of the patients with limitations in ADL preoperatively, 73% reported no limitations at T1.
3) Adduction contracture ‘diminished’ in 57% of the patients, decrease was not significant
4) Significant improvements in pinch strength, no significant difference in grip strength.
5) At T1, 88% was satisfied
6) Average SMD at T1 was 4 mm
Poole et al.28 2011 Both groups: Plaster cast 
immobilization + remov-
able splint
T0 (pre-op) and 
T1 (6 months 
postoperatively).
1) Pain intensity (Boston 
Questionnaire)
2) Limitations in ADL, (JHFT, 
AHFT)
3) Grip & pinch strength
4) Quality of life (AIMS 2)
1) Improvements in pain intensity in both groups, although no significant within group differences 
due to small sample size. No significant differences between groups, although a larger decrease 
in symptom severity was found in the hand therapy group.
2) Higher improvements in limitations in ADL in the hand therapy group for both the JHFT as the 
AHFT, although not significant due to sample size.
3) Improvements in grip (+13%) & 3-point pinch strength (+27%) were only found in the hand ther-
apy group, while grip (-8%) & 3-point pinch strength (-6%) decreased in the home program group
4) Significant improvements in several subscales of the Arthritis Impact Measurement Scales 2 
for both groups, no between group differences.
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Table 4. Overview of studies comparing different types of immobilization and of studies using a total immobilization period of 4-6 weeks or ≤4 weeks. Immobilization methods and outcomes per study are displayed.
Studies with a 
total immobiliza-
tion period 
4-6 weeks
Immobilization methods Measures at Measurements &
instruments
Outcomes
Kriegs-Au et al.21 
2004
Plaster cast immobilization 
+ removable splint
T0 (preopera-
tive), T1 (48.2 
months, range 
32-64 months)
1) ROM
2) Grip & pinch strength
3) Buck-Gramcko score
4) Self-designed ques-
tionnaires: pain, strength, 
daily function, dexterity, 
cosmetic appearance, will-
ingness to undergo surgery 
again, overall satisfaction 
with result, current and past 
employment status and 
activity levels.
5) Joint imaging (SMD)
All outcomes: Significant improvements, although no differences for different types of surgery 
mentioned. Proximal migration of the first metacarpal was 37-42%.
Kuhns et al.39 2003 Plaster cast immobilization 
+ removable splint gradual-
ly reduced
T0 (preoper-
ative), T1 (6 
months), T2 (24 
months)
1) Pain relief (measurement 
instrument unclear)
2) Limitations in ADL 
(Jebsen subtests II and III 
dexterity tests, AIMS2)
3) ROM (descriptive only)
4) Grip & pinch strength.
5) Joint imaging
1) At final follow-up, 92% was pain free.
2) Significant improvements in 3 subscales of the AIMS 2
3) At T1, 92% adducted fully into the plane of the palm and 96% opposed to the fifth metacarpal 
head
4) Significant improvements in grip (+47%), key pinch (+33%), and tip pinch (+23%) strength at T2
5) SMD decreased with 51% at T1 compared to T0, no correlation between proximal migration 
and functional outcomes.
Nylen et al.41 1993 Plaster cast immobilization 
+ removable splint
T0 (preoper-
ative), T1 (36 
months, range 
24-54 months)
1) Pain intensity (self de-
signed)
2) Limitations in ADL (self 
designed)
3) ROM: Adduction contrac-
ture (self designed: severe, 
moderate, slight, none)
4) Grip & pinch strength
5) Satisfaction, return to 
work (self-designed)
6) Joint imaging (SMD)
1) At T1, 49% was ‘pain free’ and 51% had ‘some pain’
2) Of the patients with limitations in ADL preoperatively, 73% reported no limitations at T1.
3) Adduction contracture ‘diminished’ in 57% of the patients, decrease was not significant
4) Significant improvements in pinch strength, no significant difference in grip strength.
5) At T1, 88% was satisfied
6) Average SMD at T1 was 4 mm
Poole et al.28 2011 Both groups: Plaster cast 
immobilization + remov-
able splint
T0 (pre-op) and 
T1 (6 months 
postoperatively).
1) Pain intensity (Boston 
Questionnaire)
2) Limitations in ADL, (JHFT, 
AHFT)
3) Grip & pinch strength
4) Quality of life (AIMS 2)
1) Improvements in pain intensity in both groups, although no significant within group differences 
due to small sample size. No significant differences between groups, although a larger decrease 
in symptom severity was found in the hand therapy group.
2) Higher improvements in limitations in ADL in the hand therapy group for both the JHFT as the 
AHFT, although not significant due to sample size.
3) Improvements in grip (+13%) & 3-point pinch strength (+27%) were only found in the hand ther-
apy group, while grip (-8%) & 3-point pinch strength (-6%) decreased in the home program group
4) Significant improvements in several subscales of the Arthritis Impact Measurement Scales 2 
for both groups, no between group differences.
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Table 4. Overview of studies comparing different types of immobilization and of studies using a total immobilization period of 4-6 weeks or ≤4 weeks. Immobilization methods and outcomes per study are displayed.
Studies with a 
total immobiliza-
tion period 
4-6 weeks
Immobilization methods Measures at Measurements &
instruments
Outcomes
Prosser et al.29 2014 Rigid vs. semi-rigid immobi-
lization:
Thermoplastic splint until 6 
weeks with full immobiliza-
tion of the thumb and wrist 
vs. combined thermoplas-
tic and neoprene splint 
until 6 weeks allowing 
thumb and wrist motion
T0 (preoperative)
T1 (6 weeks)
T2 (3 months)
T3 (1 year)
1) Pain intensity and 
limitations in ADL (PRWHE, 
MHQ)
2) Pinch strength
3) Complications
1) No significant differences in pain intensity and limitations in ADL. Insufficient data was provid-
ed to calculate ES.
2) No significant differences in pinch strength. Insufficient data was provided to calculate ES.
3) Complications were observed in 14% of the participants in the rigid group compared to 7% in 
the semi-rigid group.
Rocchi et al.31 2011 Plaster cast immobilization 
+ removable splint gradual-
ly reduced
T0 (preoperative)
T1 (3 months)
T2 (6 months)
T3 (12 months)
1) Pain intensity (VAS 
mentioned, but results 
expressed as no pain and 
restriction, mild pain with 
use and some restriction, 
pain at rest and some 
restriction and pain at rest 
and severe restriction)
2) Satisfaction (VAS)
3) Limitations in ADL 
(DASH)
4) Grip & key pinch 
strength.
5) Joint imaging (SMD)
1) At T3, zero patients had any pain at rest, only 1 occasional mild pain. No significance men-
tioned.
2) Satisfaction 9.6, time point unknown.
3) DASH at T0: 43.3, T1: 25.5, T2: 19.1 T3: 14.5, no significance mentioned.
4) Grip strength at T0: 16.0 kg, at T3: 19.2 kg, key pinch at T0: 3.7 kg and at T3: 5.6 kg, no signifi-
cance mentioned.
5) At T3, SMD averaged 6.4 mm
Sirotakova et al.42 
2007
Plaster cast immobilization 
+ removable splint gradual-
ly reduced
T0 (preoper-
ative), T1 (6 
months)
T2 (12 months)
1) Pain intensity, stiffness, 
weakness of the hand, 
functional disability (self 
designed)
2) ROM
3) Grip & pinch strength
4) Joint imaging (SMD)
1) ‘Excellent’ results in terms of pain relief were achieved in 91%
2) Improvements in all ROM measures at T2 (not statistically tested)
3) Grip & pinch strength improved in all measures at T2 (not statistically tested)
4) SMD decreased with 29% at T2
Vermeulen et al.19 
2009
Plaster cast immobilization 
+ removable splint
T0 (preoperative) 
T1 (0 months)
T2 (3 months)
T3 (6 months)
T4 (12 months)
1) Limitations in ADL 
(DASH, Specific Personal 
Questionnaire)
2) ROM
3) Grip & pinch strength
1) DASH score: at T0: 51, T2: 36, T3: 30.5, T4: 30 (p<.001)
2) Significant improvements in inter metacarpal distance, Kapandji score
3) Significant improvements in 3-point pinch strength, and overall grip strength at final follow-up.
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Table 4. Overview of studies comparing different types of immobilization and of studies using a total immobilization period of 4-6 weeks or ≤4 weeks. Immobilization methods and outcomes per study are displayed.
Studies with a 
total immobiliza-
tion period 
4-6 weeks
Immobilization methods Measures at Measurements &
instruments
Outcomes
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Thermoplastic splint until 6 
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tion of the thumb and wrist 
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tic and neoprene splint 
until 6 weeks allowing 
thumb and wrist motion
T0 (preoperative)
T1 (6 weeks)
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T3 (1 year)
1) Pain intensity and 
limitations in ADL (PRWHE, 
MHQ)
2) Pinch strength
3) Complications
1) No significant differences in pain intensity and limitations in ADL. Insufficient data was provid-
ed to calculate ES.
2) No significant differences in pinch strength. Insufficient data was provided to calculate ES.
3) Complications were observed in 14% of the participants in the rigid group compared to 7% in 
the semi-rigid group.
Rocchi et al.31 2011 Plaster cast immobilization 
+ removable splint gradual-
ly reduced
T0 (preoperative)
T1 (3 months)
T2 (6 months)
T3 (12 months)
1) Pain intensity (VAS 
mentioned, but results 
expressed as no pain and 
restriction, mild pain with 
use and some restriction, 
pain at rest and some 
restriction and pain at rest 
and severe restriction)
2) Satisfaction (VAS)
3) Limitations in ADL 
(DASH)
4) Grip & key pinch 
strength.
5) Joint imaging (SMD)
1) At T3, zero patients had any pain at rest, only 1 occasional mild pain. No significance men-
tioned.
2) Satisfaction 9.6, time point unknown.
3) DASH at T0: 43.3, T1: 25.5, T2: 19.1 T3: 14.5, no significance mentioned.
4) Grip strength at T0: 16.0 kg, at T3: 19.2 kg, key pinch at T0: 3.7 kg and at T3: 5.6 kg, no signifi-
cance mentioned.
5) At T3, SMD averaged 6.4 mm
Sirotakova et al.42 
2007
Plaster cast immobilization 
+ removable splint gradual-
ly reduced
T0 (preoper-
ative), T1 (6 
months)
T2 (12 months)
1) Pain intensity, stiffness, 
weakness of the hand, 
functional disability (self 
designed)
2) ROM
3) Grip & pinch strength
4) Joint imaging (SMD)
1) ‘Excellent’ results in terms of pain relief were achieved in 91%
2) Improvements in all ROM measures at T2 (not statistically tested)
3) Grip & pinch strength improved in all measures at T2 (not statistically tested)
4) SMD decreased with 29% at T2
Vermeulen et al.19 
2009
Plaster cast immobilization 
+ removable splint
T0 (preoperative) 
T1 (0 months)
T2 (3 months)
T3 (6 months)
T4 (12 months)
1) Limitations in ADL 
(DASH, Specific Personal 
Questionnaire)
2) ROM
3) Grip & pinch strength
1) DASH score: at T0: 51, T2: 36, T3: 30.5, T4: 30 (p<.001)
2) Significant improvements in inter metacarpal distance, Kapandji score
3) Significant improvements in 3-point pinch strength, and overall grip strength at final follow-up.
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Table 4. Overview of studies comparing different types of immobilization and of studies using a total immobilization period of 4-6 weeks or ≤4 weeks. Immobilization methods and outcomes per study are displayed.
Studies with a 
total immobiliza-
tion period 
4-6 weeks
Immobilization methods Measures at Measurements &
instruments
Outcomes
Vermeulen et al.20 
2014
Plaster cast immobilization 
+ removable splint
T0 (preoperative) 
T1 (3 months)
T2 (12 months)
1) Pain intensity and 
limitations in ADL (PRWHE, 
DASH)
2) ROM
3) Grip & pinch strength
4) Complications
5) Joint imaging (SMD)
1) Pain intensity (PRWHE) decreased significantly for both types of surgery at T2 (Weilby: -17 
points vs. Burton-Pellegrini: -18 points (score range 0-50)). DASH: significant improvements for 
both types of surgery (Weilby: -16 points vs. Burton-Pellegrini: -20 points (score range 0-100)).
2) No differences between different types of surgery, except in CMC-1 extension (decrease in 
Burton-Pellegrini group)
3) Increase in grip strength for both types of surgery (Weilby: +3 kg vs. Burton-Pellegrini: +4 kg). 
Key pinch decreased 0.1 kg for both types of surgery, Tip-pinch increased 0.4 kg for both types 
of surgery and 3-point pinch increased for both types of surgery (Weilby: +0.3 kg vs. Burton-Pel-
legrini: +0.5 kg). Statistical testing for group differences was not reported
4) In total, complications were observed in 27,8% of the participants (Weilby: 23,1% vs. Bur-
ton-Pellegrini: 32,5%, difference not significant)
5) SMD at T2 during rest in Weilby group decreased with 33%, in Burton-Pellegrini group with 
48%, during pinch in Weilby group: 66%, Burton-Pellegrini group: 57%
Werthel et al.34 2016 Only plaster cast immobi-
lization
T0 (preoperative) 
T1 (37 months, 
range: 29–72 
months)
1) Pain intensity (VAS)
2) Limitations in ADL 
(DASH)
3) ROM
4) Grip & pinch strength
1) VAS during rest at T0: 2.3, at T1: 0.3 (p<0.05), VAS during key pinch at T0: 5.4, at T1: 1.3 (p<0.05)
2) Quick DASH at T0: 49.4, at T1: 22.1 (p<0.05)
3) Significant improvements in all ROM measures, except MCP-1 hyperextension.
4) Pinch strength at T0: 3.3, T1: 5.1 (p<0.05), no change in grip strength.
Wong et al.18 2009 Only plaster cast immobi-
lization
T0 (preoperative) 
T1 (2 weeks)
T2 (4 weeks)
T3 (8 weeks)
T4 (12 weeks)
T5 (24 weeks)
T6 (52 weeks)
T7 (48 months, 
range 12-72 
months)
1) Pain intensity (self de-
signed)
2) ROM
3) Grip & pinch strength
4) Joint imaging (SMD)
1) At final follow-up, 82% was ‘pain free’
2) Kapandji score increased from 4 at T0 to 6 at T7 (p=0.04)
3) When comparing T0 with T7, differences were found in grip strength (+4 kg, p=0.03), tip pinch 
(+0.7 kg, p=0.04) and key pinch (+1.0 kg, p=0.03)
4) At T7 SMD space ratio decreased with 9% and SMD in mm decreased with 13%
Studies with a
total immobili-
zation period ≤4 
weeks
Immobilization methods Measures at Measurements & 
instruments
Outcomes
Eaton et al.38 1985 Only plaster cast immobi-
lization
T0 (preoperative)
T1 (37,5 months, 
range 14-60 
months)
1) Pinch strength
2) Clinical results were 
graded as excellent, good, 
fair or failure
1) Pinch strength at T0: 5.5 kg, T1: 6.1 kg (no significance reported)
2) All patients had ‘relief of pain’ at T1. 55% reported no pain whatsoever, and 44% described ‘an 
occasional twinge or rare mild ache’. No patient had postoperative pain, even those whose clini-
cal results were graded as fair. According to the grading system, 41.7% of the cases were graded 
as excellent, 50% were good, and 8.3% were fair
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Table 4. Overview of studies comparing different types of immobilization and of studies using a total immobilization period of 4-6 weeks or ≤4 weeks. Immobilization methods and outcomes per study are displayed.
Studies with a 
total immobiliza-
tion period 
4-6 weeks
Immobilization methods Measures at Measurements &
instruments
Outcomes
Vermeulen et al.20 
2014
Plaster cast immobilization 
+ removable splint
T0 (preoperative) 
T1 (3 months)
T2 (12 months)
1) Pain intensity and 
limitations in ADL (PRWHE, 
DASH)
2) ROM
3) Grip & pinch strength
4) Complications
5) Joint imaging (SMD)
1) Pain intensity (PRWHE) decreased significantly for both types of surgery at T2 (Weilby: -17 
points vs. Burton-Pellegrini: -18 points (score range 0-50)). DASH: significant improvements for 
both types of surgery (Weilby: -16 points vs. Burton-Pellegrini: -20 points (score range 0-100)).
2) No differences between different types of surgery, except in CMC-1 extension (decrease in 
Burton-Pellegrini group)
3) Increase in grip strength for both types of surgery (Weilby: +3 kg vs. Burton-Pellegrini: +4 kg). 
Key pinch decreased 0.1 kg for both types of surgery, Tip-pinch increased 0.4 kg for both types 
of surgery and 3-point pinch increased for both types of surgery (Weilby: +0.3 kg vs. Burton-Pel-
legrini: +0.5 kg). Statistical testing for group differences was not reported
4) In total, complications were observed in 27,8% of the participants (Weilby: 23,1% vs. Bur-
ton-Pellegrini: 32,5%, difference not significant)
5) SMD at T2 during rest in Weilby group decreased with 33%, in Burton-Pellegrini group with 
48%, during pinch in Weilby group: 66%, Burton-Pellegrini group: 57%
Werthel et al.34 2016 Only plaster cast immobi-
lization
T0 (preoperative) 
T1 (37 months, 
range: 29–72 
months)
1) Pain intensity (VAS)
2) Limitations in ADL 
(DASH)
3) ROM
4) Grip & pinch strength
1) VAS during rest at T0: 2.3, at T1: 0.3 (p<0.05), VAS during key pinch at T0: 5.4, at T1: 1.3 (p<0.05)
2) Quick DASH at T0: 49.4, at T1: 22.1 (p<0.05)
3) Significant improvements in all ROM measures, except MCP-1 hyperextension.
4) Pinch strength at T0: 3.3, T1: 5.1 (p<0.05), no change in grip strength.
Wong et al.18 2009 Only plaster cast immobi-
lization
T0 (preoperative) 
T1 (2 weeks)
T2 (4 weeks)
T3 (8 weeks)
T4 (12 weeks)
T5 (24 weeks)
T6 (52 weeks)
T7 (48 months, 
range 12-72 
months)
1) Pain intensity (self de-
signed)
2) ROM
3) Grip & pinch strength
4) Joint imaging (SMD)
1) At final follow-up, 82% was ‘pain free’
2) Kapandji score increased from 4 at T0 to 6 at T7 (p=0.04)
3) When comparing T0 with T7, differences were found in grip strength (+4 kg, p=0.03), tip pinch 
(+0.7 kg, p=0.04) and key pinch (+1.0 kg, p=0.03)
4) At T7 SMD space ratio decreased with 9% and SMD in mm decreased with 13%
Studies with a
total immobili-
zation period ≤4 
weeks
Immobilization methods Measures at Measurements & 
instruments
Outcomes
Eaton et al.38 1985 Only plaster cast immobi-
lization
T0 (preoperative)
T1 (37,5 months, 
range 14-60 
months)
1) Pinch strength
2) Clinical results were 
graded as excellent, good, 
fair or failure
1) Pinch strength at T0: 5.5 kg, T1: 6.1 kg (no significance reported)
2) All patients had ‘relief of pain’ at T1. 55% reported no pain whatsoever, and 44% described ‘an 
occasional twinge or rare mild ache’. No patient had postoperative pain, even those whose clini-
cal results were graded as fair. According to the grading system, 41.7% of the cases were graded 
as excellent, 50% were good, and 8.3% were fair
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Table 4. Overview of studies comparing different types of immobilization and of studies using a total immobilization period of 4-6 weeks or ≤4 weeks. Immobilization methods and outcomes per study are displayed.
Studies with a 
total immobiliza-
tion period 
4-6 weeks
Immobilization methods Measures at Measurements &
instruments
Outcomes
Lee et al.26 2015 Only plaster cast immobi-
lization
T0 (preoperative) 
T1 (36 months, 
range 19 to 73.7 
months)
1) Pain intensity (VAS)
2) Limitations in ADL 
(DASH)
3) ROM
4) Grip & pinch strength
5) Patient satisfaction (self 
designed)
6) Returning to work (self 
designed)
7) Joint imaging
1) VAS at T0: 7.2, T1: 1.7 (p<0.05)
2) DASH at T0: 41, T1: 18, (p<0.05)
3) Significant improvements in al ROM measurements at T1
4) Increase of 1.1 kg in power pinch (p<0.05) at T1, no difference in tip pinch and grip strength at 
T1.
5) “All patients expressed their satisfaction for improved postoperative appearance of the hand.”
6) Of the working participants, 77% returned to their work or activities without any difficulty or 
occupation modification, in 23% modifications were required
7) SMD decreased 34.3% (p<0.05)
Roberts et al.30 2001 Plaster cast immobilization 
+ removable splint
T0 (preopera-
tive) T1 (median 
1 year and 11 
months, range 3 
months-11 years, 
Q1 1 year, Q3 3 
years 4 months)
1) Pain intensity (VAS 0-10), 
measured retrospectively
2) Limitations in ADL (self 
designed: 15-item daily 
living checklist), measured 
retrospectively
3) Grip & pinch strength
1) VAS scores decreased with 8 points (p=0.04)
2) Limitations in ADL showed 60% improvement (p=0.4)
3) Significant improvements in grip & pinch strength in group with hemi-resections, except in 
groups with full-trapezium resections
Saehle et al.32 2002 Only plaster cast immobi-
lization
T0 (preoperative) 
T1 (41 months, 
range 16-60 
months)
1) Pain intensity (VAS 0-100, 
only at T1)
2) Limitations in ADL 
(self-designed at T0 and T1 
& DASH, only at T1)
3) ROM (only at T1)
4) Grip & pinch strength 
(compared with other hand, 
only at T1)
5) Cosmetics (VAS 0-100, 
only at T1)
6) Joint imaging (SMD)
1) Median VAS pain intensity at T1: 11
2) ADL function measured with self-designed questionnaire improved in 51% of the patients at T1 
compared to T0. Median DASH scores for the disability/symptom and work scales were both 28.
3) The distal phalanx of the 5th finger could be reached by 52 of the 55 operated hands
4) Average key pinch and grip strengths of the operated hands were reduced with 11% and 22% 
respectively compared to unaffected side.
5) Median VAS score for the cosmetic result at T1: 5
6) SMD decreased with 55% at T1 compared to T0, no correlation between proximal migration 
and clinical results.
Soejima et al.33 
2006
Only plaster cast immobi-
lization
T0 (preoperative) 
T1 (33 months, 
range 12-71 
months)
1) Pain intensity (self de-
signed)
2) ROM
3) Grip & pinch strength
4) Joint imaging (SMD)
1) At T1, 61% had no pain, 24% had mild pain with strenuous activities and 14% had mild pain with 
light work
2) ROM radial and palmar abduction increased with 14° (p=0.09) and 8° (p=0.07) degrees respec-
tively
3) Grip and the pinch strength increased with 2 kg (p=0.18) and from 1.3 kg (p=0.23), respectively
4) SMD decreased with 15% (p<0.05)
Note: VAS = Visual Analogue Scale, ROM = Range of Motion, ES = Effect Size (positive scores indi-
cate better performance of experimental treatment compared to control treatment), MCP-1 = First 
Metacarpophalangeal joint, ADL = Activities of Daily Life, PRWHE = Patiënt Rated Wrist & Hand 
Evaluation, MHQ = Michigan Hand outcomes Questionnaire, DASH = Disabilities of Arm, Shoulder 
and Hand, AIMS2 = Arthritis Impact Measurement Scales 2, JHFT = Jebsen Hand Function Test, 
AHFT = Arthritis Hand Function Test, SMD = distance between base of first metacarpal and distal 
end of scaphoid, TMD = distance between base of first metacarpal and radial border of trapezoid
≤4 we ks
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Table 4. Overview of studies comparing different types of immobilization and of studies using a total immobilization period of 4-6 weeks or ≤4 weeks. Immobilization methods and outcomes per study are displayed.
Studies with a 
total immobiliza-
tion period 
4-6 weeks
Immobilization methods Measures at Measurements &
instruments
Outcomes
Lee et al.26 2015 Only plaster cast immobi-
lization
T0 (preoperative) 
T1 (36 months, 
range 19 to 73.7 
months)
1) Pain intensity (VAS)
2) Limitations in ADL 
(DASH)
3) ROM
4) Grip & pinch strength
5) Patient satisfaction (self 
designed)
6) Returning to work (self 
designed)
7) Joint imaging
1) VAS at T0: 7.2, T1: 1.7 (p<0.05)
2) DASH at T0: 41, T1: 18, (p<0.05)
3) Significant improvements in al ROM measurements at T1
4) Increase of 1.1 kg in power pinch (p<0.05) at T1, no difference in tip pinch and grip strength at 
T1.
5) “All patients expressed their satisfaction for improved postoperative appearance of the hand.”
6) Of the working participants, 77% returned to their work or activities without any difficulty or 
occupation modification, in 23% modifications were required
7) SMD decreased 34.3% (p<0.05)
Roberts et al.30 2001 Plaster cast immobilization 
+ removable splint
T0 (preopera-
tive) T1 (median 
1 year and 11 
months, range 3 
months-11 years, 
Q1 1 year, Q3 3 
years 4 months)
1) Pain intensity (VAS 0-10), 
measured retrospectively
2) Limitations in ADL (self 
designed: 15-item daily 
living checklist), measured 
retrospectively
3) Grip & pinch strength
1) VAS scores decreased with 8 points (p=0.04)
2) Limitations in ADL showed 60% improvement (p=0.4)
3) Significant improvements in grip & pinch strength in group with hemi-resections, except in 
groups with full-trapezium resections
Saehle et al.32 2002 Only plaster cast immobi-
lization
T0 (preoperative) 
T1 (41 months, 
range 16-60 
months)
1) Pain intensity (VAS 0-100, 
only at T1)
2) Limitations in ADL 
(self-designed at T0 and T1 
& DASH, only at T1)
3) ROM (only at T1)
4) Grip & pinch strength 
(compared with other hand, 
only at T1)
5) Cosmetics (VAS 0-100, 
only at T1)
6) Joint imaging (SMD)
1) Median VAS pain intensity at T1: 11
2) ADL function measured with self-designed questionnaire improved in 51% of the patients at T1 
compared to T0. Median DASH scores for the disability/symptom and work scales were both 28.
3) The distal phalanx of the 5th finger could be reached by 52 of the 55 operated hands
4) Average key pinch and grip strengths of the operated hands were reduced with 11% and 22% 
respectively compared to unaffected side.
5) Median VAS score for the cosmetic result at T1: 5
6) SMD decreased with 55% at T1 compared to T0, no correlation between proximal migration 
and clinical results.
Soejima et al.33 
2006
Only plaster cast immobi-
lization
T0 (preoperative) 
T1 (33 months, 
range 12-71 
months)
1) Pain intensity (self de-
signed)
2) ROM
3) Grip & pinch strength
4) Joint imaging (SMD)
1) At T1, 61% had no pain, 24% had mild pain with strenuous activities and 14% had mild pain with 
light work
2) ROM radial and palmar abduction increased with 14° (p=0.09) and 8° (p=0.07) degrees respec-
tively
3) Grip and the pinch strength increased with 2 kg (p=0.18) and from 1.3 kg (p=0.23), respectively
4) SMD decreased with 15% (p<0.05)
Note: VAS = Visual Analogue Scale, ROM = Range of Motion, ES = Effect Size (positive scores indi-
cate better performance of experimental treatment compared to control treatment), MCP-1 = First 
Metacarpophalangeal joint, ADL = Activities of Daily Life, PRWHE = Patiënt Rated Wrist & Hand 
Evaluation, MHQ = Michigan Hand outcomes Questionnaire, DASH = Disabilities of Arm, Shoulder 
and Hand, AIMS2 = Arthritis Impact Measurement Scales 2, JHFT = Jebsen Hand Function Test, 
AHFT = Arthritis Hand Function Test, SMD = distance between base of first metacarpal and distal 
end of scaphoid, TMD = distance between base of first metacarpal and radial border of trapezoid
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Postoperative exercises/therapy
Large variations were observed in postoperative exercises/therapy regimens of 
the included studies. One comparative study28 investigated the added value of 
hand therapy compared to a home program only in postoperative rehabilitation. 
No significant differences were found between the groups due to a small sample 
size, although higher improvements were found for pain intensity, limitations in 
ADL and grip & pinch six months postoperatively in the group that received hand 
therapy (Table 5). Effect sizes on pain intensity, limitations in ADL, grip & pinch 
strength and quality of life range from 0.33 to 0.95, indicating superior treatment 
effects of hand therapy compared to a home program only.
Five studies19,26,32,34,41 did not describe the content of postoperative exercises/
therapy. When the other 23 studies are summarized, three phases can be iden-
tified on postoperative exercises/therapy: (1) the ‘acute postoperative phase’ 
(range: zero to six weeks postoperatively); (2) the ‘unloaded phase’ (range: one to 
twelve weeks postoperatively) and (3) the ‘functional phase’ (range: three weeks 
to six months postoperatively).
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Table 5. Overview of studies investigating benefits of postoperative exercises/therapy and of studies ini-
tiating thumb range of motion or strengthening exercises ≤4 weeks. Exercises of other joints (i.e. fingers, 
wrist) are not described.
Studies on benefits of 
postoperative exercis-
es/therapy
Methods Measures at Measurements &
instruments
Outcomes
Poole et al.28 2011 Home program group: 4 
weeks: 1 consult initiating 
ROM exercises
Hand therapy group: ROM 
exercises, one therapy ses-
sion every week
T0 (pre-op) and T1 
(6 months postop-
eratively).
5) Pain intensity (Boston 
Questionnaire)
6) Limitations in ADL, 
(JHFT, AHFT)
7) Grip & pinch strength
8) Quality of life (AIMS 2)
5) Improvements in pain intensity in both groups, although no significant within group differences 
due to small sample size. No significant differences between groups, although a larger decrease 
in symptom severity was found in the hand therapy group (ES = 0.53)
6) Higher improvements in limitations in ADL in the hand therapy group for both the JHFT 
(ES = 0.52) as the AHFT (ES = 0.33), although not significant due to sample size.
7) Improvements in grip (+13%) & 3-point pinch strength (+27%) were only found in the hand ther-
apy group, while grip (-8%) & 3-point pinch strength (-6%) decreased in the home program group 
(ES grip strength = 0.77, ES 3-point pinch = 0.95).
8) Significant improvements in several subscales of the Arthritis Impact Measurement Scales 2 
for both groups, no between group differences.
Ataker et al.36 2012 4 weeks: AROM exercises for 
CMC1 and MCP1 supervised 
by a PT, no CMC flexion/ad-
duction, opposition
T0 (preoperative) 
T1 (12 weeks)
T2 (31.5 months, 
range: 12-57 
months)
1) Pain intensity (VAS)
2) Limitations in ADL 
(DASH)
3) ROM
4) Grip & pinch strength
5) Joint imaging (SMD)
1) VAS at T0: 8, T1: 3, T2: 3 (p<0.001).
2) DASH at T0: 56, T1: 29, T2: 24 (p<0.001).
3) Increase in palmar and radial abduction, Kapandji score (p<0.001).
4) Grip strength (kg) at T0: 12, T1: 18 (p<0.001), T2: 13, Lateral pinch at T0: 3, T1: 5, T2: 4 (p<0.001).
5) Joint imaging at T0: 11 mm, T1: 5 mm, T2: 3 mm
Burton et al.24 1986 4 weeks: 1) Active abduction 
and extension while avoiding 
flexion and adduction, 2) 
AROM flexion of the MCP 
and IP joints with MC1 sup-
ported in abduction by the 
patient’s opposite hand
T0 (preoperative) 
T1 (2 years, range 
1-4.5 years).
1) Pain relief (self de-
signed, only measured 
at T1)
2) Grip & pinch strength
3) Joint imaging
1) Pain relief: 92% of patients enjoyed excellent pain relief and were satisfied with the thumb
2) T1 showed an overall improvement in grip and pinch strength of 19% compared with T0 values 
(no significance mentioned).
3) Average loss of 11% of the initial postoperative arthroplasty space
Eaton et al.38 1985 4 weeks: extension and 
circumduction of the CMC-1 
joint is emphasized
T0 (preoperative)
T1 (37,5 months, 
range 14-60 
months)
1) Pinch strength
2) Clinical results were 
graded as excellent, 
good, fair or failure
3) Pinch strength at T0: 5.5 kg, T1: 6.1 kg (no significance reported)
4) All patients had ‘relief of pain’ at T1. 55% reported no pain whatsoever, and 44% described ‘an 
occasional twinge or rare mild ache’. No patient had postoperative pain, even those whose clini-
cal results were graded as fair. According to the grading system, 41.7% of the cases were graded 
as excellent, 50% were good, and 8.3% were fair
Horlock et al.25 2002 Early group, 1 week: Light 
use of the hand allowed 
and active exercises for the 
thumb
Late group, 2 weeks: Gentle 
use and mobilization were 
allowed out of the splint
T0 (preoperative)
T1 (6-8 months)
6) Pain intensity, Hand 
function, Opinion about 
rehabilitation regimen, 
Satisfaction with opera-
tion (VAS 0-100)
7) ROM
8) Grip & pinch strength.
9) Complications
10) Joint imaging (SMD 
& TMD)
6) No significant difference in pain intensity decrease, although ES = -0.66 due to preoperative 
group differences, but VAS score at T1: Late group = 30, Early group = 28. The early group experi-
enced more convenience compared to the late group (ES = 0.66, p<0.05).
7) Significant decrease in MCP-1 ROM was found in the late mobilization group but not in de 
early group (ES = 0.19, within group p<0.02).
8) No significant difference in grip & pinch strength, although the early group performed slightly 
better when pooling effect sizes of grip, pulp pinch and key pinch strength (ES = 0.05).
9) Complications were observed in 15% of the participants in the early group compared to 5% in 
the late group.
10) No differences between groups in median SDM, 2 mm larger decrease in TM within the early 
group, but not significant
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Table 5. Overview of studies investigating benefits of postoperative exercises/therapy and of studies ini-
tiating thumb range of motion or strengthening exercises ≤4 weeks. Exercises of other joints (i.e. fingers, 
wrist) are not described.
Studies on benefits of 
postoperative exercis-
es/therapy
Methods Measures at Measurements &
instruments
Outcomes
Poole et al.28 2011 Home program group: 4 
weeks: 1 consult initiating 
ROM exercises
Hand therapy group: ROM 
exercises, one therapy ses-
sion every week
T0 (pre-op) and T1 
(6 months postop-
eratively).
5) Pain intensity (Boston 
Questionnaire)
6) Limitations in ADL, 
(JHFT, AHFT)
7) Grip & pinch strength
8) Quality of life (AIMS 2)
5) Improvements in pain intensity in both groups, although no significant within group differences 
due to small sample size. No significant differences between groups, although a larger decrease 
in symptom severity was found in the hand therapy group (ES = 0.53)
6) Higher improvements in limitations in ADL in the hand therapy group for both the JHFT 
(ES = 0.52) as the AHFT (ES = 0.33), although not significant due to sample size.
7) Improvements in grip (+13%) & 3-point pinch strength (+27%) were only found in the hand ther-
apy group, while grip (-8%) & 3-point pinch strength (-6%) decreased in the home program group 
(ES grip strength = 0.77, ES 3-point pinch = 0.95).
8) Significant improvements in several subscales of the Arthritis Impact Measurement Scales 2 
for both groups, no between group differences.
Ataker et al.36 2012 4 weeks: AROM exercises for 
CMC1 and MCP1 supervised 
by a PT, no CMC flexion/ad-
duction, opposition
T0 (preoperative) 
T1 (12 weeks)
T2 (31.5 months, 
range: 12-57 
months)
1) Pain intensity (VAS)
2) Limitations in ADL 
(DASH)
3) ROM
4) Grip & pinch strength
5) Joint imaging (SMD)
1) VAS at T0: 8, T1: 3, T2: 3 (p<0.001).
2) DASH at T0: 56, T1: 29, T2: 24 (p<0.001).
3) Increase in palmar and radial abduction, Kapandji score (p<0.001).
4) Grip strength (kg) at T0: 12, T1: 18 (p<0.001), T2: 13, Lateral pinch at T0: 3, T1: 5, T2: 4 (p<0.001).
5) Joint imaging at T0: 11 mm, T1: 5 mm, T2: 3 mm
Burton et al.24 1986 4 weeks: 1) Active abduction 
and extension while avoiding 
flexion and adduction, 2) 
AROM flexion of the MCP 
and IP joints with MC1 sup-
ported in abduction by the 
patient’s opposite hand
T0 (preoperative) 
T1 (2 years, range 
1-4.5 years).
1) Pain relief (self de-
signed, only measured 
at T1)
2) Grip & pinch strength
3) Joint imaging
1) Pain relief: 92% of patients enjoyed excellent pain relief and were satisfied with the thumb
2) T1 showed an overall improvement in grip and pinch strength of 19% compared with T0 values 
(no significance mentioned).
3) Average loss of 11% of the initial postoperative arthroplasty space
Eaton et al.38 1985 4 weeks: extension and 
circumduction of the CMC-1 
joint is emphasized
T0 (preoperative)
T1 (37,5 months, 
range 14-60 
months)
1) Pinch strength
2) Clinical results were 
graded as excellent, 
good, fair or failure
3) Pinch strength at T0: 5.5 kg, T1: 6.1 kg (no significance reported)
4) All patients had ‘relief of pain’ at T1. 55% reported no pain whatsoever, and 44% described ‘an 
occasional twinge or rare mild ache’. No patient had postoperative pain, even those whose clini-
cal results were graded as fair. According to the grading system, 41.7% of the cases were graded 
as excellent, 50% were good, and 8.3% were fair
Horlock et al.25 2002 Early group, 1 week: Light 
use of the hand allowed 
and active exercises for the 
thumb
Late group, 2 weeks: Gentle 
use and mobilization were 
allowed out of the splint
T0 (preoperative)
T1 (6-8 months)
6) Pain intensity, Hand 
function, Opinion about 
rehabilitation regimen, 
Satisfaction with opera-
tion (VAS 0-100)
7) ROM
8) Grip & pinch strength.
9) Complications
10) Joint imaging (SMD 
& TMD)
6) No significant difference in pain intensity decrease, although ES = -0.66 due to preoperative 
group differences, but VAS score at T1: Late group = 30, Early group = 28. The early group experi-
enced more convenience compared to the late group (ES = 0.66, p<0.05).
7) Significant decrease in MCP-1 ROM was found in the late mobilization group but not in de 
early group (ES = 0.19, within group p<0.02).
8) No significant difference in grip & pinch strength, although the early group performed slightly 
better when pooling effect sizes of grip, pulp pinch and key pinch strength (ES = 0.05).
9) Complications were observed in 15% of the participants in the early group compared to 5% in 
the late group.
10) No differences between groups in median SDM, 2 mm larger decrease in TM within the early 
group, but not significant
7
184
Chapter 7
Table 5. Continued
Studies initiating 
CMC-1 ROM ≤4 weeks
Description of ROM exer-
cises initiated ≤4 weeks
Measures at Measurements &
instruments
Outcomes
Lins et al.40 1996 4 weeks: gentle ROM exer-
cises
T0 (preoperative) 
T1 (42-43 months, 
range 14-88 
months)
1) Pain intensity (self 
designed)
2) Functional status 
/ satisfaction (self 
designed)
3) ROM (web space)
4) Grip & pinch strength
5) Joint imaging (SMD)
1) At T1, 85% patients considered the frequency of pain ‘improved a lot or resolved completely’ 
compared to T0 and 89% considered the duration and severity as ‘improved a lot or completely’ 
at T1, compared to T0.
2) At T1, 89% of the patients were satisfied with the ‘relief of pain’
3) Web space increased with 1.09 cm (p<0.02)
4) Grip strength increased with 5.9 kg (p<0.001) and pinch strength increased with 1.4 kg (p<0.01)
5) SMD decreased with 30% (p>0.05)
Mo et al.27 2004 4 weeks: exercises with em-
phasis on extension/abduc-
tion, on maintaining MCP-1 
joint flexion and avoiding 
hyperextension
T0 (preoperative) 
T1 (20 months, 
range 12-44 
months
1) Limitations in ADL 
(DASH)
2) ROM
3) Grip & pinch strength
4) Joint imaging (SMD)
1) DASH outcomes associated with strength, no results over time reported
2) The distance from thumb tip to the base of the small finger during maximum flexion decreased 
with 0.4 cm (p=0.02)
3) Grip strength improved with 26% at T1 compared to T0 (p=0.01), pinch strength improved 11% 
(p=0.11).
4) SMD improved with 2.5%, no correlation between proximal migration and functional out-
comes.
Poole et al.28 2011 Home program group, 4 
weeks: 1 consult initiating 
ROM exercises
Hand therapy group: ROM 
exercises, one therapy ses-
sion every week
T0 (pre-op) and T1 
(6 months postop-
eratively).
1) Pain intensity (Boston 
Questionnaire)
2) Limitations in ADL 
(JHFT, AHFT)
3) Grip & pinch strength
4) Quality of life (AIMS 2)
1) Improvements in pain intensity in both groups, although no significant within group differences 
due to small sample size. No significant differences between groups, although a larger decrease 
in symptom severity was found in the hand therapy group (ES = 0.53)
2) Higher improvements in limitations in ADL in the hand therapy group for both the JHFT 
(ES = 0.52) as the AHFT (ES = 0.33), although not significant due to sample size.
3) Improvements in grip (+13%) & 3-point pinch strength (+27%) were only found in the hand ther-
apy group, while grip (-8%) & 3-point pinch strength (-6%) decreased in the home program group 
(ES grip strength = 0.77, ES 3-point pinch = 0.95).
4) Significant improvements in several subscales of the Arthritis Impact Measurement Scales 2 
for both groups, no between group differences.
Prosser et al.29 2014 Rigid vs. Semi-rigid immo-
bilization. Both groups at 4 
weeks: abduction exercises
T0 (preoperative)
T1 (6 weeks)
T2 (3 months)
T3 (1 year)
4) Pain intensity and lim-
itations in ADL (PRWHE, 
MHQ)
5) Pinch strength
6) Complications
4) No significant differences in pain intensity and limitations in ADL. Insufficient data was provid-
ed to calculate ES.
5) No significant differences in pinch strength. Insufficient data was provided to calculate ES.
6) Complications were observed in 14% of the participants in the rigid group compared to 7% in 
the semi-rigid group.
Roberts et al.30 2001 3 weeks: thumb ROM exer-
cises
T0 (preoperative) 
T1 (median 1 year 
and 11 months, 
range 3 months-
11 years, Q1 1 
year, Q3 3 years 4 
months)
1) Pain intensity (VAS 
0-10), measured retro-
spectively
2) Limitations in ADL 
(self designed: 15-item 
daily living checklist), 
measured retrospec-
tively
3) Grip & pinch strength
4) VAS scores decreased with 8 points (p=0.04)
5) Limitations in ADL showed 60% improvement (p=0.4)
6) Significant improvements in grip & pinch strength in group with hemi-resections, except in 
groups with full-trapezium resections
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Table 5. Continued
Studies initiating 
CMC-1 ROM ≤4 weeks
Description of ROM exer-
cises initiated ≤4 weeks
Measures at Measurements &
instruments
Outcomes
Lins et al.40 1996 4 weeks: gentle ROM exer-
cises
T0 (preoperative) 
T1 (42-43 months, 
range 14-88 
months)
1) Pain intensity (self 
designed)
2) Functional status 
/ satisfaction (self 
designed)
3) ROM (web space)
4) Grip & pinch strength
5) Joint imaging (SMD)
1) At T1, 85% patients considered the frequency of pain ‘improved a lot or resolved completely’ 
compared to T0 and 89% considered the duration and severity as ‘improved a lot or completely’ 
at T1, compared to T0.
2) At T1, 89% of the patients were satisfied with the ‘relief of pain’
3) Web space increased with 1.09 cm (p<0.02)
4) Grip strength increased with 5.9 kg (p<0.001) and pinch strength increased with 1.4 kg (p<0.01)
5) SMD decreased with 30% (p>0.05)
Mo et al.27 2004 4 weeks: exercises with em-
phasis on extension/abduc-
tion, on maintaining MCP-1 
joint flexion and avoiding 
hyperextension
T0 (preoperative) 
T1 (20 months, 
range 12-44 
months
1) Limitations in ADL 
(DASH)
2) ROM
3) Grip & pinch strength
4) Joint imaging (SMD)
1) DASH outcomes associated with strength, no results over time reported
2) The distance from thumb tip to the base of the small finger during maximum flexion decreased 
with 0.4 cm (p=0.02)
3) Grip strength improved with 26% at T1 compared to T0 (p=0.01), pinch strength improved 11% 
(p=0.11).
4) SMD improved with 2.5%, no correlation between proximal migration and functional out-
comes.
Poole et al.28 2011 Home program group, 4 
weeks: 1 consult initiating 
ROM exercises
Hand therapy group: ROM 
exercises, one therapy ses-
sion every week
T0 (pre-op) and T1 
(6 months postop-
eratively).
1) Pain intensity (Boston 
Questionnaire)
2) Limitations in ADL 
(JHFT, AHFT)
3) Grip & pinch strength
4) Quality of life (AIMS 2)
1) Improvements in pain intensity in both groups, although no significant within group differences 
due to small sample size. No significant differences between groups, although a larger decrease 
in symptom severity was found in the hand therapy group (ES = 0.53)
2) Higher improvements in limitations in ADL in the hand therapy group for both the JHFT 
(ES = 0.52) as the AHFT (ES = 0.33), although not significant due to sample size.
3) Improvements in grip (+13%) & 3-point pinch strength (+27%) were only found in the hand ther-
apy group, while grip (-8%) & 3-point pinch strength (-6%) decreased in the home program group 
(ES grip strength = 0.77, ES 3-point pinch = 0.95).
4) Significant improvements in several subscales of the Arthritis Impact Measurement Scales 2 
for both groups, no between group differences.
Prosser et al.29 2014 Rigid vs. Semi-rigid immo-
bilization. Both groups at 4 
weeks: abduction exercises
T0 (preoperative)
T1 (6 weeks)
T2 (3 months)
T3 (1 year)
4) Pain intensity and lim-
itations in ADL (PRWHE, 
MHQ)
5) Pinch strength
6) Complications
4) No significant differences in pain intensity and limitations in ADL. Insufficient data was provid-
ed to calculate ES.
5) No significant differences in pinch strength. Insufficient data was provided to calculate ES.
6) Complications were observed in 14% of the participants in the rigid group compared to 7% in 
the semi-rigid group.
Roberts et al.30 2001 3 weeks: thumb ROM exer-
cises
T0 (preoperative) 
T1 (median 1 year 
and 11 months, 
range 3 months-
11 years, Q1 1 
year, Q3 3 years 4 
months)
1) Pain intensity (VAS 
0-10), measured retro-
spectively
2) Limitations in ADL 
(self designed: 15-item 
daily living checklist), 
measured retrospec-
tively
3) Grip & pinch strength
4) VAS scores decreased with 8 points (p=0.04)
5) Limitations in ADL showed 60% improvement (p=0.4)
6) Significant improvements in grip & pinch strength in group with hemi-resections, except in 
groups with full-trapezium resections
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Table 5. Continued
Studies initiating 
CMC-1 ROM ≤4 weeks
Description of ROM exer-
cises initiated ≤4 weeks
Measures at Measurements &
instruments
Outcomes
Rocchi et al.31 2011 4 weeks: exercises to regain 
full ability; i.e. opposition 
exercises which gradually 
progressed from aiming at 
the tip of the fifth finger, then 
towards reaching its base
T0 (preoperative)
T1 (3 months)
T2 (6 months)
T3 (12 months)
6) Pain intensity (VAS 
mentioned, but results 
expressed as no pain 
and restriction, mild pain 
with use and some re-
striction, pain at rest and 
some restriction and 
pain at rest and severe 
restriction)
7) Satisfaction (VAS)
8) Limitations in ADL 
(DASH)
9) Grip & key pinch 
strength.
10) Joint imaging (SMD)
6) At T3, zero patients had any pain at rest, only 1 occasional mild pain. No significance men-
tioned.
7) Satisfaction 9.6, time point unknown.
8) DASH at T0: 43.3, T1: 25.5, T2: 19.1 T3: 14.5, no significance mentioned.
9) Grip strength at T0: 16.0 kg, at T3: 19.2 kg, key pinch at T0: 3.7 kg and at T3: 5.6 kg, no signifi-
cance mentioned.
10) At T3, SMD averaged 6.4 mm
Sirotakova et al.42 2007 2 weeks: opposition exer-
cises
T0 (preoperative), 
T1 (6 months)
T2 (12 months)
1) Pain intensity, stiff-
ness, weakness of the 
hand, functional disabili-
ty (self designed)
2) ROM
3) Grip & pinch strength
4) Joint imaging (SMD)
5) ‘Excellent’ results in terms of pain relief were achieved in 91%
6) Improvements in all ROM measures at T2 (not statistically tested)
7) Grip & pinch strength improved in all measures at T2 (not statistically tested)
8) SMD decreased with 29% at T2
Soejima et al.33 2006 2 weeks: ROM exercises 
were initiated
T0 (preoperative) 
T1 (33 months, 
range 12-71 
months)
5) Pain intensity (self 
designed)
6) ROM
7) Grip & pinch strength
8) Joint imaging (SMD)
5) At T1, 61% had no pain, 24% had mild pain with strenuous activities and 14% had mild pain 
with light work
6) ROM radial and palmar abduction increased with 14° (p=0.09) and 8° (p=0.07) degrees respec-
tively
7) Grip and the pinch strength increased with 2 kg (p=0.18) and from 1.3 kg (p=0.23), respectively
8) SMD decreased with 15% (p<0.05)
Vermeulen et al.20 2014 4 weeks: standardized hand 
therapy focused on regain-
ing functionality by increas-
ing mobility
T0 (preoperative) 
T1 (3 months)
T2 (12 months)
1) Pain intensity and lim-
itations in ADL (PRWHE, 
DASH)
2) ROM
3) Grip & pinch strength
4) Complications
5) Joint imaging (SMD)
6) Pain intensity (PRWHE) decreased significantly for both types of surgery at T2 (Weilby: -17 
points vs. Burton-Pellegrini: -18 points (score range 0-50)). DASH: significant improvements for 
both types of surgery (Weilby: -16 points vs. Burton-Pellegrini: -20 points (score range 0-100)).
7) No differences between different types of surgery, except in CMC-1 extension (decrease in 
Burton-Pellegrini group)
8) Increase in grip strength for both types of surgery (Weilby: +3 kg vs. Burton-Pellegrini: +4 kg). 
Key pinch decreased 0.1 kg for both types of surgery, Tip-pinch increased 0.4 kg for both types 
of surgery and 3-point pinch increased for both types of surgery (Weilby: +0.3 kg vs. Burton-Pel-
legrini: +0.5 kg). Statistical testing for group differences was not reported
9) In total, complications were observed in 27,8% of the participants (Weilby: 23,1% vs. Bur-
ton-Pellegrini: 32,5%, difference not significant)
10) SMD at T2 during rest in Weilby group decreased with 33%, in Burton-Pellegrini group with 
48%, during pinch in Weilby group: 66%, Burton-Pellegrini group: 57%
Yao et al.17 2014 10 days: Active ROM exer-
cises
T0 (preoperative) 
T1 (11 months)
1) Limitations in ADL 
(DASH)
1) DASH at T0: 63, at T1: 10 (single case)
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Table 5. Continued
Studies initiating 
CMC-1 ROM ≤4 weeks
Description of ROM exer-
cises initiated ≤4 weeks
Measures at Measurements &
instruments
Outcomes
Rocchi et al.31 2011 4 weeks: exercises to regain 
full ability; i.e. opposition 
exercises which gradually 
progressed from aiming at 
the tip of the fifth finger, then 
towards reaching its base
T0 (preoperative)
T1 (3 months)
T2 (6 months)
T3 (12 months)
6) Pain intensity (VAS 
mentioned, but results 
expressed as no pain 
and restriction, mild pain 
with use and some re-
striction, pain at rest and 
some restriction and 
pain at rest and severe 
restriction)
7) Satisfaction (VAS)
8) Limitations in ADL 
(DASH)
9) Grip & key pinch 
strength.
10) Joint imaging (SMD)
6) At T3, zero patients had any pain at rest, only 1 occasional mild pain. No significance men-
tioned.
7) Satisfaction 9.6, time point unknown.
8) DASH at T0: 43.3, T1: 25.5, T2: 19.1 T3: 14.5, no significance mentioned.
9) Grip strength at T0: 16.0 kg, at T3: 19.2 kg, key pinch at T0: 3.7 kg and at T3: 5.6 kg, no signifi-
cance mentioned.
10) At T3, SMD averaged 6.4 mm
Sirotakova et al.42 2007 2 weeks: opposition exer-
cises
T0 (preoperative), 
T1 (6 months)
T2 (12 months)
1) Pain intensity, stiff-
ness, weakness of the 
hand, functional disabili-
ty (self designed)
2) ROM
3) Grip & pinch strength
4) Joint imaging (SMD)
5) ‘Excellent’ results in terms of pain relief were achieved in 91%
6) Improvements in all ROM measures at T2 (not statistically tested)
7) Grip & pinch strength improved in all measures at T2 (not statistically tested)
8) SMD decreased with 29% at T2
Soejima et al.33 2006 2 weeks: ROM exercises 
were initiated
T0 (preoperative) 
T1 (33 months, 
range 12-71 
months)
5) Pain intensity (self 
designed)
6) ROM
7) Grip & pinch strength
8) Joint imaging (SMD)
5) At T1, 61% had no pain, 24% had mild pain with strenuous activities and 14% had mild pain 
with light work
6) ROM radial and palmar abduction increased with 14° (p=0.09) and 8° (p=0.07) degrees respec-
tively
7) Grip and the pinch strength increased with 2 kg (p=0.18) and from 1.3 kg (p=0.23), respectively
8) SMD decreased with 15% (p<0.05)
Vermeulen et al.20 2014 4 weeks: standardized hand 
therapy focused on regain-
ing functionality by increas-
ing mobility
T0 (preoperative) 
T1 (3 months)
T2 (12 months)
1) Pain intensity and lim-
itations in ADL (PRWHE, 
DASH)
2) ROM
3) Grip & pinch strength
4) Complications
5) Joint imaging (SMD)
6) Pain intensity (PRWHE) decreased significantly for both types of surgery at T2 (Weilby: -17 
points vs. Burton-Pellegrini: -18 points (score range 0-50)). DASH: significant improvements for 
both types of surgery (Weilby: -16 points vs. Burton-Pellegrini: -20 points (score range 0-100)).
7) No differences between different types of surgery, except in CMC-1 extension (decrease in 
Burton-Pellegrini group)
8) Increase in grip strength for both types of surgery (Weilby: +3 kg vs. Burton-Pellegrini: +4 kg). 
Key pinch decreased 0.1 kg for both types of surgery, Tip-pinch increased 0.4 kg for both types 
of surgery and 3-point pinch increased for both types of surgery (Weilby: +0.3 kg vs. Burton-Pel-
legrini: +0.5 kg). Statistical testing for group differences was not reported
9) In total, complications were observed in 27,8% of the participants (Weilby: 23,1% vs. Bur-
ton-Pellegrini: 32,5%, difference not significant)
10) SMD at T2 during rest in Weilby group decreased with 33%, in Burton-Pellegrini group with 
48%, during pinch in Weilby group: 66%, Burton-Pellegrini group: 57%
Yao et al.17 2014 10 days: Active ROM exer-
cises
T0 (preoperative) 
T1 (11 months)
1) Limitations in ADL 
(DASH)
1) DASH at T0: 63, at T1: 10 (single case)
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Table 5. Continued
Studies initiating 
CMC-1 ROM ≤4 weeks
Description of ROM exer-
cises initiated ≤4 weeks
Measures at Measurements &
instruments
Outcomes
Poole et al.28 2011 Hand therapy group, 4 
weeks: strength exercises
T0 (pre-op) and T1 
(6 months postop-
eratively).
1) Pain intensity (Boston 
Questionnaire)
2) Limitations in ADL, 
(JHFT, AHFT)
3) Grip & pinch strength
4) Quality of life (AIMS 2)
1) Improvements in pain intensity in both groups, although no significant within group differences 
due to small sample size. No significant differences between groups, although a larger decrease 
in symptom severity was found in the hand therapy group (ES = 0.53)
2) Higher improvements in limitations in ADL in the hand therapy group for both the JHFT 
(ES = 0.52) as the AHFT (ES = 0.33), although not significant due to sample size.
3) Improvements in grip (+13%) & 3-point pinch strength (+27%) were only found in the hand ther-
apy group, while grip (-8%) & 3-point pinch strength (-6%) decreased in the home program group 
(ES grip strength = 0.77, ES 3-point pinch = 0.95).
4) Significant improvements in several subscales of the Arthritis Impact Measurement Scales 2 
for both groups, no between group differences.
Soejima et al.33 2006 2 weeks: strength exercises T0 (preoperative) 
T1 (33 months, 
range 12-71 
months)
1) Pain intensity (self 
designed)
2) ROM
3) Grip & pinch strength
4) Joint imaging (SMD)
1) At T1, 61% had no pain, 24% had mild pain with strenuous activities and 14% had mild pain with 
light work
2) ROM radial and palmar abduction increased with 14° (p=0.09) and 8° (p=0.07) degrees respec-
tively
3) Grip and the pinch strength increased with 2 kg (p=0.18) and from 1.3 kg (p=0.23), respectively
4) SMD decreased with 15% (p<0.05)
Vermeulen et al.20 2014 4 weeks: standardized hand 
therapy focused on regain-
ing functionality by increas-
ing strength
T0 (preoperative) 
T1 (3 months)
T2 (12 months)
1) Pain intensity and lim-
itations in ADL (PRWHE, 
DASH)
2) ROM
3) Grip & pinch strength
4) Complications
5) Joint imaging (SMD)
1) Pain intensity (PRWHE) decreased significantly for both types of surgery at T2 (Weilby: -17 
points vs. Burton-Pellegrini: -18 points (score range 0-50)). DASH: significant improvements for 
both types of surgery (Weilby: -16 points vs. Burton-Pellegrini: -20 points (score range 0-100)).
2) No differences between different types of surgery, except in CMC-1 extension (decrease in 
Burton-Pellegrini group)
3) Increase in grip strength for both types of surgery (Weilby: +3 kg vs. Burton-Pellegrini: +4 kg). 
Key pinch decreased 0.1 kg for both types of surgery, Tip-pinch increased 0.4 kg for both types 
of surgery and 3-point pinch increased for both types of surgery (Weilby: +0.3 kg vs. Burton-Pel-
legrini: +0.5 kg). Statistical testing for group differences was not reported
4) In total, complications were observed in 27,8% of the participants (Weilby: 23,1% vs. Bur-
ton-Pellegrini: 32,5%, difference not significant)
5) SMD at T2 during rest in Weilby group decreased with 33%, in Burton-Pellegrini group with 
48%, during pinch in Weilby group: 66%, Burton-Pellegrini group: 57%
J. Yao et al.17 2014 18 days: isometric exercis-
es lateral pinch strength 
exercises
T0 (preoperative) 
T1 (11 months)
1) Limitations in ADL 
(DASH)
1) DASH at T0: 63, at T1: 10 (single case)
Note: VAS = Visual Analogue Scale, ROM = Range of Motion, ES = Effect Size (positive scores indi-
cate better performance of experimental treatment compared to control treatment), MCP-1 = First 
Metacarpophalangeal joint, ADL = Activities of Daily Life, PRWHE = Patient Rated Wrist & Hand 
Evaluation, MHQ = Michigan Hand outcomes Questionnaire, DASH = Disabilities of Arm, Shoulder 
and Hand, AIMS2 = Arthritis Impact Measurement Scales 2, JHFT = Jebsen Hand Function Test, 
AHFT = Arthritis Hand Function Test, IP = Interphalangeal joint, SMD = distance between base of 
first metacarpal and distal end of scaphoid, TMD = distance between base of first metacarpal and 
radial border of trapezoid
Studies init ating strength-
ening exercises ≤4 weeks
Description of strengthening 
exercises initiated ≤4 weeks
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Table 5. Continued
Studies initiating 
CMC-1 ROM ≤4 weeks
Description of ROM exer-
cises initiated ≤4 weeks
Measures at Measurements &
instruments
Outcomes
Poole et al.28 2011 Hand therapy group, 4 
weeks: strength exercises
T0 (pre-op) and T1 
(6 months postop-
eratively).
1) Pain intensity (Boston 
Questionnaire)
2) Limitations in ADL, 
(JHFT, AHFT)
3) Grip & pinch strength
4) Quality of life (AIMS 2)
1) Improvements in pain intensity in both groups, although no significant within group differences 
due to small sample size. No significant differences between groups, although a larger decrease 
in symptom severity was found in the hand therapy group (ES = 0.53)
2) Higher improvements in limitations in ADL in the hand therapy group for both the JHFT 
(ES = 0.52) as the AHFT (ES = 0.33), although not significant due to sample size.
3) Improvements in grip (+13%) & 3-point pinch strength (+27%) were only found in the hand ther-
apy group, while grip (-8%) & 3-point pinch strength (-6%) decreased in the home program group 
(ES grip strength = 0.77, ES 3-point pinch = 0.95).
4) Significant improvements in several subscales of the Arthritis Impact Measurement Scales 2 
for both groups, no between group differences.
Soejima et al.33 2006 2 weeks: strength exercises T0 (preoperative) 
T1 (33 months, 
range 12-71 
months)
1) Pain intensity (self 
designed)
2) ROM
3) Grip & pinch strength
4) Joint imaging (SMD)
1) At T1, 61% had no pain, 24% had mild pain with strenuous activities and 14% had mild pain with 
light work
2) ROM radial and palmar abduction increased with 14° (p=0.09) and 8° (p=0.07) degrees respec-
tively
3) Grip and the pinch strength increased with 2 kg (p=0.18) and from 1.3 kg (p=0.23), respectively
4) SMD decreased with 15% (p<0.05)
Vermeulen et al.20 2014 4 weeks: standardized hand 
therapy focused on regain-
ing functionality by increas-
ing strength
T0 (preoperative) 
T1 (3 months)
T2 (12 months)
1) Pain intensity and lim-
itations in ADL (PRWHE, 
DASH)
2) ROM
3) Grip & pinch strength
4) Complications
5) Joint imaging (SMD)
1) Pain intensity (PRWHE) decreased significantly for both types of surgery at T2 (Weilby: -17 
points vs. Burton-Pellegrini: -18 points (score range 0-50)). DASH: significant improvements for 
both types of surgery (Weilby: -16 points vs. Burton-Pellegrini: -20 points (score range 0-100)).
2) No differences between different types of surgery, except in CMC-1 extension (decrease in 
Burton-Pellegrini group)
3) Increase in grip strength for both types of surgery (Weilby: +3 kg vs. Burton-Pellegrini: +4 kg). 
Key pinch decreased 0.1 kg for both types of surgery, Tip-pinch increased 0.4 kg for both types 
of surgery and 3-point pinch increased for both types of surgery (Weilby: +0.3 kg vs. Burton-Pel-
legrini: +0.5 kg). Statistical testing for group differences was not reported
4) In total, complications were observed in 27,8% of the participants (Weilby: 23,1% vs. Bur-
ton-Pellegrini: 32,5%, difference not significant)
5) SMD at T2 during rest in Weilby group decreased with 33%, in Burton-Pellegrini group with 
48%, during pinch in Weilby group: 66%, Burton-Pellegrini group: 57%
J. Yao et al.17 2014 18 days: isometric exercis-
es lateral pinch strength 
exercises
T0 (preoperative) 
T1 (11 months)
1) Limitations in ADL 
(DASH)
1) DASH at T0: 63, at T1: 10 (single case)
Note: VAS = Visual Analogue Scale, ROM = Range of Motion, ES = Effect Size (positive scores indi-
cate better performance of experimental treatment compared to control treatment), MCP-1 = First 
Metacarpophalangeal joint, ADL = Activities of Daily Life, PRWHE = Patient Rated Wrist & Hand 
Evaluation, MHQ = Michigan Hand outcomes Questionnaire, DASH = Disabilities of Arm, Shoulder 
and Hand, AIMS2 = Arthritis Impact Measurement Scales 2, JHFT = Jebsen Hand Function Test, 
AHFT = Arthritis Hand Function Test, IP = Interphalangeal joint, SMD = distance between base of 
first metacarpal and distal end of scaphoid, TMD = distance between base of first metacarpal and 
radial border of trapezoid
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Table 6 provides a summary of the phases and the physical therapy content per 
phase as used in the included studies and Table 7 provides an overview of the 
phases per study. In general in postoperative exercises/therapy, emphasis is 
placed on MCP-1 flexion and CMC palmar abduction and extension, while CMC 
flexion, adduction and opposition is avoided.
Table 5 provides the outcomes for studies initiating ROM or strengthening exer-
cises respectively ≤4 weeks postoperatively. Thirteen studies17,20,24,25,27-31,33,38,40,42 
initiated ROM exercises and four studies17,20,28,33 initiated strengthening exercises 
≤4 weeks. No comparative studies on different regimens of ROM or strength-
ening exercises were found. We did not find more complications or worse 
outcomes in studies that initiated ROM or strengthening exercises ≤4 weeks 
compared to studies that initiated ROM or strengthening exercises ≥4 weeks.
Table 6. Summary of the phases and content of postoperative rehabilitation following thumb base 
arthroplasty as used in the literature. Note: The displayed time frames indicate the range from start 
to end (minimum – maximum period) of the used period in the literature. Abbreviation: IP-1, thumb 
interphalangeal joint.
Phase Weeks postoperative Physical therapy content
1. Acute Range: 0 – 6wk Composite finger flexion/extension, thumb IP-1 flexion/
extension, wrist/elbow/shoulder movement is empha-
sized and no CMC-1 or MCP-1 movement is encouraged
2. Unloaded Range: 1 – 12wk ROM-exercises for MCP-1 and CMC-1 are initiated. In 
general, emphasis is placed on MCP-1 flexion and CMC 
palmar abduction and extension, while CMC flexion, 
adduction and opposition are avoided. The exercises 
are supplemented with scar management and edema 
control
3. Functional Range: 3wk to 6mo Progressive ROM of the CMC-1 and MCP-1 is allowed, 
and strength exercises are initiated.
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DISCUSSION
The aim of this systematic review was to describe the different components of 
postoperative rehabilitation protocols for patients who underwent CMC-1 arthro-
plasty and several components of rehabilitation protocols were specifically inves-
tigated. Twenty-seven studies were included with a total of 1015 participants 
in whom 1118 procedures were performed. This systematic review presents a 
summary of the used postoperative rehabilitation for different surgical interven-
tions (Figure 2). We found positive outcomes of partial instead of complete immo-
bilization until 6 weeks, a total immobilization period 4-6 or ≤4 weeks and the 
initiation of ROM or strengthening exercises ≤4 weeks, but too few comparative 
studies are available in order to draw firm conclusions on relative effectiveness. 
Additionally, we identified three phases on postoperative exercises/therapy as 
used in the included studies: the ‘acute phase’, the ‘unloaded phase’ and the 
‘functional phase’ (Table 6-7).
In general in this review, postoperative exercises/therapy emphasizes on posi-
tioning the CMC-1 in extension and abduction, while flexion and adduction is 
avoided during rehabilitation.44,45 Furthermore, MCP-1 hyperextension should be 
avoided while MCP-1 flexion is encouraged to prevent the development of a z-de-
formity.44 Despite the fact that no conclusions regarding effectiveness can be 
drawn, the presented summary for different surgical interventions and the identi-
fication of the aforementioned phases may provide guidance in clinical decision 
making for hand therapists and surgeons in the postoperative rehabilitation for 
patients who underwent CMC-1 arthroplasty. However, there is considerable 
variation in time frames of the individual phases, possibly since the phases are 
carried out more quickly over the years in literature (Table 7). Hence, further 
exploration of these phases is needed in future research. Furthermore, these 
phases should be identified for different surgical procedures specifically.
Wolfe et al. concluded that there was too much variation in the literature in order 
to formulate recommendations on postoperative immobilization and exercises.9 
In the present systematic review, we also conclude that there are insufficient 
comparative studies to draw conclusions regarding the effectiveness of post-
operative rehabilitation. However, we do present a more extensive overview of 
the postoperative rehabilitation as used in the literature compared to the results 
by Wolfe et al.9 All the nineteen studies included by Wolfe et al.9 were identified 
in the literature search of the present study, but only four were included in the 
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present review. For example, Wolfe et al. also included several types of joint pros-
theses while we excluded joint prostheses. The inclusion of other studies than 
included by Wolfe et al. may have resulted in a different representation of postop-
erative rehabilitation for patients who underwent CMC-1 arthroplasty.
Two comparative studies25,29 on postoperative immobilization were included 
in this review (Table 4). Similar or better outcomes were found when partial 
instead of complete immobilization was used in the first six weeks postopera-
tively. Horlock et al., where partial instead of complete immobilization was used 
following simple trapeziectomy, found an effect size of -0.66 on pain intensity, 
indicating worse outcomes in the early mobilization group. However, the 
difference was not statistically significant and mostly due to a mean difference 
at baseline between both groups. Furthermore, Visual Analogue Scale score for 
pain intensity at follow-up were comparable with previously reported outcomes 
following simple trapeziectomy.8 Therefore, the effect size of -0.66 on pain 
intensity should be interpreted with caution.
On MCP-1 flexion and experienced convenience by the participants, the early 
mobilization group performed significantly better than the late mobilization group 
with effect sizes 0.19 and 0.66 respectively, indicating small to large treatment 
effects16. Hence, these studies suggest that partial instead of complete immobi-
lization demonstrates good outcomes but more randomized controlled trials on 
postoperative immobilization are needed to confirm this.
The study by Poole et al.28 was the sole study that compared rehabilitation 
including a home program only with a more extensive rehabilitation program 
including hand therapy following CMC-1 arthroplasty. No significant between-
group differences were found postoperatively, probably due to a small sample 
size (n=9) although more within-group improvements were found on pain 
intensity, limitations in ADL and grip & pinch strength in the group that received 
hand therapy with effect sizes between 0.33 and 0.95, indicating small to large 
treatment effects16. For example, improvements were found in postoperative 
grip strength (+13%) & pinch strength (+27%) in the hand therapy group, while 
a decrease in grip strength (-8%) and pinch strength (-6%) was found in the 
group that did not receive hand therapy. These findings suggest that additional 
hand therapy is beneficial in reducing pain intensity and limitations in ADL and 
improving grip & pinch strength after CMC-1 arthroplasty, but randomized 
controlled trials with larger sample sizes are needed.
7
196
Chapter 7
Several studies investigated the concept of ‘early active recovery’, which 
includes short immobilization and allows patients to exercise in an early post-
operative phase.25,28,29 A trend is identifiable indicating that early active recovery 
(including short immobilization, early initiation of ROM and strength exercises) 
provides positive outcomes on pain, limitations in ADL and grip & pinch strength, 
but no conclusions on effectiveness can be drawn since comparative studies are 
lacking. Additionally, Table 7 indicates a trend that, over the years, early active 
rehabilitation is applied more often in literature. This accelerated type of rehabil-
itation does not lead to worse outcomes or more complications. Faster recovery 
may result in faster return to work, which could be beneficial for patients with 
CMC-1 OA considering the fact that ageing populations need to participate 
longer in working life. Hence, future high-quality studies are needed in order to 
determine the effectiveness of early active recovery.
Historically, determining of postoperative scaphometacarpal distance (SMD) 
by joint imaging has been a particular outcome of interest in many studies on 
CMC-1 arthroplasty, since the hypothesis is that maintenance of SMD after 
surgery results in better function and less pain.8 The sole comparative study on 
evaluating SMD was by Horlock et al.25, in which no difference in SMD was found 
between the early and late mobilization group. Additionally, Wajon et al.8 reported 
that there is no clinically relevant correlation between SMD and pinch strength 
and all of the studies included in the present review did not find a correlation 
between SMD and clinical outcomes. Therefore, the influence of different types 
of postoperative rehabilitation on SMD and the predictive value of SMD on 
clinical outcomes remains unclear and should be addressed in future research.
Study limitations
A weakness of this systematic review is the large amount of low-quality studies 
included (Supplementary Table 2, Appendix 2). Despite that findings of the individual 
studies are in line with each other, no conclusions on effectiveness of postoperative 
rehabilitation following CMC-1 arthroplasty can be drawn since comparative studies 
are lacking and large heterogeneity in outcome measures and measurement instru-
ments is present. Therefore, we recommend, predominantly in line with Vermeulen 
et al.7 and Wajon et al.8 that future studies report homogenous outcome measures, 
preferably measured with validated measurement instruments. Additionally, 
confounding may be present regarding the fulfillment of the different components 
of rehabilitation. The outcomes of studies without group comparisons are based on 
an interaction between type of surgery, immobilization type, immobilization period 
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and postoperative exercises/therapy. Hence, no conclusions can be drawn on the 
specific effects of one of the aforementioned components of treatment. Therefore, 
future research should explore different postoperative regimes within the same 
surgical procedure, which allows researchers to study the effectiveness of specific 
rehabilitation protocols for individual surgical techniques.
Another limitation is that many studies regarding CMC-1 arthroplasty provide very 
little or no information on postoperative rehabilitation.6,8 This may have resulted 
in a biased reflection of the actual postoperative regime for CMC-1 arthroplasty. 
Therefore, it is strictly recommended that future studies on CMC-1 arthroplasty 
provide an adequate description of the postoperative regime, including an adequate 
description of postoperative immobilization and postoperative exercises/therapy.
CONCLUSIONS
In conclusion, this review presents an overview of postoperative rehabilitation for 
different surgical interventions on CMC-1 OA. Furthermore, three postoperative 
phases were identified with regard to postoperative exercises/therapy: the ‘acute 
phase’, the ‘unloaded phase’ and the ‘functional phase’. In addition, we found that 
early active recovery (including short immobilization, early initiation of ROM and 
strength exercises) provides positive outcomes for patients who underwent CMC-1 
arthroplasty and is used more often in literature, but more high-quality studies 
comparing different postoperative rehabilitation protocols are needed to get more 
insight in the effectiveness of postoperative rehabilitation. Additionally, it is strongly 
recommended that future studies regarding CMC-1 arthroplasty provide adequate 
descriptions of their postoperative regime.
7
198
Chapter 7
REFERENCES
1. Bijlsma JWJ, Berenbaum F, Lafeber FPJG. Osteoarthritis: An update with relevance 
for clinical practice. The Lancet. 2011;377(9783):2115-2126.
2. Dahaghin S, Bierma-Zeinstra SMA, Ginai AZ, Pols HAP, Hazes JMW, Koes BW. Prev-
alence and pattern of radiographic hand osteoarthritis and association with pain 
and disability (the Rotterdam study). Ann Rheum Dis. 2005;64(5):682-687.
3. Haugen IK, Englund M, Aliabadi P, Niu J, Clancy M, Kvien TK, Felson DT. Prevalence, 
incidence and progression of hand osteoarthritis in the general population: the 
Framingham Osteoarthritis Study. Ann Rheum Dis. 2011;70(9):1581-1586.
4. www.cbs.nl. Centraal Bureau voor Statistiek. Published 2013. Accessed 2019.
5. Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliabadi P, Felson DT. Prevalence of 
symptomatic hand osteoarthritis and its impact on functional status among the 
elderly: The framingham study. Am J Epidemiol. 2002;156(11):1021-1027.
6. NVPC, NVvH. Dutch Plastic (NVPC) and Hand (NVvH) Surgery Societies: Guideline 
for conservative and surgical treatment for primary osteoarthritis of the thumb base 
joint (Richtlijn Conservatieve en Chirurgische Behandeling van Primaire Artrose 
van de Duimbasis). Amsterdam, N-Holland, The Netherlands: NVvH; 2014.
7. Vermeulen G, Slijper H, Feitz R, Hovius SER, Moojen T, Selles R. Surgical 
management of primary thumb carpometacarpal osteoarthritis: a systematic 
review. The Journal of hand surgery. 2011;36(1):157-169.
8. Wajon A, Vinycomb T, Carr E, Edmunds I, Ada L. Surgery for thumb (trapeziometa-
carpal joint) osteoarthritis. The Cochrane database of systematic reviews. 
2015;2:Cd004631.
9. Wolfe T, Chu JY, Woods T, Lubahn JD. A systematic review of postoperative hand 
therapy management of basal joint arthritis. Clinical orthopaedics and related 
research. 2014;472(4):1190-1197.
10. Ireton JE, Unger JG, Rohrich RJ. The role of wound healing and its everyday appli-
cation in plastic surgery: a practical perspective and systematic review. Plastic and 
reconstructive surgery Global open. 2013;1(1).
11. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for 
systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 
2009;62(10):1006-1012.
12. Thomas H. Quality assessment tool for quantitative studies. Effective public health 
practice project. Toronto: McMaster University. 2003.
13. Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of 
the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 
2003;83(8):713-721.
14. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the 
assessment of majority agreement among multiple observers. Biometrics. 
1977;33(2):363-374.
15. Morris SB. Estimating Effect Sizes From Pretest-Posttest-Control Group Designs. 
Organizational Research Methods. 2008;11(2):364-386.
199
Postoperative Rehabilitation: a Systematic Review
16. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, N.J.: L. 
Erlbaum Associates; 1988.
17. Yao J, Lashgari D. Thumb basal joint: Utilizing new technology for the treatment of a 
common problem. Journal of hand therapy : official journal of the American Society 
of Hand Therapists. 2014;27(2):127-132; quiz 133.
18. Wong TC, Ip FK. A modified technique of interpositional arthroplasty in treating 
the Basal joint arthritis of the thumb in a Chinese population. Hand surgery : an 
international journal devoted to hand and upper limb surgery and related research 
: journal of the Asia-Pacific Federation of Societies for Surgery of the Hand. 
2009;14(2-3):83-87.
19. Vermeulen GM, Brink SM, Sluiter J, Elias SG, Hovius SE, Moojen TM. Ligament 
reconstruction arthroplasty for primary thumb carpometacarpal osteoarthritis 
(weilby technique): prospective cohort study. J Hand Surg Am. 2009;34(8):1393-1401.
20. Vermeulen GM, Spekreijse KR, Slijper H, Feitz R, Hovius SER, Selles RW. 
Comparison of arthroplasties with or without bone tunnel creation for thumb basal 
joint arthritis: A randomized controlled trial. J Hand Surg Am. 2014;39(9):1692-1698.
21. Kriegs-Au G, Petje G, Fojtl E, Ganger R, Zachs I. Ligament reconstruction with or 
without tendon interposition to treat primary thumb carpometacarpal osteoarthritis. 
A prospective randomized study. J Bone Joint Surg Am. 2004;86-a(2):209-218.
22. Başar H, Başar B, Erol B, Tetik C. Ligament reconstruction and tendon interposition 
arthroplasty of the trapeziometacarpal joint with the use of the full thickness of the 
flexor carpi radialis tendon. Chirurgie de la Main. 2012;31(6):331-336.
23. Abbas K, Hashmi P, Raza H. Short term results of ligament reconstruction and 
tendon interposition resection arthroplasty for basal joint arthritis. J Pak Med Assoc. 
2012;62(4):398-401.
24. Burton RI, Pellegrini VD, Jr. Surgical management of basal joint arthritis of the 
thumb. Part II. Ligament reconstruction with tendon interposition arthroplasty. J 
Hand Surg Am. 1986;11(3):324-332.
25. Horlock N, Belcher HJ. Early versus late mobilisation after simple excision of the 
trapezium. J Bone Joint Surg Br. 2002;84(8):1111-1115.
26. Lee HJ, Kim PT, Deslivia MF, Jeon IH, Lee SJ, Nam SJ. Results of abductor pollicis 
longus suspension ligamentoplasty for treatment of advanced first carpometa-
carpal arthritis. CiOS Clinics in Orthopedic Surgery. 2015;7(3):372-376.
27. Mo JH, Gelberman RH. Ligament reconstruction with trapezium retention arthro-
plasty for carpometacarpal arthritis. J Hand Surg Am. 2004;29(2):240-246.
28. Poole JL, Walenta MH, Alonzo V, Coe A, Moneim M. A Pilot Study Comparing of 
Two Therapy Regimens Following Carpometacarpal Joint Arthroplasty. Physical & 
Occupational Therapy in Geriatrics. 2011;29(4):327-336.
29. Prosser R, Hancock MJ, Nicholson L, Merry C, Thorley F, Wheen D. Rigid versus 
semi-rigid orthotic use following TMC arthroplasty: a randomized controlled trial. 
Journal of hand therapy : official journal of the American Society of Hand Thera-
pists. 2014;27(4):265-270; quiz 271.
30. Roberts RA, Jabaley ME, Nick TG. Results following trapeziometacarpal arthro-
plasty of the thumb. J Hand Ther. 2001;14(3):202-207.
7
200
Chapter 7
31. Rocchi L, Merolli A, Cotroneo C, Morini A, Brunelli F, Catalano F. Abductor pollicis 
longus hemitendon looping around the first intermetacarpal ligament as interpo-
sition following trapeziectomy: a one-year follow-up study. Orthop Traumatol Surg 
Res. 2011;97(7):726-733.
32. Saehle T, Sande S, Finsen V. Abductor pollicis longus tendon interposition for 
arthrosis in the first carpometacarpal joint: 55 thumbs reviewed after 3 (1-5) years. 
Acta Orthop Scand. 2002;73(6):674-677.
33. Soejima O, Hanamura T, Kikuta T, Iida H, Naito M. Suspensionplasty with the 
abductor pollicis longus tendon for osteoarthritis in the carpometacarpal joint of 
the thumb. J Hand Surg Am. 2006;31(3):425-428.
34. Werthel JD, Dubert T. Use of the entire flexor carpi radialis tendon for basal thumb 
ligament reconstruction interposition arthroplasty. Hand Surgery and Rehabili-
tation. 2016;35(2):107-113.
35. Yang Y, Tien HY, Kumar KK, Chen SL, Li ZZ, Tian W, Tian GL. Ligament recon-
struction with tendon interposition arthroplasty for first carpometacarpal joint 
osteoarthritis. Chinese Medical Journal. 2014;127(22):3921-3925.
36. Ataker Y, Gudemez E, Ece SC, Canbulat N, Gulgonen A. Rehabilitation protocol after 
suspension arthroplasty of thumb carpometacarpal joint osteoarthritis. Journal 
of hand therapy : official journal of the American Society of Hand Therapists. 
2012;25(4):374-382; quiz 383.
37. Davis TRC, Brady O, Dias JJ. Excision of the trapezium for osteoarthritis of the 
trapeziometacarpal joint: A study of the benefit of ligament reconstruction or 
tendon interposition. Journal of Hand Surgery. 2004;29(6):1069-1077.
38. Eaton RG, Glickel SZ, Littler JW. Tendon interposition arthroplasty for degen-
erative arthritis of the trapeziometacarpal joint of the thumb. J Hand Surg Am. 
1985;10(5):645-654.
39. Kuhns CA, Emerson ET, Meals RA. Hematoma and distraction arthroplasty for 
thumb basal joint osteoarthritis: a prospective, single-surgeon study including 
outcomes measures. J Hand Surg Am. 2003;28(3):381-389.
40. Lins RE, Gelberman RH, McKeown L, Katz JN, Kadiyala RK. Basal joint arthritis: 
trapeziectomy with ligament reconstruction and tendon interposition arthroplasty. J 
Hand Surg Am. 1996;21(2):202-209.
41. Nylen S, Johnson A, Rosenquist AM. Trapeziectomy and ligament reconstruction 
for osteoarthrosis of the base of the thumb. A prospective study of 100 operations. J 
Hand Surg Br. 1993;18(5):616-619.
42. Sirotakova M, Figus A, Elliot D. A new abductor pollicis longus suspension arthro-
plasty. J Hand Surg Am. 2007;32(1):12-22.
43. Varitimidis SE, Fox RJ, King JA, Taras J, Sotereanos DG. Trapeziometacarpal 
arthroplasty using the entire flexor carpi radialis tendon. Clin Orthop Relat Res. 
2000(370):164-170.
44. Neumann DBT. The carpometacarpal joint of the thumb: stability, deformity, and 
therapeutic intervention. The Journal of orthopaedic and sports physical therapy. 
2003;33(7):386-399.
201
Postoperative Rehabilitation: a Systematic Review
45. Valdes K, Von Der Heyde R. An exercise program for carpometacarpal osteoar-
thritis based on biomechanical principles. J Hand Ther. 2012;25(3):251-262.
7
CHAPTER 8
SHORTER VERSUS LONGER 
IMMOBILIZATION AFTER SURGERY 
FOR THUMB CARPOMETACARPAL 
OSTEOARTHRITIS: A PROPENSITY 
SCORE MATCHED STUDY
Jonathan Tsehaie* and Robbert M. Wouters*
Reinier Feitz
Steven E.R. Hovius
Harm P. Slijper
Ruud W. Selles
for the Hand-Wrist Study Group
2019; Archives of Physical Medicine and Rehabilitation
*Both authors contributed equally to this article
204
Chapter 8
ABSTRACT
Objective: To investigate if shorter immobilization is non-inferior to longer immo-
bilization after Weilby procedure for thumb carpometacarpal osteoarthritis
Design: Prospective cohort study with propensity score matching (PSM)
Setting: Data collection took place in sixteen outpatient clinics for hand surgery 
and hand therapy
Intervention: Shorter immobilization (3-5 days plaster cast followed by a thumb 
spica orthosis including wrist until 4 weeks postoperatively) was compared with 
longer immobilization (10-14 days plaster cast followed by a thumb spica orthosis 
including wrist until 6 weeks postoperatively) after Weilby procedure for CMC-1 
osteoarthritis. PSM was used to control for confounders.
Main outcome measures: Outcomes were pain measured with a Visual 
Analogue Scale (VAS) and hand function measured with the Michigan Hand 
outcomes Questionnaire (MHQ) at three and twelve months. Secondary 
outcomes were complications, range of motion, grip and pinch strength, satis-
faction with treatment and return to work.
Results: We matched 131 participants with shorter immobilization and 131 
participants with longer immobilization. No significant differences were found 
in VAS pain (effect size 0.03, 95% C.I. -0.21-0.27) or the MHQ (effect size 0.01, 
95% C.I. -0.23-0.25) between the groups at three months or at twelve months. 
Furthermore, no differences were found in complication rate or in other 
secondary outcomes.
Conclusions: In conclusion, shorter immobilization of 3-5 days of a plaster cast 
after Weilby procedure is equal compared to longer immobilization for outcomes 
on pain, hand function and our secondary outcomes. These results indicate 
that shorter immobilization is safe and can be recommended, since discomfort 
of longer immobilization may be prevented and patients may be able to recover 
sooner which may lead to reduced loss of productivity. Future studies need to 
investigate effectiveness of early active and more progressive hand therapy 
following CMC-1 arthroplasty.
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INTRODUCTION
Osteoarthritis (OA) of the thumb base joint (CMC-1) is a common disorder in the 
elderly, with a radiologically diagnosed prevalence of 33-40% amongst females 
aged ≥50 years.1-3 CMC-1 osteoarthritis can occur in both thumbs, and patients 
often experience pain, reduced pinch- or grip strength and limitations in activities 
of daily life (ADL).1,4 There is an overall weakened hand strength due to muscular 
atrophy, incorrect thumb position, and by avoiding painful movements or activ-
ities.4 Limitations in activity of daily living usually comprises of pinch movements 
with the thumb, such as turning a key, opening a jar or gripping a pen.1,4 When 
non-operative treatment modalities (i.e. orthosis, hand therapy, steroid injections, 
analgesics or patient education) fail to provide sufficient pain relieve or functional 
improvement, CMC-1 arthroplasty may be indicated.5
Several studies emphasize the importance of postoperative rehabilitation for 
patients who underwent CMC-1 arthroplasty to reduce postoperative pain and 
improve function, limitations in ADL, satisfaction, range of motion (ROM) and 
grip & pinch strength.6-8 Recently, we published a systematic review on postop-
erative rehabilitation following CMC-1 arthroplasty, which indicated, based on 
very limited evidence, that early active rehabilitation (including shorter immo-
bilization and early initiation of exercises/hand therapy) is increasingly used in 
literature without worse outcomes or more complications.7 Theoretically, early 
active recovery would be beneficial by preventing longer patient discomfort and 
reducing postoperative complications due to longer immobilization. In addition, a 
shorter immobilization period allows the patient to return to daily activities more 
quickly during rehabilitation.
Various time frames on postoperative immobilization after CMC-1 arthroplasty 
have been reported in literature, with cast immobilization varying from zero to 
five weeks, while the total immobilization period even varies between two to 
twelve weeks postoperatively.7 However, no evidence is available whether a long 
period of immobilization is necessary and if shorter immobilization will lead to 
similar results. Therefore, more insight in the effectiveness of shorter immobili-
zation following CMC-1 arthroplasty is needed to ensure that it is safe, does not 
lead to more complications and has at least similar outcome in terms of pain and 
hand function.
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The aim of this prospective cohort study is to investigate if shorter immobili-
zation is non-inferior to longer immobilization after CMC-1 arthroplasty (Weilby 
procedure) in terms of hand function and pain intensity postoperatively. Shorter 
immobilization comprises a 3-5 days plaster cast followed by a thermoplastic 
thumb spica orthosis immobilization until 4 weeks, while longer immobilization 
comprises 10-14 days plaster cast followed by a thermoplastic thumb spica 
orthosis immobilization until 6 weeks.
METHODS
Study design
This is a prospective cohort study with propensity score matching (PSM), 
reported following the Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) statement.9 We compared short versus longer immobi-
lization by comparing patients that were treated in two different time periods, in 
which different postoperative regimes were used and matched the participants 
using propensity score matching.
This study was performed in sixteen outpatient clinics of a specialized treatment 
center for hand surgery and hand therapy in The Netherlands and data collection 
was part of usual care. The Medical Research Ethical Committee of the Erasmus 
MC Rotterdam approved this study and written informed consent was obtained 
from all participants. Certified hand surgeons diagnosed patients with CMC-1 OA 
by physical examination and radiographic evaluation to determine Eaton stage.10 
Following the treatment protocol, all the participants received three months of 
non-operative treatment first, regardless of the disease severity or duration of 
symptoms.5 The decision to proceed to surgery was made when patients had 
insufficient pain relieve or insufficient functional improvement.
Participants
Participants were eligible for inclusion when they were: 1) adult and diagnosed 
with stage I-IV10 CMC-1 OA by a certified hand surgeon and 2) underwent a Weil-
by-sling procedure. Exclusion criteria included: 1) secondary CMC-1 OA (i.e. due 
Bennett’s fracture); 2) occurrence of a co-intervention (i.e. carpal tunnel release); 
3) patient history of surgery interfering with treatment or outcome (i.e. due to 
Bennett’s fracture); or 4) steroid injections given within 6 weeks in hand or wrist 
prior to surgery due to 1) it was not part of the treatment protocol and 2) to keep 
the studied population as homogenous as possible.
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Surgical treatment
The surgical treatment consisted of a Weilby procedure: after a Wagner incision 
over the radial side of the CMC-1 joint and preservation of the radial superficial 
nerve, the trapezium was fully removed. Subsequently, either a Flexor Carpi 
Radialis (FCR) or Abductor Pollicis Longus (APL) tendon graft was intertwined 
in a figure-of-eight-reconstruction between the remaining half of the its own 
insertion and the APL/FCR insertion. The remaining tendon split was stored in 
the trapezial cavity.11,12
Postoperative treatment
Due to the observational design of this study, the postoperative treatment was not 
completely standardized such as in most randomized controlled trials. However, 
the hand therapists of all treatment locations carried out the same, protocolized 
postoperative regime following strict guidelines developed by Handtherapie 
Nederland, which is based on the Dutch national guideline and recent liter-
ature.7,13 Naturally, all hand therapists were informed when the new postoperative 
regime was introduced and compliance was randomly checked internally by 
auditing patient charts. To further ensure that all therapists had adjusted to the 
new protocol and did not (partly) used the previous protocol, we created a half 
year inclusion gap for this study. More specifically, all patients treated between 
January 2012 and April 2015 were included in the longer immobilization group 
and all patients treated between October 2015 and April 2017 were included in 
the shorter immobilization group.
The patients in the longer immobilization group were primarily immobilized in a 
plaster cast for 10-14 days. After this period, the hand therapist removed the cast 
and a thermoplastic thumb spica orthosis including wrist immobilization (Figure 
1) was applied until 6 weeks postoperatively. Patients were instructed to wear 
the thermoplastic thumb spica orthosis 24 hours/day, except during exercises. 
Afterwards, a butterfly orthosis (Figure 1) was applied 24 hours/day until 8 weeks 
(except during exercises), which was phased out until 3 months postoperatively.
The patients in the shorter immobilization group were primarily immobilized in 
a plaster cast for 3-5 days. The hand therapist removed the cast and a thermo-
plastic thumb spica orthosis including wrist immobilization was applied until 4 
weeks postoperatively. Patients were instructed to wear the thermoplastic thumb 
spica orthosis 24 hours/day, except during exercises. Afterwards, a butterfly 
orthosis was applied until 8 weeks 24 hours/day, except during exercises, which 
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was phased out until 10 weeks postoperatively. Figure 1 provides a graphic 
overview of the immobilization periods for both groups.
The rationale for selecting these orthotic devices was to provide enough 
protection and stability for these specific postoperative phases, while allowing 
range of motion exercises when safe and preventing excessive joint stiffness. All 
orthotic devices were fabricated by experienced and trained hand therapists to 
assure consistency and quality of application.
In both groups, the hand therapy exercises directly postoperatively (acute phase) 
included tendon-gliding exercises of the fingers and the thumb interphalangeal 
joint. After 10-14 days, sutures were removed. Hand therapy and home exercises 
in the unloaded phase (2-6 weeks) focused on active wrist flexion/extension, 
CMC-1 palmar and radial abduction and metacarpophalangeal (MCP-1) flexion 
(with support to the first metacarpal), along with scar management. In this 
phase, no flexion/adduction and thumb opposition were allowed. The functional 
phase included the initiation of static pinch exercises by 6 weeks, after which 
increased grip & pinch exercises were performed, usually until three months 
postoperatively.
Variables
Primary outcomes
The primary outcomes in this study were hand function, measured with the 
Michigan Hand outcomes Questionnaire (MHQ) and pain, measured with a 
Visual Analogue Scale (VAS) at baseline, six weeks, three months and twelve 
months. The rationale behind measuring pain and function is that the decision to 
proceed to surgery is usually based on persistent pain and limited hand function, 
and outcomes on these domains are highly relevant for this particular group of 
patients.
The MHQ (range: 0–100, higher scores indicate better performance except for 
the subscale pain) is a validated questionnaire with a high internal consistency, 
high internal validity, acceptable reliability and is particularly applicable for 
patients with hand OA. The minimal clinical important difference (MCID) for the 
MHQ is 8-13 (3-23 for the subscales).14-16 The MHQ subscales were secondary 
outcomes.
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For pain, we measured VAS pain at rest (range: 0-100, higher scores indicate 
more pain) and VAS pain during physical load. The VAS is a reliable and valid 
instrument to measure pain intensity in patients with rheumatic diseases and 
has a minimal detectable change (MDC) of eleven points.17 For this article, we 
decided to report VAS pain and MHQ at three months as primary outcome, since 
we assumed that three months after surgery is the first relevant moment to expe-
rience improvement in pain and function due to the surgery and the different 
immobilization periods.5,6 However, outcome in VAS pain at six weeks and twelve 
months are also reported, as well as outcome in MHQ at twelve months, to study 
both early recovery as well as long-term recovery.
Secondary outcomes
Secondary outcomes were complications, ROM, grip & pinch strength, return 
to work and an additional satisfaction with treatment questionnaire. Complica-
tions of surgery were scored by authors JT & RW by reviewing patient charts. 
The following events were scored as a complication: tendovaginitis stenosans 
of the thumb, Quervain tenosynovitis, FCR tendinitis, FCR rupture, carpal tunnel 
syndrome, complex regional pain syndrome (CRPS), presence of neuroma, 
infection, clinically and radiologically diagnosed metacarpal abutment with the 
scaphoid, radial superficial nerve injury or revision surgery.
ROM measurements were performed at baseline and three months using the 
recommendations of the American Society of Hand Therapists.18 Grip & key 
pinch strength was measured at baseline and three months using the Biometric 
E-Link© following Mathiowetz et al.19-21 Return to work and patient satisfaction 
was assessed at three months using self-designed questionnaires on the 
patient’s ability to work and the experienced treatment effect respectively.
Study size
In non-inferiority studies, a priori power analysis is different from the more 
commonly used superiority studies. It has been described that defining the 
non-inferiority margin should be based on clinical judgment and statistical 
reasoning.22 We used a conventional small to medium effect size of .35, defined 
by Cohen et al.23 as a non-inferiority margin, resulting in a total sample of 204 
participants for a power of .80 (α=0.05).
Due to the nature of propensity score matching, a number of participants will not 
be matched to other participants and will therefore be excluded from the analysis. 
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In a study by Zhou et al. on Dupuytren’s disease24, propensity score matching 
was also used and 60% of the total sample was included in the final analysis. To 
account for this, we decided to enlarge the total sample to >400 participants.
Statistical methods
Usually, comparing groups in observational studies is difficult due to the presence 
of covariates.25 propensity score matching involves the use of a propensity score, 
which is the probability for an individual to be assigned to a particular treatment 
given a vector of observed covariates.26,27 propensity score matching allows 
researchers to compare matched individuals without introducing bias, the only 
difference being whether the individual is treated with the intervention of interest 
or not, assuming that all relevant covariates are included in the model estimating 
the propensity score. 25,27
The propensity scores were estimated using logistic regression, in which 
treatment status is regressed on baseline characteristics. 26-28 The following 
baseline characteristics were used as covariates for estimating the propensity 
score: age, gender, type of work, duration of symptoms, dominant side treated, 
the MHQ subscales, VAS pain at rest, VAS pain during physical load, grip strength, 
key pinch strength, CMC-1 palmar abduction angle, CMC-1 radial abduction 
angle, MCP-1 flexion angle and MCP-1 extension angle. The propensity scores 
were subsequently used to match participants on a one-to-one basis using a 
nearest-neighbor algorithm with a matching tolerance width of 0.2 SD of the logit 
of the propensity score.26-28
Since the matched samples were dependent, the between-group differences 
in demographic characteristics were analyzed using Standard Error of Mean 
Difference (SEMD). A SEMD of greater than 10 percent was suggested as 
substantial imbalance in a certain variable between groups.29 Propensity score 
matching was performed using the MatchIt package. Between group differences 
were tested with Whitney tests.
We performed Chi-square tests to study both differences in total number of 
complications as well as individual complications between both groups.
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Group
WEEK
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Short
immobilization
3-5 
days
Prolonged 
immobilization
10-14 
days
Legend
Phase Short Immobilization
Prolonged 
Immobilization
Plaster cast immobilization:
3-5 days 10-14 days
Thumb spica splint incl. wrist immobilization:
Until 4 weeks Until 6 weeks
Thumb butterfly splint:
Until 8 weeks Until 8 weeks
Orthosis phased out Until 10 weeks Until 3 months
Orthosis completely discontinued >10 weeks > 3 months
Figure 1. Timeline and legend for postoperative immobilization period and methods.
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As described earlier, a conventional small to medium effect size of .35 was used 
as a non-inferiority margin. Following Hahn22, equality was considered if the 
95% CIs lie within both the negative and positive non-inferiority margin, whereas 
non-inferiority was considered if one bound of the 95% CI lies outside the 
non-inferiority margin but an effect size of zero lies within the other bound.22 All 
analyses were performed in R, version 3.4.1.
Figure 2. Flowchart of the study.
RESULTS
Patient characteristics
Between 2011 and 2017, a total of 648 patients underwent a Weilby procedure in 
one of our clinics. After applying the eligibility criteria, 489 patients were included 
in the initial cohort. After surgery, 70% underwent longer immobilization and 
30% shorter immobilization, reflecting the shorter inclusion period for the shorter 
immobilization. After propensity score matching, each group contained 131 
patients (Figure 2).
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Table 1 shows the baseline characteristics of the patients before and after 
propensity score matching. Before propensity score matching, the shorter immo-
bilization group had on average a slightly shorter duration of symptoms, higher 
pain during physical load, larger MCP-1 extension and less range of motion 
during MCP-1 flexion at baseline. After propensity score matching, the stan-
dardized error mean difference between the groups were within the margin of 
ten percent for all variables except some small imbalance in age, RAB angle and 
moderate workload (Table 1).
Table 1. Baseline characteristics before and after propensity score matching.
All patients Matched patients
Continuous variables
Prolonged 
immobiliza-
tion group
(N= 344)
Short im-
mobilization 
group
(N= 145)
Prolonged 
immobiliza-
tion group
(N= 131)
Short im-
mobilization 
group
(N= 131)
Standard 
error of 
mean differ-
ence
(%)
Age 60 ± 8 60 ± 9 61 ± 8 60 ± 8 12.5
Duration complaints 
(months) 44 ± 51 38 ± 41 39 ± 49 39 ± 42 0
MHQ function 49 ± 15 51 ± 19 51 ± 16 52 ± 19 5.7
MHQ ADL 52 ± 22 55 ± 21 55 ± 22 55 ± 22 0
MHQ work 49 ± 24 49 ± 26 49 ± 25 49 ± 26 0
MHQ pain 35 ± 14 35 ± 14 35 ± 14 35 ± 14 0
MHQ esthetics 80 ± 19 79 ± 21 79 ± 20 80 ± 21 4.9
MHQ satisfaction 31 ± 18 32 ± 20 33 ± 20 32 ± 20 5.0
VAS pain during rest 49 ± 22 51 ± 23 52 ± 22 50 ± 18 9.5
VAS pain during 
physical load 73 ±19 75 ± 17 74 ± 17 75 ± 17 9.9
PAB angle 46 ± 10 46 ± 11 46 ± 9 46 ± 11 0
RAB angle 47 ± 28 52 ± 46 47 ± 10 53 ± 47 18
MCP extension -14 ± 15 -16 ± 12 -16 ± 15 -16 ± 12 0
MCP flexion 67 ±13 64 ± 14 64 ± 13 64 ± 14 0
Categorical variables
Gender, female (%) 80 75 70 74 8.9
Treated side 
dominant side (%) 48 48 45 48 6.0
Workload
 Not working (%)
 Light work (%)
 Moderate work (%)
 Heavy work (%)
46
21
23
10
51
16
23
10
52
18
18
12
50
17
23
10
4.0
2.6
12.4
6.4
Abbreviations: MHQ: Michigan hand questionnaire, VAS: Visual Analogue Scale, SEMD: Standard 
error of mean difference, MCP: Metacarpophalangeal, PAB: Palmar abduction, RAB: Radial abduction
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Outcomes for MHQ total and MHQ subscales are displayed in Figure 3. Both the 
MHQ total (effect size 0.01, 95% C.I. -0.23 - 0.25) as well as the MHQ subscales 
at three months did not show any significant differences between both groups. 
Outcome in MHQ total and subscales at twelve months was similar to the three 
months outcome, with no significant differences between both groups (Supple-
mentary Figure 1).
Figure 3. Outcome in Michigan Hand Outcomes Questionnaire at 3 months for the longer and shorter 
immobilization group. Error bars indicate standard errors. Abbreviation: ADL, activities of daily living.
In addition, both groups showed highly similar improvements in pain during 
physical load and pain during rest compared to preoperative measures (Figure 
4). Moreover, outcome in pain during physical load and pain during rest showed 
no significant differences between both groups at three months; effect size 0.11, 
95% C.I. -0.12 - 0.35 for VAS pain during physical load at three months and effect 
size 0.03, 95% C.I. -0.21 - 0.27 for VAS pain during rest at three months (Figure 
4). The magnitude of the effect sizes for the MHQ and VAS and their confidence 
intervals (lying within non-inferiority margin of 0.35) indicate equality for the MHQ 
and VAS pain during rest and non-inferiority for VAS during physical load. In 
addition, outcome in pain during physical load and pain during rest compared at 
six weeks and twelve months was similar to the three months outcome, with no 
significant differences between both groups (Figure 4).
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Figure 4. Change in visual analog scale pain at baseline, 6 weeks, 3 months, and 12 months postop-
eratively for the longer and shorter immobilization group. P-values correspond to the comparisons 
between groups at follow-up.
Figure 5 shows the satisfaction with treatment of the patients at three months, 
where both groups expressed similar satisfaction with treatment (p=0.274). In 
addition, 80% of the patients in the shorter immobilization group would choose 
the same operation again, versus 82% of the longer immobilization group 
(p=0.706).
Figure 5. Outcome in overall treatment satisfaction at 3 months in the longer and shorter immobi-
lization group.
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Table 2 displays the number of complications in the longer and the shorter immo-
bilization group. No significant differences in complication rate were present in 
the longer immobilization group compared to the shorter immobilization group 
(p=  0.102). At baseline, 50-52% of the patients were unemployed or retired. Of 
the people that were employed, no significant differences in return to work after 
three months were found between the groups (Table 3).
Table 2. Complications in the prolonged and short immobilization group.
Complications Prolonged immobilization 
group (N= 131)
Short immobilization 
group (N= 131)
p-value
Total No. complications 27 23 0.102
Tendovaginitis Stenosans 4 9
Carpal tunnel syndrome 3 1
Tendinitis 9 3
Neuroma 0 0
Quervain 8 4
FCR rupture 0 2
CRPS 3 1
Infection 0 1
Sensory changes 0 1
MC abutment 0 1
Furthermore, range of motion and grip & pinch strength (Table 3) were not signifi-
cantly different between groups, except for radial abduction with 3 degrees in 
favor of the longer immobilization group (p=0.040). However, this difference lies 
within the generally accepted measurement error in goniometry measurements, 
which is more than 5 degrees.30
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Table 3. Outcome in work and objective measures. Since more than 50% was not currently working, 
only data of patients that were working was collected. This resulted in a lower number of patients.
Outcome at 3 months Prolonged 
immobilization 
group (N= 46)
Short immobili-
zation group
(N= 38)
p-value
Currently working
- Yes (%)
- No, due to thumb complaints (%)
- No, due to other reasons (%)
96
0
4
79
0
21
1.0
Performing original working activities (%) 61 53 0.655
Current number of hours working / week 26 ± 12 23 ± 10 0.191
Key pinch (kg) 3.3 ± 1.4 3.3 ± 1.5 0.824
JAMAR (two-position) (kg) 17.4 ± 1.2 17.6 ± 1.3 0.839
PAB (º) 45 ± 8 44 ± 8 0.267
RAB (º) 47 ± 9 44 ± 14 0.040
MCP extension (º) -10 ± 12 -8 ± 19 0.430
MCP flexion (º) 60 ± 13 61 ± 18 0.749
DISCUSSION
The aim of this study was to investigate if shorter immobilization is non-inferior 
compared to longer immobilization after CMC-1 arthroplasty for outcomes on 
hand function and pain intensity postoperatively. We found that shorter immobi-
lization was equal to longer immobilization in our primary outcomes in terms of 
MHQ function and VAS pain at six weeks, three months and twelve months. In 
addition, no significant differences between groups were found in our secondary 
outcomes in terms of complications, return to work, range of motion, satisfaction 
with treatment, grip and pinch strength.
The results of our study are in line with several other studies. For example, 
Horlock et al.1 compared early with late mobilization in patients after simple 
trapeziectomy and found no significant differences between both groups in 
terms of pain, hand function, satisfaction, range of motion and pinch strength. 
However, patients in the early group experienced significantly more convenience 
with the post-operative treatment. In addition, Prosser et al.2 compared rigid 
with semi-rigid immobilization following trapeziectomy with or without ligament 
reconstruction and tendon interposition and also found no difference in pain, 
hand function and pinch strength. Furthermore, when comparing our results with 
a study by Davis et al.3 that used a 6-week period of plaster cast immobilization, 
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again, very similar outcomes are found. For example, 15 out of 62 patients had 
pain during use at three months, while we found in our study that the mean pain 
during physical load was 37 on a 0-100 scale. In addition, mean key pinch was 3.1 
kg at three months in the study of Davis et al., while our mean key pinch was 3.3 
kg at three months. Moreover, both study of Davis et al. and our study showed 
very low infection rates (<1%).
As mentioned above, our study found equal outcomes on pain and function. 
These findings suggest that shorter cast immobilization may lead to the same 
functional outcomes and an even more convenient treatment experience for 
individual patients. We postulate that shorter cast immobilization will lead to 
faster recovery of the patient with similar outcomes, which in turn will lead to 
reduced loss of productivity in working life. A study of Marks et al.4 showed 
that the average sick leave in patients treated with a LRTI was 10 weeks, with 
an average cost due to loss of productivity of €7500. We hypothesize that by 
applying shorter immobilization, patients will be able to start recovering more 
quickly while returning earlier to work and daily activities. Hence further cost 
effectiveness studies on this subject are needed to confirm this hypothesis.
Our study showed that shorter immobilization is safe and will not lead to more 
complications or worse outcome for patients following Weilby procedure for 
CMC-1 OA. Conventionally, patients were immobilized for a substantial amount 
of time after surgery, without sufficient evidence showing that this long period of 
immobilization was necessary.5 This study suggests that shorter immobilization 
may be beneficial by preventing longer patient discomfort. In this study, we only 
investigated the effect of shorter immobilization, but not of early active and more 
progressive hand therapy, including early initiation of ROM and strengthening 
exercises. Future research should investigate the feasibility and possible bene-
ficial effects of early active hand therapy in addition to shorter immobilization. 
Early active hand therapy may be preferable, since less postoperative stiffness 
and muscle atrophy will occur. Therefore, longer patient discomfort may be 
prevented and again, patients will recover more quickly while returning earlier to 
work and daily activities. Hence, future studies are needed in order to determine 
the effectiveness of early active and more progressive hand therapy. In addition, 
we did not assess the effect of different types of orthosis on outcome. Possibly, a 
different type of orthosis may influence outcome more than different duration of 
immobilization. Future research should further investigate this.
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Study Limitations
Our study has a number of strengths and limitations. The main strength of this 
study is the large sample size of 262 patients that were included after propensity 
score matching. To our knowledge, this is the largest study comparing different 
time frames of immobilization. While the observational character of this study may 
be a limitation, it is also a strength due to the pragmatic nature; since our data is 
collected in daily practice it represents the outcomes of actual daily clinical care. 
Another limitation of this study is that patients were included in two different time 
periods, resulting in therapists knowing which treatment patients were receiving. 
However, therapists treating the patients were not aware of the present research 
question at the time of treatment. Furthermore, we used propensity score 
matching to correct for potential bias, the only risk being that selection bias still 
might have occurred if not all relevant covariates were measured at baseline. 
Furthermore, a limitation of this study is that deviations of the postoperative 
treatment protocol may have occurred. However, the therapists were extensively 
trained in using the treatment guidelines and several checks were randomly 
performed to monitor adherence. Another limitation of this study is that we inves-
tigated shorter cast immobilization and earlier transition to an orthosis without 
wrist immobilization, but only small differences were present in total immobili-
zation period. For example, we did not study potential differences in outcome 
following 6 weeks or 10 weeks of total immobilization. Therefore, the effect of 
different time frames in total immobilization periods remains partially unclear and 
future studies should address this.
Furthermore, a limitation of this study is that we only report outcomes following 
Weilby procedure. Hence, it is unclear if this postoperative treatment is feasible 
as well for other surgical procedures on CMC-1 OA, thus future studies should 
investigate different types of postoperative immobilization for different surgical 
procedures.
CONCLUSIONS
In conclusion, the present study shows that shorter immobilization provides 
equal outcomes compared to longer immobilization after Weilby procedure for 
CMC-1 OA. Hence, we conclude that shorter immobilization is safe and can be 
recommended due to its potential benefits compared to longer immobilization. 
More high-quality studies on early active rehabilitation are needed in order to 
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understand which factors improve patient comfort and return to functional 
activities.
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Supplementary Figure 3: Outcome in MHQ total and subscales at twelve months.
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GENERAL DISCUSSION
In this thesis, multiple aspects of the non-operative and postoperative treatment 
of thumb base (CMC-1) osteoarthritis (OA) were addressed along with outcome 
measurement in hand and wrist conditions. This general discussion is struc-
tured in three parts, following the general structure of this thesis: 1) non-oper-
ative treatment and conversion to surgery, 2) postoperative treatment, and 3) 
outcome measurement in hand and wrist conditions. The main findings of the 
aforementioned parts and their limitations, implications, and future perspectives 
are discussed in this chapter. 
Part 1 - Non-operative treatment and conversion to surgery
The aims of Part 1 were:
• To describe the outcomes following non-surgical treatment for CMC-1 OA 
and CMC-1 instability;
• To investigate the added value of exercise therapy in addition to an orthosis 
in patients with CMC-1 OA;
• To investigate predictors for the outcomes of non-surgical treatment of 
CMC-1 OA; and
• To compare patients scheduled for CMC-1 resection arthroplasty with their 
non-surgical counterparts, in terms of sociodemographics, clinical, and 
psychological factors. 
In Part 1, we found beneficial effects of exercise therapy and an orthosis on 
pain, hand function and several other outcome domains. For CMC-1 OA, only 
15% of the patients were surgically treated after a mean follow-up of 2.2 years, 
and for CMC-1 instability, only 14% were surgically treated after 2.9 years. In 
patients with CMC-1 OA, exercise therapy in addition to an orthosis was much 
more effective than an orthosis alone for outcomes on pain and hand function. 
Further, in Part 1, we found that baseline pain, hand function, satisfaction with 
the hand, metacarpophalangeal flexion, presence of scaphotrapeziotrapezoid 
OA, and heavy physical labor predict outcome following non-surgical treatment. 
In addition, when comparing patients scheduled for CMC-1 resection arthro-
plasty with their non-surgical counterparts, we found that patients scheduled 
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to undergo surgery for CMC-1 OA have more symptoms, worse psychological 
profile and higher treatment expectations than those scheduled for non-sur-
gical treatment. Moreover, we found that having a longer symptom duration, a 
second-opinion visit, lower satisfaction with the hand, higher treatment expec-
tations, shorter perceived timeline, worse personal control and worse emotional 
response increased the probability of being scheduled for surgery. 
Limitations of Part 1
Several limitations should be acknowledged concerning the studies in Part 1. 
First, the studies in Part 1 are based on observational data. Hence, the adherence 
to treatment guidelines might have been suboptimal in some cases, thereby 
underestimating or overestimating the actual treatment effects. However, the 
therapists carrying out the treatment were trained to use our treatment guide-
lines. An additional limitation is that using data collected in daily practice also 
comes with missing data. This may have biased our results. However, throughout 
our studies we have performed extensive missing data analyses and consistently 
found that our data can be qualified as missing completely at random, for which 
we used appropriate statistical techniques.1-5 Additionally, in spite of the potential 
disadvantages of our observational study designs, a major advantage is the 
ecological validity, since our data are collected in actual daily practice. Hence, our 
results may be more representative for daily practice compared to standardized 
randomized controlled trials using strict inclusion criteria. Furthermore, in most 
studies in this thesis involving patient recruitment, we were able to include rela-
tively high numbers of patients making our studies unique in present literature.
A limitation of Chapter 3 might be that if unidentified covariates were present, 
indication bias may have occurred in treatment allocation despite the use of 
propensity score matching (PSM). For example, factors such as treatment costs 
or traveling distance may have influenced patient preferences. However, again, 
an advantage of PSM in observational setting is that it allows comparing treat-
ments while maintaining high ecological validity. Furthermore, PSM studies may 
be more feasible and less burdensome and expensive to perform in daily clinical 
practice compared to more conventional randomized controlled trials.
An additional limitation of Part 1 is that we only investigated the outcomes of one 
(Chapter 2, 4 and 5) or two (Chapter 3) different non-operative treatments. Hence, 
based on the work in this thesis, we now have more evidence for the application 
of exercise therapy in addition to an orthosis, but we did not compare it with other 
12
310
Chapter 12
non-operative treatments such as injections or placebo treatment. Hence, future 
studies should compare the outcomes of different non-operative treatments. 
Implications and future perspectives of Part 1
Whereas systematic reviews6-9 and the Dutch treatment guideline10 advise 
non-surgical treatment prior to surgical treatment for patients with CMC-1 OA, 
strong evidence supporting this recommendation was previously lacking. Based 
on the findings in Part 1, we now have more evidence supporting this recom-
mendation and we therefore strongly recommend non-surgical treatment. Our 
studies indicate that exercise therapy should be a key element of non-surgical 
treatment, since we found a relatively large treatment effect compared to using 
only an orthosis. Furthermore, no rules of thumb apply to individuals with CMC-1 
OA and baseline factors such as pain, hand function, satisfaction with the hand, 
metacarpophalangeal flexion, presence of scaphotrapeziotrapezoid OA, heavy 
physical labor, longer symptom duration, a second-opinion visit, treatment 
expectations and several aspects of illness perception should be considered in 
clinical decision making and patient education. Future studies may determine 
how these factors can be used in clinical practice, for example by implementing 
them in prediction models. 
Since PSM studies may be more feasible and less burdensome and expensive 
to perform in daily clinical practice compared to more conventional randomized 
controlled trials, future research should investigate if, and under which condi-
tions PSM studies yield similar outcomes as randomized controlled trials. 
As we have recently obtained a ZonMW grant, we will perform a multicenter 
randomized controlled trial on the (cost-) effectiveness of exercise therapy in 
addition to an orthosis in patients with CMC-1 OA in the near future. In addition 
to the primary research aims, our new study will present the opportunity to inves-
tigate if a randomized controlled trial on exercise therapy in patients with CMC-1 
OA leads to similar outcomes as the PSM study in this thesis. In addition, future 
research might explore if a new level of evidence paradigm is needed, and when 
randomized controlled trials are necessary considering new statistical tech-
niques and the rise of big data sources. 
As Part 1 identified multiple factors that influence treatment choices and 
treatment outcomes, future research should further study these determinants 
and aim to develop personalized prediction models. Personalized models that 
predict the clinical course of patients with CMC-1 OA might help clinicians and 
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patients in making treatment choices, thereby improving outcome. In addition to 
personalized prediction models, personalized treatment should also be a topic 
for future research. In many of the studies in Part 1, we found large variability in 
outcome, indicating that not every patient fits the mean and that no general rules 
of thumb apply for treating patients with CMC-1 OA. This means, for example, that 
while this thesis presents more evidence for the application of exercise therapy in 
patients with CMC-1 OA, future research should investigate the optimal exercise 
therapy content, number of treatment sessions, and other aspects of exercise 
therapy to tailor the treatment to individual patients with CMC-1 OA. 
Part 2 - Postoperative treatment
The aims of Part 2 were:
• To perform a systematic review on the postoperative rehabilitation following 
CMC-1 resection arthroplasty;
• To compare the outcomes of shorter and longer immobilization following 
CMC-1 resection arthroplasty;
• To investigate predictors for acute postoperative pain following CMC-1 
resection arthroplasty. 
In Part 2, we performed a systematic review to guide clinicians on the content 
of postoperative rehabilitation for CMC-1 arthroplasty. In this review, we provide 
an overview of the postoperative rehabilitation protocols used for CMC-1 arthro-
plasty in literature. We found that early active recovery is used more often 
in the literature and does not lead to worse outcomes or more complications. 
However, the review also clearly identified the almost complete lack of high-
quality comparative studies on postoperative rehabilitation after CMC-1 arthro-
plasty. Therefore, we compared shorter immobilization (3-5 days plaster cast 
followed by a thumb spica orthosis including wrist until 4 weeks postopera-
tively) with more prolonged immobilization (10-14 days plaster cast followed by 
a thumb spica orthosis including wrist until 6 weeks postoperatively) following 
Weilby11 procedure. In this study, we found that shorter immobilization is equal 
to more prolonged immobilization for outcomes on pain, hand function, and our 
secondary outcomes. This finding indicates that shorter immobilization is safe 
and can be recommended since discomfort of more prolonged immobilization 
may be prevented. In addition, patients may be able to recover sooner, which 
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may lead to reduced loss of productivity. In another cohort study, we found that 
psychological factors, female sex, and opioid usage enhance the prediction of 
acute postoperative pain beyond type of surgery, sociodemographic and clinical 
characteristics. Female sex and opioid usage were the strongest predictors, 
even after controlling for psychological factors. In addition, mean acute postop-
erative pain scores were lower than mean preoperative pain scores, although it 
should be taking into account that we found large variability in pain scores. 
Limitations of Part 2
Similar to Part 1, Part 2 consists of several observational studies. Hence, the afore-
mentioned limitations and advantages of Part 1 should be considered as well in 
Part 2. Furthermore, in Part 2, a limitation of our systematic review in Chapter 7 
is that we found only a few high-quality studies addressing our research ques-
tions on postoperative rehabilitation. Therefore, despite the consistency across 
the included studies, no definite conclusions on the effectiveness of the specific 
content of postoperative rehabilitation can be drawn. Another limitation in Part 
2, Chapter 8, is that only relatively small differences were present in the immo-
bilization scheme between both groups. Therefore, the difference in outcomes 
following either shorter or longer immobilization after CMC-1 resection arthro-
plasty remains partially unclear. A limitation in Part 2, Chapter 9, is that although 
medication usage was standardized and monitored, deviations on the actual 
reported opioid usage may have occurred. While opioid usage might also have 
been influenced by psychological factors12, this may have contributed to random 
error or bias, explaining why we found a small explained variance. 
Implications and future perspectives of Part 2
In patients surgically treated for CMC-1 OA we recommend short postoperative 
immobilization based on our systematic review and cohort study. However, more 
high-quality studies comparing different postoperative rehabilitation protocols 
(i.e., including early initiation of range of motion or strengthening exercises or 
larger differences in postoperative immobilization) are needed to understand 
which factors improve patient comfort and accelerate return to work or other 
functional activities. Additionally, we strongly recommend that future studies on 
CMC-1 arthroplasty provide adequate descriptions of their postoperative regime.
With regard to acute postoperative pain, we conclude that no rules of thumb 
apply and that factors such as female sex, opioid usage, preoperative higher 
satisfaction with the patient’s hand, self-reported consequences, and coherence 
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should be recognized by healthcare providers. These factors might help to better 
cope with acute postoperative pain and prevent chronic pain13,14, e.g., by adjusting 
postoperative medication or improving patient education prior to surgery. Future 
studies should investigate the influence of psychological characteristics on 
long-term outcomes following surgery for CMC-1 OA. Additionally, future studies 
should investigate sex-based approaches and optimal patient education strat-
egies for coping with acute postoperative pain. 
Part 3 - Outcome measurement in hand and wrist conditions
The aims of Part 3 were:
• To present the development, design and implementation of the hand and 
wrist study cohort;
• To describe the process of international standardization of outcome 
measurement in hand and wrist care, by developing the ICHOM standard set 
for hand and wrist conditions. 
In Part 3, we described how we successfully implemented the design of a 
routine outcome measurement system in hand and wrist care, with a total of 
52.000 individual patients included in our database. Furthermore, we described 
how our data is collected and used for improving clinical care and performing 
scientific research. In addition, we described the development of the ICHOM 
standard set for hand and wrist conditions, for which consensus was reached on 
creating five measurement tracks: a thumb, finger, wrist, nerve, and severe hand 
and/or forearm trauma track. Within these tracks, distinction is made between 
‘regular’ and ‘extended’ tracks. The following outcome domains were considered 
essential for both the regular and extended thumb track: pain, grip & pinch 
strength, patient reported hand function and activities of daily living, health-re-
lated quality of life, return to work, satisfaction with treatment result, complica-
tions, and revision. In addition, range of motion was considered essential for the 
extended thumb track. 
Limitations of Part 3
The compliance of both patients and clinicians remains a big challenge in our 
routine outcome measurement system.15 We took several measures to optimize 
compliance, for example by minimizing the burden of measurements, improving 
the use of data during interactions between patients and clinicians and 
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increasing awareness of the value of having outcome data available. Although 
the value of outcome information is broadly acknowledged, more research is 
needed to understand how outcome data can be effectively used to improve the 
quality of care.
When considering our study cohort described in Chapter 10, it should be 
acknowledged that it represents a very specific group of patients with hand and 
wrist conditions seeking treatment in the setting of a specialized clinic for hand 
surgery and therapy. Hence, our study cohort does not always allow general-
ization to other populations. Additionally, our database does not allow studies 
on patients with severe hand traumas or severe comorbidity, since those may 
be treated more often in other healthcare settings such as (academic) hospitals. 
Another limitation of our study cohort might be that if patients seek treatment 
elsewhere, they might get out of our sight with insufficient follow-up available.
A limitation of Chapter 11 can be that our consensus initiative reflects an opinion 
of a selected group of experts. However, we performed multiple systematic 
reviews to support our choices with evidence and a transparent and structured 
Delphi-process16-18 was used. Additionally, the open review period and patient 
surveys will be used to evaluate support for our approach. 
Implications and future perspectives of Part 3
Although implementing a system for routine outcome measurement in daily care 
comes with several challenges, it would be of great value if more healthcare 
providers in hand and wrist care would routinely measure outcomes. This would 
allow comparisons across organizations, treatments and countries, which in 
turn will facilitate value-based healthcare for patients with hand and wrist condi-
tions globally. In addition to our example of implementing a routine outcome 
measurement system, we hope that the development of the ICHOM hand and 
wrist standard set will lead to a common ground for more widespread compar-
isons of outcomes. However, the feasibility, completeness, and the burden of 
this newly developed standard set should be evaluated in the future, both from 
a patient and clinician perspective. Nevertheless, global standardization of 
outcome measurement using a specific set of outcome measures is needed, e.g., 
by using the ICHOM standard set for hand and wrist conditions. While measuring 
outcomes is a first step in providing value-based healthcare, next steps might be 
to use the collected data to improve the value of care, establish outcome trans-
parency, and develop value-based payment models.
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SUMMARY
In this thesis, treatment and measurement for thumb base (CMC-1) osteoarthritis 
(OA) are described. In the following sections, the main findings are summarized, 
structured by the general parts of this thesis: 1) non-operative treatment and 
conversion to surgery, 2) postoperative treatment, and 3) outcome measurement 
in hand and wrist conditions. 
Part 1 - Non-operative treatment and conversion to surgery
Treatment guidelines for CMC-1 OA advise starting non-operative treatment 
before considering surgical interventions, although strong evidence for this was 
previously lacking. Therefore, in Chapter 2, we studied the outcomes of non-op-
erative treatment for CMC-1 OA in daily clinical practice and investigated how 
many patients converted to surgery. In a sample of 809 patients with CMC-1 
OA, we found beneficial effects of non-operative treatment up to 12 months. 
Moreover, after a mean follow-up of 2.2 years, only 15% of these patients were 
surgically treated.
To explore the effectiveness of non-operative treatment in more detail, we inves-
tigated the added value of exercise therapy in addition to an orthosis in Chapter 
3. In this prospective observational study, we used propensity score matching 
and compared a combination treatment of exercise therapy and an orthosis with 
an orthosis alone (n=84 matched participants) and found that the combination 
treatment was more effective in reducing pain and improving aspects of hand 
function than an orthosis alone. In addition, we found that baseline pain, hand 
function, metacarpophalangeal flexion, presence of scaphotrapeziotrapezoid 
OA, and heavy physical labor predicted outcome for the group receiving both 
exercise therapy and an orthosis (n = 131).
Since no studies on non-operative treatment for patients with symptomatic 
CMC-1 instability are described in literature, and to investigate if our findings in 
Chapter 2 and 3 apply to patients with symptomatic CMC-1 instability as well, 
we studied the outcomes of non-operative treatment for CMC-1 instability in 
Chapter 4. In Chapter 4, we analyzed a cohort of patients (n  =  431) receiving 
non-operative treatment, including exercise therapy and an orthosis, and found 
clinically relevant improvements in pain and hand function. Furthermore, after a 
median follow-up of 2.8 years, only 14% of all patients were surgically treated.
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In Chapter 5, we performed a more in-depth analysis of predictors for outcome 
of non-operative treatment for CMC-1 OA. In this multi-center cohort study 
(n  =  809), the multivariable regression models explained 34% of the variance 
in outcome for pain and 42% for hand function. In these models, we found that 
baseline pain, hand function, and satisfaction with the hand were predictors for 
the outcome at three months or eventually converting to surgery. Furthermore, 
73% and 83% of the patients with no clinically relevant improvement in respec-
tively pain and function after 6 weeks, demonstrated no clinically relevant 
improvement after 3 months.
To investigate conversion to surgery in patients with CMC-1 OA in more detail, 
we compared patients scheduled for CMC-1 resection arthroplasty with their 
non-surgical counterparts in Chapter 6. In our sample, we found that patients 
scheduled to undergo surgery (n  =  208) have more symptoms, worse psycho-
logical profile and higher treatment expectations than patients scheduled 
for non-surgical treatment (n  =  376). Furthermore, in the hierarchical logistic 
regression analysis we found that having a longer symptom duration, a second-
opinion visit, lower satisfaction with the hand, higher treatment expectations, 
shorter perceived timeline, worse personal control, and worse emotional 
response increased the probability of being scheduled for surgery. 
Part 2 - Postoperative treatment
Despite that the Dutch guideline and systematic reviews emphasize the impor-
tance of postoperative rehabilitation following CMC-1 arthroplasty, there is no 
consensus on the most effective implementation of postoperative rehabilitation. 
Therefore, we performed a systematic review on postoperative rehabilitation 
following CMC-1 arthroplasty in Chapter 7. Twenty-seven studies were included 
in this systematic review, consisting of 1015 participants in whom 1118 surgical 
procedures were performed. We found considerable variation in postoperative 
immobilization schemes and exercise or therapy regimens. Furthermore, we 
found that early active recovery (including short immobilization, early initiation 
of range of motion, and strength exercises) is used more often in the literature 
and does not lead to worse outcomes or more complications, but compar-
ative studies were lacking. Furthermore, three postoperative exercises/therapy 
phases were identified: 1) the acute phase, 2) the unloaded phase, and 3) the 
functional phase.
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Since our systematic review identified an almost complete lack of high-quality 
comparative studies on postoperative rehabilitation following CMC-1 arthro-
plasty, we compared two different postoperative immobilization schemes in 
Chapter 8. We used propensity score matching in a sample of 262 patients to 
investigate if shorter immobilization (including 3-5 days plaster cast followed by 
a thumb spica orthosis including wrist until 4 weeks postoperatively) is non-in-
ferior to longer immobilization (including 10-14 days plaster cast followed by a 
thumb spica orthosis including wrist until 6 weeks postoperatively). Following the 
general principles of non-inferiority analyses, we found equality for hand function 
and pain at rest and non-inferiority for pain during physical load when comparing 
shorter immobilization with longer immobilization. In addition, no differences 
were found in complication rate or other secondary outcomes, indicating that 
shorter immobilization is safe and can be recommended. 
In contrast to long-term outcomes for postoperative pain following CMC-1 
arthroplasty, little is known about acute postoperative pain following CMC-1 
arthroplasty. In Chapter 9, we found that psychological factors, female sex, 
and opioid usage enhanced the prediction of acute postoperative pain beyond 
surgery type, sociodemographic and clinical characteristics in a sample of 215 
patients treated surgically for CMC-1 OA. Female sex and opioid usage were the 
strongest predictors, even after controlling for psychological factors. In addition, 
mean acute postoperative pain scores were lower than preoperative pain levels. 
Part 3 - Outcome measurement in hand and wrist conditions
In Chapter 10 we described the development, design and implementation of the 
Hand and Wrist Study Cohort at our treatment centers for hand and wrist care 
(currently 22) in the Netherlands, starting in 2011. Using this routine outcome 
measurement system, the total number of yearly assigned measurement tracks 
increased up to over 16.500 in 2018, adding up to 85.000 tracks in 52.000 patients 
in total. Implementing this system was feasible using a highly automated data 
collection infrastructure, tightly linked to the patient journey and the workflow 
of healthcare professionals. We hope that our example of a routine outcome 
measurement system encourages other healthcare providers in hand and wrist 
care globally to measure and compare outcomes. 
With an emphasis on thumb conditions, Chapter 11 describes the design 
and principles for developing the standard set for hand and wrist conditions 
by the International Consortium for Health Outcome Measurement (ICHOM). 
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An international working group of experts in hand and wrist care representing 
eleven countries was assembled to review literature and practices for assessing 
outcomes of treatment for hand and wrist conditions. Consensus was reached 
on five measurement tracks: the thumb, finger, wrist, nerve and severe trauma 
track, with a distinction between ‘regular’ and ‘extended’ tracks. The following 
outcome domains were considered ‘essential’ for the thumb track: pain, grip 
& pinch strength, patient reported hand function and activities in daily living, 
health-related quality of life, return to work, satisfaction with treatment result, 
complications, revision and range of motion (the last only in the extended track). 
Chapter 12 discusses the main findings of Parts 1-3, their limitations, implica-
tions and future perspectives.
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NEDERLANDSE SAMENVATTING 
In dit proefschrift worden de behandeling en uitkomstmetingen voor duim-
basis (CMC-1) artrose (OA) beschreven. In de volgende paragrafen worden de 
belangrijkste bevindingen samengevat, gestructureerd conform de algemene 
delen van dit proefschrift: 1) niet-operatieve behandeling en conversie naar 
chirurgie; 2) postoperatieve behandeling; en 3) uitkomstmetingen in hand- en 
polsaandoeningen. 
Deel 1 - Niet-operatieve behandeling en conversie naar chirurgie
Behandelrichtlijnen voor CMC-1 OA adviseren om met  niet-operatieve behan-
deling te starten alvorens chirurgische ingrepen te overwegen, hoewel daarvoor 
eerder geen sterk bewijs was. Daarom hebben we in hoofdstuk 2 de uitkomsten 
van niet-operatieve behandeling van CMC-1 OA in de dagelijkse klinische praktijk 
bestudeerd en onderzocht hoeveel patiënten zijn overgegaan naar operatieve 
behandeling. In een steekproef van 809 patiënten met CMC-1 OA vonden we 
gunstige effecten van niet-operatieve behandeling tot 12 maanden na aanvang 
van de behandeling. Bovendien werd na een gemiddelde follow-up van 2,2 jaar 
slechts 15% van deze patiënten chirurgisch behandeld.
Om de effectiviteit van niet-operatieve behandeling in meer detail te onderzoeken, 
hebben we de toegevoegde waarde van oefentherapie naast het gebruik van 
een duimspalk onderzocht in hoofdstuk 3. In deze prospectieve observationele 
studie hebben we propensity score matching gebruikt en een combinatiebe-
handeling van oefentherapie en een duimspalk vergeleken met een behandeling 
bestaande uit alleen een duimspalk (n = 84 deelnemers). Uit deze studie bleek 
dat de combinatiebehandeling effectiever was in het verminderen van pijn en het 
verbeteren van aspecten van handfunctie dan alleen een duimspalk. Bovendien 
bleek dat factoren zoals baseline pijn, handfunctie, metacarpophalangeale flexie, 
aanwezigheid van scaphotrapeziotrapezoïde artrose en zware fysieke arbeid de 
uitkomst voorspelde voor de groep die zowel oefentherapie als een duimspalk 
kreeg (n = 131).
Omdat er geen studies bestaan in de literatuur over niet-operatieve behandeling 
voor patiënten met symptomatische CMC-1-instabiliteit en om te onderzoeken 
of onze bevindingen uit hoofdstuk 2 en 3 ook van toepassing zijn op patiënten 
met symptomatische CMC-1-instabiliteit, hebben we de uitkomsten van niet-op-
eratieve behandeling voor CMC-1 instabiliteit onderzocht in hoofdstuk 4. In dit 
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hoofdstuk analyseerden we een cohort van patiënten (n  =  431) die niet-oper-
atieve behandeling ontvingen, bestaande uit oefentherapie en een duimspalk. 
We constateerden klinisch relevante verbeteringen op de uitkomstmaten pijn en 
handfunctie. Bovendien werd na een mediane follow-up van 2,8 jaar slechts 14% 
van alle patiënten chirurgisch behandeld.
In hoofdstuk 5 hebben we een meer diepgaande analyse van voorspellers voor 
de uitkomst van niet-operatieve behandeling van CMC-1 OA uitgevoerd. In dit 
multicenter cohortonderzoek (n = 809), verklaarden de multivariabele regressie-
modellen 34% van de variantie in uitkomst voor pijn en 42% in de uitkomst voor 
handfunctie. In deze modellen vonden we dat baseline pijn, handfunctie en tevre-
denheid met de hand voorspellers waren voor de uitkomst na drie maanden of 
conversie naar chirurgie. Wanneer er na de eerste 6 weken geen klinisch rele-
vante verbetering was opgetreden in respectievelijk pijn en handfunctie, bleek dit 
in 73% en 83% van de patiënten na 3 maanden ook niet het geval.
Om de conversie naar chirurgie bij patiënten met CMC-1 OA in meer detail te 
onderzoeken, vergeleken we patiënten die waren gepland voor CMC-1 resec-
tie-arthroplastiek met hun niet-chirurgische tegenhangers in hoofdstuk 6. In 
dit onderzoek vonden we dat patiënten die gepland waren om een  operatie te 
ondergaan (n  =  208) meer symptomen, een slechter psychologisch profiel en 
hogere verwachtingen van de behandeling hadden dan patiënten gepland voor 
niet-chirurgische behandeling (n = 376). Verder vonden we in de hiërarchische 
logistische regressieanalyse dat een langere duur van klachten, een second 
opinion bezoek, lagere tevredenheid met de hand, hogere verwachtingen van 
de behandeling, kortere verwachting van de ziekteduur, slechtere persoonlijke 
controle en slechtere emotionele respons de kans vergroten om gepland te 
worden voor operatieve behandeling. 
Deel 2 - Postoperatieve behandeling
Ondanks dat de Nederlandse richtlijn en systematische reviews het belang 
van postoperatieve revalidatie na CMC-1-artroplastiek benadrukken, bestaat er 
geen consensus over de meest effectieve invulling van postoperatieve revali-
datie. Daarom hebben we in hoofdstuk 7 een systematisch literatuuronderzoek 
uitgevoerd omtrent postoperatieve revalidatie na CMC-1-arthroplastiek. In dit 
systematische literatuuronderzoek werden 27 studies opgenomen, waarin totaal 
1015 personen deelnamen en 1118 chirurgische procedures werden uitgevoerd. 
We vonden aanzienlijke variatie in postoperatieve immobilisatieduur en oefen- of 
14
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therapieschema’s. Verder hebben we geconstateerd dat vroeg actieve revalidatie 
(bestaande uit korte immobilisatie en vroege initiatie van mobiliteits- en krach-
toefeningen) steeds vaker wordt toegepast in de literatuur en niet tot slechtere 
uitkomsten of meer complicaties leidt, echter ontbraken vergelijkende studies. 
Tevens werden drie postoperatieve therapiefasen geïdentificeerd: 1) de acute 
fase, 2) de onbelaste fase en 3) de functionele fase.
Omdat onze systematische literatuurstudie aantoonde dat er een vrijwel geen 
vergelijkende studies van hoge kwaliteit zijn uitgevoerd omtrent postoperatieve 
revalidatie na CMC-1-arthroplastiek, vergeleken we twee verschillende post-
operatieve immobilisatieschema’s in hoofdstuk 8. We gebruikten propensity 
score matching in een steekproef van 262 patiënten om te onderzoeken of 
kortere immobilisatie (bestaande uit 3-5 dagen gipsverband gevolgd door een 
verlengde duimspalk inclusief de pols tot 4 weken na de operatie) minder goede 
resultaten geeft in vergelijking met langere immobilisatie (bestaande uit 10-14 
dagen gipsverband gevolgd door een verlengde duimspalk inclusief de pols tot 
6 weken na de operatie). In deze non-inferioriteitsstudie vonden we dat de twee 
verschillende postoperatieve immobilisatieprotocollen gelijke resultaten gaven 
voor uitkomsten op handfunctie en pijn in rust en non-inferieure resultaten voor 
pijn tijdens belasting. Bovendien werden geen verschillen gevonden in compli-
caties of andere secundaire uitkomstmaten, hetgeen aangeeft dat kortere immo-
bilisatie veilig is en kan worden aanbevolen. 
In tegenstelling tot de langetermijnresultaten voor postoperatieve pijn na 
CMC-1-artroplastiek is er weinig bekend over acute postoperatieve pijn na 
CMC-1-artroplastiek. In hoofdstuk 9 vonden we in een steekproef van 215 
patiënten die chirurgisch werden behandeld voor CMC-1 OA dat psychologische 
factoren, vrouwelijk geslacht en opioïdengebruik de voorspelling van acute post-
operatieve pijn verbetert, boven type chirurgie, sociodemografische of klinische 
kenmerken. Vrouwelijk geslacht en gebruik van opioïden waren de grootste voor-
spellers, zelfs na controleren voor psychologische factoren. Bovendien waren de 
gemiddelde acute postoperatieve pijnscores lager dan preoperatieve pijnscores. 
Deel 3 - uitkomstmetingen in hand- en polsaandoeningen
In hoofdstuk 10 hebben we de ontwikkeling, het design en de implementatie 
van het “Hand and Wrist Study Cohort” in onze behandelcentra voor hand- en 
polszorg (momenteel 22) in Nederland beschreven, hetgeen plaatsvindt sinds 
2011. Met behulp van dit routinematige uitkomstmeetsysteem werden in 2018 
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een totaal van 16.500 meettrajecten toegewezen. Over alle jaren heen zijn er 
inmiddels meer dan 85.000 trajecten toegewezen aan 52.000 patiënten. De 
implementatie van dit systeem was mogelijk vanwege een zeer geautomati-
seerde infrastructuur voor dataverzameling, nauw verbonden met de zoge-
naamde “patient journey” en de workflow van zorgprofessionals. We hopen dat 
het voorbeeld van ons systeem andere zorgaanbieders wereldwijd aanmoedigt 
om ook uitkomsten te meten en deze met elkaar te vergelijken. 
Met de nadruk op duimaandoeningen wordt in hoofdstuk 11 het design en de 
principes voor het ontwikkelen van een standaard set voor hand- en polsaandoe-
ningen beschreven, welke wordt ontwikkeld door het International Consortium 
for Health Outcome Measurement (ICHOM). Een internationale werkgroep van 
experts in hand- en polszorg uit elf landen werd samengesteld, om literatuur en 
methodes te beoordelen voor het meten van uitkomsten van de behandeling voor 
hand- en polsaandoeningen. Consensus werd bereikt omtrent vijf meettrajecten: 
het duim-, vinger-, pols-, zenuw- en ernstige traumatraject, met een onderscheid 
tussen ‘reguliere’ en ‘uitgebreide’ trajecten. De volgende uitkomstdomeinen 
werden als ‘essentieel’ beschouwd voor het duimtraject: pijn, knijp- & pinch-
kracht, patiënt-gerapporteerde handfunctie en activiteiten in het dagelijks leven, 
gezondheid gerelateerde kwaliteit van leven, werkhervatting, tevredenheid met 
het resultaat van de behandeling, complicaties, revisie en bewegingsuitslag 
(laatstgenoemde alleen in het uitgebreide traject). 
Hoofdstuk 12 bespreekt de belangrijkste bevindingen van deel 1-3, de 
beperkingen, implicaties en perspectieven voor toekomstig onderzoek.
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passie voor (onderzoek in) de gezondheidszorg en je opvattingen zijn inspirerend. 
Dr. Ruud Selles, beste Ruud, wat heb ik veel aan je te danken. Begin 2015 trok ik 
de stoute schoenen aan en stuurde ik je een mail, omdat ik ervan overtuigd was 
dat ik onderzoek wilde doen bij ‘de handengroep van Rotterdam’, toch echt de 
meest toonaangevende groep op het gebied van hand- en polsaandoeningen in 
Nederland. Ik had destijds niet durven hopen dat onze samenwerking zo prettig 
en succesvol zou worden als de afgelopen jaren is gebleken. Hier ben ik je grote 
dank voor verschuldigd! In veel situaties denk je vanuit mijn belang en je hebt 
me enorm geholpen om mijn doelen te bereiken. Je bent een voorbeeld voor me, 
zowel als mens als onderzoeker.
Dr. Harm Slijper, beste Harm, ik vind het geweldig om jouw collega te zijn. Ik 
geniet van de passie waarmee je als een bezetene projecten bestormt, de manier 
waarop je over dingen kan klagen (waar ik nooit aan mee doe natuurlijk) en de 
momenten waarop er ongecensureerd geschreeuwd wordt over de belangrijke 
zaken in het leven. Dank voor de prikkelende gespreken, discussies en je altijd 
vernieuwende blik - alle papers zijn hier stuk voor stuk beter van geworden. Let’s 
always be actionable in the future! 
Em. Prof. Dr. Steven Hovius, beste Steven, het is voor mij een eer om met je 
samen te kunnen werken. Je bezieling, kritische blik en perfectionisme zijn inspir-
erend. Ik heb veel van je geleerd, ook over andere dingen dan handen - in het 
bijzonder rondom de totstandkoming van de ICHOM-set. Ik waardeer je adviezen 
en maak je bevlogenheid graag nog lange tijd van dichtbij mee. 
Dr. Jarry Porsius, beste Jarry, ik word altijd enthousiast van de gesprekken die 
we voeren - dank voor alle nieuwe vragen die ik altijd had na onze conversaties. 
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Ik waardeer je voortdurende aandrang om de invloed van ‘mindset’ op fysiek 
ongemak te begrijpen en ben hier dankzij jou ook meer en meer gefascineerd 
door geraakt. Het was geweldig om je in Boston op te zoeken en laten we snel 
weer eens proosten met een goede IPA! 
Dr. Jonathan Tsehaie, beste Jonathan, het staat er echt: Dr. Tsehaie! Voor mij ben 
je toch echt mijn ‘partner in crime’ als het gaat om duimonderzoek. Je ontwap-
enende stijl is verfrissend en ik heb er veel plezier aan beleefd om samen aan 
onze artikelen te werken. Ik heb goede herinneringen aan onze kroegsessies en 
hoop je vaak tegen te komen in de toekomst. 
Leden van de leescommissie, Prof. Dr. Jan Verhaar, Prof. Dr. Sita Bierma-Ze-
instra en Prof. Dr. Cindy Veenhof: veel dank voor het lezen en beoordelen van dit 
proefschrift. Het is een eer om de om de bevindingen uit dit proefschrift met jullie 
te mogen delen en bediscussiëren. 
Rob van Huis, beste Rob, ik ben ik je enorm dankbaar. Ik weet nog goed dat 
ik als broekie kwam solliciteren bij HNL, wie had toen gedacht dat we hier nu 
zouden staan? Ik ben trots op wat we inmiddels allemaal doen op het gebied van 
onderzoek en kijk uit naar de toekomst die ons in het verschiet ligt. Je hebt me 
altijd gesteund in mijn ambities, ook wanneer deze niet primair in het belang van 
jou of HNL waren. Mijn dank is groot! 
Hans Soeters, beste Hans, het is inmiddels lang geleden, maar ik denk nog regel-
matig terug aan de tijd waarin je me hebt opgeleid tot handtherapeut. Nadat ik 
de minor had gedaan bij Rob, heb je me gestimuleerd om tot in het kleinste detail 
de hand en pols te willen begrijpen en wanneer nodig kritisch te zijn. Je hebt me 
geïnfecteerd met het handenvirus, bedankt daarvoor!
Drs. Yara van Kooij en Pierre-Yves Pennehouat, mijn paranimfen! Bedankt voor 
alle mooie inhoudelijke gesprekken, gezamenlijke klaagmomenten over dage-
lijkse beslommeringen en inspiratie voor nieuwe onderzoeken. Ook bij jullie krijg 
ik een enorm ‘partner in crime’ gevoel, met als gemeenschappelijke deler een 
grote dosis vakinhoudelijke interesse en de drive om processen te begrijpen en 
te verbeteren. Tot bij de volgende borrel! 
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Drs. Karin Schoneveld en Dr. Ingrid van de Port, bedankt voor jullie vermogen en 
geduld om mijn vele kritische mails te beantwoorden en me te steunen tijdens dit 
proces. 
Prof. Dr. Joy MacDermid, dear Joy, thank you for the opportunity to collaborate on 
several projects. To me, you are an example as a researcher and I have learned 
a lot from working together and visiting you at McMaster/Western. Hopefully, we 
can continue this in the future.  
Dr. Ana-Maria Vranceanu, dear Ana-Maria, I would like to thank you for hosting 
me at Harvard/MGH in Boston and critically appraising our papers. Your efforts 
have improved every manuscript and it is inspiring to observe your urge to create 
more awareness for the influence of a patient’s mindset.  
Dank Mark van der Oest voor je altijd aanwezige energie, enthousiasme en 
bravoure. Je soms ietwat onconventionele aanpak is om van te smullen en kan ik 
erg waarderen! Hoe hoog wordt die enorme berg artikelen die er uit je werk voort 
zal komen? 
Drs. Reinier Feitz, Dr. Sebastiaan Souer, Dr. Guus Vermeulen en Dr. Thybout 
Moojen: dank voor de inmiddels lang bestaande samenwerking en support. 
Ik waardeer onze vele inhoudelijke conversaties, jullie innovatieve ideeën en 
heb respect voor de manier waarop jullie het vak uitoefenen. Op naar nog veel 
toekomstige gezamenlijke projecten! 
Dear ICHOM Hand & Wrist Project Team and Working Group members, thank 
you for working with me on one of the greatest projects I have ever been part 
of. I have enjoyed our meetings and discussions on outcome measurement 
in hand and wrist conditions.  Most importantly, I appreciate your willingness 
to compromise for the greater good and your mindset to achieve something 
together as a group. 
Al mijn collega handtherapeuten van HNL/ZP 1.5: mijn dank is groot! Bedankt 
voor alle borrels, de gedeelde passie voor het vak en jullie vermogen om mijn 
geleuter over onderzoek aan te horen. Jullie hebben allemaal bijgedragen aan 
de dataverzameling waar dit proefschrift op steunt; zonder jullie zou dit werk niet 
mogelijk zijn geweest. 
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Dank aan alle leden van de Hand-Wrist Study Group voor jullie bijdrage. Het is 
mooi om te zien dat we met zo’n grote groep de neuzen dezelfde kant op krijgen 
om zo samen de hand- en polszorg naar een hoger plan te tillen.   
Dank Prof. Dr. Irene Mathijssen en Prof. Dr. Gerard Ribbers voor de mogelijkheid 
om aan jullie afdeling te mogen promoveren en onderzoek te kunnen blijven 
doen. 
Dank Hetty Mulder voor het vele regelwerk dat nodig was voor de totstand-
koming van dit alles. 
Many thanks to all co-authors in this thesis for your input and improving our work. 
Members of the THETA project team: thank you for your help in obtaining this 
fantastic grant. I am sure that, together, we will make this project very successful. 
Docenten Fysiotherapiewetenschap: dank voor de kick-off die heeft geleid tot 
dit alles. Ik heb altijd genoten van de inspirerende vrijdagen op De Uithof, de 
opleiding heeft me meer gebracht dan ik van tevoren had durven hopen.  
Studiegenoten Fysiotherapiewetenschap, cohort 2013, dank voor de borrels, het 
vele samen sparren en het gezamenlijk doormaken van groei (met bijbehorende 
groeipijn ). Ik heb het als heel verfrissend ervaren om met zoveel gelijkge-
stemden in contact te komen. Heel gaaf om te zien hoe iedereen nu uitwaait, ik 
kom jullie graag weer tegen op congressen of op onze weekendjes! 
Lieve vrienden, het boekje is er! Dank voor alle momenten waarop het juist 
even niet over het boekje ging. Hopelijk komt er weer vaker tijd voor concerten, 
festivals, filmavonden, etentjes, drankjes, avondjes ongenuanceerd schreeuwen 
en meer van dat soort ongein. 
Lieve mam, pap, Christine, Cees, Tom, Judith, George en Sun-Ah: dank voor de 
onvoorwaardelijke aanwezige steun, warmte en interesse in mijn onderzoek. I’m 
a lucky guy. Datzelfde geldt voor fam. Heldring-de Ridder: het is fijn om jullie om 
me heen te hebben. 
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Tot slot, lieve Willemijn, bedankt voor het lachen om mijn geklaag, aanhoren van 
mijn overpeinzingen, bieden van rustmomenten maar don’t stopping me now.
Mijn grote liefde. 
Kom maar op met die toekomst samen.

